,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1386076,60606,Comparative Toxicogenomics Database (CTD),Clopidogrel,D000077144,Clopidogrel,https://ctdbase.org/detail.go?type=chem&acc=D000077144,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),CYP3A4 protein results in increased metabolism of clopidogrel,,,PMID:17261397|PMID:18440347,https://www.ncbi.nlm.nih.gov/pubmed/17261397|https://www.ncbi.nlm.nih.gov/pubmed/18440347,17261397|18440347,,
1,1436780,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,558,AXL,https://ctdbase.org/detail.go?type=gene&acc=558,,,558.0,AXL,9606.0,Homo sapiens (human),Adefovir dipivoxil results in increased expression of AXL mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
2,1457175,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7133,TNFRSF1B,https://ctdbase.org/detail.go?type=gene&acc=7133,,,7133.0,TNFRSF1B,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TNFRSF1B mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
3,1457176,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,27242,TNFRSF21,https://ctdbase.org/detail.go?type=gene&acc=27242,,,27242.0,TNFRSF21,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TNFRSF21 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
4,1457177,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,3604,TNFRSF9,https://ctdbase.org/detail.go?type=gene&acc=3604,,,3604.0,TNFRSF9,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TNFRSF9 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
5,1457178,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,114461,TNFRSFA,https://ctdbase.org/detail.go?type=gene&acc=114461,,,114461.0,tnfrsfa,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of TNFRSFA mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
6,1457179,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of TNFSF10 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
7,1457841,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,10475,TRIM38,https://ctdbase.org/detail.go?type=gene&acc=10475,,,10475.0,TRIM38,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TRIM38 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
8,1457842,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,287015,TRIM42,https://ctdbase.org/detail.go?type=gene&acc=287015,,,287015.0,TRIM42,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TRIM42 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
9,1457843,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,201292,TRIM65,https://ctdbase.org/detail.go?type=gene&acc=201292,,,201292.0,TRIM65,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TRIM65 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
10,1457844,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,55621,TRMT1,https://ctdbase.org/detail.go?type=gene&acc=55621,,,55621.0,TRMT1,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TRMT1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
11,1457845,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,158234,TRMT10B,https://ctdbase.org/detail.go?type=gene&acc=158234,,,158234.0,TRMT10B,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TRMT10B mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
12,1457846,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,10024,TROAP,https://ctdbase.org/detail.go?type=gene&acc=10024,,,10024.0,TROAP,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TROAP mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
13,1458446,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,10277,UBE4B,https://ctdbase.org/detail.go?type=gene&acc=10277,,,10277.0,UBE4B,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of UBE4B mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
14,1458447,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,29914,UBIAD1,https://ctdbase.org/detail.go?type=gene&acc=29914,,,29914.0,UBIAD1,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of UBIAD1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
15,1458448,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,324710,UBL3A,https://ctdbase.org/detail.go?type=gene&acc=324710,,,324710.0,ubl3a,8049.0,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of UBL3A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
16,1458449,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,79799,UGT2A3,https://ctdbase.org/detail.go?type=gene&acc=79799,,,79799.0,UGT2A3,9606.0,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of UGT2A3 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
17,1431098,72344,Comparative Toxicogenomics Database (CTD),Nobiletin,C008661,nobiletin,https://ctdbase.org/detail.go?type=chem&acc=C008661,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Nobiletin results in increased expression of CYP1B1 mRNA,,,PMID:22743247,https://www.ncbi.nlm.nih.gov/pubmed/22743247,22743247,,
18,1431099,72344,Comparative Toxicogenomics Database (CTD),Nobiletin,C008661,nobiletin,https://ctdbase.org/detail.go?type=chem&acc=C008661,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),[[nobiletin results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam|nobiletin results in increased activity of CYP3A4 protein|[nobiletin results in increased activity of CYP3A4 protein] which results in increased metabolism of midazolam,,,PMID:31756459,https://www.ncbi.nlm.nih.gov/pubmed/31756459,31756459,,
19,1456522,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,27338,UBE2S,https://ctdbase.org/detail.go?type=gene&acc=27338,,,27338.0,UBE2S,90988.0,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of UBE2S mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
20,1458159,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,440574,MICOS10,https://ctdbase.org/detail.go?type=gene&acc=440574,,,440574.0,MICOS10,7955.0,Danio rerio (zebrafish),Flusilazole results in decreased expression of MICOS10 mrna|flusilazole results in increased expression of MICOS10 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
21,1458160,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,219972,MPEG1,https://ctdbase.org/detail.go?type=gene&acc=219972,,,219972.0,MPEG1,7955.0,Danio rerio (zebrafish),Flusilazole results in decreased expression of MPEG1 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
22,1458161,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,79922,MRM1,https://ctdbase.org/detail.go?type=gene&acc=79922,,,79922.0,MRM1,10090.0,Mus musculus (house mouse),Flusilazole affects the expression of MRM1 mRNA,,,PMID:21195148,https://www.ncbi.nlm.nih.gov/pubmed/21195148,21195148,,
23,1458162,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,100009643,MS4A17A.6,https://ctdbase.org/detail.go?type=gene&acc=100009643,,,100009643.0,ms4a17a.6,7955.0,Danio rerio (zebrafish),Flusilazole results in decreased expression of MS4A17A.6 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
24,1458163,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,2956,MSH6,https://ctdbase.org/detail.go?type=gene&acc=2956,,,2956.0,MSH6,7955.0,Danio rerio (zebrafish),Flusilazole affects the expression of MSH6 mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
25,1458332,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,6307,MSMO1,https://ctdbase.org/detail.go?type=gene&acc=6307,,,6307.0,MSMO1,7955.0,Danio rerio (zebrafish),Flusilazole results in increased expression of MSMO1 mRNA,,,PMID:22664269,https://www.ncbi.nlm.nih.gov/pubmed/22664269,22664269,,
26,1458333,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,6307,MSMO1,https://ctdbase.org/detail.go?type=gene&acc=6307,,,6307.0,MSMO1,10090.0,Mus musculus (house mouse),Flusilazole affects the expression of MSMO1 mRNA,,,PMID:21195148|PMID:22634333,https://www.ncbi.nlm.nih.gov/pubmed/21195148|https://www.ncbi.nlm.nih.gov/pubmed/22634333,21195148|22634333,,
27,1458334,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,6307,MSMO1,https://ctdbase.org/detail.go?type=gene&acc=6307,,,6307.0,MSMO1,10090.0,Mus musculus (house mouse),Flusilazole results in increased expression of MSMO1 mRNA,,,PMID:21192963|PMID:29337257|PMID:34737147,https://www.ncbi.nlm.nih.gov/pubmed/21192963|https://www.ncbi.nlm.nih.gov/pubmed/29337257|https://www.ncbi.nlm.nih.gov/pubmed/34737147,21192963|29337257|34737147,,
28,1458335,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,6307,MSMO1,https://ctdbase.org/detail.go?type=gene&acc=6307,,,6307.0,MSMO1,10116.0,Rattus norvegicus (Norway rat),Flusilazole results in increased expression of MSMO1 mRNA,,,PMID:22664269|PMID:28263823,https://www.ncbi.nlm.nih.gov/pubmed/22664269|https://www.ncbi.nlm.nih.gov/pubmed/28263823,22664269|28263823,,
29,1458336,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,4597,MVD,https://ctdbase.org/detail.go?type=gene&acc=4597,,,4597.0,MVD,10090.0,Mus musculus (house mouse),Flusilazole affects the expression of MVD mRNA,,,PMID:22634333,https://www.ncbi.nlm.nih.gov/pubmed/22634333,22634333,,
30,1458337,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,4597,MVD,https://ctdbase.org/detail.go?type=gene&acc=4597,,,4597.0,MVD,10116.0,Rattus norvegicus (Norway rat),Flusilazole results in increased expression of MVD mRNA,,,PMID:28263823,https://www.ncbi.nlm.nih.gov/pubmed/28263823,28263823,,
31,1459648,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,6309,SC5D,https://ctdbase.org/detail.go?type=gene&acc=6309,,,6309.0,SC5D,10116.0,Rattus norvegicus (Norway rat),Flusilazole results in increased expression of SC5D mRNA,,,PMID:22664269|PMID:28263823,https://www.ncbi.nlm.nih.gov/pubmed/22664269|https://www.ncbi.nlm.nih.gov/pubmed/28263823,22664269|28263823,,
32,1459649,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5265,SERPINA1,https://ctdbase.org/detail.go?type=gene&acc=5265,,,5265.0,SERPINA1,7955.0,Danio rerio (zebrafish),Flusilazole affects the expression of SERPINA1 mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
33,1459650,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5275,SERPINB13,https://ctdbase.org/detail.go?type=gene&acc=5275,,,5275.0,SERPINB13,10116.0,Rattus norvegicus (Norway rat),Flusilazole results in increased expression of SERPINB13 mRNA,,,PMID:33032228,https://www.ncbi.nlm.nih.gov/pubmed/33032228,33032228,,
34,1456523,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,27430,MAT2B,https://ctdbase.org/detail.go?type=gene&acc=27430,,,27430.0,MAT2B,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MAT2B protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
35,1456524,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4146,MATN1,https://ctdbase.org/detail.go?type=gene&acc=4146,,,4146.0,MATN1,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of MATN1 mRNA",,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
36,1456525,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,9782,MATR3,https://ctdbase.org/detail.go?type=gene&acc=9782,,,9782.0,MATR3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MATR3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
37,1456526,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,79143,MBOAT7,https://ctdbase.org/detail.go?type=gene&acc=79143,,,79143.0,MBOAT7,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MBOAT7 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
38,1456527,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,326281,MBPA,https://ctdbase.org/detail.go?type=gene&acc=326281,,,326281.0,mbpa,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of MBPA mrna|curcumin inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in decreased expression of MBPA mrna]",,,PMID:37423901,https://www.ncbi.nlm.nih.gov/pubmed/37423901,37423901,,
39,1456528,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4162,MCAM,https://ctdbase.org/detail.go?type=gene&acc=4162,,,4162.0,MCAM,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MCAM protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
40,1456529,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,56922,MCCC1,https://ctdbase.org/detail.go?type=gene&acc=56922,,,56922.0,MCCC1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MCCC1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
41,1456530,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,64087,MCCC2,https://ctdbase.org/detail.go?type=gene&acc=64087,,,64087.0,MCCC2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MCCC2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
42,1456531,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,90411,MCFD2,https://ctdbase.org/detail.go?type=gene&acc=90411,,,90411.0,MCFD2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MCFD2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
43,1456532,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,28985,MCTS1,https://ctdbase.org/detail.go?type=gene&acc=28985,,,28985.0,MCTS1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MCTS1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
44,1457694,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5695,PSMB7,https://ctdbase.org/detail.go?type=gene&acc=5695,,,5695.0,PSMB7,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PSMB7 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
45,1457695,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5702,PSMC3,https://ctdbase.org/detail.go?type=gene&acc=5702,,,5702.0,PSMC3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PSMC3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
46,1457696,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5705,PSMC5,https://ctdbase.org/detail.go?type=gene&acc=5705,,,5705.0,PSMC5,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PSMC5 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
47,1457697,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5707,PSMD1,https://ctdbase.org/detail.go?type=gene&acc=5707,,,5707.0,PSMD1,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PSMD1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
48,1457698,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5716,PSMD10,https://ctdbase.org/detail.go?type=gene&acc=5716,,,5716.0,PSMD10,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PSMD10 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
49,1457990,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5795,PTPRJ,https://ctdbase.org/detail.go?type=gene&acc=5795,,,5795.0,PTPRJ,10116.0,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PTPRJ mrna|4,4'-hexafluorisopropylidene diphenol results in increased expression of PTPRJ protein",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
50,1457991,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,51651,PTRH2,https://ctdbase.org/detail.go?type=gene&acc=51651,,,51651.0,PTRH2,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PTRH2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
51,1457992,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,754,PTTG1IP,https://ctdbase.org/detail.go?type=gene&acc=754,,,754.0,PTTG1IP,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PTTG1IP protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
52,1457993,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,321786,PTTG1IPA,https://ctdbase.org/detail.go?type=gene&acc=321786,,,321786.0,pttg1ipa,7955.0,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PTTG1IPA mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
53,1457994,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5806,PTX3,https://ctdbase.org/detail.go?type=gene&acc=5806,,,5806.0,PTX3,9606.0,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PTX3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
54,1456654,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5710,PSMD4,https://ctdbase.org/detail.go?type=gene&acc=5710,,,5710.0,PSMD4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PSMD4 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PSMD4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
55,1456655,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5710,PSMD4,https://ctdbase.org/detail.go?type=gene&acc=5710,,,5710.0,PSMD4,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of PSMD4 mRNA,,,PMID:20936131,https://www.ncbi.nlm.nih.gov/pubmed/20936131,20936131,,
56,1456656,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5711,PSMD5,https://ctdbase.org/detail.go?type=gene&acc=5711,,,5711.0,PSMD5,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PSMD5 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
57,1456657,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5711,PSMD5,https://ctdbase.org/detail.go?type=gene&acc=5711,,,5711.0,PSMD5,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PSMD5 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PSMD5 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PSMD5 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
58,1456658,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9861,PSMD6,https://ctdbase.org/detail.go?type=gene&acc=9861,,,9861.0,PSMD6,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PSMD6 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
59,1456659,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9861,PSMD6,https://ctdbase.org/detail.go?type=gene&acc=9861,,,9861.0,PSMD6,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of PSMD6 mrna|ppara protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of PSMD6 mrna],,,PMID:20936131,https://www.ncbi.nlm.nih.gov/pubmed/20936131,20936131,,
60,1456660,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5713,PSMD7,https://ctdbase.org/detail.go?type=gene&acc=5713,,,5713.0,PSMD7,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PSMD7 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
61,1456661,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5713,PSMD7,https://ctdbase.org/detail.go?type=gene&acc=5713,,,5713.0,PSMD7,10090.0,Mus musculus (house mouse),PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of PSMD7 mrna]|perfluorooctane sulfonic acid results in increased expression of PSMD7 mRNA,,,PMID:20936131,https://www.ncbi.nlm.nih.gov/pubmed/20936131,20936131,,
62,1456662,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5714,PSMD8,https://ctdbase.org/detail.go?type=gene&acc=5714,,,5714.0,PSMD8,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PSMD8 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
63,1457047,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5721,PSME2,https://ctdbase.org/detail.go?type=gene&acc=5721,,,5721.0,PSME2,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of PSME2 protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
64,1457048,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23198,PSME4,https://ctdbase.org/detail.go?type=gene&acc=23198,,,23198.0,PSME4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PSME4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
65,1457049,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9491,PSMF1,https://ctdbase.org/detail.go?type=gene&acc=9491,,,9491.0,PSMF1,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PSMF1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
66,1457050,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9491,PSMF1,https://ctdbase.org/detail.go?type=gene&acc=9491,,,9491.0,PSMF1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PSMF1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PSMF1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PSMF1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
67,1457051,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8624,PSMG1,https://ctdbase.org/detail.go?type=gene&acc=8624,,,8624.0,PSMG1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PSMG1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PSMG1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
68,1457052,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84262,PSMG3,https://ctdbase.org/detail.go?type=gene&acc=84262,,,84262.0,PSMG3,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PSMG3 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
69,1457053,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84262,PSMG3,https://ctdbase.org/detail.go?type=gene&acc=84262,,,84262.0,PSMG3,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PSMG3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
70,1457054,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,389362,PSMG4,https://ctdbase.org/detail.go?type=gene&acc=389362,,,389362.0,PSMG4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PSMG4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
71,1457507,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,81490,PTDSS2,https://ctdbase.org/detail.go?type=gene&acc=81490,,,81490.0,PTDSS2,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PTDSS2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
72,1457508,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5728,PTEN,https://ctdbase.org/detail.go?type=gene&acc=5728,,,5728.0,PTEN,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PTEN mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
73,1457509,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9317,PTER,https://ctdbase.org/detail.go?type=gene&acc=9317,,,9317.0,PTER,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PTER mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
74,1457510,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5732,PTGER2,https://ctdbase.org/detail.go?type=gene&acc=5732,,,5732.0,PTGER2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of PTGER2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
75,1457511,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5734,PTGER4,https://ctdbase.org/detail.go?type=gene&acc=5734,,,5734.0,PTGER4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of PTGER4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
76,1459185,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,83448,PUS7L,https://ctdbase.org/detail.go?type=gene&acc=83448,,,83448.0,PUS7L,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PUS7L mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
77,1459186,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,126789,PUSL1,https://ctdbase.org/detail.go?type=gene&acc=126789,,,126789.0,PUSL1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PUSL1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PUSL1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
78,1459187,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,335623,PVALB5,https://ctdbase.org/detail.go?type=gene&acc=335623,,,335623.0,pvalb5,7955.0,Danio rerio (zebrafish),Perfluorooctane sulfonic acid results in increased expression of PVALB5 mRNA,,,PMID:36243200,https://www.ncbi.nlm.nih.gov/pubmed/36243200,36243200,,
79,1459188,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5817,PVR,https://ctdbase.org/detail.go?type=gene&acc=5817,,,5817.0,PVR,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PVR mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
80,1459189,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5820,PVT1,https://ctdbase.org/detail.go?type=gene&acc=5820,,,5820.0,PVT1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PVT1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
81,1459190,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5822,PWP2,https://ctdbase.org/detail.go?type=gene&acc=5822,,,5822.0,PWP2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PWP2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
82,1459191,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5822,PWP2,https://ctdbase.org/detail.go?type=gene&acc=5822,,,5822.0,PWP2,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of PWP2 protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
83,1459192,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,139221,PWWP3B,https://ctdbase.org/detail.go?type=gene&acc=139221,,,139221.0,PWWP3B,9606.0,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PWWP3B mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
84,1459193,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,434797,PWWP4C,https://ctdbase.org/detail.go?type=gene&acc=434797,,,434797.0,Pwwp4c,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PWWP4C mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
85,1459353,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51164,DCTN4,https://ctdbase.org/detail.go?type=gene&acc=51164,,,51164.0,DCTN4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of DCTN4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
86,1459354,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84516,DCTN5,https://ctdbase.org/detail.go?type=gene&acc=84516,,,84516.0,DCTN5,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of DCTN5 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
87,1459355,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,79077,DCTPP1,https://ctdbase.org/detail.go?type=gene&acc=79077,,,79077.0,DCTPP1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of DCTPP1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of DCTPP1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
88,1459356,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55208,DCUN1D2,https://ctdbase.org/detail.go?type=gene&acc=55208,,,55208.0,DCUN1D2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of DCUN1D2 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of DCUN1D2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
89,1459357,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23142,DCUN1D4,https://ctdbase.org/detail.go?type=gene&acc=23142,,,23142.0,DCUN1D4,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of DCUN1D4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
90,1459358,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51181,DCXR,https://ctdbase.org/detail.go?type=gene&acc=51181,,,51181.0,DCXR,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of DCXR protein,,,PMID:26178269,https://www.ncbi.nlm.nih.gov/pubmed/26178269,26178269,,
91,1459359,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23576,DDAH1,https://ctdbase.org/detail.go?type=gene&acc=23576,,,23576.0,DDAH1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of DDAH1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of DDAH1 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of DDAH1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
92,1460054,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,81890,QTRT1,https://ctdbase.org/detail.go?type=gene&acc=81890,,,81890.0,QTRT1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of QTRT1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
93,1460055,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,27291,R3HCC1L,https://ctdbase.org/detail.go?type=gene&acc=27291,,,27291.0,R3HCC1L,8049.0,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of R3HCC1L mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
94,1456653,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,55089,SLC38A4,https://ctdbase.org/detail.go?type=gene&acc=55089,,,55089.0,SLC38A4,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of SLC38A4 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
95,1457502,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,4087,SMAD2,https://ctdbase.org/detail.go?type=gene&acc=4087,,,4087.0,SMAD2,10116.0,Rattus norvegicus (Norway rat),Farrerol inhibits the reaction [glucose results in increased phosphorylation of SMAD2 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [glucose results in increased phosphorylation of SMAD2 protein]|diphenyleneiodonium inhibits the reaction [glucose results in increased phosphorylation of SMAD2 protein]|ly2109761 inhibits the reaction [glucose results in increased phosphorylation of SMAD2 protein]|glucose results in increased phosphorylation of SMAD2 protein,,,PMID:31838053,https://www.ncbi.nlm.nih.gov/pubmed/31838053,31838053,,
96,1457503,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,9606.0,Homo sapiens (human),"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [glucose results in increased phosphorylation of SMAD3 protein]|glucose results in increased phosphorylation of SMAD3 protein",,,PMID:26045780,https://www.ncbi.nlm.nih.gov/pubmed/26045780,26045780,,
97,1457504,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,9606.0,Homo sapiens (human),Glucose results in increased phosphorylation of and affects the localization of SMAD3 protein|protocatechualdehyde inhibits the reaction [glucose results in increased phosphorylation of and affects the localization of SMAD3 protein],,,PMID:17597607,https://www.ncbi.nlm.nih.gov/pubmed/17597607,17597607,,
98,1457505,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,150572,SMYD1,https://ctdbase.org/detail.go?type=gene&acc=150572,,,150572.0,SMYD1,10090.0,Mus musculus (house mouse),Glucose results in decreased expression of SMYD1 mRNA,,,PMID:31525975,https://www.ncbi.nlm.nih.gov/pubmed/31525975,31525975,,
99,1457506,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,4089,SMAD4,https://ctdbase.org/detail.go?type=gene&acc=4089,,,4089.0,SMAD4,9606.0,Homo sapiens (human),Isoangustone A inhibits the reaction [glucose results in increased expression of SMAD4 protein]|glucose results in increased expression of SMAD4 protein,,,PMID:21367880,https://www.ncbi.nlm.nih.gov/pubmed/21367880,21367880,,
100,1457689,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6597,SMARCA4,https://ctdbase.org/detail.go?type=gene&acc=6597,,,6597.0,SMARCA4,10090.0,Mus musculus (house mouse),[oxygen deficiency co-treated with glucose deficiency] results in increased expression of SMARCA4 mrna|[oxygen deficiency co-treated with glucose deficiency] results in increased expression of SMARCA4 protein|mir144 mRNA inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of SMARCA4 mrna]|mir144 mRNA inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of SMARCA4 protein]|[mir144 mRNA results in decreased expression of SMARCA4 protein] affects the susceptibility to [oxygen deficiency co-treated with glucose deficiency],,,PMID:29457851,https://www.ncbi.nlm.nih.gov/pubmed/29457851,29457851,,
101,1457690,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,353295,SMARCA4A,https://ctdbase.org/detail.go?type=gene&acc=353295,,,353295.0,smarca4a,10090.0,Mus musculus (house mouse),SMARCA4A protein inhibits the reaction [glucose results in increased expression of FN1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [glucose results in increased expression of TGFB1 mrna]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [glucose results in increased expression of CCN2 mrna]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [glucose results in increased expression of FN1 protein]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [glucose results in increased expression of COL4A1 mrna]]|smarca4a protein promotes the reaction [glucose results in increased expression of HMOX1 protein]|smarca4a protein inhibits the reaction [glucose results in increased expression of CCN2 mrna]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein promotes the reaction [glucose results in increased expression of HMOX1 protein]]|smarca4a protein inhibits the reaction [glucose results in increased expression of TGFB1 mrna]|smarca4a protein affects the reaction [glucose affects the localization of NFE2L2 protein]|nfe2l2 protein affects the reaction [SMARCA4A protein inhibits the reaction [glucose results in increased expression of FN1 mrna]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein promotes the reaction [glucose results in increased expression of NQO1 protein]]|glucose results in decreased expression of SMARCA4A mrna|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [glucose results in increased expression of FN1 mrna]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [glucose results in decreased phosphorylation of AKT1 protein]]|glucose results in decreased expression of SMARCA4A protein|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [SMARCA4A protein affects the reaction [glucose affects the localization of NFE2L2 protein]]|smarca4a protein promotes the reaction [glucose results in increased expression of NQO1 protein]|smarca4a protein inhibits the reaction [glucose results in increased expression of FN1 mrna]|smarca4a protein inhibits the reaction [glucose results in increased expression of COL4A1 mrna]|smarca4a protein inhibits the reaction [glucose results in decreased phosphorylation of AKT1 protein],,,PMID:33270355,https://www.ncbi.nlm.nih.gov/pubmed/33270355,33270355,,
102,1457691,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,8467,SMARCA5,https://ctdbase.org/detail.go?type=gene&acc=8467,,,8467.0,SMARCA5,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of SMARCA5 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
103,1457692,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,10051,SMC4,https://ctdbase.org/detail.go?type=gene&acc=10051,,,10051.0,SMC4,10090.0,Mus musculus (house mouse),Glucose results in increased expression of SMC4 mRNA,,,PMID:17178593,https://www.ncbi.nlm.nih.gov/pubmed/17178593,17178593,,
104,1457693,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,10051,SMC4,https://ctdbase.org/detail.go?type=gene&acc=10051,,,10051.0,SMC4,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of SMC4 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
105,1458450,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [glucose results in decreased expression of SOD1 protein]|glucose results in increased expression of SOD1 protein,,,PMID:23090186,https://www.ncbi.nlm.nih.gov/pubmed/23090186,23090186,,
106,1458451,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090.0,Mus musculus (house mouse),NFKB1 protein inhibits the reaction [SOD1 protein promotes the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of PTGS2 protein]]|sod1 protein inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of and results in increased activity of NFKB1 protein]|sod1 protein promotes the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of PTGS2 protein],,,PMID:16395278,https://www.ncbi.nlm.nih.gov/pubmed/16395278,16395278,,
107,1458452,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090.0,Mus musculus (house mouse),SOD1 protein inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased phosphorylation of MAPK3 protein]|sod1 protein inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased phosphorylation of MAPK1 protein],,,PMID:19228841,https://www.ncbi.nlm.nih.gov/pubmed/19228841,19228841,,
108,1458453,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116.0,Rattus norvegicus (Norway rat),[glucose co-treated with palmitic acid] results in decreased expression of SOD1 protein,,,PMID:28027979,https://www.ncbi.nlm.nih.gov/pubmed/28027979,28027979,,
109,1458454,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116.0,Rattus norvegicus (Norway rat),Glucose results in decreased expression of SOD1 mRNA,,,PMID:21818840,https://www.ncbi.nlm.nih.gov/pubmed/21818840,21818840,,
110,1458455,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116.0,Rattus norvegicus (Norway rat),Glucose results in increased expression of SOD1 mrna|naringenin inhibits the reaction [glucose results in increased expression of SOD1 mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
111,1459360,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,13095,CYP2C29,https://ctdbase.org/detail.go?type=gene&acc=13095,,,13095.0,Cyp2c29,10090.0,Mus musculus (house mouse),[sodium glutamate co-treated with gallocatechol co-treated with catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2C29 mRNA,,,PMID:25663641,https://www.ncbi.nlm.nih.gov/pubmed/25663641,25663641,,
112,1459361,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,56448,CYP2D22,https://ctdbase.org/detail.go?type=gene&acc=56448,,,56448.0,Cyp2d22,10090.0,Mus musculus (house mouse),[sodium glutamate co-treated with gallocatechol co-treated with catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2D22 mRNA,,,PMID:25663641,https://www.ncbi.nlm.nih.gov/pubmed/25663641,25663641,,
113,1459362,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10090.0,Mus musculus (house mouse),[sodium glutamate co-treated with gallocatechol co-treated with catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2E1 mRNA,,,PMID:25663641,https://www.ncbi.nlm.nih.gov/pubmed/25663641,25663641,,
114,1456228,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1005,CDH7,https://ctdbase.org/detail.go?type=gene&acc=1005,,,1005.0,CDH7,9606.0,Homo sapiens (human),Deguelin results in increased expression of CDH7 mRNA,,,PMID:19861542,https://www.ncbi.nlm.nih.gov/pubmed/19861542,19861542,,
115,1456229,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1007,CDH9,https://ctdbase.org/detail.go?type=gene&acc=1007,,,1007.0,CDH9,9606.0,Homo sapiens (human),Deguelin results in increased expression of CDH9 mRNA,,,PMID:19861542,https://www.ncbi.nlm.nih.gov/pubmed/19861542,19861542,,
116,1456230,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Deguelin results in increased expression of CDK1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
117,1456231,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),Deguelin metabolite results in decreased expression of CDK4 protein,,,PMID:19139008,https://www.ncbi.nlm.nih.gov/pubmed/19139008,19139008,,
118,1456232,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),Deguelin results in decreased expression of CDK4 protein,,,PMID:19139008|PMID:19336726,https://www.ncbi.nlm.nih.gov/pubmed/19139008|https://www.ncbi.nlm.nih.gov/pubmed/19336726,19139008|19336726,,
119,1456233,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1020,CDK5,https://ctdbase.org/detail.go?type=gene&acc=1020,,,1020.0,CDK5,9606.0,Homo sapiens (human),Deguelin results in decreased expression of CDK5 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
120,1456234,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,8851,CDK5R1,https://ctdbase.org/detail.go?type=gene&acc=8851,,,8851.0,CDK5R1,9606.0,Homo sapiens (human),Deguelin results in decreased expression of CDK5R1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
121,1456235,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1021,CDK6,https://ctdbase.org/detail.go?type=gene&acc=1021,,,1021.0,CDK6,9606.0,Homo sapiens (human),Deguelin results in increased expression of CDK6 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
122,1456928,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1284,COL4A2,https://ctdbase.org/detail.go?type=gene&acc=1284,,,1284.0,COL4A2,9606.0,Homo sapiens (human),Deguelin results in increased expression of COL4A2 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
123,1456929,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1312,COMT,https://ctdbase.org/detail.go?type=gene&acc=1312,,,1312.0,COMT,9606.0,Homo sapiens (human),Deguelin results in increased expression of COMT mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
124,1456930,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,10987,COPS5,https://ctdbase.org/detail.go?type=gene&acc=10987,,,10987.0,COPS5,9606.0,Homo sapiens (human),Deguelin results in decreased expression of COPS5 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
125,1456931,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,11151,CORO1A,https://ctdbase.org/detail.go?type=gene&acc=11151,,,11151.0,CORO1A,9606.0,Homo sapiens (human),Deguelin results in decreased expression of CORO1A mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
126,1456932,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,8895,CPNE3,https://ctdbase.org/detail.go?type=gene&acc=8895,,,8895.0,CPNE3,9606.0,Homo sapiens (human),Deguelin results in decreased expression of CPNE3 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
127,1456933,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,57585,CRAMP1,https://ctdbase.org/detail.go?type=gene&acc=57585,,,57585.0,CRAMP1,9606.0,Homo sapiens (human),Deguelin results in decreased expression of CRAMP1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
128,1456934,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,153222,CREBRF,https://ctdbase.org/detail.go?type=gene&acc=153222,,,153222.0,CREBRF,9606.0,Homo sapiens (human),Deguelin results in increased expression of CREBRF mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
129,1456935,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1398,CRK,https://ctdbase.org/detail.go?type=gene&acc=1398,,,1398.0,CRK,9606.0,Homo sapiens (human),Deguelin results in decreased expression of CRK mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
130,1456936,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1399,CRKL,https://ctdbase.org/detail.go?type=gene&acc=1399,,,1399.0,CRKL,9606.0,Homo sapiens (human),Deguelin results in increased expression of CRKL mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
131,1456937,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1436,CSF1R,https://ctdbase.org/detail.go?type=gene&acc=1436,,,1436.0,CSF1R,10090.0,Mus musculus (house mouse),Deguelin inhibits the reaction [TNF protein results in increased export of CSF1R protein],,,PMID:34126350,https://www.ncbi.nlm.nih.gov/pubmed/34126350,34126350,,
132,1457301,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,23002,DAAM1,https://ctdbase.org/detail.go?type=gene&acc=23002,,,23002.0,DAAM1,9606.0,Homo sapiens (human),Deguelin results in decreased expression of DAAM1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
133,1457302,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,1616,DAXX,https://ctdbase.org/detail.go?type=gene&acc=1616,,,1616.0,DAXX,9606.0,Homo sapiens (human),Deguelin results in decreased expression of DAXX mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
134,1459494,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,51015,ISOC1,https://ctdbase.org/detail.go?type=gene&acc=51015,,,51015.0,ISOC1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of ISOC1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
135,1459495,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9798,IST1,https://ctdbase.org/detail.go?type=gene&acc=9798,,,9798.0,IST1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of IST1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
136,1459496,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,51477,ISYNA1,https://ctdbase.org/detail.go?type=gene&acc=51477,,,51477.0,ISYNA1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of ISYNA1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
137,1459497,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,3655,ITGA6,https://ctdbase.org/detail.go?type=gene&acc=3655,,,3655.0,ITGA6,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of ITGA6 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
138,1459498,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,3697,ITIH1,https://ctdbase.org/detail.go?type=gene&acc=3697,,,3697.0,ITIH1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of ITIH1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
139,1459499,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,3699,ITIH3,https://ctdbase.org/detail.go?type=gene&acc=3699,,,3699.0,ITIH3,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of ITIH3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
140,1459500,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,3704,ITPA,https://ctdbase.org/detail.go?type=gene&acc=3704,,,3704.0,ITPA,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of ITPA protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
141,1459651,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,25959,KANK2,https://ctdbase.org/detail.go?type=gene&acc=25959,,,25959.0,KANK2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of KANK2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
142,1459652,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,283219,KCTD21,https://ctdbase.org/detail.go?type=gene&acc=283219,,,283219.0,KCTD21,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of KCTD21 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
143,1459653,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,23028,KDM1A,https://ctdbase.org/detail.go?type=gene&acc=23028,,,23028.0,KDM1A,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of KDM1A protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
144,1459654,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,8570,KHSRP,https://ctdbase.org/detail.go?type=gene&acc=8570,,,8570.0,KHSRP,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of KHSRP protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
145,1459655,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,57710,KIAA1614,https://ctdbase.org/detail.go?type=gene&acc=57710,,,57710.0,KIAA1614,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of KIAA1614 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
146,1459656,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,3827,KNG1,https://ctdbase.org/detail.go?type=gene&acc=3827,,,3827.0,KNG1,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of KNG1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
147,1459657,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,3838,KPNA2,https://ctdbase.org/detail.go?type=gene&acc=3838,,,3838.0,KPNA2,9606.0,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of KPNA2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
148,1386074,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,26064,RAI14,https://ctdbase.org/detail.go?type=gene&acc=26064,,,26064.0,RAI14,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of RAI14 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
149,1386075,158103,Comparative Toxicogenomics Database (CTD),gomisin N,C015499,schizandrin B,https://ctdbase.org/detail.go?type=chem&acc=C015499,5901,RAN,https://ctdbase.org/detail.go?type=gene&acc=5901,,,5901.0,RAN,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of RAN mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
150,1473655,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55198,APPL2,https://ctdbase.org/detail.go?type=gene&acc=55198,,,55198.0,APPL2,9606.0,Homo sapiens (human),Abrine results in decreased expression of APPL2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
151,1473656,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,282679,AQP11,https://ctdbase.org/detail.go?type=gene&acc=282679,,,282679.0,AQP11,9606.0,Homo sapiens (human),Abrine results in decreased expression of AQP11 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
152,1447240,165641,Toxin and Toxin Target Database (T3DB),Vanadium fluoride (VF5),T3D1636,Vanadium(IV) fluoride,http://www.t3db.ca/toxins/T3D1636,BE0005236,Tyrosine-protein phosphatase non-receptor type 20,http://www.t3db.ca/biodb/bio_entities/BE0005236,Q4JDL3,Tyrosine-protein phosphatase non-receptor type 20,26095.0,PTPN20,9606.0,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
153,1457837,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606.0,Homo sapiens (human),"SB 203580 inhibits the reaction [polysaccharides results in increased secretion of IL10 protein]|sb 203580 inhibits the reaction [drugs, chinese herbal results in increased secretion of IL10 protein]",,,PMID:15894585,https://www.ncbi.nlm.nih.gov/pubmed/15894585,15894585,,
154,1457838,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [lipopolysaccharides results in increased expression of IL10 mrna],,,PMID:21135123,https://www.ncbi.nlm.nih.gov/pubmed/21135123,21135123,,
155,1457839,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [poly I-C results in increased secretion of IL10 protein]|sb 203580 inhibits the reaction [zymosan results in increased secretion of IL10 protein]|sb 203580 inhibits the reaction [lipopolysaccharides results in increased secretion of IL10 protein],,,PMID:17698565,https://www.ncbi.nlm.nih.gov/pubmed/17698565,17698565,,
156,1457840,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [methotrexate results in increased expression of IL10 protein],,,PMID:19100307,https://www.ncbi.nlm.nih.gov/pubmed/19100307,19100307,,
157,1456382,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,547,KIF1A,https://ctdbase.org/detail.go?type=gene&acc=547,,,547.0,KIF1A,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KIF1A mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
158,1456383,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,3796,KIF2A,https://ctdbase.org/detail.go?type=gene&acc=3796,,,3796.0,KIF2A,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KIF2A mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
159,1456811,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,84626,KRBA1,https://ctdbase.org/detail.go?type=gene&acc=84626,,,84626.0,KRBA1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KRBA1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
160,1456812,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,3858,KRT10,https://ctdbase.org/detail.go?type=gene&acc=3858,,,3858.0,KRT10,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KRT10 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
161,1456813,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,3861,KRT14,https://ctdbase.org/detail.go?type=gene&acc=3861,,,3861.0,KRT14,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KRT14 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
162,1456814,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,66322,KRT88,https://ctdbase.org/detail.go?type=gene&acc=66322,,,66322.0,Krt88,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KRT88 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
163,1456815,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,200634,KRTCAP3,https://ctdbase.org/detail.go?type=gene&acc=200634,,,200634.0,KRTCAP3,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KRTCAP3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
164,1456816,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,112970,KTI12,https://ctdbase.org/detail.go?type=gene&acc=112970,,,112970.0,KTI12,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KTI12 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
165,1456817,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,3895,KTN1,https://ctdbase.org/detail.go?type=gene&acc=3895,,,3895.0,KTN1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KTN1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
166,1456818,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,56267,KYAT3,https://ctdbase.org/detail.go?type=gene&acc=56267,,,56267.0,KYAT3,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of KYAT3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
167,1456819,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,3908,LAMA2,https://ctdbase.org/detail.go?type=gene&acc=3908,,,3908.0,LAMA2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl affects the expression of LAMA2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
168,1458740,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4815,NINJ2,https://ctdbase.org/detail.go?type=gene&acc=4815,,,4815.0,NINJ2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NINJ2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
169,1458741,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,55335,NIPSNAP3B,https://ctdbase.org/detail.go?type=gene&acc=55335,,,55335.0,NIPSNAP3B,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NIPSNAP3B mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
170,1458742,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,55922,NKRF,https://ctdbase.org/detail.go?type=gene&acc=55922,,,55922.0,NKRF,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NKRF mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
171,1458743,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4825,NKX6-1,https://ctdbase.org/detail.go?type=gene&acc=4825,,,4825.0,NKX6-1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NKX6-1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
172,1458744,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,79671,NLRX1,https://ctdbase.org/detail.go?type=gene&acc=79671,,,79671.0,NLRX1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NLRX1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
173,1458745,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4832,NME3,https://ctdbase.org/detail.go?type=gene&acc=4832,,,4832.0,NME3,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NME3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
174,1458746,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10316,NMUR1,https://ctdbase.org/detail.go?type=gene&acc=10316,,,10316.0,NMUR1,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NMUR1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
175,1458747,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,56923,NMUR2,https://ctdbase.org/detail.go?type=gene&acc=56923,,,56923.0,NMUR2,10116.0,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NMUR2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
176,1458328,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),NSC668394 results in increased expression of MYC mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
177,1458329,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,29116,MYLIP,https://ctdbase.org/detail.go?type=gene&acc=29116,,,29116.0,MYLIP,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of MYLIP mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
178,1458330,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,10403,NDC80,https://ctdbase.org/detail.go?type=gene&acc=10403,,,10403.0,NDC80,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of NDC80 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
179,1458331,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,4693,NDP,https://ctdbase.org/detail.go?type=gene&acc=4693,,,4693.0,NDP,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of NDP mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
180,1458906,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5292,PIM1,https://ctdbase.org/detail.go?type=gene&acc=5292,,,5292.0,PIM1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PIM1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
181,1458907,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,415116,PIM3,https://ctdbase.org/detail.go?type=gene&acc=415116,,,415116.0,PIM3,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PIM3 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
182,1458908,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5321,PLA2G4A,https://ctdbase.org/detail.go?type=gene&acc=5321,,,5321.0,PLA2G4A,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PLA2G4A mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
183,1458909,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5327,PLAT,https://ctdbase.org/detail.go?type=gene&acc=5327,,,5327.0,PLAT,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PLAT mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
184,1458910,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,79156,PLEKHF1,https://ctdbase.org/detail.go?type=gene&acc=79156,,,79156.0,PLEKHF1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PLEKHF1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
185,1458911,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,84513,PLPP5,https://ctdbase.org/detail.go?type=gene&acc=84513,,,84513.0,PLPP5,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PLPP5 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
186,1458912,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5359,PLSCR1,https://ctdbase.org/detail.go?type=gene&acc=5359,,,5359.0,PLSCR1,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of PLSCR1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
187,1458913,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5366,PMAIP1,https://ctdbase.org/detail.go?type=gene&acc=5366,,,5366.0,PMAIP1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of PMAIP1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
188,1458914,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,64208,POPDC3,https://ctdbase.org/detail.go?type=gene&acc=64208,,,64208.0,POPDC3,9606.0,Homo sapiens (human),NSC668394 results in increased expression of POPDC3 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
189,1459772,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,389015,SLC9A4,https://ctdbase.org/detail.go?type=gene&acc=389015,,,389015.0,SLC9A4,9606.0,Homo sapiens (human),NSC668394 results in increased expression of SLC9A4 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
190,1459773,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,6591,SNAI2,https://ctdbase.org/detail.go?type=gene&acc=6591,,,6591.0,SNAI2,9606.0,Homo sapiens (human),NSC668394 results in increased expression of SNAI2 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
191,1459774,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,84973,SNHG7,https://ctdbase.org/detail.go?type=gene&acc=84973,,,84973.0,SNHG7,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of SNHG7 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
192,1459775,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,55084,SOBP,https://ctdbase.org/detail.go?type=gene&acc=55084,,,55084.0,SOBP,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of SOBP mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
193,1459776,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,26206,SPAG8,https://ctdbase.org/detail.go?type=gene&acc=26206,,,26206.0,SPAG8,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of SPAG8 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
194,1459777,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,10252,SPRY1,https://ctdbase.org/detail.go?type=gene&acc=10252,,,10252.0,SPRY1,9606.0,Homo sapiens (human),NSC668394 results in decreased expression of SPRY1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
195,1459778,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,10253,SPRY2,https://ctdbase.org/detail.go?type=gene&acc=10253,,,10253.0,SPRY2,9606.0,Homo sapiens (human),NSC668394 results in increased expression of SPRY2 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
196,1459779,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,6432,SRSF7,https://ctdbase.org/detail.go?type=gene&acc=6432,,,6432.0,SRSF7,9606.0,Homo sapiens (human),NSC668394 results in increased expression of SRSF7 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
197,1459780,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,140809,SRXN1,https://ctdbase.org/detail.go?type=gene&acc=140809,,,140809.0,SRXN1,9606.0,Homo sapiens (human),NSC668394 results in increased expression of SRXN1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
198,1458601,408285,Therapeutic Target Database (TTD),4-(2-Aminoethyl)morpholine,D07DYJ,N-Aminoethylmorpholine,https://idrblab.net/ttd/data/drug/details/D07DYJ,T67102,Cathepsin D (CTSD),https://idrblab.net/ttd/data/target/details/T67102,P07339,Cathepsin D,1509.0,CTSD,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
199,1458592,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,179907,D1086.3,https://ctdbase.org/detail.go?type=gene&acc=179907,,,179907.0,D1086.3,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of D1086.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
200,1458593,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,183933,D1086.5,https://ctdbase.org/detail.go?type=gene&acc=183933,,,183933.0,D1086.5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of D1086.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
201,1458594,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,179904,D1086.6,https://ctdbase.org/detail.go?type=gene&acc=179904,,,179904.0,D1086.6,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of D1086.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
202,1458595,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,183936,D2005.6,https://ctdbase.org/detail.go?type=gene&acc=183936,,,183936.0,D2005.6,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of D2005.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
203,1458596,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,183947,D2024.1,https://ctdbase.org/detail.go?type=gene&acc=183947,,,183947.0,D2024.1,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of D2024.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
204,1458597,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,183952,D2045.5,https://ctdbase.org/detail.go?type=gene&acc=183952,,,183952.0,D2045.5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of D2045.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
205,1458598,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,183955,D2062.5,https://ctdbase.org/detail.go?type=gene&acc=183955,,,183955.0,D2062.5,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of D2062.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
206,1458599,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,172380,D2092.8,https://ctdbase.org/detail.go?type=gene&acc=172380,,,172380.0,D2092.8,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of D2092.8 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
207,1458600,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177633,D2096.6,https://ctdbase.org/detail.go?type=gene&acc=177633,,,177633.0,D2096.6,6239.0,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of D2096.6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
208,1456373,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,114907,FBXO32,https://ctdbase.org/detail.go?type=gene&acc=114907,,,114907.0,FBXO32,10090.0,Mus musculus (house mouse),Lithium chloride results in decreased expression of FBXO32 mRNA,,,PMID:21832246,https://www.ncbi.nlm.nih.gov/pubmed/21832246,21832246,,
209,1456374,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,55294,FBXW7,https://ctdbase.org/detail.go?type=gene&acc=55294,,,55294.0,FBXW7,9606.0,Homo sapiens (human),FBXW7 protein inhibits the reaction [lithium chloride results in increased expression of RICTOR protein],,,PMID:25897075,https://www.ncbi.nlm.nih.gov/pubmed/25897075,25897075,,
210,1456375,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,56776,FMN2,https://ctdbase.org/detail.go?type=gene&acc=56776,,,56776.0,FMN2,9606.0,Homo sapiens (human),Lithium chloride results in decreased expression of FMN2 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
211,1456376,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10116.0,Rattus norvegicus (Norway rat),Butyrates promotes the reaction [lithium chloride results in increased expression of FOS protein]|lithium chloride results in increased expression of FOS protein,,,PMID:20346924,https://www.ncbi.nlm.nih.gov/pubmed/20346924,20346924,,
212,1456377,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,30539,FOXA,https://ctdbase.org/detail.go?type=gene&acc=30539,,,30539.0,foxa,7668.0,Strongylocentrotus purpuratus (purple sea urchin),Lithium chloride results in increased expression of FOXA mRNA,,,PMID:17506889,https://www.ncbi.nlm.nih.gov/pubmed/17506889,17506889,,
213,1456378,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,565796,FOXQ2,https://ctdbase.org/detail.go?type=gene&acc=565796,,,565796.0,foxq2,7668.0,Strongylocentrotus purpuratus (purple sea urchin),Lithium chloride results in decreased expression of FOXQ2 mRNA,,,PMID:17506889,https://www.ncbi.nlm.nih.gov/pubmed/17506889,17506889,,
214,1456379,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,53827,FXYD5,https://ctdbase.org/detail.go?type=gene&acc=53827,,,53827.0,FXYD5,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of FXYD5 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
215,1456380,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2534,FYN,https://ctdbase.org/detail.go?type=gene&acc=2534,,,2534.0,FYN,10116.0,Rattus norvegicus (Norway rat),Lithium chloride inhibits the reaction [[1-methyl-4-phenylpyridinium co-treated with puerarin] results in decreased phosphorylation of FYN protein],,,PMID:32763437,https://www.ncbi.nlm.nih.gov/pubmed/32763437,32763437,,
216,1456381,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2534,FYN,https://ctdbase.org/detail.go?type=gene&acc=2534,,,2534.0,FYN,10116.0,Rattus norvegicus (Norway rat),Lithium chloride inhibits the reaction [triptolide results in increased expression of FYN protein],,,PMID:30926361,https://www.ncbi.nlm.nih.gov/pubmed/30926361,30926361,,
217,1456810,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,196996,GRAMD2A,https://ctdbase.org/detail.go?type=gene&acc=196996,,,196996.0,GRAMD2A,9606.0,Homo sapiens (human),Lithium chloride results in increased expression of GRAMD2A mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
218,1457180,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),GSK3B protein mutant form inhibits the reaction [lithium chloride results in decreased expression of and results in decreased activity of ACHE protein]|gsk3b protein mutant form inhibits the reaction [lithium chloride results in increased degradation of ACHE protein],,,PMID:22944069,https://www.ncbi.nlm.nih.gov/pubmed/22944069,22944069,,
219,1457181,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),"Lithium chloride inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in decreased expression of GSK3B protein modified form]",,,PMID:30703377,https://www.ncbi.nlm.nih.gov/pubmed/30703377,30703377,,
220,1457182,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [celastrol results in decreased phosphorylation of GSK3B protein],,,PMID:31715269,https://www.ncbi.nlm.nih.gov/pubmed/31715269,31715269,,
221,1457183,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [fipronil results in decreased phosphorylation of GSK3B protein],,,PMID:21296133,https://www.ncbi.nlm.nih.gov/pubmed/21296133,21296133,,
222,1457184,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [hydroquinone results in increased expression of GSK3B protein],,,PMID:28886972,https://www.ncbi.nlm.nih.gov/pubmed/28886972,28886972,,
223,1457185,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),"Lithium chloride inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in decreased phosphorylation of GSK3B protein]",,,PMID:35985571,https://www.ncbi.nlm.nih.gov/pubmed/35985571,35985571,,
224,1458738,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Lithium chloride affects the reaction [[gastrodin co-treated with rhyncophylline] affects the reaction [1-methyl-4-phenylpyridinium affects the expression of HMOX1 protein]],,,PMID:33645131,https://www.ncbi.nlm.nih.gov/pubmed/33645131,33645131,,
225,1458739,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Lithium chloride inhibits the reaction [matrines results in decreased expression of HMOX1 protein],,,PMID:37075934,https://www.ncbi.nlm.nih.gov/pubmed/37075934,37075934,,
226,1456663,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,1812,DRD1,https://ctdbase.org/detail.go?type=gene&acc=1812,,,1812.0,DRD1,10116.0,Rattus norvegicus (Norway rat),Norepinephrine inhibits the reaction [rotenone results in decreased expression of DRD1 protein]|norepinephrine inhibits the reaction [rotenone results in decreased expression of DRD1 mrna],,,PMID:20887679,https://www.ncbi.nlm.nih.gov/pubmed/20887679,20887679,,
227,1457055,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,2002,ELK1,https://ctdbase.org/detail.go?type=gene&acc=2002,,,2002.0,ELK1,10116.0,Rattus norvegicus (Norway rat),"[norepinephrine co-treated with propranolol] results in increased phosphorylation of ELK1 protein|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[norepinephrine co-treated with propranolol] results in increased phosphorylation of ELK1 protein]",,,PMID:11880281,https://www.ncbi.nlm.nih.gov/pubmed/11880281,11880281,,
228,1457056,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,83401,ELOVL3,https://ctdbase.org/detail.go?type=gene&acc=83401,,,83401.0,ELOVL3,10090.0,Mus musculus (house mouse),Dactinomycin inhibits the reaction [norepinephrine results in increased expression of ELOVL3 mrna]|rosiglitazone promotes the reaction [[dexamethasone co-treated with norepinephrine] results in increased expression of ELOVL3 mrna]|[dexamethasone co-treated with norepinephrine] results in increased expression of ELOVL3 mrna|norepinephrine results in increased expression of and results in decreased degradation of ELOVL3 mrna|norepinephrine results in increased expression of ELOVL3 mRNA,,,PMID:17726147,https://www.ncbi.nlm.nih.gov/pubmed/17726147,17726147,,
229,1495557,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,6128,RPL6,https://ctdbase.org/detail.go?type=gene&acc=6128,,,6128.0,RPL6,10116.0,Rattus norvegicus (Norway rat),Propiverine binds to RPL6 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
230,1456225,443289,Comparative Toxicogenomics Database (CTD),Cyclo(D-trp-D-asp-pro-D-val-leu),C072247,cyclo(Trp-Asp-Pro-Val-Leu),https://ctdbase.org/detail.go?type=chem&acc=C072247,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606.0,Homo sapiens (human),Cyclo(trp-asp-pro-val-leu) inhibits the reaction [VEGFC protein results in decreased expression of CDKN1B protein],,,PMID:24184161,https://www.ncbi.nlm.nih.gov/pubmed/24184161,24184161,,
231,1456226,443289,Comparative Toxicogenomics Database (CTD),Cyclo(D-trp-D-asp-pro-D-val-leu),C072247,cyclo(Trp-Asp-Pro-Val-Leu),https://ctdbase.org/detail.go?type=chem&acc=C072247,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090.0,Mus musculus (house mouse),Cyclo(trp-asp-pro-val-leu) inhibits the reaction [AGT protein results in increased expression of COL1A1 protein]|edn1 protein affects the reaction [cyclo(trp-asp-pro-val-leu) inhibits the reaction [AGT protein results in increased expression of COL1A1 protein]],,,PMID:17391658,https://www.ncbi.nlm.nih.gov/pubmed/17391658,17391658,,
232,1456227,443292,Comparative Toxicogenomics Database (CTD),"6-Hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole",C095803,E 3040,https://ctdbase.org/detail.go?type=chem&acc=C095803,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606.0,Homo sapiens (human),[SLCO1B1 protein co-treated with ABCC2 protein] results in increased transport of E 3040 analog,,,PMID:19628752,https://www.ncbi.nlm.nih.gov/pubmed/19628752,19628752,,
233,1457303,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,568316,PRKAG2B,https://ctdbase.org/detail.go?type=gene&acc=568316,,,568316.0,prkag2b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PRKAG2B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
234,1457304,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5573,PRKAR1A,https://ctdbase.org/detail.go?type=gene&acc=5573,,,5573.0,PRKAR1A,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of PRKAR1A protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
235,1457305,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5575,PRKAR1B,https://ctdbase.org/detail.go?type=gene&acc=5575,,,5575.0,PRKAR1B,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of PRKAR1B protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
236,1457306,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5575,PRKAR1B,https://ctdbase.org/detail.go?type=gene&acc=5575,,,5575.0,PRKAR1B,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PRKAR1B mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
237,1457307,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5575,PRKAR1B,https://ctdbase.org/detail.go?type=gene&acc=5575,,,5575.0,PRKAR1B,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRKAR1B mRNA,,,PMID:16322246,https://www.ncbi.nlm.nih.gov/pubmed/16322246,16322246,,
238,1457308,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5576,PRKAR2A,https://ctdbase.org/detail.go?type=gene&acc=5576,,,5576.0,PRKAR2A,9606.0,Homo sapiens (human),Sodium arsenite promotes the reaction [PRKAR2A protein binds to CAPRIN1 protein],,,PMID:33939924,https://www.ncbi.nlm.nih.gov/pubmed/33939924,33939924,,
239,1457309,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5576,PRKAR2A,https://ctdbase.org/detail.go?type=gene&acc=5576,,,5576.0,PRKAR2A,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PRKAR2A mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
240,1457310,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5577,PRKAR2B,https://ctdbase.org/detail.go?type=gene&acc=5577,,,5577.0,PRKAR2B,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRKAR2B mRNA,,,PMID:31170414,https://www.ncbi.nlm.nih.gov/pubmed/31170414,31170414,,
241,1457995,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100506939,PRKG1-AS1,https://ctdbase.org/detail.go?type=gene&acc=100506939,,,100506939.0,PRKG1-AS1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of PRKG1-AS1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
242,1457996,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,566430,PRKG1B,https://ctdbase.org/detail.go?type=gene&acc=566430,,,566430.0,prkg1b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PRKG1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
243,1457997,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5593,PRKG2,https://ctdbase.org/detail.go?type=gene&acc=5593,,,5593.0,PRKG2,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of PRKG2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
244,1457998,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5593,PRKG2,https://ctdbase.org/detail.go?type=gene&acc=5593,,,5593.0,PRKG2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PRKG2 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
245,1457999,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5593,PRKG2,https://ctdbase.org/detail.go?type=gene&acc=5593,,,5593.0,PRKG2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PRKG2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
246,1458164,443495,Toxin and Toxin Target Database (T3DB),Sodium arsenite,T3D0243,Sodium arsenite,http://www.t3db.ca/toxins/T3D0243,BE0003398,Putative tubulin-like protein alpha-4B,http://www.t3db.ca/biodb/bio_entities/BE0003398,Q9H853,Putative tubulin-like protein alpha-4B,,,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
247,1458165,443495,Toxin and Toxin Target Database (T3DB),Sodium arsenite,T3D0243,Sodium arsenite,http://www.t3db.ca/toxins/T3D0243,BE0000571,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000571,P08559,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",5160.0,PDHA1,9606.0,Homo sapiens (human),"Arsenic disrupts ATP production through several mechanisms. at the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1)",,,,,,,
248,1458166,443495,Toxin and Toxin Target Database (T3DB),Sodium arsenite,T3D0243,Sodium arsenite,http://www.t3db.ca/toxins/T3D0243,BE0000609,"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000609,P29803,"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial",5161.0,PDHA2,9606.0,Homo sapiens (human),"Arsenic disrupts ATP production through several mechanisms. at the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1)",,,,,,,
249,1458167,443495,Toxin and Toxin Target Database (T3DB),Sodium arsenite,T3D0243,Sodium arsenite,http://www.t3db.ca/toxins/T3D0243,BE0000098,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000098,P11177,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",5162.0,PDHB,9606.0,Homo sapiens (human),"Arsenic disrupts ATP production through several mechanisms. at the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1)",,,,,,,
250,1458168,443495,Toxin and Toxin Target Database (T3DB),Sodium arsenite,T3D0243,Sodium arsenite,http://www.t3db.ca/toxins/T3D0243,BE0005052,"Pyruvate dehydrogenase protein X component, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005052,O00330,"Pyruvate dehydrogenase protein X component, mitochondrial",8050.0,PDHX,9606.0,Homo sapiens (human),"Arsenic disrupts ATP production through several mechanisms. at the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. (T1)",,,,,,,
251,1458905,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5627,PROS1,https://ctdbase.org/detail.go?type=gene&acc=5627,,,5627.0,PROS1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PROS1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
252,1459194,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4168,MCF2,https://ctdbase.org/detail.go?type=gene&acc=4168,,,4168.0,MCF2,9606.0,Homo sapiens (human),[sodium arsenite co-treated with cadmium chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MCF2 mRNA,,,PMID:12634122,https://www.ncbi.nlm.nih.gov/pubmed/12634122,12634122,,
253,1459920,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84515,MCM8,https://ctdbase.org/detail.go?type=gene&acc=84515,,,84515.0,MCM8,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MCM8 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
254,1459921,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84515,MCM8,https://ctdbase.org/detail.go?type=gene&acc=84515,,,84515.0,MCM8,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MCM8 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
255,1459922,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,254394,MCM9,https://ctdbase.org/detail.go?type=gene&acc=254394,,,254394.0,MCM9,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MCM9 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
256,1459923,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,79892,MCMBP,https://ctdbase.org/detail.go?type=gene&acc=79892,,,79892.0,MCMBP,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MCMBP mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
257,1459924,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,255231,MCOLN2,https://ctdbase.org/detail.go?type=gene&acc=255231,,,255231.0,MCOLN2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MCOLN2 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
258,1459925,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,255231,MCOLN2,https://ctdbase.org/detail.go?type=gene&acc=255231,,,255231.0,MCOLN2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MCOLN2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
259,1459926,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55283,MCOLN3,https://ctdbase.org/detail.go?type=gene&acc=55283,,,55283.0,MCOLN3,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of MCOLN3 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
260,1459927,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55283,MCOLN3,https://ctdbase.org/detail.go?type=gene&acc=55283,,,55283.0,MCOLN3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of MCOLN3 mRNA,,,PMID:22714537|PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/22714537|https://www.ncbi.nlm.nih.gov/pubmed/29301061,22714537|29301061,,
261,1459928,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55283,MCOLN3,https://ctdbase.org/detail.go?type=gene&acc=55283,,,55283.0,MCOLN3,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MCOLN3 mRNA,,,PMID:37668303,https://www.ncbi.nlm.nih.gov/pubmed/37668303,37668303,,
262,1456820,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8877,SPHK1,https://ctdbase.org/detail.go?type=gene&acc=8877,,,8877.0,SPHK1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SPHK1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
263,1459043,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,9606.0,Homo sapiens (human),Trichostatin A inhibits the reaction [nicotine results in decreased expression of STAR mrna],,,PMID:24709674,https://www.ncbi.nlm.nih.gov/pubmed/24709674,24709674,,
264,1459044,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10090.0,Mus musculus (house mouse),Trichostatin A inhibits the reaction [dexamethasone results in decreased expression of STAR mrna],,,PMID:29902490,https://www.ncbi.nlm.nih.gov/pubmed/29902490,29902490,,
265,1459045,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10809,STARD10,https://ctdbase.org/detail.go?type=gene&acc=10809,,,10809.0,STARD10,9606.0,Homo sapiens (human),Trichostatin A affects the expression of STARD10 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
266,1459046,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,90627,STARD13,https://ctdbase.org/detail.go?type=gene&acc=90627,,,90627.0,STARD13,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of STARD13 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
267,1459047,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,83930,STARD3NL,https://ctdbase.org/detail.go?type=gene&acc=83930,,,83930.0,STARD3NL,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of STARD3NL mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
268,1459048,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,134429,STARD4,https://ctdbase.org/detail.go?type=gene&acc=134429,,,134429.0,STARD4,9606.0,Homo sapiens (human),Trichostatin A affects the expression of STARD4 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
269,1459049,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,80765,STARD5,https://ctdbase.org/detail.go?type=gene&acc=80765,,,80765.0,STARD5,9606.0,Homo sapiens (human),Trichostatin A affects the expression of STARD5 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
270,1459050,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6773,STAT2,https://ctdbase.org/detail.go?type=gene&acc=6773,,,6773.0,STAT2,9606.0,Homo sapiens (human),Trichostatin A affects the expression of STAT2 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
271,1459051,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6775,STAT4,https://ctdbase.org/detail.go?type=gene&acc=6775,,,6775.0,STAT4,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of STAT4 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
272,1459052,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6776,STAT5A,https://ctdbase.org/detail.go?type=gene&acc=6776,,,6776.0,STAT5A,10090.0,Mus musculus (house mouse),Trichostatin A inhibits the reaction [STAT5A gene mutant form results in increased expression of CISH mrna],,,PMID:25769527,https://www.ncbi.nlm.nih.gov/pubmed/25769527,25769527,,
273,1459501,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6781,STC1,https://ctdbase.org/detail.go?type=gene&acc=6781,,,6781.0,STC1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STC1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
274,1459502,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6781,STC1,https://ctdbase.org/detail.go?type=gene&acc=6781,,,6781.0,STC1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of STC1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
275,1459919,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,11037,STON1,https://ctdbase.org/detail.go?type=gene&acc=11037,,,11037.0,STON1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STON1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
276,1551064,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,23143,LRCH1,https://ctdbase.org/detail.go?type=gene&acc=23143,,,23143.0,LRCH1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of LRCH1 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
277,1608183,3000322,Comparative Toxicogenomics Database (CTD),Scopolamine,D012601,Scopolamine,https://ctdbase.org/detail.go?type=chem&acc=D012601,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,10116.0,Rattus norvegicus (Norway rat),Scopolamine results in decreased expression of EGR1 mRNA,,,PMID:17540011|PMID:8861055,https://www.ncbi.nlm.nih.gov/pubmed/17540011|https://www.ncbi.nlm.nih.gov/pubmed/8861055,17540011|8861055,,
278,2029387,12627221,Therapeutic Target Database (TTD),N-(2-phenylethyl)-1H-indole-2-carboxamide,D0YO7C,N-(2-Phenylethyl)-1H-indole-2-carboxamide,https://idrblab.net/ttd/data/drug/details/D0YO7C,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
279,2029388,12627221,Therapeutic Target Database (TTD),N-(2-phenylethyl)-1H-indole-2-carboxamide,D0YO7C,N-(2-Phenylethyl)-1H-indole-2-carboxamide,https://idrblab.net/ttd/data/drug/details/D0YO7C,T83875,Monoamine oxidase type A (MAO-A),https://idrblab.net/ttd/data/target/details/T83875,P21397,Amine oxidase [flavin-containing] A,4128.0,MAOA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
280,2029389,12668023,Drug Gene Interaction database (DGIdb),"Fenoldopam, (R)-",,IL-2,https://www.dgidb.org/drugs/iuphar.ligand:4985,,IL2RA,https://www.dgidb.org/genes/hgnc:6008,,,3559.0,IL2RA,9606.0,Homo sapiens (human),,,,,,,,
281,2029390,12668023,Drug Gene Interaction database (DGIdb),"Fenoldopam, (R)-",,IL-2,https://www.dgidb.org/drugs/iuphar.ligand:4985,,PRF1,https://www.dgidb.org/genes/hgnc:9360,,,5551.0,PRF1,9606.0,Homo sapiens (human),,,,,,,,
282,2029391,12668023,Drug Gene Interaction database (DGIdb),"Fenoldopam, (R)-",,IL-2,https://www.dgidb.org/drugs/iuphar.ligand:4985,,MAPK14,https://www.dgidb.org/genes/hgnc:6876,,,1432.0,MAPK14,9606.0,Homo sapiens (human),,,,,,,,
283,2029392,12668023,Drug Gene Interaction database (DGIdb),"Fenoldopam, (R)-",,IL-2,https://www.dgidb.org/drugs/iuphar.ligand:4985,,FCGR3A,https://www.dgidb.org/genes/hgnc:3619,,,2214.0,FCGR3A,9606.0,Homo sapiens (human),,,,,,,,
284,2029393,12668023,Drug Gene Interaction database (DGIdb),"Fenoldopam, (R)-",,IL-2,https://www.dgidb.org/drugs/iuphar.ligand:4985,,FCGR2B,https://www.dgidb.org/genes/hgnc:3618,,,2213.0,FCGR2B,9606.0,Homo sapiens (human),,,,,,,,
285,2029394,12668023,Drug Gene Interaction database (DGIdb),"Fenoldopam, (R)-",,IL-2,https://www.dgidb.org/drugs/iuphar.ligand:4985,,FCGR3B,https://www.dgidb.org/genes/hgnc:3620,,,2215.0,FCGR3B,9606.0,Homo sapiens (human),,,,,,,,
286,2029395,12668023,Drug Gene Interaction database (DGIdb),"Fenoldopam, (R)-",,IL-2,https://www.dgidb.org/drugs/iuphar.ligand:4985,,CBL,https://www.dgidb.org/genes/hgnc:1541,,,867.0,CBL,9606.0,Homo sapiens (human),,,,,,,,
287,2029396,12668023,Drug Gene Interaction database (DGIdb),"Fenoldopam, (R)-",,IL-2,https://www.dgidb.org/drugs/iuphar.ligand:4985,,PIK3CA,https://www.dgidb.org/genes/hgnc:8975,,,5290.0,PIK3CA,9606.0,Homo sapiens (human),,,,,,,,
288,2029397,12668023,Drug Gene Interaction database (DGIdb),"Fenoldopam, (R)-",,IL-2,https://www.dgidb.org/drugs/iuphar.ligand:4985,,TNFAIP1,https://www.dgidb.org/genes/hgnc:11894,,,7126.0,TNFAIP1,9606.0,Homo sapiens (human),,,,,,,,
289,2029398,12789146,Therapeutic Target Database (TTD),1-(9H-beta-Carbolin-3-yl)ethan-1-one,D02HEK,1-(9H-beta-Carbolin-3-yl)-ethanone,https://idrblab.net/ttd/data/drug/details/D02HEK,T51487,GABA(A) receptor alpha-1 (GABRA1),https://idrblab.net/ttd/data/target/details/T51487,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
290,2029399,12870397,Therapeutic Target Database (TTD),N-3-(4-bromophenyl)propyl imidazole,D02ZQK,N-3-(4-bromophenyl)propyl imidazole,https://idrblab.net/ttd/data/drug/details/D02ZQK,T89041,Steroid 17-alpha-monooxygenase (S17AH),https://idrblab.net/ttd/data/target/details/T89041,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",1586.0,CYP17A1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
291,2029400,12905388,Therapeutic Target Database (TTD),"1-Ethyl-3-methyl-3,7-dihydro-purine-2,6-dione",D04WBU,"1-Ethyl-3-methyl-3,7-dihydro-purine-2,6-dione",https://idrblab.net/ttd/data/drug/details/D04WBU,T77365,Adenosine A2a receptor (ADORA2A),https://idrblab.net/ttd/data/target/details/T77365,P29274,Adenosine receptor A2a,135.0,ADORA2A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
292,2029401,12985748,Therapeutic Target Database (TTD),(S)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid,D0X1BT,(S)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid,https://idrblab.net/ttd/data/drug/details/D0X1BT,T84316,Voltage-gated calcium channel alpha-2/delta-1 (CACNA2D1),https://idrblab.net/ttd/data/target/details/T84316,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,781.0,CACNA2D1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
293,2029713,16664733,BindingDB,"(2S)-2-[(5-{[4-(3-acetamidophenyl)phenyl]methyl}-1,3-oxazol-4-yl)formamido]-3-phenylpropanoic acid",23963,"(2S)-2-[(5-{[4-(3-acetamidophenyl)phenyl]methyl}-1,3-oxazol-4-yl)formamido]-3-phenylpropanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23963,2444,Prostacyclin receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2444,P43119,Prostacyclin receptor,5739.0,PTGIR,9606.0,Homo sapiens (human),,IC50 (nM),476,PMID:17239589|DOI:10.1016/j.bmcl.2006.12.025,https://www.ncbi.nlm.nih.gov/pubmed/17239589|https://doi.org/10.1016/j.bmcl.2006.12.025,17239589,10.1016/j.bmcl.2006.12.025,
294,2029341,16733021,BindingDB,5-{5-[(2S)-2-amino-3-(4-chlorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16544,(2S)-1-(4-chlorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16544,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),11,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
295,2029342,16733023,BindingDB,5-{5-[(2S)-2-amino-3-(3-bromophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16546,(2S)-1-(3-bromophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16546,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),2.1,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
296,2029343,16733025,BindingDB,5-{5-[(2S)-2-amino-3-(3-iodophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16548,(2S)-1-(3-iodophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16548,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),0.9,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
297,2029344,16733027,BindingDB,"5-{5-[(2S)-2-amino-3-(2,3-dichlorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16551,"(2S)-1-(2,3-dichlorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16551,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),5.6,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
298,2029345,16733156,BindingDB,"5-{5-[(2S)-2-amino-3-(2,3,4-trifluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16540,"(2S)-1-(2,3,4-trifluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16540,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),12,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
299,2029346,16733278,BindingDB,5-{5-[(2S)-2-amino-3-(3-fluoro-4-methylphenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16561,(2S)-1-(3-fluoro-4-methylphenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16561,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),2.4,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
300,2029355,16733284,BindingDB,5-{5-[(2S)-2-amino-3-(3-chloro-4-fluorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16549,(2S)-1-(3-chloro-4-fluorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16549,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),3.1,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
301,2029356,16733286,BindingDB,"5-{5-[(2S)-2-amino-3-[3,5-bis(trifluoromethyl)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16566,"(2S)-1-[3,5-bis(trifluoromethyl)phenyl]-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16566,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),57,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
302,2029357,16733397,BindingDB,5-{5-[(2S)-2-amino-3-(5-fluoro-2-methoxyphenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16563,(2S)-1-(5-fluoro-2-methoxyphenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16563,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),7.7,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
303,2029358,16733398,BindingDB,5-{5-[(2S)-2-amino-3-[4-(trifluoromethyl)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16565,(2S)-1-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}-3-[4-(trifluoromethyl)phenyl]propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16565,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),18,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
304,2029359,16733399,BindingDB,5-{5-[(2S)-2-amino-3-[3-fluoro-5-(trifluoromethyl)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16568,(2S)-1-[5-fluoro-3-(trifluoromethyl)phenyl]-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16568,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),13.3,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
305,2029360,16733400,BindingDB,5-{5-[(2S)-2-amino-3-[3-fluoro-4-(trifluoromethyl)phenyl]propoxy]pyridin-3-yl}-3-methyl-1H-indazole,16570,(2S)-1-[3-fluoro-4-(trifluoromethyl)phenyl]-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16570,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),3.1,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
306,2030278,16733403,BindingDB,"5-{5-[(2S)-2-amino-3-(3,4-dichlorophenyl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole",16552,"(2S)-1-(3,4-dichlorophenyl)-3-{[5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl]oxy}propan-2-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16552,1610,"RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1610,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),1.8,PMID:17523610|DOI:10.1021/jm0701019,https://www.ncbi.nlm.nih.gov/pubmed/17523610|https://doi.org/10.1021/jm0701019,17523610,10.1021/jm0701019,
307,2030279,16746348,BindingDB,"(3R,3aS,7R,7aS)-2-benzyl-3-(3-chloro-4-methoxyphenyl)-7-ethyl-3a,6,7,7a-tetrahydro-3H-isoindol-1-one",53401,"(3R,3aS,7R,7aS)-2-benzyl-3-(3-chloro-4-methoxy-phenyl)-7-ethyl-3a,6,7,7a-tetrahydro-3H-isoindol-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=53401,4689,Peptidyl-prolyl cis-trans isomerase ESS1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4689,P22696,Peptidyl-prolyl cis-trans isomerase ESS1,853475.0,ESS1,559292.0,Saccharomyces cerevisiae S288C,,IC50 (nM),2.0e+3,PMID:12573694|DOI:10.1016/S1074-5521(02)00310-1,https://www.ncbi.nlm.nih.gov/pubmed/12573694|https://doi.org/10.1016/S1074-5521(02)00310-1,12573694,10.1016/S1074-5521(02)00310-1,
308,2030280,16746506,BindingDB,"4-(4-Methoxyphenyl)-5,8-dimethyl-2-phenyl-chroman-2-ol",53405,"4-(4-methoxyphenyl)-5,8-dimethyl-2-phenyl-3,4-dihydro-2H-1-benzopyran-2-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=53405,4689,Peptidyl-prolyl cis-trans isomerase ESS1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4689,P22696,Peptidyl-prolyl cis-trans isomerase ESS1,853475.0,ESS1,559292.0,Saccharomyces cerevisiae S288C,,IC50 (nM),5.0e+3,PMID:12573694|DOI:10.1016/S1074-5521(02)00310-1,https://www.ncbi.nlm.nih.gov/pubmed/12573694|https://doi.org/10.1016/S1074-5521(02)00310-1,12573694,10.1016/S1074-5521(02)00310-1,
309,2030281,16746512,BindingDB,"(6Z)-1-benzoyl-4-(4-fluorobenzyl)-5-(4-methoxyphenyl)-5,8-dihydro-2H-1,4-diazocin-3-one",53406,"(6Z)-1-benzoyl-4-(4-fluorobenzyl)-5-(4-methoxyphenyl)-5,8-dihydro-2H-1,4-diazocin-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=53406,4689,Peptidyl-prolyl cis-trans isomerase ESS1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4689,P22696,Peptidyl-prolyl cis-trans isomerase ESS1,853475.0,ESS1,559292.0,Saccharomyces cerevisiae S288C,,IC50 (nM),>1.0e+4,PMID:12573694|DOI:10.1016/S1074-5521(02)00310-1,https://www.ncbi.nlm.nih.gov/pubmed/12573694|https://doi.org/10.1016/S1074-5521(02)00310-1,12573694,10.1016/S1074-5521(02)00310-1,
310,2030282,16746565,BindingDB,"benzyl (2S)-2-[[5-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-1H-imidazole-4-carbonyl]amino]-4-methylpentanoate",53408,"(2S)-2-[[5-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-1H-imidazole-4-carbonyl]amino]-4-methyl-valeric acid benzyl ester",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=53408,4689,Peptidyl-prolyl cis-trans isomerase ESS1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4689,P22696,Peptidyl-prolyl cis-trans isomerase ESS1,853475.0,ESS1,559292.0,Saccharomyces cerevisiae S288C,,IC50 (nM),>1.5e+3,PMID:12573694|DOI:10.1016/S1074-5521(02)00310-1,https://www.ncbi.nlm.nih.gov/pubmed/12573694|https://doi.org/10.1016/S1074-5521(02)00310-1,12573694,10.1016/S1074-5521(02)00310-1,
311,2030283,16746570,BindingDB,(2S)-2-[[4-[[(1S)-2-tert-butoxy-2-keto-1-methyl-ethyl]carbamoyl]-1H-imidazole-5-carbonyl]amino]-4-methyl-valeric acid benzyl ester,53409,(2S)-2-[[4-[[(1S)-2-tert-butoxy-2-keto-1-methyl-ethyl]carbamoyl]-1H-imidazole-5-carbonyl]amino]-4-methyl-valeric acid benzyl ester,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=53409,4689,Peptidyl-prolyl cis-trans isomerase ESS1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4689,P22696,Peptidyl-prolyl cis-trans isomerase ESS1,853475.0,ESS1,559292.0,Saccharomyces cerevisiae S288C,,IC50 (nM),>1.0e+4,PMID:12573694|DOI:10.1016/S1074-5521(02)00310-1,https://www.ncbi.nlm.nih.gov/pubmed/12573694|https://doi.org/10.1016/S1074-5521(02)00310-1,12573694,10.1016/S1074-5521(02)00310-1,
312,2029711,16750524,Therapeutic Target Database (TTD),1-(3-Methoxyphenyl)-2-(phenylsulfonyl)ethanone,D0EU9W,1-(3-methoxyphenyl)-2-(phenylsulfonyl)ethanone,https://idrblab.net/ttd/data/drug/details/D0EU9W,T65200,Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1),https://idrblab.net/ttd/data/target/details/T65200,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
313,2029629,16759921,Therapeutic Target Database (TTD),"9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",D08ZBD,"9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D08ZBD,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q00653,Nuclear factor NF-kappa-B p100 subunit ,4791.0,NFKB2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
314,2029630,16759921,Therapeutic Target Database (TTD),"9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",D08ZBD,"9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D08ZBD,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q04206,Transcription factor p65,5970.0,RELA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
315,2029631,16759921,Therapeutic Target Database (TTD),"9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",D08ZBD,"9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D08ZBD,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q01201,Transcription factor RelB,5971.0,RELB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
316,2029632,16759921,Therapeutic Target Database (TTD),"9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",D08ZBD,"9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D08ZBD,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q04864,Proto-oncogene c-Rel,5966.0,REL,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
317,2029712,16759921,Therapeutic Target Database (TTD),"9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",D08ZBD,"9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D08ZBD,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,P19838,Nuclear factor NF-kappa-B p105 subunit,4790.0,NFKB1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
318,2029633,16759925,Therapeutic Target Database (TTD),"9-methyl-5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide",D08KJM,"9-methyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D08KJM,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,P19838,Nuclear factor NF-kappa-B p105 subunit,4790.0,NFKB1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
319,2029634,16759925,Therapeutic Target Database (TTD),"9-methyl-5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide",D08KJM,"9-methyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D08KJM,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q00653,Nuclear factor NF-kappa-B p100 subunit ,4791.0,NFKB2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
320,2029635,16759925,Therapeutic Target Database (TTD),"9-methyl-5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide",D08KJM,"9-methyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D08KJM,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q04206,Transcription factor p65,5970.0,RELA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
321,2029636,16759925,Therapeutic Target Database (TTD),"9-methyl-5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide",D08KJM,"9-methyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D08KJM,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q01201,Transcription factor RelB,5971.0,RELB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
322,2029637,16759925,Therapeutic Target Database (TTD),"9-methyl-5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide",D08KJM,"9-methyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D08KJM,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q04864,Proto-oncogene c-Rel,5966.0,REL,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
323,2029638,16759933,Therapeutic Target Database (TTD),"9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",D01NVL,"9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D01NVL,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,P19838,Nuclear factor NF-kappa-B p105 subunit,4790.0,NFKB1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
324,2029704,16759933,Therapeutic Target Database (TTD),"9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",D01NVL,"9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D01NVL,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q00653,Nuclear factor NF-kappa-B p100 subunit ,4791.0,NFKB2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
325,2029705,16759933,Therapeutic Target Database (TTD),"9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",D01NVL,"9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D01NVL,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q04206,Transcription factor p65,5970.0,RELA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
326,2029706,16759933,Therapeutic Target Database (TTD),"9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",D01NVL,"9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D01NVL,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q01201,Transcription factor RelB,5971.0,RELB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
327,2029707,16759933,Therapeutic Target Database (TTD),"9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",D01NVL,"9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide",https://idrblab.net/ttd/data/drug/details/D01NVL,T83145,Nuclear factor NF-kappa-B (NFKB),https://idrblab.net/ttd/data/target/details/T83145,Q04864,Proto-oncogene c-Rel,5966.0,REL,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
328,2029708,16760391,IUPHAR/BPS Guide to PHARMACOLOGY,DNA-PK Inhibitor V,5961,DNA-PK inhibitor V,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5961,2800,"protein kinase, DNA-activated, catalytic subunit",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2800,P78527,DNA-dependent protein kinase catalytic subunit,5591.0,PRKDC,9606.0,Homo sapiens (human),Inhibition,pIC50,6.57,PMID:17562705,https://www.ncbi.nlm.nih.gov/pubmed/17562705,17562705,,
329,2029709,16760394,BindingDB,Z-Devd-fmk,228619,"US9345789, Z-DEVD-FMK",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228619,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),6810,PMID:32803196|DOI:10.1101/2020.07.17.207019,https://www.ncbi.nlm.nih.gov/pubmed/32803196|https://doi.org/10.1101/2020.07.17.207019,32803196,10.1101/2020.07.17.207019,
330,2029710,16777501,BindingDB,"2-(5-ethyl-2,3-dioxo-2,3-dihydro-1H-indol-1-yl)acetic acid",496151,LOR-NOR-c954e7ad-4,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496151,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),99500,,,,,
331,2029335,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [butylbenzyl phthalate binds to and results in increased activity of ESR1 protein]|tamoxifen inhibits the reaction [diethylhexyl phthalate binds to and results in increased activity of ESR1 protein]|tamoxifen inhibits the reaction [dicyclohexyl phthalate binds to and results in increased activity of ESR1 protein]|tamoxifen inhibits the reaction [diisobutyl phthalate binds to and results in increased activity of ESR1 protein]|tamoxifen inhibits the reaction [phthalic acid metabolite binds to and results in increased activity of ESR1 protein]|tamoxifen inhibits the reaction [dibutyl phthalate binds to and results in increased activity of ESR1 protein]|tamoxifen inhibits the reaction [di-n-pentyl phthalate binds to and results in increased activity of ESR1 protein]|tamoxifen inhibits the reaction [di-n-hexyl phthalate binds to and results in increased activity of ESR1 protein],,,PMID:15840436,https://www.ncbi.nlm.nih.gov/pubmed/15840436,15840436,,
332,2029336,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),"Tamoxifen inhibits the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased activity of ESR1 protein]|tamoxifen inhibits the reaction [chlorpyrifos results in increased activity of ESR1 protein]",,,PMID:32171938,https://www.ncbi.nlm.nih.gov/pubmed/32171938,32171938,,
333,2029337,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [bisphenol A results in increased activity of ESR1 protein mutant form]|tamoxifen inhibits the reaction [coumestrol results in increased activity of ESR1 protein]|tamoxifen promotes the reaction [coumestrol results in increased activity of ESR1 protein mutant form]|tamoxifen promotes the reaction [estradiol results in increased activity of ESR1 protein mutant form],,,PMID:16328721,https://www.ncbi.nlm.nih.gov/pubmed/16328721,16328721,,
334,2029338,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [ESR1 protein binds to CYP19A1 promoter]|tamoxifen inhibits the reaction [diethyl phthalate promotes the reaction [ESR1 protein binds to CYP19A1 promoter]],,,PMID:24994688,https://www.ncbi.nlm.nih.gov/pubmed/24994688,24994688,,
335,2029339,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [dithiothreitol results in increased activity of ESR1 protein],,,PMID:22403704,https://www.ncbi.nlm.nih.gov/pubmed/22403704,22403704,,
336,2029340,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR1 protein] results in increased expression of TMOD1 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of RIPOR2 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of TIPARP mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of IDH2 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of ENPP2 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of NLRP3 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of TMPRSS3 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of KLRC2 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of SEMA3B mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of RGS16 mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of ANKRD28 mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of CCN3 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of LPL mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of RASGRP1 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of CA12 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of RGS4 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of HEG1 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of RET mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of TNFRSF11B mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of SGK1 mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of CSF2 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of EIF1 mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of KCNN4 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of KCTD12 mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of LINC00312 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of CRISPLD2 mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of ENC1 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of OSBPL3 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of RHOBTB3 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of GRK5 mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of HAS2 mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of TGFBI mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of SLN mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of NPR2 mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of PLAU mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of PFKFB3 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of ZNF395 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of EDNRA mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of PTPRE mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of LMCD1 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of G0S2 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of FHL2 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of SYBU mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of MSMB mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of HK1 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of ISG20 mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of TXNIP mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
337,2029347,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR1 protein] results in increased expression of BGLAP mrna|[tamoxifen co-treated with ESR1 protein] results in decreased expression of EGFR protein|[tamoxifen co-treated with ESR1 protein] results in decreased expression of EGFR mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of BSP mRNA,,,PMID:19347870,https://www.ncbi.nlm.nih.gov/pubmed/19347870,19347870,,
338,2029348,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),[tamoxifen co-treated with estradiol] results in decreased expression of ESR1 mRNA,,,PMID:19434490,https://www.ncbi.nlm.nih.gov/pubmed/19434490,19434490,,
339,2029349,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 mrna|[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 protein|tamoxifen results in decreased expression of ESR1 protein alternative form|[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 protein alternative form|[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 mRNA alternative form,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
340,2029350,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [16 alpha-iodoestradiol binds to ESR1 protein],,,PMID:9048584,https://www.ncbi.nlm.nih.gov/pubmed/9048584,9048584,,
341,2029351,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [[endosulfan affects the activity of ESR1 protein] promotes the reaction [LIF protein results in increased activity of STAT3 protein]]|tamoxifen inhibits the reaction [[bisphenol A affects the activity of ESR1 protein] promotes the reaction [LIF protein results in increased activity of STAT3 protein]]|tamoxifen inhibits the reaction [[methoxychlor affects the activity of ESR1 protein] promotes the reaction [LIF protein results in increased activity of STAT3 protein]],,,PMID:14975756,https://www.ncbi.nlm.nih.gov/pubmed/14975756,14975756,,
342,2029352,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [bisphenol A results in increased activity of ESR1 protein],,,PMID:16328721|PMID:22403704,https://www.ncbi.nlm.nih.gov/pubmed/16328721|https://www.ncbi.nlm.nih.gov/pubmed/22403704,16328721|22403704,,
343,2029353,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [ESR1 protein binds to CDKN1A promoter],,,PMID:20696891,https://www.ncbi.nlm.nih.gov/pubmed/20696891,20696891,,
344,2029354,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [ESR1 protein binds to NFKBIB protein]|tamoxifen inhibits the reaction [ESR1 protein binds to DHX30 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to MGMT protein]|tamoxifen inhibits the reaction [ESR1 protein binds to NCOR1 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to NCOA1 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to NR0B1 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to NR0B2 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to ILK protein]|tamoxifen inhibits the reaction [ESR1 protein binds to NCOR2 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to PRAME protein]|tamoxifen inhibits the reaction [ESR1 protein binds to CNOT1 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to EP300 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to PELP1 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to TXNRD1 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to NCOA2 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to NELFB protein]|tamoxifen inhibits the reaction [ESR1 protein binds to TRRAP protein]|tamoxifen inhibits the reaction [ESR1 protein binds to NRIP1 protein]|tamoxifen inhibits the reaction [ESR1 protein binds to NCOA6 protein],,,PMID:23665804,https://www.ncbi.nlm.nih.gov/pubmed/23665804,23665804,,
345,2029361,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol binds to and results in increased activity of ESR1 protein],,,PMID:12676605|PMID:29162470,https://www.ncbi.nlm.nih.gov/pubmed/12676605|https://www.ncbi.nlm.nih.gov/pubmed/29162470,12676605|29162470,,
346,2029362,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol binds to ESR1 protein],,,PMID:12127041,https://www.ncbi.nlm.nih.gov/pubmed/12127041,12127041,,
347,2029363,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol promotes the reaction [ESR1 protein binds to AICDA promoter]],,,PMID:19139166,https://www.ncbi.nlm.nih.gov/pubmed/19139166,19139166,,
348,2029364,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol promotes the reaction [ESR1 protein binds to ESR1 protein]],,,PMID:15713566,https://www.ncbi.nlm.nih.gov/pubmed/15713566,15713566,,
349,2029365,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol results in decreased expression of ESR1 mrna]|tamoxifen inhibits the reaction [triiodothyronine results in decreased expression of ESR1 mrna],,,PMID:19942988,https://www.ncbi.nlm.nih.gov/pubmed/19942988,19942988,,
350,2029366,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol results in increased activity of ESR1 protein],,,PMID:16328721|PMID:17716812|PMID:19672399|PMID:20061804|PMID:20204298|PMID:22403704|PMID:30077407|PMID:30582956,https://www.ncbi.nlm.nih.gov/pubmed/16328721|https://www.ncbi.nlm.nih.gov/pubmed/17716812|https://www.ncbi.nlm.nih.gov/pubmed/19672399|https://www.ncbi.nlm.nih.gov/pubmed/20061804|https://www.ncbi.nlm.nih.gov/pubmed/20204298|https://www.ncbi.nlm.nih.gov/pubmed/22403704|https://www.ncbi.nlm.nih.gov/pubmed/30077407|https://www.ncbi.nlm.nih.gov/pubmed/30582956,16328721|17716812|19672399|20061804|20204298|22403704|30077407|30582956,,
351,2029367,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol results in increased expression of ESR1 mrna],,,PMID:12377985,https://www.ncbi.nlm.nih.gov/pubmed/12377985,12377985,,
352,2029368,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol results in increased expression of ESR1 protein],,,PMID:27163517|PMID:38133387,https://www.ncbi.nlm.nih.gov/pubmed/27163517|https://www.ncbi.nlm.nih.gov/pubmed/38133387,27163517|38133387,,
353,2029369,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estrogens results in increased activity of ESR1 protein],,,PMID:35077665,https://www.ncbi.nlm.nih.gov/pubmed/35077665,35077665,,
354,2029370,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [MEN1 protein binds to ESR1 protein],,,PMID:19847644,https://www.ncbi.nlm.nih.gov/pubmed/19847644,19847644,,
355,2029371,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),"Tamoxifen inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased activity of ESR1 protein]",,,PMID:26812056,https://www.ncbi.nlm.nih.gov/pubmed/26812056,26812056,,
356,2029372,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]],,,PMID:17513867,https://www.ncbi.nlm.nih.gov/pubmed/17513867,17513867,,
357,2029373,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen metabolite binds to ESR1 protein,,,PMID:15135306,https://www.ncbi.nlm.nih.gov/pubmed/15135306,15135306,,
358,2029374,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [ESR1 protein binds to AGR2 promoter]|tamoxifen promotes the reaction [[ESR1 protein binds to AGR2 promoter] which results in increased expression of AGR2 mrna],,,PMID:20531310,https://www.ncbi.nlm.nih.gov/pubmed/20531310,20531310,,
359,2029375,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [ESR1 protein binds to ESR1 protein],,,PMID:20061804|PMID:36513145,https://www.ncbi.nlm.nih.gov/pubmed/20061804|https://www.ncbi.nlm.nih.gov/pubmed/36513145,20061804|36513145,,
360,2029376,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [ESR1 protein binds to ESR2 protein],,,PMID:20061804,https://www.ncbi.nlm.nih.gov/pubmed/20061804,20061804,,
361,2029377,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [ESR1 protein binds to KLRC3 gene],,,PMID:17395694,https://www.ncbi.nlm.nih.gov/pubmed/17395694,17395694,,
362,2029378,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [SP1 protein binds to ESR1 protein]|tamoxifen promotes the reaction [[ESR1 protein binds to SP1 protein] which binds to E2F1 promoter]|tamoxifen promotes the reaction [[[ESR1 protein binds to SP1 protein] which binds to E2F1 promoter] which results in increased expression of E2F1 mrna],,,PMID:20215421,https://www.ncbi.nlm.nih.gov/pubmed/20215421,20215421,,
363,2029379,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [ESR1 protein binds to TFF1 promoter],,,PMID:17157789|PMID:19858209|PMID:20406620,https://www.ncbi.nlm.nih.gov/pubmed/17157789|https://www.ncbi.nlm.nih.gov/pubmed/19858209|https://www.ncbi.nlm.nih.gov/pubmed/20406620,17157789|19858209|20406620,,
364,2029380,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen results in decreased activity of ESR1 protein,,,PMID:20208560|PMID:21543282,https://www.ncbi.nlm.nih.gov/pubmed/20208560|https://www.ncbi.nlm.nih.gov/pubmed/21543282,20208560|21543282,,
365,2029381,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of ESR1 mRNA,,,PMID:20549698|PMID:27163517|PMID:30153467|PMID:30467747|PMID:32530119,https://www.ncbi.nlm.nih.gov/pubmed/20549698|https://www.ncbi.nlm.nih.gov/pubmed/27163517|https://www.ncbi.nlm.nih.gov/pubmed/30153467|https://www.ncbi.nlm.nih.gov/pubmed/30467747|https://www.ncbi.nlm.nih.gov/pubmed/32530119,20549698|27163517|30153467|30467747|32530119,,
366,2029382,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of ESR1 mRNA alternative form,,,PMID:30153467|PMID:32530119,https://www.ncbi.nlm.nih.gov/pubmed/30153467|https://www.ncbi.nlm.nih.gov/pubmed/32530119,30153467|32530119,,
367,2029383,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of ESR1 protein,,,PMID:27163517|PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/27163517|https://www.ncbi.nlm.nih.gov/pubmed/30153467,27163517|30153467,,
368,2029384,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen results in increased activity of ESR1 protein,,,PMID:15103026|PMID:17716812|PMID:17962382|PMID:20360387|PMID:20406620,https://www.ncbi.nlm.nih.gov/pubmed/15103026|https://www.ncbi.nlm.nih.gov/pubmed/17716812|https://www.ncbi.nlm.nih.gov/pubmed/17962382|https://www.ncbi.nlm.nih.gov/pubmed/20360387|https://www.ncbi.nlm.nih.gov/pubmed/20406620,15103026|17716812|17962382|20360387|20406620,,
369,2029385,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of ESR1 mRNA,,,PMID:16010412|PMID:19432593,https://www.ncbi.nlm.nih.gov/pubmed/16010412|https://www.ncbi.nlm.nih.gov/pubmed/19432593,16010412|19432593,,
370,2029386,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of ESR1 protein,,,PMID:12627041|PMID:19244106|PMID:19435893|PMID:20549698|PMID:24856822,https://www.ncbi.nlm.nih.gov/pubmed/12627041|https://www.ncbi.nlm.nih.gov/pubmed/19244106|https://www.ncbi.nlm.nih.gov/pubmed/19435893|https://www.ncbi.nlm.nih.gov/pubmed/20549698|https://www.ncbi.nlm.nih.gov/pubmed/24856822,12627041|19244106|19435893|20549698|24856822,,
371,2029402,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen results in increased stability of ESR1 protein,,,PMID:19477949,https://www.ncbi.nlm.nih.gov/pubmed/19477949,19477949,,
372,2029403,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),TP53 protein inhibits the reaction [tamoxifen results in increased expression of ESR1 protein],,,PMID:20549698,https://www.ncbi.nlm.nih.gov/pubmed/20549698,20549698,,
373,2029404,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,7998.0,Ictalurus punctatus (channel catfish),Tamoxifen inhibits the reaction [estradiol binds to ESR1 protein],,,PMID:9439733,https://www.ncbi.nlm.nih.gov/pubmed/9439733,9439733,,
374,2029405,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9541.0,Macaca fascicularis (crab-eating macaque),Tamoxifen results in decreased expression of ESR1 protein,,,PMID:21411722,https://www.ncbi.nlm.nih.gov/pubmed/21411722,21411722,,
375,2029406,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,29154.0,Micropogonias undulatus (Atlantic croaker),Tamoxifen binds to ESR1 protein,,,PMID:15001543,https://www.ncbi.nlm.nih.gov/pubmed/15001543,15001543,,
376,2029407,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),[arsenic trioxide co-treated with tamoxifen] results in increased expression of ESR1 protein|[arsenic trioxide co-treated with tamoxifen] results in decreased methylation of ESR1 gene|[arsenic trioxide co-treated with tamoxifen] results in increased expression of ESR1 mRNA,,,PMID:23159075,https://www.ncbi.nlm.nih.gov/pubmed/23159075,23159075,,
377,2029408,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),ESR1 protein affects the reaction [tamoxifen results in increased expression of MMD2 mrna]|esr1 protein affects the susceptibility to tamoxifen,,,PMID:22841776,https://www.ncbi.nlm.nih.gov/pubmed/22841776,22841776,,
378,2029409,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),[ESR1 protein mutant form co-treated with tamoxifen] results in increased expression of CAR2 mrna|tamoxifen inhibits the reaction [ESR1 protein mutant form results in decreased expression of CAR2 mrna]|esr1 protein mutant form inhibits the reaction [tamoxifen results in decreased expression of AQP1 mrna]|tamoxifen inhibits the reaction [ESR1 protein mutant form results in decreased expression of AQP9 protein]|tamoxifen inhibits the reaction [ESR1 protein mutant form results in decreased expression of SLC9A3 protein]|tamoxifen inhibits the reaction [ESR1 protein mutant form results in decreased expression of SLC9A3 mrna]|tamoxifen inhibits the reaction [ESR1 protein mutant form results in decreased expression of AQP1 mrna]|esr1 protein mutant form inhibits the reaction [tamoxifen results in decreased expression of SLC9A3 mrna]|tamoxifen inhibits the reaction [ESR1 protein mutant form results in decreased expression of AQP9 mrna],,,PMID:23213263,https://www.ncbi.nlm.nih.gov/pubmed/23213263,23213263,,
379,2029410,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),[sodium arsenite co-treated with tamoxifen] results in increased expression of ESR1 protein,,,PMID:16712894,https://www.ncbi.nlm.nih.gov/pubmed/16712894,16712894,,
380,2029411,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of ESR1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
381,2029412,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),Tamoxifen binds to and results in increased activity of ESR1 protein mutant form,,,PMID:21873215|PMID:23213263,https://www.ncbi.nlm.nih.gov/pubmed/21873215|https://www.ncbi.nlm.nih.gov/pubmed/23213263,21873215|23213263,,
382,2029413,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),Tamoxifen binds to ESR1 protein,,,PMID:11162928|PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/11162928|https://www.ncbi.nlm.nih.gov/pubmed/19913605,11162928|19913605,,
383,2029414,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),[tamoxifen co-treated with BRCA1 protein mutant form] results in decreased expression of ESR1 protein,,,PMID:15750629,https://www.ncbi.nlm.nih.gov/pubmed/15750629,15750629,,
384,2029415,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),Tamoxifen inhibits the reaction [manganese chloride results in decreased expression of ESR1 protein],,,PMID:29183790,https://www.ncbi.nlm.nih.gov/pubmed/29183790,29183790,,
385,2029416,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),Tamoxifen promotes the reaction [estradiol results in increased expression of ESR1 protein],,,PMID:19340542,https://www.ncbi.nlm.nih.gov/pubmed/19340542,19340542,,
386,2029417,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),Tamoxifen promotes the reaction [linseed oil results in decreased expression of ESR1 protein],,,PMID:21138602,https://www.ncbi.nlm.nih.gov/pubmed/21138602,21138602,,
387,2029418,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of ESR1 mRNA,,,PMID:15236189,https://www.ncbi.nlm.nih.gov/pubmed/15236189,15236189,,
388,2029432,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,8022.0,Oncorhynchus mykiss (rainbow trout),[estradiol co-treated with tamoxifen] results in increased expression of ESR1 mRNA,,,PMID:17823450,https://www.ncbi.nlm.nih.gov/pubmed/17823450,17823450,,
389,2029433,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,8022.0,Oncorhynchus mykiss (rainbow trout),Tamoxifen binds to and results in decreased activity of ESR1 protein,,,PMID:18348622,https://www.ncbi.nlm.nih.gov/pubmed/18348622,18348622,,
390,2029434,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,8090.0,Oryzias latipes (Japanese medaka),Tamoxifen inhibits the reaction [ethinyl estradiol results in increased expression of ESR1 mrna],,,PMID:21963593,https://www.ncbi.nlm.nih.gov/pubmed/21963593,21963593,,
391,2029435,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,90988.0,Pimephales promelas (fathead minnow),Tamoxifen binds to ESR1 protein,,,PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/19913605,19913605,,
392,2029436,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116.0,Rattus norvegicus (Norway rat),Tamoxifen inhibits the reaction [estradiol promotes the reaction [ESR1 protein binds to NCOA1 protein]],,,PMID:19460436,https://www.ncbi.nlm.nih.gov/pubmed/19460436,19460436,,
393,2029437,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116.0,Rattus norvegicus (Norway rat),Tamoxifen metabolite binds to ESR1 protein,,,PMID:16790557,https://www.ncbi.nlm.nih.gov/pubmed/16790557,16790557,,
394,2029438,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116.0,Rattus norvegicus (Norway rat),Tamoxifen results in increased expression of ESR1 protein,,,PMID:11748029,https://www.ncbi.nlm.nih.gov/pubmed/11748029,11748029,,
395,2029439,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,8030.0,Salmo salar (Atlantic salmon),Tamoxifen inhibits the reaction [4-nonylphenol results in increased expression of ESR1 mrna],,,PMID:17291011,https://www.ncbi.nlm.nih.gov/pubmed/17291011,17291011,,
396,2029440,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,30871.0,Serranidae (sea basses),Tamoxifen affects the reaction [ochratoxin A affects the reaction [estradiol results in increased expression of ESR1 mrna]],,,PMID:30716354,https://www.ncbi.nlm.nih.gov/pubmed/30716354,30716354,,
397,2029441,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,8175.0,Sparus aurata (gilthead seabream),Tamoxifen binds to ESR1 protein,,,PMID:19303142,https://www.ncbi.nlm.nih.gov/pubmed/19303142,19303142,,
398,2029442,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen binds to and results in decreased activity of ESR1 protein,,,PMID:21843587|PMID:22561550,https://www.ncbi.nlm.nih.gov/pubmed/21843587|https://www.ncbi.nlm.nih.gov/pubmed/22561550,21843587|22561550,,
399,2029443,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen binds to ESR1 protein,,,PMID:16010412|PMID:16679488,https://www.ncbi.nlm.nih.gov/pubmed/16010412|https://www.ncbi.nlm.nih.gov/pubmed/16679488,16010412|16679488,,
400,2029444,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of ESR1,,,PMID:19528477,https://www.ncbi.nlm.nih.gov/pubmed/19528477,19528477,,
401,2029445,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),CXCL12 protein promotes the reaction [tamoxifen promotes the reaction [ESR2 protein binds to CCND1 promoter]]|tamoxifen promotes the reaction [ESR2 protein binds to CCND1 promoter],,,PMID:19584281,https://www.ncbi.nlm.nih.gov/pubmed/19584281,19584281,,
402,2029446,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen binds to and results in decreased activity of ESR2 protein,,,PMID:21843587,https://www.ncbi.nlm.nih.gov/pubmed/21843587,21843587,,
403,2029447,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,317734,ESR2A,https://ctdbase.org/detail.go?type=gene&acc=317734,,,317734.0,esr2a,7955.0,Danio rerio (zebrafish),Tamoxifen results in increased expression of ESR2A mRNA,,,PMID:26908177,https://www.ncbi.nlm.nih.gov/pubmed/26908177,26908177,,
404,2029448,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),ESR2 protein affects the reaction [tamoxifen results in decreased expression of PTPRH mrna]|esr2 protein affects the reaction [tamoxifen results in decreased expression of F13A1 mrna]|esr2 protein affects the reaction [tamoxifen results in decreased expression of MAFF mrna]|esr2 protein affects the reaction [tamoxifen results in decreased expression of IVL mrna]|esr2 protein affects the reaction [tamoxifen results in increased expression of NNMT mrna]|esr2 protein affects the reaction [tamoxifen results in decreased expression of KLRC3 mrna],,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
405,2029449,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [ESR2 protein binds to [[FOS protein binds to JUN protein] which binds to PTPRO promoter]]|esr2 protein affects the reaction [tamoxifen results in increased expression of PTPRO mrna],,,PMID:19095770,https://www.ncbi.nlm.nih.gov/pubmed/19095770,19095770,,
406,2029450,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),ESR2 protein affects the susceptibility to tamoxifen,,,PMID:19434490,https://www.ncbi.nlm.nih.gov/pubmed/19434490,19434490,,
407,2029451,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),ESR2 protein promotes the reaction [tamoxifen results in increased expression of BIK protein],,,PMID:17638070,https://www.ncbi.nlm.nih.gov/pubmed/17638070,17638070,,
408,2029452,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),ESR2 protein results in decreased susceptibility to tamoxifen,,,PMID:16010412,https://www.ncbi.nlm.nih.gov/pubmed/16010412,16010412,,
409,2029453,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),ESR2 protein results in increased susceptibility to tamoxifen,,,PMID:15821116|PMID:17638070,https://www.ncbi.nlm.nih.gov/pubmed/15821116|https://www.ncbi.nlm.nih.gov/pubmed/17638070,15821116|17638070,,
410,2029454,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of ESR2 mrna]|plant extracts promotes the reaction [tamoxifen inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of ESR2 mrna]],,,PMID:20559769,https://www.ncbi.nlm.nih.gov/pubmed/20559769,20559769,,
411,2029455,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen binds to and results in decreased activity of ESR2 protein,,,PMID:25752796|PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/25752796|https://www.ncbi.nlm.nih.gov/pubmed/33049310,25752796|33049310,,
412,2029456,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in decreased expression of FADD mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of RFK mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of IFNGR2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of ST3GAL1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of MAPKAPK2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of KAZN mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of TCIM mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of LMNB2 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of ADAM19 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of TACC2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of TBXA2R mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of OTUB2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of CA12 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of FHL2 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of SERPINE1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of LRRC20 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of NDRG4 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of OCLN mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of PTX3 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of PTGER3 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of MDFIC mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of ARL4C mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of HBEGF mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of EVI2A mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of INPP5A mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of C14ORF132 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of SYNJ2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of CEBPB mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of PDLIM3 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of TNS3 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of HEG1 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of MAP2K3 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of PDP1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of NUAK1 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of TMEM158 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of ABCC1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of SEMA3F mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of KRT34 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of NR3C1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of SYNPO mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of NFKBIE mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of CASP7 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of IVL mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of INHBA mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of SOD2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of GPRC5C mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of HMOX1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of MAFF mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of ZNF395 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of EDNRA mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of ACKR3 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of NCOA4 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of MMP12 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of ENDOD1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of STK24 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of HSPB8 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of ADORA2B mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of NCF2 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of RCAN2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of ELF3 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of GAD1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of NFKBIA mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of JAG1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of CYP26B1 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of AREG mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of RET mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of LRIG1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of CASKIN2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of AKAP1 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of DCBLD2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of RFTN1 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of TNIK mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of TACC1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of KLRC3 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of TMOD1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of NFATC1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of HTR3A mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of SALL1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of WNT5A mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of GRB10 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of RRAD mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of CRISPLD2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of PITPNC1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of ZCCHC24 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of FGFR2 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of RASGRP1 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of TGFB2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of FLNB mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of NAB1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of FOSL2 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of RGS4 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of C2CD2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of PHF11 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of MAP3K8 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of KIF3C mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of CXCL12 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of CCL2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of SYBU mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of FUT9 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of CYP24A1 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of NR4A3 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of CALM1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of SERPINB6 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of TRAF5 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of ASB13 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of NAV2 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of CCL20 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of KRT17 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of KCTD12 mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of TNFRSF11B mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of CUEDC1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of MPPED2 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of NCOA1 mrna|[tamoxifen co-treated with ESR2 protein] results in decreased expression of SCNN1A mrna|[tamoxifen co-treated with ESR2 protein] results in de,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
413,2029457,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen binds to ESR2 protein,,,PMID:11518614|PMID:12224631|PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/11518614|https://www.ncbi.nlm.nih.gov/pubmed/12224631|https://www.ncbi.nlm.nih.gov/pubmed/19913605,11518614|12224631|19913605,,
414,2029458,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in increased expression of EGFR mrna|[tamoxifen co-treated with ESR2 protein] results in increased expression of EGFR protein,,,PMID:19347870,https://www.ncbi.nlm.nih.gov/pubmed/19347870,19347870,,
415,2029459,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in increased expression of PTGS2 mRNA,,,PMID:19059307|PMID:19347870,https://www.ncbi.nlm.nih.gov/pubmed/19059307|https://www.ncbi.nlm.nih.gov/pubmed/19347870,19059307|19347870,,
416,2029460,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),[tamoxifen co-treated with naringenin] results in increased expression of ESR2 mrna|[tamoxifen co-treated with naringenin] results in increased expression of ESR2 protein,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
417,2029461,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),"Tamoxifen inhibits the reaction [3,3'-diindolylmethane results in increased expression of ESR2 mrna]",,,PMID:20160136,https://www.ncbi.nlm.nih.gov/pubmed/20160136,20160136,,
418,2029462,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol results in increased activity of ESR2 protein],,,PMID:19672399|PMID:26778350|PMID:30582956,https://www.ncbi.nlm.nih.gov/pubmed/19672399|https://www.ncbi.nlm.nih.gov/pubmed/26778350|https://www.ncbi.nlm.nih.gov/pubmed/30582956,19672399|26778350|30582956,,
419,2029463,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol results in increased expression of ESR2 mrna],,,PMID:12377985,https://www.ncbi.nlm.nih.gov/pubmed/12377985,12377985,,
420,2029464,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen metabolite binds to ESR2 protein,,,PMID:15135306,https://www.ncbi.nlm.nih.gov/pubmed/15135306,15135306,,
421,2029465,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [ESR1 protein binds to ESR2 protein],,,PMID:20061804,https://www.ncbi.nlm.nih.gov/pubmed/20061804,20061804,,
422,2029466,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [ESR2 protein binds to ESR2 protein],,,PMID:36513145,https://www.ncbi.nlm.nih.gov/pubmed/36513145,36513145,,
423,2029467,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [quercetin results in decreased expression of ESR2 mrna],,,PMID:32530119,https://www.ncbi.nlm.nih.gov/pubmed/32530119,32530119,,
424,2029468,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of ESR2 mRNA,,,PMID:30153467|PMID:32530119,https://www.ncbi.nlm.nih.gov/pubmed/30153467|https://www.ncbi.nlm.nih.gov/pubmed/32530119,30153467|32530119,,
425,2029469,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of ESR2 protein,,,PMID:16202921|PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/16202921|https://www.ncbi.nlm.nih.gov/pubmed/30153467,16202921|30153467,,
426,2029470,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of ESR2 protein,,,PMID:16739346,https://www.ncbi.nlm.nih.gov/pubmed/16739346,16739346,,
427,2029471,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090.0,Mus musculus (house mouse),Linseed oil inhibits the reaction [tamoxifen results in decreased expression of ESR2 mrna]|tamoxifen results in decreased expression of ESR2 mRNA,,,PMID:21138602,https://www.ncbi.nlm.nih.gov/pubmed/21138602,21138602,,
428,2029472,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090.0,Mus musculus (house mouse),Tamoxifen binds to ESR2 protein,,,PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/19913605,19913605,,
429,2029473,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of ESR2 protein,,,PMID:19279558,https://www.ncbi.nlm.nih.gov/pubmed/19279558,19279558,,
430,2029474,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,8022.0,Oncorhynchus mykiss (rainbow trout),[estradiol co-treated with tamoxifen] results in increased expression of ESR2 mrna|tamoxifen results in increased expression of ESR2 mRNA,,,PMID:17823450,https://www.ncbi.nlm.nih.gov/pubmed/17823450,17823450,,
431,2029475,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116.0,Rattus norvegicus (Norway rat),Tamoxifen inhibits the reaction [ESR2 protein binds to NCOA1 protein]|[estradiol co-treated with tamoxifen] results in increased expression of ESR2 protein,,,PMID:19460436,https://www.ncbi.nlm.nih.gov/pubmed/19460436,19460436,,
432,2029476,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116.0,Rattus norvegicus (Norway rat),Tamoxifen inhibits the reaction [16 alpha-iodoestradiol binds to ESR2 protein],,,PMID:9048584,https://www.ncbi.nlm.nih.gov/pubmed/9048584,9048584,,
433,2029477,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116.0,Rattus norvegicus (Norway rat),Tamoxifen inhibits the reaction [ESR2 protein binds to H19 gene],,,PMID:19683557,https://www.ncbi.nlm.nih.gov/pubmed/19683557,19683557,,
434,2029478,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116.0,Rattus norvegicus (Norway rat),Tamoxifen inhibits the reaction [estradiol binds to ESR2 protein alternative form],,,PMID:9492041,https://www.ncbi.nlm.nih.gov/pubmed/9492041,9492041,,
435,2029479,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116.0,Rattus norvegicus (Norway rat),Tamoxifen inhibits the reaction [estradiol results in increased activity of ESR2 protein],,,PMID:8650195,https://www.ncbi.nlm.nih.gov/pubmed/8650195,8650195,,
436,2029480,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116.0,Rattus norvegicus (Norway rat),Tamoxifen results in increased expression of ESR2 mRNA,,,PMID:12834913,https://www.ncbi.nlm.nih.gov/pubmed/12834913,12834913,,
437,2029481,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,8030.0,Salmo salar (Atlantic salmon),"Tamoxifen inhibits the reaction [[4-nonylphenol co-treated with 3,4,3',4'-tetrachlorobiphenyl] results in decreased expression of ESR2 mrna]",,,PMID:17291011,https://www.ncbi.nlm.nih.gov/pubmed/17291011,17291011,,
438,2029482,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),ESR2 gene modified form affects the susceptibility to tamoxifen,,,PMID:24169358,https://www.ncbi.nlm.nih.gov/pubmed/24169358,24169358,,
439,2029483,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,317734,ESR2A,https://ctdbase.org/detail.go?type=gene&acc=317734,,,317734.0,esr2a,29154.0,Micropogonias undulatus (Atlantic croaker),Tamoxifen binds to ESR2A protein,,,PMID:15001543,https://www.ncbi.nlm.nih.gov/pubmed/15001543,15001543,,
440,2029484,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,317734,ESR2A,https://ctdbase.org/detail.go?type=gene&acc=317734,,,317734.0,esr2a,8175.0,Sparus aurata (gilthead seabream),Tamoxifen binds to ESR2A protein,,,PMID:19303142,https://www.ncbi.nlm.nih.gov/pubmed/19303142,19303142,,
441,2029485,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,317733,ESR2B,https://ctdbase.org/detail.go?type=gene&acc=317733,,,317733.0,esr2b,29154.0,Micropogonias undulatus (Atlantic croaker),Tamoxifen binds to ESR2B protein,,,PMID:15001543,https://www.ncbi.nlm.nih.gov/pubmed/15001543,15001543,,
442,2029486,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2101,ESRRA,https://ctdbase.org/detail.go?type=gene&acc=2101,,,2101.0,ESRRA,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of ESRRA protein|tamoxifen promotes the reaction [SP1 protein binds to ESRRA promoter]|pertussis toxin inhibits the reaction [tamoxifen results in increased expression of ESRRA mrna]|gper1 protein promotes the reaction [tamoxifen results in increased expression of ESRRA mrna]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tamoxifen results in increased expression of ESRRA mrna]|tamoxifen promotes the reaction [SP3 protein binds to ESRRA promoter]|ag 1879 inhibits the reaction [tamoxifen results in increased expression of ESRRA mrna],,,PMID:20211987,https://www.ncbi.nlm.nih.gov/pubmed/20211987,20211987,,
443,2029487,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2101,ESRRA,https://ctdbase.org/detail.go?type=gene&acc=2101,,,2101.0,ESRRA,9606.0,Homo sapiens (human),Bisphenol A inhibits the reaction [tamoxifen results in increased expression of ESRRA mrna],,,PMID:30467747,https://www.ncbi.nlm.nih.gov/pubmed/30467747,30467747,,
444,2029488,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2101,ESRRA,https://ctdbase.org/detail.go?type=gene&acc=2101,,,2101.0,ESRRA,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of ESRRA mRNA,,,PMID:20211987|PMID:30467747,https://www.ncbi.nlm.nih.gov/pubmed/20211987|https://www.ncbi.nlm.nih.gov/pubmed/30467747,20211987|30467747,,
445,2029489,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2104,ESRRG,https://ctdbase.org/detail.go?type=gene&acc=2104,,,2104.0,ESRRG,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of ESRRG mrna|bisphenol A inhibits the reaction [tamoxifen results in decreased expression of ESRRG mrna],,,PMID:30467747,https://www.ncbi.nlm.nih.gov/pubmed/30467747,30467747,,
446,2029490,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2104,ESRRG,https://ctdbase.org/detail.go?type=gene&acc=2104,,,2104.0,ESRRG,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [PPARGC1A protein binds to ESRRG protein]|tamoxifen binds to and affects the activity of ESRRG protein,,,PMID:16889744,https://www.ncbi.nlm.nih.gov/pubmed/16889744,16889744,,
447,2029491,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2104,ESRRG,https://ctdbase.org/detail.go?type=gene&acc=2104,,,2104.0,ESRRG,9606.0,Homo sapiens (human),Tamoxifen binds to ESRRG protein,,,PMID:11447273,https://www.ncbi.nlm.nih.gov/pubmed/11447273,11447273,,
448,2029492,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,144363,ETFRF1,https://ctdbase.org/detail.go?type=gene&acc=144363,,,144363.0,ETFRF1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of ETFRF1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
449,2029493,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,55224,ETNK2,https://ctdbase.org/detail.go?type=gene&acc=55224,,,55224.0,ETNK2,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of ETNK2 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
450,2029494,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,13996,ETOHD2,https://ctdbase.org/detail.go?type=gene&acc=13996,,,13996.0,Etohd2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of ETOHD2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
451,2029495,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2114,ETS2,https://ctdbase.org/detail.go?type=gene&acc=2114,,,2114.0,ETS2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of ETS2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
452,2029496,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2118,ETV4,https://ctdbase.org/detail.go?type=gene&acc=2118,,,2118.0,ETV4,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of ETV4 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
453,2029497,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2123,EVI2A,https://ctdbase.org/detail.go?type=gene&acc=2123,,,2123.0,EVI2A,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in decreased expression of EVI2A mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
454,2029498,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2123,EVI2A,https://ctdbase.org/detail.go?type=gene&acc=2123,,,2123.0,EVI2A,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EVI2A mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
455,2029499,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,5394,EXOSC10,https://ctdbase.org/detail.go?type=gene&acc=5394,,,5394.0,EXOSC10,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EXOSC10 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
456,2029500,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,56915,EXOSC5,https://ctdbase.org/detail.go?type=gene&acc=56915,,,56915.0,EXOSC5,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EXOSC5 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
457,2029501,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2132,EXT2,https://ctdbase.org/detail.go?type=gene&acc=2132,,,2132.0,EXT2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of EXT2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
458,2029502,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2146,EZH2,https://ctdbase.org/detail.go?type=gene&acc=2146,,,2146.0,EZH2,9606.0,Homo sapiens (human),[EZH2 protein results in decreased expression of ESR1 protein] which results in decreased susceptibility to tamoxifen,,,PMID:20306127,https://www.ncbi.nlm.nih.gov/pubmed/20306127,20306127,,
459,2029503,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2162,F13A1,https://ctdbase.org/detail.go?type=gene&acc=2162,,,2162.0,F13A1,9606.0,Homo sapiens (human),ESR2 protein affects the reaction [tamoxifen results in decreased expression of F13A1 mrna]|tamoxifen affects the expression of F13A1 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
460,2029504,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2147,F2,https://ctdbase.org/detail.go?type=gene&acc=2147,,,2147.0,F2,9606.0,Homo sapiens (human),Tamoxifen affects the expression of F2 protein,,,PMID:8200368,https://www.ncbi.nlm.nih.gov/pubmed/8200368,8200368,,
461,2029505,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2149,F2R,https://ctdbase.org/detail.go?type=gene&acc=2149,,,2149.0,F2R,9606.0,Homo sapiens (human),Tamoxifen affects the expression of F2R mrna|esr1 protein affects the reaction [tamoxifen results in decreased expression of F2R mrna],,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
462,2029506,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2152,F3,https://ctdbase.org/detail.go?type=gene&acc=2152,,,2152.0,F3,9606.0,Homo sapiens (human),Tamoxifen affects the expression of F3 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
463,2029507,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2152,F3,https://ctdbase.org/detail.go?type=gene&acc=2152,,,2152.0,F3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of F3 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
464,2029508,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2152,F3,https://ctdbase.org/detail.go?type=gene&acc=2152,,,2152.0,F3,8022.0,Oncorhynchus mykiss (rainbow trout),[estradiol co-treated with tamoxifen] results in decreased expression of F3 mRNA,,,PMID:17823450,https://www.ncbi.nlm.nih.gov/pubmed/17823450,17823450,,
465,2029509,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2155,F7,https://ctdbase.org/detail.go?type=gene&acc=2155,,,2155.0,F7,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of F7 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
466,2029510,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2157,F8,https://ctdbase.org/detail.go?type=gene&acc=2157,,,2157.0,F8,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of F8 protein,,,PMID:15850603,https://www.ncbi.nlm.nih.gov/pubmed/15850603,15850603,,
467,2029511,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2157,F8,https://ctdbase.org/detail.go?type=gene&acc=2157,,,2157.0,F8,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of F8 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
468,2029512,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2158,F9,https://ctdbase.org/detail.go?type=gene&acc=2158,,,2158.0,F9,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of F9 protein,,,PMID:15850603,https://www.ncbi.nlm.nih.gov/pubmed/15850603,15850603,,
469,2029513,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of FABP1 mRNA,,,PMID:15342952|PMID:17567588,https://www.ncbi.nlm.nih.gov/pubmed/15342952|https://www.ncbi.nlm.nih.gov/pubmed/17567588,15342952|17567588,,
470,2029514,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,10116.0,Rattus norvegicus (Norway rat),Tamoxifen results in decreased expression of FABP1 mRNA,,,PMID:19224547,https://www.ncbi.nlm.nih.gov/pubmed/19224547,19224547,,
471,2029515,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2169,FABP2,https://ctdbase.org/detail.go?type=gene&acc=2169,,,2169.0,FABP2,10116.0,Rattus norvegicus (Norway rat),[tamoxifen co-treated with bexarotene] results in decreased expression of FABP2 mrna|tamoxifen results in decreased expression of FABP2 mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
472,2029516,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2170,FABP3,https://ctdbase.org/detail.go?type=gene&acc=2170,,,2170.0,FABP3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FABP3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
473,2029517,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2170,FABP3,https://ctdbase.org/detail.go?type=gene&acc=2170,,,2170.0,FABP3,10116.0,Rattus norvegicus (Norway rat),[bexarotene co-treated with tamoxifen] results in increased expression of FABP3 mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
474,2029518,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FABP4 protein,,,PMID:27358406,https://www.ncbi.nlm.nih.gov/pubmed/27358406,27358406,,
475,2029519,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2173,FABP7,https://ctdbase.org/detail.go?type=gene&acc=2173,,,2173.0,FABP7,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FABP7 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
476,2029520,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8772,FADD,https://ctdbase.org/detail.go?type=gene&acc=8772,,,8772.0,FADD,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in decreased expression of FADD mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
477,2029521,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8772,FADD,https://ctdbase.org/detail.go?type=gene&acc=8772,,,8772.0,FADD,9606.0,Homo sapiens (human),Tamoxifen results in increased phosphorylation of FADD protein,,,PMID:16450001,https://www.ncbi.nlm.nih.gov/pubmed/16450001,16450001,,
478,2029522,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,3992,FADS1,https://ctdbase.org/detail.go?type=gene&acc=3992,,,3992.0,FADS1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FADS1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
479,2029523,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,3992,FADS1,https://ctdbase.org/detail.go?type=gene&acc=3992,,,3992.0,FADS1,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FADS1 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
480,2029524,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,3992,FADS1,https://ctdbase.org/detail.go?type=gene&acc=3992,,,3992.0,FADS1,10116.0,Rattus norvegicus (Norway rat),Tamoxifen results in decreased expression of FADS1 mRNA,,,PMID:28138993,https://www.ncbi.nlm.nih.gov/pubmed/28138993,28138993,,
481,2029525,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9415,FADS2,https://ctdbase.org/detail.go?type=gene&acc=9415,,,9415.0,FADS2,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FADS2 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
482,2029534,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9415,FADS2,https://ctdbase.org/detail.go?type=gene&acc=9415,,,9415.0,FADS2,10116.0,Rattus norvegicus (Norway rat),[tamoxifen co-treated with bexarotene] results in increased expression of FADS2 mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
483,2029535,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9415,FADS2,https://ctdbase.org/detail.go?type=gene&acc=9415,,,9415.0,FADS2,10116.0,Rattus norvegicus (Norway rat),Tamoxifen results in decreased expression of FADS2 mRNA,,,PMID:17630414|PMID:28138993,https://www.ncbi.nlm.nih.gov/pubmed/17630414|https://www.ncbi.nlm.nih.gov/pubmed/28138993,17630414|28138993,,
484,2029536,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,81889,FAHD1,https://ctdbase.org/detail.go?type=gene&acc=81889,,,81889.0,FAHD1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FAHD1 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
485,2029537,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,11170,FAM107A,https://ctdbase.org/detail.go?type=gene&acc=11170,,,11170.0,FAM107A,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FAM107A mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
486,2029538,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,83641,FAM107B,https://ctdbase.org/detail.go?type=gene&acc=83641,,,83641.0,FAM107B,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FAM107B mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
487,2029539,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,83541,FAM110A,https://ctdbase.org/detail.go?type=gene&acc=83541,,,83541.0,FAM110A,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FAM110A mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
488,2029540,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,90362,FAM110B,https://ctdbase.org/detail.go?type=gene&acc=90362,,,90362.0,FAM110B,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FAM110B mRNA,,,PMID:17555576|PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/17555576|https://www.ncbi.nlm.nih.gov/pubmed/25123088,17555576|25123088,,
489,2029541,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,642273,FAM110C,https://ctdbase.org/detail.go?type=gene&acc=642273,,,642273.0,FAM110C,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FAM110C mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
490,2029542,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,84498,FAM120B,https://ctdbase.org/detail.go?type=gene&acc=84498,,,84498.0,FAM120B,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FAM120B mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
491,2029551,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10144,FAM13A,https://ctdbase.org/detail.go?type=gene&acc=10144,,,10144.0,FAM13A,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FAM13A mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
492,2029552,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,338094,FAM151A,https://ctdbase.org/detail.go?type=gene&acc=338094,,,338094.0,FAM151A,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FAM151A mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
493,2029553,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,148753,FAM163A,https://ctdbase.org/detail.go?type=gene&acc=148753,,,148753.0,FAM163A,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FAM163A mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
494,2029554,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,165215,FAM171B,https://ctdbase.org/detail.go?type=gene&acc=165215,,,165215.0,FAM171B,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FAM171B mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
495,2029555,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,27146,FAM184B,https://ctdbase.org/detail.go?type=gene&acc=27146,,,27146.0,FAM184B,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FAM184B mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
496,2029556,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,131177,FAM3D,https://ctdbase.org/detail.go?type=gene&acc=131177,,,131177.0,FAM3D,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FAM3D mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
497,2029557,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9679,FAM53B,https://ctdbase.org/detail.go?type=gene&acc=9679,,,9679.0,FAM53B,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FAM53B mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
498,2029558,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,375061,FAM89A,https://ctdbase.org/detail.go?type=gene&acc=375061,,,375061.0,FAM89A,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FAM89A mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
499,2029559,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2175,FANCA,https://ctdbase.org/detail.go?type=gene&acc=2175,,,2175.0,FANCA,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FANCA mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
500,2029560,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2176,FANCC,https://ctdbase.org/detail.go?type=gene&acc=2176,,,2176.0,FANCC,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FANCC mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
501,2029582,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2191,FAP,https://ctdbase.org/detail.go?type=gene&acc=2191,,,2191.0,FAP,9606.0,Homo sapiens (human),Tamoxifen affects the expression of FAP mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
502,2029583,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10667,FARS2,https://ctdbase.org/detail.go?type=gene&acc=10667,,,10667.0,FARS2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FARS2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
503,2029584,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,14103,FASL,https://ctdbase.org/detail.go?type=gene&acc=14103,,,14103.0,Fasl,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FASL protein,,,PMID:12721755,https://www.ncbi.nlm.nih.gov/pubmed/12721755,12721755,,
504,2029585,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,14103,FASL,https://ctdbase.org/detail.go?type=gene&acc=14103,,,14103.0,Fasl,10116.0,Rattus norvegicus (Norway rat),[BCL2 co-treated with tamoxifen] results in increased expression of FASL protein,,,PMID:15606891,https://www.ncbi.nlm.nih.gov/pubmed/15606891,15606891,,
505,2029586,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [[tetradecanoylphorbol acetate co-treated with ionomycin co-treated with estradiol] results in decreased expression of FASLG mrna],,,PMID:20529085,https://www.ncbi.nlm.nih.gov/pubmed/20529085,20529085,,
506,2029587,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,9606.0,Homo sapiens (human),[tamoxifen results in increased expression of TGFB1 protein] which results in increased expression of FASLG mrna|tamoxifen results in decreased expression of FASLG mRNA,,,PMID:20145137,https://www.ncbi.nlm.nih.gov/pubmed/20145137,20145137,,
507,2029588,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of FASLG protein,,,PMID:12721755,https://www.ncbi.nlm.nih.gov/pubmed/12721755,12721755,,
508,2029589,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,10116.0,Rattus norvegicus (Norway rat),Tamoxifen inhibits the reaction [estradiol results in increased expression of FASLG protein],,,PMID:15545282,https://www.ncbi.nlm.nih.gov/pubmed/15545282,15545282,,
509,2029590,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FASN mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
510,2029591,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FASN mRNA,,,PMID:23038002,https://www.ncbi.nlm.nih.gov/pubmed/23038002,23038002,,
511,2029592,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,10116.0,Rattus norvegicus (Norway rat),[tamoxifen co-treated with bexarotene] results in increased expression of FASN mrna|tamoxifen results in increased expression of FASN mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
512,2029593,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,10116.0,Rattus norvegicus (Norway rat),Tamoxifen results in decreased expression of FASN mRNA,,,PMID:17630414|PMID:19224547,https://www.ncbi.nlm.nih.gov/pubmed/17630414|https://www.ncbi.nlm.nih.gov/pubmed/19224547,17630414|19224547,,
513,2029594,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,84893,FBH1,https://ctdbase.org/detail.go?type=gene&acc=84893,,,84893.0,FBH1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FBH1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
514,2029595,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2199,FBLN2,https://ctdbase.org/detail.go?type=gene&acc=2199,,,2199.0,FBLN2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FBLN2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
515,2029596,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10516,FBLN5,https://ctdbase.org/detail.go?type=gene&acc=10516,,,10516.0,FBLN5,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FBLN5 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
516,2029597,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,54850,FBXL12,https://ctdbase.org/detail.go?type=gene&acc=54850,,,54850.0,FBXL12,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FBXL12 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
517,2029598,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,26224,FBXL3,https://ctdbase.org/detail.go?type=gene&acc=26224,,,26224.0,FBXL3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FBXL3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
518,2029599,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,80204,FBXO11,https://ctdbase.org/detail.go?type=gene&acc=80204,,,80204.0,FBXO11,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FBXO11 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
519,2029600,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,23014,FBXO21,https://ctdbase.org/detail.go?type=gene&acc=23014,,,23014.0,FBXO21,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FBXO21 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
520,2029656,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,23291,FBXW11,https://ctdbase.org/detail.go?type=gene&acc=23291,,,23291.0,FBXW11,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FBXW11 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
521,2029657,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,6468,FBXW4,https://ctdbase.org/detail.go?type=gene&acc=6468,,,6468.0,FBXW4,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FBXW4 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
522,2029658,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2213,FCGR2B,https://ctdbase.org/detail.go?type=gene&acc=2213,,,2213.0,FCGR2B,10116.0,Rattus norvegicus (Norway rat),[bexarotene co-treated with tamoxifen] results in decreased expression of FCGR2B mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
523,2029659,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,14131,FCGR3,https://ctdbase.org/detail.go?type=gene&acc=14131,,,14131.0,Fcgr3,10116.0,Rattus norvegicus (Norway rat),[bexarotene co-treated with tamoxifen] results in decreased expression of FCGR3 mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
524,2029660,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9214,FCMR,https://ctdbase.org/detail.go?type=gene&acc=9214,,,9214.0,FCMR,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [EGF protein results in increased expression of FCMR mrna],,,PMID:24758408,https://www.ncbi.nlm.nih.gov/pubmed/24758408,24758408,,
525,2029661,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,14133,FCNA,https://ctdbase.org/detail.go?type=gene&acc=14133,,,14133.0,Fcna,10116.0,Rattus norvegicus (Norway rat),[bexarotene co-treated with tamoxifen] results in decreased expression of FCNA mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
526,2029662,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2237,FEN1,https://ctdbase.org/detail.go?type=gene&acc=2237,,,2237.0,FEN1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FEN1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
527,2029663,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,121512,FGD4,https://ctdbase.org/detail.go?type=gene&acc=121512,,,121512.0,FGD4,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FGD4 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
528,2029664,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,55785,FGD6,https://ctdbase.org/detail.go?type=gene&acc=55785,,,55785.0,FGD6,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in decreased expression of FGD6 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
529,2029665,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247.0,FGF2,9606.0,Homo sapiens (human),FGF2 protein results in decreased susceptibility to tamoxifen|tamoxifen inhibits the reaction [FGF2 protein results in increased expression of CCND1 protein],,,PMID:20179196,https://www.ncbi.nlm.nih.gov/pubmed/20179196,20179196,,
530,2029733,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,26291,FGF21,https://ctdbase.org/detail.go?type=gene&acc=26291,,,26291.0,FGF21,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FGF21 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
531,2029734,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2252,FGF7,https://ctdbase.org/detail.go?type=gene&acc=2252,,,2252.0,FGF7,7955.0,Danio rerio (zebrafish),Tamoxifen results in decreased expression of FGF7 mRNA,,,PMID:26908177,https://www.ncbi.nlm.nih.gov/pubmed/26908177,26908177,,
532,2029735,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2252,FGF7,https://ctdbase.org/detail.go?type=gene&acc=2252,,,2252.0,FGF7,9606.0,Homo sapiens (human),FGF7 results in decreased susceptibility to tamoxifen|fgfr2 inhibits the reaction [FGF7 results in decreased susceptibility to tamoxifen],,,PMID:18575591,https://www.ncbi.nlm.nih.gov/pubmed/18575591,18575591,,
533,2029736,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2254,FGF9,https://ctdbase.org/detail.go?type=gene&acc=2254,,,2254.0,FGF9,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FGF9 mRNA,,,PMID:24769059,https://www.ncbi.nlm.nih.gov/pubmed/24769059,24769059,,
534,2029737,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2260,FGFR1,https://ctdbase.org/detail.go?type=gene&acc=2260,,,2260.0,FGFR1,9606.0,Homo sapiens (human),FGFR1 protein results in decreased susceptibility to tamoxifen,,,PMID:20179196,https://www.ncbi.nlm.nih.gov/pubmed/20179196,20179196,,
535,2029738,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,26127,FGFR1OP2,https://ctdbase.org/detail.go?type=gene&acc=26127,,,26127.0,FGFR1OP2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FGFR1OP2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
536,2029739,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2263,FGFR2,https://ctdbase.org/detail.go?type=gene&acc=2263,,,2263.0,FGFR2,9606.0,Homo sapiens (human),FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to tamoxifen],,,PMID:18575591,https://www.ncbi.nlm.nih.gov/pubmed/18575591,18575591,,
537,2029740,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2263,FGFR2,https://ctdbase.org/detail.go?type=gene&acc=2263,,,2263.0,FGFR2,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in decreased expression of FGFR2 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
538,2029741,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2261,FGFR3,https://ctdbase.org/detail.go?type=gene&acc=2261,,,2261.0,FGFR3,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FGFR3 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
539,2029742,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,53834,FGFRL1,https://ctdbase.org/detail.go?type=gene&acc=53834,,,53834.0,FGFRL1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FGFRL1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
540,2029768,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,14194,FH1,https://ctdbase.org/detail.go?type=gene&acc=14194,,,14194.0,Fh1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FH1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
541,2029769,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2273,FHL1,https://ctdbase.org/detail.go?type=gene&acc=2273,,,2273.0,FHL1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FHL1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
542,2029770,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2273,FHL1,https://ctdbase.org/detail.go?type=gene&acc=2273,,,2273.0,FHL1,10116.0,Rattus norvegicus (Norway rat),Tamoxifen inhibits the reaction [estradiol results in decreased expression of FHL1 mrna],,,PMID:20149813,https://www.ncbi.nlm.nih.gov/pubmed/20149813,20149813,,
543,2029771,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2274,FHL2,https://ctdbase.org/detail.go?type=gene&acc=2274,,,2274.0,FHL2,9606.0,Homo sapiens (human),Tamoxifen affects the expression of FHL2 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
544,2029772,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2274,FHL2,https://ctdbase.org/detail.go?type=gene&acc=2274,,,2274.0,FHL2,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in decreased expression of FHL2 mrna|[tamoxifen co-treated with ESR1 protein] results in increased expression of FHL2 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
545,2029773,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2274,FHL2,https://ctdbase.org/detail.go?type=gene&acc=2274,,,2274.0,FHL2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FHL2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
546,2029774,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,9158,FIBP,https://ctdbase.org/detail.go?type=gene&acc=9158,,,9158.0,FIBP,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FIBP mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
547,2029775,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,11153,FICD,https://ctdbase.org/detail.go?type=gene&acc=11153,,,11153.0,FICD,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of FICD mRNA,,,PMID:15590111,https://www.ncbi.nlm.nih.gov/pubmed/15590111,15590111,,
548,2029776,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2281,FKBP1B,https://ctdbase.org/detail.go?type=gene&acc=2281,,,2281.0,FKBP1B,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FKBP1B mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
549,2029777,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2288,FKBP4,https://ctdbase.org/detail.go?type=gene&acc=2288,,,2288.0,FKBP4,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FKBP4 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
550,2029809,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2289,FKBP5,https://ctdbase.org/detail.go?type=gene&acc=2289,,,2289.0,FKBP5,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FKBP5 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
551,2029810,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,63943,FKBPL,https://ctdbase.org/detail.go?type=gene&acc=63943,,,63943.0,FKBPL,9606.0,Homo sapiens (human),FKBPL protein inhibits the reaction [tamoxifen results in increased phosphorylation of ESR1 protein]|fkbpl protein results in increased susceptibility to tamoxifen,,,PMID:20103631,https://www.ncbi.nlm.nih.gov/pubmed/20103631,20103631,,
552,2029811,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2317,FLNB,https://ctdbase.org/detail.go?type=gene&acc=2317,,,2317.0,FLNB,9606.0,Homo sapiens (human),Tamoxifen affects the expression of FLNB mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
553,2029812,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2317,FLNB,https://ctdbase.org/detail.go?type=gene&acc=2317,,,2317.0,FLNB,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in decreased expression of FLNB mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
554,2029813,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2317,FLNB,https://ctdbase.org/detail.go?type=gene&acc=2317,,,2317.0,FLNB,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FLNB mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
555,2029814,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2318,FLNC,https://ctdbase.org/detail.go?type=gene&acc=2318,,,2318.0,FLNC,9606.0,Homo sapiens (human),Tamoxifen affects the expression of FLNC mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
556,2029815,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10211,FLOT1,https://ctdbase.org/detail.go?type=gene&acc=10211,,,10211.0,FLOT1,9606.0,Homo sapiens (human),ESR1 protein affects the reaction [tamoxifen results in increased expression of FLOT1 mrna]|tamoxifen affects the expression of FLOT1 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
557,2029816,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10211,FLOT1,https://ctdbase.org/detail.go?type=gene&acc=10211,,,10211.0,FLOT1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FLOT1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
558,2029817,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,23769,FLRT1,https://ctdbase.org/detail.go?type=gene&acc=23769,,,23769.0,FLRT1,9606.0,Homo sapiens (human),Tamoxifen affects the expression of FLRT1 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
559,2029818,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,23769,FLRT1,https://ctdbase.org/detail.go?type=gene&acc=23769,,,23769.0,FLRT1,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FLRT1 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
560,2029819,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,114984,FLYWCH2,https://ctdbase.org/detail.go?type=gene&acc=114984,,,114984.0,FLYWCH2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FLYWCH2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
561,2029820,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,752,FMNL1,https://ctdbase.org/detail.go?type=gene&acc=752,,,752.0,FMNL1,9606.0,Homo sapiens (human),Tamoxifen affects the expression of FMNL1 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
562,2029821,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2326,FMO1,https://ctdbase.org/detail.go?type=gene&acc=2326,,,2326.0,FMO1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FMO1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
563,2029822,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2328,FMO3,https://ctdbase.org/detail.go?type=gene&acc=2328,,,2328.0,FMO3,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FMO3 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
564,2029823,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2329,FMO4,https://ctdbase.org/detail.go?type=gene&acc=2329,,,2329.0,FMO4,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FMO4 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
565,2029824,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2330,FMO5,https://ctdbase.org/detail.go?type=gene&acc=2330,,,2330.0,FMO5,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FMO5 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
566,2029825,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2332,FMR1,https://ctdbase.org/detail.go?type=gene&acc=2332,,,2332.0,FMR1,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FMR1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
567,2029826,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606.0,Homo sapiens (human),Tamoxifen affects the expression of FN1 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
568,2029827,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FN1 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
569,2029828,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,54874,FNBP1L,https://ctdbase.org/detail.go?type=gene&acc=54874,,,54874.0,FNBP1L,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FNBP1L mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
570,2029875,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,23360,FNBP4,https://ctdbase.org/detail.go?type=gene&acc=23360,,,23360.0,FNBP4,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FNBP4 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
571,2029876,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,64838,FNDC4,https://ctdbase.org/detail.go?type=gene&acc=64838,,,64838.0,FNDC4,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of FNDC4 mRNA,,,PMID:15342952|PMID:17175557,https://www.ncbi.nlm.nih.gov/pubmed/15342952|https://www.ncbi.nlm.nih.gov/pubmed/17175557,15342952|17175557,,
572,2029877,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [ESR2 protein binds to [[FOS protein binds to JUN protein] which binds to PTPRO promoter]],,,PMID:19095770,https://www.ncbi.nlm.nih.gov/pubmed/19095770,19095770,,
573,2029878,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [FOS protein binds to MMP1 promoter],,,PMID:17157789,https://www.ncbi.nlm.nih.gov/pubmed/17157789,17157789,,
574,2029879,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of FOS mRNA,,,PMID:19432593,https://www.ncbi.nlm.nih.gov/pubmed/19432593,19432593,,
575,2029880,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FOS mRNA,,,PMID:17555576|PMID:19400957,https://www.ncbi.nlm.nih.gov/pubmed/17555576|https://www.ncbi.nlm.nih.gov/pubmed/19400957,17555576|19400957,,
576,2029881,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10116.0,Rattus norvegicus (Norway rat),Tamoxifen results in increased expression of FOS mRNA,,,PMID:19400957,https://www.ncbi.nlm.nih.gov/pubmed/19400957,19400957,,
577,2029882,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,59729.0,Taeniopygia guttata (zebra finch),Tamoxifen results in decreased expression of FOS mRNA,,,PMID:19420261,https://www.ncbi.nlm.nih.gov/pubmed/19420261,19420261,,
578,2029883,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,394198,FOSAB,https://ctdbase.org/detail.go?type=gene&acc=394198,,,394198.0,fosab,7955.0,Danio rerio (zebrafish),Tamoxifen results in increased expression of FOSAB mRNA,,,PMID:26908177,https://www.ncbi.nlm.nih.gov/pubmed/26908177,26908177,,
579,2029884,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8061,FOSL1,https://ctdbase.org/detail.go?type=gene&acc=8061,,,8061.0,FOSL1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FOSL1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
580,2029885,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2355,FOSL2,https://ctdbase.org/detail.go?type=gene&acc=2355,,,2355.0,FOSL2,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in decreased expression of FOSL2 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
581,2029886,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,3169,FOXA1,https://ctdbase.org/detail.go?type=gene&acc=3169,,,3169.0,FOXA1,9606.0,Homo sapiens (human),FOXA1 protein affects the reaction [tamoxifen affects the activity of ESR1 protein],,,PMID:21151129,https://www.ncbi.nlm.nih.gov/pubmed/21151129,21151129,,
582,2029887,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,3169,FOXA1,https://ctdbase.org/detail.go?type=gene&acc=3169,,,3169.0,FOXA1,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of FOXA1 mRNA,,,PMID:27089845,https://www.ncbi.nlm.nih.gov/pubmed/27089845,27089845,,
583,2029888,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,3171,FOXA3,https://ctdbase.org/detail.go?type=gene&acc=3171,,,3171.0,FOXA3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FOXA3 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
584,2029889,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2296,FOXC1,https://ctdbase.org/detail.go?type=gene&acc=2296,,,2296.0,FOXC1,9606.0,Homo sapiens (human),Tamoxifen affects the expression of FOXC1 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
585,2029890,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,22887,FOXJ3,https://ctdbase.org/detail.go?type=gene&acc=22887,,,22887.0,FOXJ3,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FOXJ3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
586,2029891,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,668,FOXL2,https://ctdbase.org/detail.go?type=gene&acc=668,,,668.0,FOXL2,9606.0,Homo sapiens (human),FOXL2 protein inhibits the reaction [[tamoxifen results in increased activity of ESR1 protein] which results in increased expression of PTGS2 mrna]|tamoxifen promotes the reaction [ESR1 protein binds to FOXL2 protein],,,PMID:19797124,https://www.ncbi.nlm.nih.gov/pubmed/19797124,19797124,,
587,2029892,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,668,FOXL2,https://ctdbase.org/detail.go?type=gene&acc=668,,,668.0,FOXL2,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FOXL2 protein|tamoxifen results in decreased expression of FOXL2 mRNA,,,PMID:24769059,https://www.ncbi.nlm.nih.gov/pubmed/24769059,24769059,,
588,2029893,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2305,FOXM1,https://ctdbase.org/detail.go?type=gene&acc=2305,,,2305.0,FOXM1,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [HDAC1 protein binds to FOXM1 promoter]|esr1 protein promotes the reaction [tamoxifen results in decreased expression of FOXM1 protein]|tamoxifen promotes the reaction [HDAC2 protein binds to FOXM1 promoter]|foxm1 protein results in decreased susceptibility to tamoxifen|tamoxifen results in decreased expression of FOXM1 mrna|esr1 protein inhibits the reaction [tamoxifen results in decreased expression of FOXM1 mrna]|tamoxifen results in decreased expression of FOXM1 protein|foxm1 protein affects the reaction [ESR1 protein results in increased susceptibility to tamoxifen],,,PMID:20208560,https://www.ncbi.nlm.nih.gov/pubmed/20208560,20208560,,
589,2029949,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2305,FOXM1,https://ctdbase.org/detail.go?type=gene&acc=2305,,,2305.0,FOXM1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol promotes the reaction [[ESR1 protein binds to FOXM1 promoter] which results in increased expression of FOXM1 mrna]],,,PMID:20208560,https://www.ncbi.nlm.nih.gov/pubmed/20208560,20208560|20208560,,
590,2029950,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1112,FOXN3,https://ctdbase.org/detail.go?type=gene&acc=1112,,,1112.0,FOXN3,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of FOXN3 mRNA,,,PMID:15849065,https://www.ncbi.nlm.nih.gov/pubmed/15849065,15849065,,
591,2029951,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,9606.0,Homo sapiens (human),Tamoxifen affects the expression of FOXO1 mrna|esr1 protein affects the reaction [tamoxifen results in increased expression of FOXO1 mrna],,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
592,2029952,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in decreased expression of FOXO1 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
593,2029953,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FOXO1 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
594,2029954,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,9606.0,Homo sapiens (human),Tamoxifen affects the localization of FOXO3 protein|gper1 protein affects the reaction [tamoxifen affects the localization of FOXO3 protein],,,PMID:26470790,https://www.ncbi.nlm.nih.gov/pubmed/26470790,26470790,,
595,2029955,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FOXO3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
596,2029956,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,50943,FOXP3,https://ctdbase.org/detail.go?type=gene&acc=50943,,,50943.0,FOXP3,9606.0,Homo sapiens (human),TGFB1 protein promotes the reaction [tamoxifen results in increased expression of FOXP3 mrna]|tamoxifen results in increased expression of FOXP3 mRNA,,,PMID:20145137,https://www.ncbi.nlm.nih.gov/pubmed/20145137,20145137,,
597,2029957,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,94234,FOXQ1,https://ctdbase.org/detail.go?type=gene&acc=94234,,,94234.0,FOXQ1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FOXQ1 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
598,2030014,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2356,FPGS,https://ctdbase.org/detail.go?type=gene&acc=2356,,,2356.0,FPGS,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FPGS mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
599,2030015,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2358,FPR2,https://ctdbase.org/detail.go?type=gene&acc=2358,,,2358.0,FPR2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FPR2 mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
600,2030016,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,83786,FRMD8,https://ctdbase.org/detail.go?type=gene&acc=83786,,,83786.0,FRMD8,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FRMD8 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
601,2030017,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2487,FRZB,https://ctdbase.org/detail.go?type=gene&acc=2487,,,2487.0,FRZB,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FRZB mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
602,2030018,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,6624,FSCN1,https://ctdbase.org/detail.go?type=gene&acc=6624,,,6624.0,FSCN1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FSCN1 mRNA,,,PMID:17555576|PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/17555576|https://www.ncbi.nlm.nih.gov/pubmed/20937368,17555576|20937368,,
603,2030019,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,29999,FSCN3,https://ctdbase.org/detail.go?type=gene&acc=29999,,,29999.0,FSCN3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FSCN3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
604,2030020,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of FSHB protein,,,PMID:9208491,https://www.ncbi.nlm.nih.gov/pubmed/9208491,9208491,,
605,2030021,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116.0,Rattus norvegicus (Norway rat),Tamoxifen results in decreased secretion of FSHB protein|tamoxifen results in decreased expression of FSHB mRNA,,,PMID:27395752,https://www.ncbi.nlm.nih.gov/pubmed/27395752,27395752,,
606,2030022,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,175797.0,Silurus meridionalis,Tamoxifen results in decreased expression of FSHB mRNA,,,PMID:19152838,https://www.ncbi.nlm.nih.gov/pubmed/19152838,19152838,,
607,2030023,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,8355.0,Xenopus laevis (African clawed frog),Tamoxifen results in increased expression of FSHB mRNA,,,PMID:16330033,https://www.ncbi.nlm.nih.gov/pubmed/16330033,16330033,,
608,2030024,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10468,FST,https://ctdbase.org/detail.go?type=gene&acc=10468,,,10468.0,FST,9606.0,Homo sapiens (human),Tamoxifen affects the expression of FST mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
609,2030025,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10468,FST,https://ctdbase.org/detail.go?type=gene&acc=10468,,,10468.0,FST,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in decreased expression of FST mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
610,2030026,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10468,FST,https://ctdbase.org/detail.go?type=gene&acc=10468,,,10468.0,FST,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of FST mRNA,,,PMID:16298037,https://www.ncbi.nlm.nih.gov/pubmed/16298037,16298037,,
611,2030027,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8880,FUBP1,https://ctdbase.org/detail.go?type=gene&acc=8880,,,8880.0,FUBP1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FUBP1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
612,2030028,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2517,FUCA1,https://ctdbase.org/detail.go?type=gene&acc=2517,,,2517.0,FUCA1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FUCA1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
613,2030029,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2521,FUS,https://ctdbase.org/detail.go?type=gene&acc=2521,,,2521.0,FUS,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of FUS mRNA,,,PMID:16202921,https://www.ncbi.nlm.nih.gov/pubmed/16202921,16202921,,
614,2030030,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,84750,FUT10,https://ctdbase.org/detail.go?type=gene&acc=84750,,,84750.0,FUT10,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FUT10 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
615,2030031,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2530,FUT8,https://ctdbase.org/detail.go?type=gene&acc=2530,,,2530.0,FUT8,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FUT8 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
616,2030032,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10690,FUT9,https://ctdbase.org/detail.go?type=gene&acc=10690,,,10690.0,FUT9,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in increased expression of FUT9 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
617,2030033,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,53828,FXYD4,https://ctdbase.org/detail.go?type=gene&acc=53828,,,53828.0,FXYD4,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FXYD4 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
618,2030092,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2535,FZD2,https://ctdbase.org/detail.go?type=gene&acc=2535,,,2535.0,FZD2,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FZD2 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
619,2030093,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8323,FZD6,https://ctdbase.org/detail.go?type=gene&acc=8323,,,8323.0,FZD6,9606.0,Homo sapiens (human),Tamoxifen affects the expression of FZD6 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
620,2030094,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8324,FZD7,https://ctdbase.org/detail.go?type=gene&acc=8324,,,8324.0,FZD7,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FZD7 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
621,2030095,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8324,FZD7,https://ctdbase.org/detail.go?type=gene&acc=8324,,,8324.0,FZD7,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of FZD7 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
622,2030096,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8325,FZD8,https://ctdbase.org/detail.go?type=gene&acc=8325,,,8325.0,FZD8,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of FZD8 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
623,2030097,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,51343,FZR1,https://ctdbase.org/detail.go?type=gene&acc=51343,,,51343.0,FZR1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of FZR1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
624,2030098,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,50486,G0S2,https://ctdbase.org/detail.go?type=gene&acc=50486,,,50486.0,G0S2,9606.0,Homo sapiens (human),ESR1 protein affects the reaction [tamoxifen results in increased expression of G0S2 mrna]|tamoxifen affects the expression of G0S2 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
625,2030099,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,50486,G0S2,https://ctdbase.org/detail.go?type=gene&acc=50486,,,50486.0,G0S2,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR1 protein] results in increased expression of G0S2 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
626,2030100,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,50486,G0S2,https://ctdbase.org/detail.go?type=gene&acc=50486,,,50486.0,G0S2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of G0S2 mRNA,,,PMID:17555576|PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/17555576|https://www.ncbi.nlm.nih.gov/pubmed/20937368,17555576|20937368,,
627,2030101,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,50486,G0S2,https://ctdbase.org/detail.go?type=gene&acc=50486,,,50486.0,G0S2,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of G0S2 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
628,2030138,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,9606.0,Homo sapiens (human),Tamoxifen affects the expression of G6PD mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
629,2030139,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,14381,G6PDX,https://ctdbase.org/detail.go?type=gene&acc=14381,,,14381.0,G6pdx,10116.0,Rattus norvegicus (Norway rat),Tamoxifen results in increased expression of G6PDX mRNA,,,PMID:19224547,https://www.ncbi.nlm.nih.gov/pubmed/19224547,19224547,,
630,2030140,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2549,GAB1,https://ctdbase.org/detail.go?type=gene&acc=2549,,,2549.0,GAB1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GAB1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
631,2030141,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2571,GAD1,https://ctdbase.org/detail.go?type=gene&acc=2571,,,2571.0,GAD1,9606.0,Homo sapiens (human),[tamoxifen co-treated with ESR2 protein] results in increased expression of GAD1 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
632,2030142,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2572,GAD2,https://ctdbase.org/detail.go?type=gene&acc=2572,,,2572.0,GAD2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GAD2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
633,2030143,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2572,GAD2,https://ctdbase.org/detail.go?type=gene&acc=2572,,,2572.0,GAD2,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of GAD2 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
634,2030144,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [EGF protein results in increased expression of GADD45A mrna],,,PMID:24758408,https://www.ncbi.nlm.nih.gov/pubmed/24758408,24758408,,
635,2030145,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of GADD45A mRNA,,,PMID:15604281|PMID:20549698,https://www.ncbi.nlm.nih.gov/pubmed/15604281|https://www.ncbi.nlm.nih.gov/pubmed/20549698,15604281|20549698,,
636,2030146,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606.0,Homo sapiens (human),TP53 protein promotes the reaction [tamoxifen results in increased expression of GADD45A mrna],,,PMID:20549698,https://www.ncbi.nlm.nih.gov/pubmed/20549698,20549698,,
637,2030147,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GADD45A mRNA,,,PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/20937368,20937368,,
638,2030179,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,10090.0,Mus musculus (house mouse),Tamoxifen results in decreased expression of GADD45A mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
639,2030180,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,10912,GADD45G,https://ctdbase.org/detail.go?type=gene&acc=10912,,,10912.0,GADD45G,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GADD45G mRNA,,,PMID:17555576|PMID:20937368,https://www.ncbi.nlm.nih.gov/pubmed/17555576|https://www.ncbi.nlm.nih.gov/pubmed/20937368,17555576|20937368,,
640,2030181,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,51083,GAL,https://ctdbase.org/detail.go?type=gene&acc=51083,,,51083.0,GAL,9606.0,Homo sapiens (human),Tamoxifen results in decreased expression of GAL mRNA,,,PMID:15590111,https://www.ncbi.nlm.nih.gov/pubmed/15590111,15590111,,
641,2030182,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2581,GALC,https://ctdbase.org/detail.go?type=gene&acc=2581,,,2581.0,GALC,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GALC mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
642,2030183,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2588,GALNS,https://ctdbase.org/detail.go?type=gene&acc=2588,,,2588.0,GALNS,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GALNS mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
643,2030184,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,55568,GALNT10,https://ctdbase.org/detail.go?type=gene&acc=55568,,,55568.0,GALNT10,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of GALNT10 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
644,2030185,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2590,GALNT2,https://ctdbase.org/detail.go?type=gene&acc=2590,,,2590.0,GALNT2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GALNT2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
645,2030186,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2591,GALNT3,https://ctdbase.org/detail.go?type=gene&acc=2591,,,2591.0,GALNT3,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GALNT3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
646,2030187,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2592,GALT,https://ctdbase.org/detail.go?type=gene&acc=2592,,,2592.0,GALT,9606.0,Homo sapiens (human),Tamoxifen affects the expression of GALT mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
647,2030188,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2592,GALT,https://ctdbase.org/detail.go?type=gene&acc=2592,,,2592.0,GALT,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GALT mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
648,2030284,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,23193,GANAB,https://ctdbase.org/detail.go?type=gene&acc=23193,,,23193.0,GANAB,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GANAB mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
649,2030285,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2618,GART,https://ctdbase.org/detail.go?type=gene&acc=2618,,,2618.0,GART,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GART mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
650,2030286,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2619,GAS1,https://ctdbase.org/detail.go?type=gene&acc=2619,,,2619.0,GAS1,9606.0,Homo sapiens (human),Tamoxifen affects the expression of GAS1 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
651,2030287,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2619,GAS1,https://ctdbase.org/detail.go?type=gene&acc=2619,,,2619.0,GAS1,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GAS1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
652,2030288,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2621,GAS6,https://ctdbase.org/detail.go?type=gene&acc=2621,,,2621.0,GAS6,9606.0,Homo sapiens (human),Tamoxifen results in increased expression of GAS6 mrna|fulvestrant inhibits the reaction [tamoxifen results in increased expression of GAS6 mrna],,,PMID:19429434,https://www.ncbi.nlm.nih.gov/pubmed/19429434,19429434,,
653,2030289,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2621,GAS6,https://ctdbase.org/detail.go?type=gene&acc=2621,,,2621.0,GAS6,10116.0,Rattus norvegicus (Norway rat),[bexarotene co-treated with tamoxifen] results in decreased expression of GAS6 mRNA,,,PMID:17630414,https://www.ncbi.nlm.nih.gov/pubmed/17630414,17630414,,
654,2030290,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,8522,GAS7,https://ctdbase.org/detail.go?type=gene&acc=8522,,,8522.0,GAS7,10090.0,Mus musculus (house mouse),Tamoxifen results in increased expression of GAS7 mRNA,,,PMID:25123088,https://www.ncbi.nlm.nih.gov/pubmed/25123088,25123088,,
655,2030291,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2624,GATA2,https://ctdbase.org/detail.go?type=gene&acc=2624,,,2624.0,GATA2,9606.0,Homo sapiens (human),Tamoxifen affects the expression of GATA2 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
656,2030292,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2624,GATA2,https://ctdbase.org/detail.go?type=gene&acc=2624,,,2624.0,GATA2,10090.0,Mus musculus (house mouse),Tamoxifen affects the expression of GATA2 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
657,2030293,20057167,Comparative Toxicogenomics Database (CTD),"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylate",D013629,Tamoxifen,https://ctdbase.org/detail.go?type=chem&acc=D013629,2625,GATA3,https://ctdbase.org/detail.go?type=gene&acc=2625,,,2625.0,GATA3,9606.0,Homo sapiens (human),ESR1 protein affects the reaction [GATA3 protein affects the susceptibility to tamoxifen],,,PMID:19084267,https://www.ncbi.nlm.nih.gov/pubmed/19084267,19084267,,
658,2029966,21192814,BindingDB,"5-Fluoro-2-thiophen-2-yl-1,2-dihydroquinazolin-4-amine",36395,"5-Fluoro-2-thiophen-2-yl-1,2-dihydroquinazolin-4-amine, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36395,437,"Nitric oxide synthase, endothelial",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=437,P29474,"Nitric oxide synthase, endothelial",4846.0,NOS3,9606.0,Homo sapiens (human),,IC50 (nM),2.5e+3,PMID:18849972|DOI:10.1038/nchembio.115,https://www.ncbi.nlm.nih.gov/pubmed/18849972|https://doi.org/10.1038/nchembio.115,18849972,10.1038/nchembio.115,
659,2029967,21192814,BindingDB,"5-Fluoro-2-thiophen-2-yl-1,2-dihydroquinazolin-4-amine",36395,"5-Fluoro-2-thiophen-2-yl-1,2-dihydroquinazolin-4-amine, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36395,3611,"Nitric oxide synthase, brain",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3611,P29475,"Nitric oxide synthase, brain",4842.0,NOS1,9606.0,Homo sapiens (human),,IC50 (nM),1.0e+3,PMID:18849972|DOI:10.1038/nchembio.115,https://www.ncbi.nlm.nih.gov/pubmed/18849972|https://doi.org/10.1038/nchembio.115,18849972,10.1038/nchembio.115,
660,2029968,21250674,BindingDB,,14397,"5-(5-acetyl-2-ethoxyphenyl)-1-methyl-3-propyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14397,1540,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1540,P54827,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",403911.0,PDE6G,9615.0,Canis lupus familiaris (dog),,IC50 (nM),0.9,PMID:16759100|DOI:10.1021/jm060113e,https://www.ncbi.nlm.nih.gov/pubmed/16759100|https://doi.org/10.1021/jm060113e,16759100,10.1021/jm060113e,
661,2029969,21250674,BindingDB,,14397,"5-(5-acetyl-2-ethoxyphenyl)-1-methyl-3-propyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14397,5066,"cGMP-specific 3',5'-cyclic phosphodiesterase",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5066,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",8654.0,PDE5A,9606.0,Homo sapiens (human),,IC50 (nM),17,PMID:16759100|DOI:10.1021/jm060113e,https://www.ncbi.nlm.nih.gov/pubmed/16759100|https://doi.org/10.1021/jm060113e,16759100,10.1021/jm060113e,
662,2029970,21363056,BindingDB,"(1S,2R,4aS,6aS,6bR,10R,11R,12aR,12bR,14bS)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid",23199,"(1S,2R,4aS,6aS,6bR,10R,11R,12aR,12bR,14bS)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23199,2338,"Glycogen phosphorylase, muscle form",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2338,P00489,"Glycogen phosphorylase, muscle form",100008972.0,PYGM,9986.0,Oryctolagus cuniculus (rabbit),,IC50 (nM),20000,PMID:18517260|DOI:10.1021/jm8000949,https://www.ncbi.nlm.nih.gov/pubmed/18517260|https://doi.org/10.1021/jm8000949,18517260,10.1021/jm8000949,
663,2029971,21397854,Therapeutic Target Database (TTD),4-tert-butyl-N-hydroxybenzamide,D03FOD,4-tert-butyl-N-hydroxybenzamide,https://idrblab.net/ttd/data/drug/details/D03FOD,T68547,Histone deacetylase 1 (HDAC1),https://idrblab.net/ttd/data/target/details/T68547,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
664,2029972,21428850,BindingDB,"4-Chloro-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide",36419,"4-Chloro-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide, 50",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36419,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),,IC50 (nM),55,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
665,2030041,21428850,BindingDB,"4-Chloro-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide",36419,"4-Chloro-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide, 50",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36419,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),,IC50 (nM),130,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
666,2030042,21428850,BindingDB,"4-Chloro-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide",36419,"4-Chloro-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide, 50",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36419,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),,IC50 (nM),910,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
667,2030043,21428850,BindingDB,"4-Chloro-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide",36419,"4-Chloro-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide, 50",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36419,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),,,,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
668,2030044,21428850,BindingDB,"4-Chloro-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide",36419,"4-Chloro-N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)benzamide, 50",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36419,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),,,,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
669,2030045,21428857,BindingDB,"N-(2-(4-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)furan-2-carboxamide",36424,CID21428857,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36424,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),,IC50 (nM),360,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
670,2030046,21428857,BindingDB,"N-(2-(4-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)furan-2-carboxamide",36424,CID21428857,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36424,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),,,,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
671,2030047,21428857,BindingDB,"N-(2-(4-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)furan-2-carboxamide",36424,CID21428857,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36424,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),,IC50 (nM),1400,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
672,2030048,21428857,BindingDB,"N-(2-(4-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)furan-2-carboxamide",36424,CID21428857,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36424,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),,IC50 (nM),790,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
673,2012764,23664719,Toxin and Toxin Target Database (T3DB),Monosodium methanearsonate,T3D0309,"Methylarsonic acid, monosodium salt",http://www.t3db.ca/toxins/T3D0309,BE0001388,Tubulin alpha-1C chain,http://www.t3db.ca/biodb/bio_entities/BE0001388,Q9BQE3,Tubulin alpha-1C chain,84790.0,TUBA1C,9606.0,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
674,2029867,24689999,Therapeutic Target Database (TTD),N-hydroxy-2-(naphthalen-2-yl)acetamide,D0KB6Q,N-Hydroxy-2-naphthalen-2-yl-acetamide,https://idrblab.net/ttd/data/drug/details/D0KB6Q,T00140,Arachidonate 5-lipoxygenase (5-LOX),https://idrblab.net/ttd/data/target/details/T00140,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
675,2029868,24749070,Therapeutic Target Database (TTD),Mycophenolic hydroxamic acid,D01LDQ,Mycophenolic hydroxamic acid,https://idrblab.net/ttd/data/drug/details/D01LDQ,T97713,Amidophosphoribosyltransferase (PPAT),https://idrblab.net/ttd/data/target/details/T97713,Q06203,Amidophosphoribosyltransferase,5471.0,PPAT,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
676,2029869,24749070,Therapeutic Target Database (TTD),Mycophenolic hydroxamic acid,D01LDQ,Mycophenolic hydroxamic acid,https://idrblab.net/ttd/data/drug/details/D01LDQ,T89360,Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2),https://idrblab.net/ttd/data/target/details/T89360,P12268,Inosine-5'-monophosphate dehydrogenase 2,3615.0,IMPDH2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
677,2029862,24780383,IUPHAR/BPS Guide to PHARMACOLOGY,"N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)pyridin-2-yl]-N-methyl-6-(trifluoromethyl)pyridine-3-carboxamide",5616,ATL802,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5616,21,A3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=21,,,11542.0,Adora3,10090.0,Mus musculus (house mouse),Antagonist,pKi,5,PMID:10737749,https://www.ncbi.nlm.nih.gov/pubmed/10737749,10737749,,
678,2029863,24780383,IUPHAR/BPS Guide to PHARMACOLOGY,"N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)pyridin-2-yl]-N-methyl-6-(trifluoromethyl)pyridine-3-carboxamide",5616,ATL802,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5616,21,A3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=21,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),Antagonist,pKi,6,PMID:10737749,https://www.ncbi.nlm.nih.gov/pubmed/10737749,10737749,,
679,2029864,24785538,Drug Gene Interaction database (DGIdb),Bms-754807,,BMS-754807,https://www.dgidb.org/drugs/drugbank:DB15399,,AKT1,https://www.dgidb.org/genes/hgnc:391,,,207.0,AKT1,9606.0,Homo sapiens (human),,,,,,,,
680,2029865,24788740,Drug Gene Interaction database (DGIdb),Ipatasertib,,IPATASERTIB,https://www.dgidb.org/drugs/ncit:C91072,,FLT3,https://www.dgidb.org/genes/hgnc:3765,,,2322.0,FLT3,9606.0,Homo sapiens (human),,,,,,,,
681,2029866,24788740,Drug Gene Interaction database (DGIdb),Ipatasertib,,IPATASERTIB,https://www.dgidb.org/drugs/ncit:C91072,,PIK3CA,https://www.dgidb.org/genes/hgnc:8975,,,5290.0,PIK3CA,9606.0,Homo sapiens (human),,,,,,,,
682,2029870,24788740,Drug Gene Interaction database (DGIdb),Ipatasertib,,IPATASERTIB,https://www.dgidb.org/drugs/ncit:C91072,,AKT1,https://www.dgidb.org/genes/hgnc:391,,,207.0,AKT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
683,2029871,24788740,Drug Gene Interaction database (DGIdb),Ipatasertib,,IPATASERTIB,https://www.dgidb.org/drugs/ncit:C91072,,AKT3,https://www.dgidb.org/genes/hgnc:393,,,10000.0,AKT3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
684,2029872,24795069,Drug Gene Interaction database (DGIdb),Valbenazine,,VALBENAZINE,https://www.dgidb.org/drugs/rxcui:1918219,,SLC18A2,https://www.dgidb.org/genes/hgnc:10935,,,6571.0,SLC18A2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
685,2029873,24795070,IUPHAR/BPS Guide to PHARMACOLOGY,"N-[(1-methylpiperidin-4-yl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine",8784,SGI-1776,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8784,2028,histone H3 associated protein kinase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2028,Q8TF76,Serine/threonine-protein kinase haspin,83903.0,HASPIN,9606.0,Homo sapiens (human),Inhibition,pIC50,7.47,PMID:22924342,https://www.ncbi.nlm.nih.gov/pubmed/22924342,22924342,,
686,2029874,24796254,Therapeutic Target Database (TTD),4-formylphenyl-O-beta-D-ribopyranoside,D0FS3L,4-formylphenyl-O-beta-D-ribopyranoside,https://idrblab.net/ttd/data/drug/details/D0FS3L,T30082,Acetylcholinesterase (AChE),https://idrblab.net/ttd/data/target/details/T30082,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
687,2029940,24808495,BindingDB,"(3,3-Dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",32522,"pyridine amide, 30",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=32522,4019,"11-beta-hydroxysteroid dehydrogenase 1 [23-292,A23S,F278E]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4019,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),0.1,PMID:18485702|DOI:10.1016/j.bmcl.2008.04.069,https://www.ncbi.nlm.nih.gov/pubmed/18485702|https://doi.org/10.1016/j.bmcl.2008.04.069,18485702,10.1016/j.bmcl.2008.04.069,
688,2029941,24812720,BindingDB,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,32573,CHEMBL427896,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=32573,4020,"11-beta-hydroxysteroid dehydrogenase 1 [24-292,C272S]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4020,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606.0,Homo sapiens (human),,IC50 (nM),3,PMID:18511278|DOI:10.1016/j.bmcl.2008.05.025,https://www.ncbi.nlm.nih.gov/pubmed/18511278|https://doi.org/10.1016/j.bmcl.2008.05.025,18511278,10.1016/j.bmcl.2008.05.025,
689,2029942,24812720,BindingDB,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,32573,CHEMBL427896,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=32573,1408,11-beta-hydroxysteroid dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1408,P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,15483.0,Hsd11b1,10090.0,Mus musculus (house mouse),,IC50 (nM),53,PMID:18511278|DOI:10.1016/j.bmcl.2008.05.025,https://www.ncbi.nlm.nih.gov/pubmed/18511278|https://doi.org/10.1016/j.bmcl.2008.05.025,18511278,10.1016/j.bmcl.2008.05.025,
690,2029943,24821094,IUPHAR/BPS Guide to PHARMACOLOGY,Ibrutinib,6912,ibrutinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6912,2026,"FYN proto-oncogene, Src family tyrosine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2026,P06241,Tyrosine-protein kinase Fyn,2534.0,FYN,9606.0,Homo sapiens (human),Inhibition,pIC50,7.54,PMID:26641137,https://www.ncbi.nlm.nih.gov/pubmed/26641137,26641137,,
691,2029944,24821094,IUPHAR/BPS Guide to PHARMACOLOGY,Ibrutinib,6912,ibrutinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6912,2019,erb-b2 receptor tyrosine kinase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2019,P04626,Receptor tyrosine-protein kinase erbB-2,2064.0,ERBB2,9606.0,Homo sapiens (human),Inhibition,pIC50,8.19,PMID:26641137,https://www.ncbi.nlm.nih.gov/pubmed/26641137,26641137,,
692,2029945,24821094,IUPHAR/BPS Guide to PHARMACOLOGY,Ibrutinib,6912,ibrutinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6912,2032,"HCK proto-oncogene, Src family tyrosine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2032,P08631,Tyrosine-protein kinase HCK,3055.0,HCK,9606.0,Homo sapiens (human),Inhibition,pIC50,7.54,PMID:26641137,https://www.ncbi.nlm.nih.gov/pubmed/26641137,26641137,,
693,2029946,24821094,IUPHAR/BPS Guide to PHARMACOLOGY,Ibrutinib,6912,ibrutinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6912,2046,IL2 inducible T cell kinase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2046,Q08881,Tyrosine-protein kinase ITK/TSK,3702.0,ITK,9606.0,Homo sapiens (human),Inhibition,pIC50,8.31,PMID:26641137,https://www.ncbi.nlm.nih.gov/pubmed/26641137,26641137,,
694,2029947,24821094,IUPHAR/BPS Guide to PHARMACOLOGY,Ibrutinib,6912,ibrutinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6912,2060,"LYN proto-oncogene, Src family tyrosine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2060,P07948,Tyrosine-protein kinase Lyn,4067.0,LYN,9606.0,Homo sapiens (human),Inhibition,pIC50,7.7,PMID:26641137,https://www.ncbi.nlm.nih.gov/pubmed/26641137,26641137,,
695,2029948,24821094,IUPHAR/BPS Guide to PHARMACOLOGY,Ibrutinib,6912,ibrutinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6912,2053,"LCK proto-oncogene, Src family tyrosine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2053,P06239,Tyrosine-protein kinase Lck,3932.0,LCK,9606.0,Homo sapiens (human),Inhibition,pIC50,8.2,PMID:26641137,https://www.ncbi.nlm.nih.gov/pubmed/26641137,26641137,,
696,2029778,24967374,BindingDB,"20-[2-(Benzyloxy)ethoxy]-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",24956,"20-[2-(benzyloxy)ethoxy]-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24956,6817,Mitogen-activated protein kinase kinase kinase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6817,P80192,Mitogen-activated protein kinase kinase kinase 9,4293.0,MAP3K9,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
697,2029779,24967374,BindingDB,"20-[2-(Benzyloxy)ethoxy]-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",24956,"20-[2-(benzyloxy)ethoxy]-3-(2-hydroxyethyl)-3,13-diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1,4,6,8,10,15,17,19,21-nonaen-14-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24956,50001795,Mitogen-activated protein kinase kinase kinase 11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001795,Q16584,Mitogen-activated protein kinase kinase kinase 11,4296.0,MAP3K11,9606.0,Homo sapiens (human),,,,PMID:18714982|DOI:10.1021/jm8005838,https://www.ncbi.nlm.nih.gov/pubmed/18714982|https://doi.org/10.1021/jm8005838,18714982,10.1021/jm8005838,
698,2029780,24970878,Comparative Toxicogenomics Database (CTD),Cl-amidine,C558727,N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide,https://ctdbase.org/detail.go?type=chem&acc=C558727,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,9606.0,Homo sapiens (human),N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide inhibits the reaction [dieldrin results in increased expression of FOS mrna],,,PMID:31068361,https://www.ncbi.nlm.nih.gov/pubmed/31068361,31068361,,
699,2029781,24971312,BindingDB,"5-Chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile",24632,"5-chloro-7-(propan-2-ylamino)pyrazolo[1,5-a]pyrimidine-3-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24632,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),1500,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
700,2029782,24971313,BindingDB,"5-[(4-Aminocyclohexyl)amino]-7-(propan-2-ylamino)pyrazolo[1,5-A]pyrimidine-3-carbonitrile",24633,"5-[(4-aminocyclohexyl)amino]-7-(propan-2-ylamino)pyrazolo[1,5-a]pyrimidine-3-carbonitrile",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24633,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),30,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
701,2029783,24971314,BindingDB,4-amino-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,24638,4-amino-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24638,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),85000,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
702,2029784,24971315,BindingDB,N-(4-fluorophenyl)-4-(2-hydroxyacetamido)-1H-pyrazole-3-carboxamide,24640,N-(4-fluorophenyl)-4-(2-hydroxyacetamido)-1H-pyrazole-3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24640,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),730,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
703,2029829,24971316,BindingDB,N-(4-fluorophenyl)-4-(2-phenylacetamido)-1H-pyrazole-3-carboxamide,24641,N-(4-fluorophenyl)-4-(2-phenylacetamido)-1H-pyrazole-3-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24641,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),1600,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
704,2029830,24971317,BindingDB,"Pyrazole diamide, 21",24642,"4-N-cyclohexane-3-N-(4-fluorophenyl)-1H-pyrazole-3,4-diamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24642,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),90,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
705,2029831,24971318,BindingDB,"Pyrazole diamide, 24",24645,"3-N-(cyclopropylmethyl)-4-N-(2,6-difluorobenzene)-1H-pyrazole-3,4-diamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24645,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),25,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
706,2029832,24971319,BindingDB,"Pyrazole diamide, 25",24646,"3-N-cyclohexyl-4-N-(2,6-difluorobenzene)-1H-pyrazole-3,4-diamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24646,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),12,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
707,2029833,24971319,BindingDB,"Pyrazole diamide, 25",24646,"3-N-cyclohexyl-4-N-(2,6-difluorobenzene)-1H-pyrazole-3,4-diamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24646,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),55,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
708,2029834,24971320,BindingDB,"Pyrazole diamide, 26",24647,"4-N-(2,6-difluorobenzene)-3-N-(4-hydroxycyclohexyl)-1H-pyrazole-3,4-diamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24647,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),45,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
709,2029835,24971320,BindingDB,"Pyrazole diamide, 26",24647,"4-N-(2,6-difluorobenzene)-3-N-(4-hydroxycyclohexyl)-1H-pyrazole-3,4-diamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24647,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),19,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
710,2029836,24971321,BindingDB,"Pyrazole diamide, 27",24648,"3-N-(4-aminocyclohexyl)-4-N-(2,6-difluorobenzene)-1H-pyrazole-3,4-diamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24648,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),38,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
711,2029854,24971321,BindingDB,"Pyrazole diamide, 27",24648,"3-N-(4-aminocyclohexyl)-4-N-(2,6-difluorobenzene)-1H-pyrazole-3,4-diamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24648,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),440,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
712,2029855,24971322,BindingDB,"Pyrazole diamide, 30",24651,"3-N-(piperidin-4-yl)-4-N-(2,4,6-trifluorobenzene)-1H-pyrazole-3,4-diamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24651,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),750,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
713,2029856,24971323,BindingDB,"Pyrazole diamide, 32",24653,"4-N-(2-chloro-6-fluorobenzene)-3-N-(piperidin-4-yl)-1H-pyrazole-3,4-diamido",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24653,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),110,PMID:18656911|DOI:10.1021/jm800382h,https://www.ncbi.nlm.nih.gov/pubmed/18656911|https://doi.org/10.1021/jm800382h,18656911,10.1021/jm800382h,
714,2029857,24971324,BindingDB,2-(4-phenyl-1H-imidazol-1-yl)ethan-1-amine,24659,2-(4-phenyl-1H-imidazol-1-yl)ethan-1-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24659,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,,,PMID:18665584|DOI:10.1021/jm800512z,https://www.ncbi.nlm.nih.gov/pubmed/18665584|https://doi.org/10.1021/jm800512z,18665584,10.1021/jm800512z,
715,2029858,24971325,BindingDB,methyl[(4-phenyl-1H-imidazol-2-yl)methyl]amine,24662,"4-phenylimidazole (4-PI) derivative, 30",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24662,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,,,PMID:18665584|DOI:10.1021/jm800512z,https://www.ncbi.nlm.nih.gov/pubmed/18665584|https://doi.org/10.1021/jm800512z,18665584,10.1021/jm800512z,
716,2029859,24971326,BindingDB,"2-(1H-Imidazol-4-yl)benzene-1,3-diol",24664,"2-(1H-imidazol-4-yl)benzene-1,3-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24664,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),5300,PMID:18665584|DOI:10.1021/jm800512z,https://www.ncbi.nlm.nih.gov/pubmed/18665584|https://doi.org/10.1021/jm800512z,18665584,10.1021/jm800512z,
717,2029860,24971327,BindingDB,3-(1H-imidazol-5-yl)benzenethiol,24665,3-(1H-imidazol-4-yl)benzene-1-thiol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24665,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,Ki (nM),5300,PMID:18665584|DOI:10.1021/jm800512z,https://www.ncbi.nlm.nih.gov/pubmed/18665584|https://doi.org/10.1021/jm800512z,18665584,10.1021/jm800512z,
718,2029861,24971328,BindingDB,4-(1H-imidazol-4-yl)benzene-1-thiol,24666,4-(1H-imidazol-4-yl)benzene-1-thiol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24666,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,Ki (nM),4800,PMID:18665584|DOI:10.1021/jm800512z,https://www.ncbi.nlm.nih.gov/pubmed/18665584|https://doi.org/10.1021/jm800512z,18665584,10.1021/jm800512z,
719,2029894,24971329,BindingDB,2-(1H-imidazol-4-yl)benzene-1-thiol,24667,2-(1H-imidazol-4-yl)benzene-1-thiol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24667,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),25000,PMID:18665584|DOI:10.1021/jm800512z,https://www.ncbi.nlm.nih.gov/pubmed/18665584|https://doi.org/10.1021/jm800512z,18665584,10.1021/jm800512z,
720,2029895,24971330,BindingDB,4-[2-(methylsulfanyl)phenyl]-1H-imidazole,24668,4-[2-(methylsulfanyl)phenyl]-1H-imidazole,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24668,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),38000,PMID:18665584|DOI:10.1021/jm800512z,https://www.ncbi.nlm.nih.gov/pubmed/18665584|https://doi.org/10.1021/jm800512z,18665584,10.1021/jm800512z,
721,2029896,24971331,BindingDB,4-[3-(methylsulfanyl)phenyl]-1H-imidazole,24670,4-[3-(methylsulfanyl)phenyl]-1H-imidazole,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24670,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),73000,PMID:18665584|DOI:10.1021/jm800512z,https://www.ncbi.nlm.nih.gov/pubmed/18665584|https://doi.org/10.1021/jm800512z,18665584,10.1021/jm800512z,
722,2029897,24971332,BindingDB,3-(1H-Imidazol-4-yl)phenol,24674,3-(1H-imidazol-4-yl)phenol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24674,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),365000,PMID:18665584|DOI:10.1021/jm800512z,https://www.ncbi.nlm.nih.gov/pubmed/18665584|https://doi.org/10.1021/jm800512z,18665584,10.1021/jm800512z,
723,2029898,24971333,BindingDB,"4-(2,6-Dimethoxyphenyl)-1H-imidazole",24675,"4-(2,6-dimethoxyphenyl)-1H-imidazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24675,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),734000,PMID:18665584|DOI:10.1021/jm800512z,https://www.ncbi.nlm.nih.gov/pubmed/18665584|https://doi.org/10.1021/jm800512z,18665584,10.1021/jm800512z,
724,2029899,24971334,BindingDB,,24685,"10-thiomethyl-DDACTHF, 10R-3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24685,5124,Bifunctional purine biosynthesis protein ATIC,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5124,P31939,Bifunctional purine biosynthesis protein ATIC,471.0,ATIC,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
725,2029900,24971334,BindingDB,,24685,"10-thiomethyl-DDACTHF, 10R-3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24685,8137,Trifunctional purine biosynthetic protein adenosine-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8137,P22102,Trifunctional purine biosynthetic protein adenosine-3,2618.0,GART,9606.0,Homo sapiens (human),,Ki (nM),210,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
726,2029901,24971335,BindingDB,,24686,"10-thiomethyl-DDACTHF, 10S-3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24686,8137,Trifunctional purine biosynthetic protein adenosine-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8137,P22102,Trifunctional purine biosynthetic protein adenosine-3,2618.0,GART,9606.0,Homo sapiens (human),,Ki (nM),180,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
727,2029932,24971335,BindingDB,,24686,"10-thiomethyl-DDACTHF, 10S-3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24686,5124,Bifunctional purine biosynthesis protein ATIC,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5124,P31939,Bifunctional purine biosynthesis protein ATIC,471.0,ATIC,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
728,2029933,24971336,BindingDB,,24687,"10-hydroxy-DDACTHF, 10R-7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24687,5124,Bifunctional purine biosynthesis protein ATIC,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5124,P31939,Bifunctional purine biosynthesis protein ATIC,471.0,ATIC,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
729,2029934,24971336,BindingDB,,24687,"10-hydroxy-DDACTHF, 10R-7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24687,8137,Trifunctional purine biosynthetic protein adenosine-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8137,P22102,Trifunctional purine biosynthetic protein adenosine-3,2618.0,GART,9606.0,Homo sapiens (human),,Ki (nM),1100,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
730,2029935,24971337,BindingDB,,24688,"10-hydroxy-DDACTHF, 10S-7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24688,8137,Trifunctional purine biosynthetic protein adenosine-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8137,P22102,Trifunctional purine biosynthetic protein adenosine-3,2618.0,GART,9606.0,Homo sapiens (human),,Ki (nM),1400,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
731,2029936,24971337,BindingDB,,24688,"10-hydroxy-DDACTHF, 10S-7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24688,5124,Bifunctional purine biosynthesis protein ATIC,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5124,P31939,Bifunctional purine biosynthesis protein ATIC,471.0,ATIC,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
732,2029937,24971338,BindingDB,,24689,"10-methoxy-DDACTHF, 10R-8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24689,5124,Bifunctional purine biosynthesis protein ATIC,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5124,P31939,Bifunctional purine biosynthesis protein ATIC,471.0,ATIC,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
733,2029938,24971338,BindingDB,,24689,"10-methoxy-DDACTHF, 10R-8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24689,8137,Trifunctional purine biosynthetic protein adenosine-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8137,P22102,Trifunctional purine biosynthetic protein adenosine-3,2618.0,GART,9606.0,Homo sapiens (human),,Ki (nM),850,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
734,2029939,24971339,BindingDB,,24690,"10-methoxy-DDACTHF, 10S-8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24690,8137,Trifunctional purine biosynthetic protein adenosine-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8137,P22102,Trifunctional purine biosynthetic protein adenosine-3,2618.0,GART,9606.0,Homo sapiens (human),,Ki (nM),1200,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
735,2029958,24971339,BindingDB,,24690,"10-methoxy-DDACTHF, 10S-8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24690,5124,Bifunctional purine biosynthesis protein ATIC,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5124,P31939,Bifunctional purine biosynthesis protein ATIC,471.0,ATIC,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
736,2029959,24971340,BindingDB,,24691,"2-[(4-{2-[3-(2,4-diamino-6-oxo-1,6-dihydropyrimidin-5-yl)propyl]-1,3-dithian-2-yl}phenyl)formamido]pentanedioic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24691,5124,Bifunctional purine biosynthesis protein ATIC,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5124,P31939,Bifunctional purine biosynthesis protein ATIC,471.0,ATIC,9606.0,Homo sapiens (human),,Ki (nM),20000,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
737,2029960,24971340,BindingDB,,24691,"2-[(4-{2-[3-(2,4-diamino-6-oxo-1,6-dihydropyrimidin-5-yl)propyl]-1,3-dithian-2-yl}phenyl)formamido]pentanedioic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24691,8137,Trifunctional purine biosynthetic protein adenosine-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8137,P22102,Trifunctional purine biosynthetic protein adenosine-3,2618.0,GART,9606.0,Homo sapiens (human),,Ki (nM),1100,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
738,2029961,24971341,BindingDB,,24693,10-CF3CO-DDACTHF (5),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24693,5124,Bifunctional purine biosynthesis protein ATIC,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5124,P31939,Bifunctional purine biosynthesis protein ATIC,471.0,ATIC,9606.0,Homo sapiens (human),,Ki (nM),>100000,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
739,2029962,24971341,BindingDB,,24693,10-CF3CO-DDACTHF (5),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24693,8137,Trifunctional purine biosynthetic protein adenosine-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8137,P22102,Trifunctional purine biosynthetic protein adenosine-3,2618.0,GART,9606.0,Homo sapiens (human),,Ki (nM),30,PMID:18686942|DOI:10.1021/jm800555h,https://www.ncbi.nlm.nih.gov/pubmed/18686942|https://doi.org/10.1021/jm800555h,18686942,10.1021/jm800555h,
740,2029963,24971342,BindingDB,"5-bromo-4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-N-[(3-methyl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine",24694,"4-aminopyrazolylpyrimidine analogue, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24694,6476,BDNF/NT-3 growth factors receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6476,Q16620,BDNF/NT-3 growth factors receptor,4915.0,NTRK2,9606.0,Homo sapiens (human),,IC50 (nM),1100,PMID:18646745|DOI:10.1021/jm800343j,https://www.ncbi.nlm.nih.gov/pubmed/18646745|https://doi.org/10.1021/jm800343j,18646745,10.1021/jm800343j,
741,2029964,24971342,BindingDB,"5-bromo-4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-N-[(3-methyl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine",24694,"4-aminopyrazolylpyrimidine analogue, 5",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24694,3688,High affinity nerve growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3688,P04629,High affinity nerve growth factor receptor,4914.0,NTRK1,9606.0,Homo sapiens (human),,IC50 (nM),270,PMID:18646745|DOI:10.1021/jm800343j,https://www.ncbi.nlm.nih.gov/pubmed/18646745|https://doi.org/10.1021/jm800343j,18646745,10.1021/jm800343j,
742,2029965,24971343,BindingDB,,24719,"13-methyl-8,11,12-triazatetracyclo[7.6.0.0^{2,7}.0^{10,14}]pentadeca-1(9),2,4,6,10,13-hexaene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24719,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),870,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
743,2030034,24971343,BindingDB,,24719,"13-methyl-8,11,12-triazatetracyclo[7.6.0.0^{2,7}.0^{10,14}]pentadeca-1(9),2,4,6,10,13-hexaene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24719,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),880,PMID:18630890|DOI:10.1021/jm800052b,https://www.ncbi.nlm.nih.gov/pubmed/18630890|https://doi.org/10.1021/jm800052b,18630890,10.1021/jm800052b,
744,2030035,24971344,BindingDB,N~2~-(naphthalen-2-ylcarbonyl)-L-lysyl-N-[(1S)-4-carbamimidamido-1-formylbutyl]-L-lysinamide,24728,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-(naphthalen-2-ylformamido)hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24728,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),41,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
745,2030036,24971346,BindingDB,(2S)-6-amino-2-[(2S)-6-amino-2-[(2E)-3-phenylprop-2-enamido]hexanamido]-N-[(2S)-5-carbamimidamido-1-oxopentan-2-yl]hexanamide,24730,(2S)-6-amino-2-[(2S)-6-amino-2-[(2E)-3-phenylprop-2-enamido]hexanamido]-N-[(2S)-5-carbamimidamido-1-oxopentan-2-yl]hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24730,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),104,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
746,2030037,24971347,BindingDB,"Capped tripeptide aldehyde inhibitor, 3",24731,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-(1-phenylacetamido)hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24731,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),9,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
747,2030038,24971348,BindingDB,"Capped tripeptide aldehyde inhibitor, 10",24732,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-[1-(4-phenylphenyl)acetamido]hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24732,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),6,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
748,2030039,24971349,BindingDB,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-[(2S)-2-(6-methoxynaphthalen-2-yl)propanamido]hexanamide,24733,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-[(2S)-2-(6-methoxynaphthalen-2-yl)propanamido]hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24733,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),20,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
749,2030040,24971350,BindingDB,"Capped tripeptide aldehyde inhibitor, 21",24734,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-[1-(3-methoxyphenyl)acetamido]hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24734,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),11,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
750,2030065,24971351,BindingDB,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-[(benzylcarbamoyl)amino]hexanamide,24735,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-[(benzylcarbamoyl)amino]hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24735,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),26,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
751,2030066,24971352,BindingDB,benzyl N-[(1S)-5-amino-1-{[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]carbamoyl}pentyl]carbamate,24736,"Capped tripeptide aldehyde inhibitor, 24",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24736,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),40,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
752,2030067,24971353,BindingDB,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-(phenylformamido)hexanamide,24737,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-(phenylformamido)hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24737,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),49,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
753,2030068,24971354,BindingDB,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-(3-phenylpropanamido)hexanamide,24738,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-(3-phenylpropanamido)hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24738,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),81,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
754,2030069,24971355,BindingDB,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-(2-phenoxyacetamido)hexanamide,24739,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-(2-phenoxyacetamido)hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24739,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),19,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
755,2030070,24971356,BindingDB,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-[(2-aminophenyl)formamido]hexanamide,24740,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-2-[(2-aminophenyl)formamido]hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24740,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),160,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
756,2030071,24971357,BindingDB,"Capped tripeptide aldehyde inhibitor, 29",24741,(2S)-6-amino-N-[(2S)-5-carbamimidamido-1-oxopentan-2-yl]-2-[(2S)-5-carbamimidamido-2-(1-phenylacetamido)pentanamido]hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24741,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),28,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
757,2030110,24971358,BindingDB,"Capped tripeptide aldehyde inhibitor, 30",24742,(2S)-6-amino-2-[(2S)-5-amino-2-(1-phenylacetamido)pentanamido]-N-[(2S)-5-carbamimidamido-1-oxopentan-2-yl]hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24742,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),46,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
758,2030111,24971359,BindingDB,"Capped tripeptide aldehyde inhibitor, 31",24743,(2S)-6-amino-N-[(2S)-5-carbamimidamido-1-oxopentan-2-yl]-2-[(2S)-5-(carbamoylamino)-2-(1-phenylacetamido)pentanamido]hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24743,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),111,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
759,2030112,24971360,BindingDB,"Capped tripeptide aldehyde inhibitor, 32",24744,(2S)-N-[(1S)-5-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}pentyl]-6-carbamimidamido-2-(1-phenylacetamido)hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24744,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),44,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
760,2030113,24971361,BindingDB,"Capped tripeptide aldehyde inhibitor, 33",24745,(2S)-6-amino-N-[(1S)-4-carbamimidamido-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}butyl]-2-(1-phenylacetamido)hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24745,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),58,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
761,2030114,24971362,BindingDB,"Capped tripeptide aldehyde inhibitor, 34",24746,(2S)-6-amino-N-[(1S)-4-amino-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}butyl]-2-(1-phenylacetamido)hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24746,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),13,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
762,2030115,24971363,BindingDB,"Capped tripeptide aldehyde inhibitor, 35",24747,(2S)-6-amino-N-[(1S)-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}-4-(carbamoylamino)butyl]-2-(1-phenylacetamido)hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24747,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),2073,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
763,2030116,24971364,BindingDB,"Capped tripeptide aldehyde inhibitor, 36",24748,(2S)-2-[(2S)-6-amino-2-(1-phenylacetamido)hexanamido]-6-carbamimidamido-N-[(2S)-5-carbamimidamido-1-oxopentan-2-yl]hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24748,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),53,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
764,2030132,24971365,BindingDB,"Capped tripeptide aldehyde inhibitor, 37",24749,(2S)-6-amino-N-[(1S)-5-amino-1-{[(2S)-1-(1H-indol-3-yl)-3-oxopropan-2-yl]carbamoyl}pentyl]-2-(1-phenylacetamido)hexanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24749,210,Genome polyprotein [1424-1463]/[1502-1685],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=210,P06935,Genome polyprotein,912267.0,POLY,11082.0,West Nile virus,,Ki (nM),4604,PMID:18729351|DOI:10.1021/jm800503y,https://www.ncbi.nlm.nih.gov/pubmed/18729351|https://doi.org/10.1021/jm800503y,18729351,10.1021/jm800503y,
765,2030133,24971366,BindingDB,"N-[(5-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)(phenyl)methyl]-2-(dimethylamino)acetamide",24760,"N-[(5-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)(phenyl)methyl]-2-(dimethylamino)acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24760,4906,Hepatocyte growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4906,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),,Ki (nM),30,PMID:18763753|DOI:10.1021/jm8006189,https://www.ncbi.nlm.nih.gov/pubmed/18763753|https://doi.org/10.1021/jm8006189,18763753,10.1021/jm8006189,
766,2030134,24971367,BindingDB,"N-[(5-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)(phenyl)methyl]propanamide",24761,"N-[(5-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)(phenyl)methyl]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24761,4906,Hepatocyte growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4906,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),,Ki (nM),71,PMID:18763753|DOI:10.1021/jm8006189,https://www.ncbi.nlm.nih.gov/pubmed/18763753|https://doi.org/10.1021/jm8006189,18763753,10.1021/jm8006189,
767,2030135,24971368,BindingDB,"N-[(5-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)(phenyl)methyl]-3-(methylsulfanyl)propanamide",24762,"N-[(5-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)(phenyl)methyl]-3-(methylsulfanyl)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24762,4906,Hepatocyte growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4906,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),,Ki (nM),52,PMID:18763753|DOI:10.1021/jm8006189,https://www.ncbi.nlm.nih.gov/pubmed/18763753|https://doi.org/10.1021/jm8006189,18763753,10.1021/jm8006189,
768,2030136,24971369,BindingDB,"1-[(5-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)(phenyl)methyl]-3,3-dimethylurea",24763,"1-[(5-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)(phenyl)methyl]-3,3-dimethylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24763,4906,Hepatocyte growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4906,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),,Ki (nM),368,PMID:18763753|DOI:10.1021/jm8006189,https://www.ncbi.nlm.nih.gov/pubmed/18763753|https://doi.org/10.1021/jm8006189,18763753,10.1021/jm8006189,
769,2030137,24971370,BindingDB,"(11S,13S)-14,14-dimethyl-12,15-dioxatetracyclo[8.5.0.0^{3,8}.0^{11,13}]pentadeca-1(10),3(8),4,6-tetraene-2,9-dione",24796,"(11S,13S)-14,14-dimethyl-12,15-dioxatetracyclo[8.5.0.0^{3,8}.0^{11,13}]pentadeca-1(10),3(8),4,6-tetraene-2,9-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24796,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),4950,PMID:18318466|DOI:10.1021/jm7014155,https://www.ncbi.nlm.nih.gov/pubmed/18318466|https://doi.org/10.1021/jm7014155,18318466,10.1021/jm7014155,
770,2030156,24971371,BindingDB,"(3S,4S)-3-hydroxy-4-methoxy-2,2-dimethyl-2H,3H,4H,5H,10H-naphtho[2,3-b]pyran-5,10-dione",24805,"(3S,4S)-3-hydroxy-4-methoxy-2,2-dimethyl-2H,3H,4H,5H,10H-naphtho[2,3-b]pyran-5,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24805,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),976,PMID:18318466|DOI:10.1021/jm7014155,https://www.ncbi.nlm.nih.gov/pubmed/18318466|https://doi.org/10.1021/jm7014155,18318466,10.1021/jm7014155,
771,2030157,24971372,BindingDB,"(3R,4S)-3-hydroxy-4-methoxy-2,2-dimethyl-2H,3H,4H,5H,10H-naphtho[2,3-b]pyran-5,10-dione",24806,"(3R,4S)-3-hydroxy-4-methoxy-2,2-dimethyl-2H,3H,4H,5H,10H-naphtho[2,3-b]pyran-5,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24806,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),3960,PMID:18318466|DOI:10.1021/jm7014155,https://www.ncbi.nlm.nih.gov/pubmed/18318466|https://doi.org/10.1021/jm7014155,18318466,10.1021/jm7014155,
772,2030158,24971373,BindingDB,"(3S,4R)-3-bromo-4-hydroxy-2,2-dimethyl-2H,3H,4H,5H,10H-naphtho[2,3-b]pyran-5,10-dione",24811,"(3S,4R)-3-bromo-4-hydroxy-2,2-dimethyl-2H,3H,4H,5H,10H-naphtho[2,3-b]pyran-5,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24811,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),512,PMID:18318466|DOI:10.1021/jm7014155,https://www.ncbi.nlm.nih.gov/pubmed/18318466|https://doi.org/10.1021/jm7014155,18318466,10.1021/jm7014155,
773,2030159,24971374,BindingDB,"(3R,4R)-3,4-dihydroxy-2,2-dimethyl-2H,3H,4H,5H,10H-naphtho[2,3-b]pyran-5,10-dione",24812,"(3R,4R)-3,4-dihydroxy-2,2-dimethyl-2H,3H,4H,5H,10H-naphtho[2,3-b]pyran-5,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24812,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,IC50 (nM),1500,PMID:18318466|DOI:10.1021/jm7014155,https://www.ncbi.nlm.nih.gov/pubmed/18318466|https://doi.org/10.1021/jm7014155,18318466,10.1021/jm7014155,
774,2030160,24971375,BindingDB,"N-[2-(4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",24837,"N-[2-(4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24837,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),210,PMID:18456494|DOI:10.1016/j.bmcl.2008.04.034,https://www.ncbi.nlm.nih.gov/pubmed/18456494|https://doi.org/10.1016/j.bmcl.2008.04.034,18456494,10.1016/j.bmcl.2008.04.034,
775,2030161,24971376,BindingDB,"7-methyl-N-[2-(4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",24838,"7-methyl-N-[2-(4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24838,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:18456494|DOI:10.1016/j.bmcl.2008.04.034,https://www.ncbi.nlm.nih.gov/pubmed/18456494|https://doi.org/10.1016/j.bmcl.2008.04.034,18456494,10.1016/j.bmcl.2008.04.034,
776,2030162,24971377,BindingDB,"5-methyl-N-[2-(4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",24839,"5-methyl-N-[2-(4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24839,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),425,PMID:18456494|DOI:10.1016/j.bmcl.2008.04.034,https://www.ncbi.nlm.nih.gov/pubmed/18456494|https://doi.org/10.1016/j.bmcl.2008.04.034,18456494,10.1016/j.bmcl.2008.04.034,
777,2030189,24971378,BindingDB,"5-chloro-N-[2-(4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",24840,"5-chloro-N-[2-(4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24840,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),318,PMID:18456494|DOI:10.1016/j.bmcl.2008.04.034,https://www.ncbi.nlm.nih.gov/pubmed/18456494|https://doi.org/10.1016/j.bmcl.2008.04.034,18456494,10.1016/j.bmcl.2008.04.034,
778,2030190,24971379,BindingDB,"N-[4-chloro-2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",24842,"N-[4-chloro-2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24842,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),171,PMID:18456494|DOI:10.1016/j.bmcl.2008.04.034,https://www.ncbi.nlm.nih.gov/pubmed/18456494|https://doi.org/10.1016/j.bmcl.2008.04.034,18456494,10.1016/j.bmcl.2008.04.034,
779,2030191,24971380,BindingDB,"N-[5-chloro-2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",24843,"N-[5-chloro-2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24843,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:18456494|DOI:10.1016/j.bmcl.2008.04.034,https://www.ncbi.nlm.nih.gov/pubmed/18456494|https://doi.org/10.1016/j.bmcl.2008.04.034,18456494,10.1016/j.bmcl.2008.04.034,
780,2030192,24971381,BindingDB,"5-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine",24844,"5-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24844,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),294,PMID:18456494|DOI:10.1016/j.bmcl.2008.04.034,https://www.ncbi.nlm.nih.gov/pubmed/18456494|https://doi.org/10.1016/j.bmcl.2008.04.034,18456494,10.1016/j.bmcl.2008.04.034,
781,2030193,24971382,BindingDB,"1'-Methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)spiro[indoline-3,4'-piperidine]",24849,"1'-methyl-1-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1,2-dihydrospiro[indole-3,4'-piperidine]",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24849,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),12.7,PMID:18456494|DOI:10.1016/j.bmcl.2008.04.034,https://www.ncbi.nlm.nih.gov/pubmed/18456494|https://doi.org/10.1016/j.bmcl.2008.04.034,18456494,10.1016/j.bmcl.2008.04.034,
782,2030194,24971383,BindingDB,"Pyrrolopyrimidine, 13e",24850,"1-(5-fluoro-1-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1,2-dihydrospiro[indole-3,4'-piperidine])ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24850,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),2790,PMID:18456494|DOI:10.1016/j.bmcl.2008.04.034,https://www.ncbi.nlm.nih.gov/pubmed/18456494|https://doi.org/10.1016/j.bmcl.2008.04.034,18456494,10.1016/j.bmcl.2008.04.034,
783,2030195,24971384,BindingDB,"Pyrrolopyrimidine, 13f",24851,"5-fluoro-1'-methanesulfonyl-1-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1,2-dihydrospiro[indole-3,4'-piperidine]",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24851,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),3190,PMID:18456494|DOI:10.1016/j.bmcl.2008.04.034,https://www.ncbi.nlm.nih.gov/pubmed/18456494|https://doi.org/10.1016/j.bmcl.2008.04.034,18456494,10.1016/j.bmcl.2008.04.034,
784,2030254,24971385,BindingDB,"Pyrrolopyrimidine, 13i",24854,"1-{5-benzyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1,2-dihydrospiro[indole-3,4'-piperidine]",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24854,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),1330,PMID:18456494|DOI:10.1016/j.bmcl.2008.04.034,https://www.ncbi.nlm.nih.gov/pubmed/18456494|https://doi.org/10.1016/j.bmcl.2008.04.034,18456494,10.1016/j.bmcl.2008.04.034,
785,2030255,24971386,BindingDB,"3-[({4-[2-(Methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)amino]propanamide",24856,"3-[({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)amino]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24856,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),226,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
786,2030256,24971386,BindingDB,"3-[({4-[2-(Methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)amino]propanamide",24856,"3-[({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)amino]propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24856,527,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208.0,AKT2,9606.0,Homo sapiens (human),,IC50 (nM),1299,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
787,2030257,24971387,BindingDB,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(1H-1,2,4-triazol-3-yl)ethyl]amine",24859,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(1H-1,2,4-triazol-3-yl)ethyl]amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24859,527,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208.0,AKT2,9606.0,Homo sapiens (human),,IC50 (nM),1709,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
788,2030258,24971387,BindingDB,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(1H-1,2,4-triazol-3-yl)ethyl]amine",24859,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(1H-1,2,4-triazol-3-yl)ethyl]amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24859,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),139,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
789,2030259,24971388,BindingDB,"({4-[2-(Methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(1,3-thiazol-2-yl)ethyl]amine",24860,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(1,3-thiazol-2-yl)ethyl]amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24860,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),198,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
790,2030260,24971388,BindingDB,"({4-[2-(Methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(1,3-thiazol-2-yl)ethyl]amine",24860,"({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)[2-(1,3-thiazol-2-yl)ethyl]amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24860,527,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208.0,AKT2,9606.0,Homo sapiens (human),,IC50 (nM),1381,PMID:18249537|DOI:10.1016/j.bmcl.2008.01.054,https://www.ncbi.nlm.nih.gov/pubmed/18249537|https://doi.org/10.1016/j.bmcl.2008.01.054,18249537,10.1016/j.bmcl.2008.01.054,
791,2036965,24978544,Comparative Toxicogenomics Database (CTD),bis[1-(hydroxy-kO)-5-{[2-(2-methoxyethoxy)ethoxy]methyl}-2-(sulfanyl-kS)pyridiniumato(2-)]zinc,C568608,PCI 5002,https://ctdbase.org/detail.go?type=chem&acc=C568608,79943,ZNF696,https://ctdbase.org/detail.go?type=gene&acc=79943,,,79943.0,ZNF696,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of ZNF696 mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
792,2036966,24978544,Comparative Toxicogenomics Database (CTD),bis[1-(hydroxy-kO)-5-{[2-(2-methoxyethoxy)ethoxy]methyl}-2-(sulfanyl-kS)pyridiniumato(2-)]zinc,C568608,PCI 5002,https://ctdbase.org/detail.go?type=chem&acc=C568608,155061,ZNF746,https://ctdbase.org/detail.go?type=gene&acc=155061,,,155061.0,ZNF746,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of ZNF746 mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
793,2036967,24978544,Comparative Toxicogenomics Database (CTD),bis[1-(hydroxy-kO)-5-{[2-(2-methoxyethoxy)ethoxy]methyl}-2-(sulfanyl-kS)pyridiniumato(2-)]zinc,C568608,PCI 5002,https://ctdbase.org/detail.go?type=chem&acc=C568608,7627,ZNF75A,https://ctdbase.org/detail.go?type=gene&acc=7627,,,7627.0,ZNF75A,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of ZNF75A mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
794,2036968,24978544,Comparative Toxicogenomics Database (CTD),bis[1-(hydroxy-kO)-5-{[2-(2-methoxyethoxy)ethoxy]methyl}-2-(sulfanyl-kS)pyridiniumato(2-)]zinc,C568608,PCI 5002,https://ctdbase.org/detail.go?type=chem&acc=C568608,79149,ZSCAN5A,https://ctdbase.org/detail.go?type=gene&acc=79149,,,79149.0,ZSCAN5A,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of ZSCAN5A mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
795,2036969,24978544,Comparative Toxicogenomics Database (CTD),bis[1-(hydroxy-kO)-5-{[2-(2-methoxyethoxy)ethoxy]methyl}-2-(sulfanyl-kS)pyridiniumato(2-)]zinc,C568608,PCI 5002,https://ctdbase.org/detail.go?type=chem&acc=C568608,57688,ZSWIM6,https://ctdbase.org/detail.go?type=gene&acc=57688,,,57688.0,ZSWIM6,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of ZSWIM6 mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
796,2036970,24983123,BindingDB,N-(4-methylcyclohexyl)-3-(4-methylpiperazino)sulfonyl-benzamide,87060,"Lignan, 4",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=87060,1718,Chymotrypsin-C,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1718,Q99895,Chymotrypsin-C,11330.0,CTRC,9606.0,Homo sapiens (human),,Ki (nM),4.711e+4,PMID:18569346|DOI:10.1080/14756360701584653,https://www.ncbi.nlm.nih.gov/pubmed/18569346|https://doi.org/10.1080/14756360701584653,18569346,10.1080/14756360701584653,
797,2036971,24995215,Comparative Toxicogenomics Database (CTD),"1,1,1,2,2-Pentafluoro-7-phenylheptan-3-one",C533806,"1,1,1,2,2-pentafluoro-7-phenylheptan-3-one",https://ctdbase.org/detail.go?type=chem&acc=C533806,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606.0,Homo sapiens (human),"[1,1,1,2,2-pentafluoro-7-phenylheptan-3-one co-treated with orlistat] inhibits the reaction [APP protein modified form results in increased secretion of arachidonic acid]",,,PMID:28721267,https://www.ncbi.nlm.nih.gov/pubmed/28721267,28721267,,
798,2036972,24997708,BindingDB,"Pyridazinone, 2-39",33352,"pyridazinone, 2-39",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33352,4084,Sortase family protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4084,,,,,,,,IC50 (nM),>50000,PMID:19781950|DOI:10.1016/j.bmc.2009.08.067,https://www.ncbi.nlm.nih.gov/pubmed/19781950|https://doi.org/10.1016/j.bmc.2009.08.067,19781950,10.1016/j.bmc.2009.08.067,
799,2036973,25015677,Therapeutic Target Database (TTD),"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide",D05WDM,Ro5203280,https://idrblab.net/ttd/data/drug/details/D05WDM,T40694,Polo-like kinase 1 (PLK1),https://idrblab.net/ttd/data/target/details/T40694,P53350,Serine/threonine-protein kinase PLK1,5347.0,PLK1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
800,2036974,25015749,Therapeutic Target Database (TTD),"2-[3-(4-Chlorophenyl)-2-[(2,4-dichlorobenzoyl)imino]-4-oxo-5-thiazolidinylidene]-acetic acid, methyl ester",D0Z4NX,FR-171113,https://idrblab.net/ttd/data/drug/details/D0Z4NX,T36483,Proteinase activated receptor 1 (F2R),https://idrblab.net/ttd/data/target/details/T36483,P25116,Proteinase-activated receptor 1,2149.0,F2R,9606.0,Homo sapiens (human),Modulator,,,,,,,
801,2036975,25016538,IUPHAR/BPS Guide to PHARMACOLOGY,"(4S)-4-[(N-ethylanilino)methyl]-4,5-dihydro-1,3-oxazol-2-amine",5862,RO5166017,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5862,364,TA1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=364,Q923Y9,Trace amine-associated receptor 1,113914.0,Taar1,10116.0,Rattus norvegicus (Norway rat),Full agonist,pEC50,7.9,PMID:21525407,https://www.ncbi.nlm.nih.gov/pubmed/21525407,21525407,,
802,2036976,25016538,IUPHAR/BPS Guide to PHARMACOLOGY,"(4S)-4-[(N-ethylanilino)methyl]-4,5-dihydro-1,3-oxazol-2-amine",5862,RO5166017,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5862,364,TA1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=364,Q923Y9,Trace amine-associated receptor 1,113914.0,Taar1,10116.0,Rattus norvegicus (Norway rat),Full agonist,pKi,8.6,PMID:21525407,https://www.ncbi.nlm.nih.gov/pubmed/21525407,21525407,,
803,2036977,25016538,IUPHAR/BPS Guide to PHARMACOLOGY,"(4S)-4-[(N-ethylanilino)methyl]-4,5-dihydro-1,3-oxazol-2-amine",5862,RO5166017,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5862,364,TA1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=364,Q923Y8,Trace amine-associated receptor 1,111174.0,Taar1,10090.0,Mus musculus (house mouse),Partial agonist,pEC50,8.5,PMID:21525407,https://www.ncbi.nlm.nih.gov/pubmed/21525407,21525407,,
804,2036978,25016538,IUPHAR/BPS Guide to PHARMACOLOGY,"(4S)-4-[(N-ethylanilino)methyl]-4,5-dihydro-1,3-oxazol-2-amine",5862,RO5166017,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5862,364,TA1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=364,Q923Y8,Trace amine-associated receptor 1,111174.0,Taar1,10090.0,Mus musculus (house mouse),Partial agonist,pKi,8.7,PMID:21525407,https://www.ncbi.nlm.nih.gov/pubmed/21525407,21525407,,
805,2036979,25016538,IUPHAR/BPS Guide to PHARMACOLOGY,"(4S)-4-[(N-ethylanilino)methyl]-4,5-dihydro-1,3-oxazol-2-amine",5862,RO5166017,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5862,364,TA1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=364,Q96RJ0,Trace amine-associated receptor 1,134864.0,TAAR1,9606.0,Homo sapiens (human),Full agonist,pEC50,7.3,PMID:21525407,https://www.ncbi.nlm.nih.gov/pubmed/21525407,21525407,,
806,2036980,25016538,IUPHAR/BPS Guide to PHARMACOLOGY,"(4S)-4-[(N-ethylanilino)methyl]-4,5-dihydro-1,3-oxazol-2-amine",5862,RO5166017,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5862,364,TA1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=364,Q96RJ0,Trace amine-associated receptor 1,134864.0,TAAR1,9606.0,Homo sapiens (human),Full agonist,pKi,7.5,PMID:21525407,https://www.ncbi.nlm.nih.gov/pubmed/21525407,21525407,,
807,2036981,25019714,Therapeutic Target Database (TTD),"2(1H)-Pyridinone, 1-((4-methyl-3-(((2-methyl-4-(4-methyl-1H-pyrazol-3-yl)-8-quinolinyl)oxy)methyl)-2-pyridinyl)methyl)-3-(trifluoromethyl)-",D07OCC,JSM-10292,https://idrblab.net/ttd/data/drug/details/D07OCC,T23714,B2 bradykinin receptor (BDKRB2),https://idrblab.net/ttd/data/target/details/T23714,P30411,B2 bradykinin receptor,624.0,BDKRB2,9606.0,Homo sapiens (human),Antagonist,,,,,,,
808,2036535,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [JZL 184 inhibits the reaction [sulfur dioxide results in increased cleavage of and results in increased activity of CASP3 protein]]|cnr1 protein affects the reaction [JZL 184 inhibits the reaction [sulfur dioxide results in increased cleavage of and results in increased activity of CASP3 protein]]|jzl 184 inhibits the reaction [sulfur dioxide results in increased cleavage of and results in increased activity of CASP3 protein],,,PMID:26209559,https://www.ncbi.nlm.nih.gov/pubmed/26209559,26209559,,
809,2036536,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),JZL 184 results in decreased expression of CCL2 mRNA,,,PMID:30301768,https://www.ncbi.nlm.nih.gov/pubmed/30301768,30301768,,
810,2036537,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,10090.0,Mus musculus (house mouse),JZL 184 results in decreased expression of CCL3 mRNA,,,PMID:30301768,https://www.ncbi.nlm.nih.gov/pubmed/30301768,30301768,,
811,2036538,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,6351,CCL4,https://ctdbase.org/detail.go?type=gene&acc=6351,,,6351.0,CCL4,10090.0,Mus musculus (house mouse),JZL 184 results in decreased expression of CCL4 mRNA,,,PMID:30301768,https://www.ncbi.nlm.nih.gov/pubmed/30301768,30301768,,
812,2036539,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,1066,CES1,https://ctdbase.org/detail.go?type=gene&acc=1066,,,1066.0,CES1,9606.0,Homo sapiens (human),[JZL 184 results in decreased activity of CES1 protein] which results in decreased hydrolysis of prostaglandin E2 glyceryl ester|[jzl 184 results in decreased activity of CES1 protein] which results in decreased hydrolysis of dinoprost|jzl 184 results in decreased activity of CES1 protein|[jzl 184 results in decreased activity of CES1 protein] which results in decreased hydrolysis of glyceryl 2-arachidonate,,,PMID:21049984,https://www.ncbi.nlm.nih.gov/pubmed/21049984,21049984,,
813,2036540,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10090.0,Mus musculus (house mouse),CNR1 protein affects the reaction [JZL 184 inhibits the reaction [sulfur dioxide results in increased phosphorylation of RELA protein]]|cnr1 protein affects the reaction [JZL 184 inhibits the reaction [sulfur dioxide results in increased cleavage of and results in increased activity of CASP3 protein]]|cnr1 protein affects the reaction [JZL 184 inhibits the reaction [sulfur dioxide results in increased expression of PTGS2 protein]],,,PMID:26209559,https://www.ncbi.nlm.nih.gov/pubmed/26209559,26209559,,
814,2036541,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10090.0,Mus musculus (house mouse),CNR1 protein affects the reaction [JZL 184 results in increased expression of BCL11B mrna]|cnr1 protein affects the reaction [JZL 184 results in decreased expression of SATB2 mrna]|cnr1 protein affects the reaction [JZL 184 results in increased expression of ETV1 mrna]|cnr1 protein affects the reaction [JZL 184 results in decreased expression of CUX2 mrna],,,PMID:33168583,https://www.ncbi.nlm.nih.gov/pubmed/33168583,33168583,,
815,2036542,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10090.0,Mus musculus (house mouse),CNR1 protein affects the reaction [JZL 184 results in increased phosphorylation of AKT1 protein]|cnr1 protein affects the susceptibility to JZL 184|CNR1 protein affects the reaction [JZL 184 results in increased phosphorylation of MAPK3 protein]|cnr1 protein affects the reaction [JZL 184 results in increased phosphorylation of MAPK1 protein],,,PMID:27543109,https://www.ncbi.nlm.nih.gov/pubmed/27543109,27543109,,
816,2036543,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,23316,CUX2,https://ctdbase.org/detail.go?type=gene&acc=23316,,,23316.0,CUX2,10090.0,Mus musculus (house mouse),JZL 184 results in decreased expression of CUX2 mrna|cnr1 protein affects the reaction [JZL 184 results in decreased expression of CUX2 mrna],,,PMID:33168583,https://www.ncbi.nlm.nih.gov/pubmed/33168583,33168583,,
817,2036544,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,2115,ETV1,https://ctdbase.org/detail.go?type=gene&acc=2115,,,2115.0,ETV1,10090.0,Mus musculus (house mouse),CNR1 protein affects the reaction [JZL 184 results in increased expression of ETV1 mrna]|jzl 184 results in increased expression of ETV1 mRNA,,,PMID:33168583,https://www.ncbi.nlm.nih.gov/pubmed/33168583,33168583,,
818,2036545,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,2166,FAAH,https://ctdbase.org/detail.go?type=gene&acc=2166,,,2166.0,FAAH,10090.0,Mus musculus (house mouse),JZL 184 results in decreased activity of FAAH protein,,,PMID:25030704,https://www.ncbi.nlm.nih.gov/pubmed/25030704,25030704,,
819,2036546,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,2915,GRM5,https://ctdbase.org/detail.go?type=gene&acc=2915,,,2915.0,GRM5,10090.0,Mus musculus (house mouse),GRM5 protein affects the reaction [JZL 184 results in increased phosphorylation of MAPK3 protein]|grm5 protein affects the susceptibility to JZL 184|GRM5 protein affects the reaction [JZL 184 results in increased phosphorylation of AKT1 protein]|grm5 protein affects the reaction [JZL 184 results in increased phosphorylation of MAPK1 protein]|grm5 protein affects the reaction [[JZL 184 co-treated with glutamic acid] results in increased phosphorylation of AKT1 protein]|grm5 protein affects the reaction [[JZL 184 co-treated with glutamic acid] results in increased phosphorylation of MAPK3 protein]|grm5 protein affects the reaction [[JZL 184 co-treated with glutamic acid] results in increased phosphorylation of MAPK1 protein],,,PMID:27543109,https://www.ncbi.nlm.nih.gov/pubmed/27543109,27543109,,
820,2036547,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,10090.0,Mus musculus (house mouse),JZL 184 results in decreased expression of IL1A mRNA,,,PMID:30301768,https://www.ncbi.nlm.nih.gov/pubmed/30301768,30301768,,
821,2036548,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),JZL 184 results in decreased expression of IL1B mRNA,,,PMID:30301768,https://www.ncbi.nlm.nih.gov/pubmed/30301768,30301768,,
822,2036549,25021165,Comparative Toxicogenomics Database (CTD),"4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate",C534333,JZL 184,https://ctdbase.org/detail.go?type=chem&acc=C534333,56778,LY6C,https://ctdbase.org/detail.go?type=gene&acc=56778,,,56778.0,Ly6c,10090.0,Mus musculus (house mouse),JZL 184 results in decreased expression of LY6C mRNA,,,PMID:30301768,https://www.ncbi.nlm.nih.gov/pubmed/30301768,30301768,,
823,2036982,25022354,Drug Gene Interaction database (DGIdb),Evogliptin,,EVOGLIPTIN,https://www.dgidb.org/drugs/ncit:C171769,,DPP4,https://www.dgidb.org/genes/hgnc:3009,,,1803.0,DPP4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
824,2036983,25022354,ChEMBL,Evogliptin,CHEMBL1779710,EVOGLIPTIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1779710/,CHEMBL284,Dipeptidyl peptidase IV,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL284/,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),Dipeptidyl peptidase IV inhibitor,,,PMID:22056373|PMID:26541763,https://www.ncbi.nlm.nih.gov/pubmed/22056373|https://www.ncbi.nlm.nih.gov/pubmed/26541763,22056373|26541763,,
825,2036984,25023714,BindingDB,"4-[1-Ethyl-7-(piperidin-4-yloxy)-1H-imidazo[4,5-c]pyridin-2-yl]-furazan-3-ylamine",24989,"4-[1-ethyl-7-(piperidin-4-yloxy)-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24989,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),79,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
826,2037025,25023719,BindingDB,"2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-N-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridine-7-carboxamide",24995,"2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-N-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridine-7-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24995,1612,RAC-gamma serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1612,Q9Y243,RAC-gamma serine/threonine-protein kinase,10000.0,AKT3,9606.0,Homo sapiens (human),,IC50 (nM),2290,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
827,2037026,25023719,BindingDB,"2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-N-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridine-7-carboxamide",24995,"2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-N-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridine-7-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24995,335,Rho-associated protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=335,Q63644,Rho-associated protein kinase 1 ,,,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),6,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
828,2037034,25023719,BindingDB,"2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-N-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridine-7-carboxamide",24995,"2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-N-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridine-7-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24995,527,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208.0,AKT2,9606.0,Homo sapiens (human),,IC50 (nM),2570,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
829,2037035,25023719,BindingDB,"2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-N-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridine-7-carboxamide",24995,"2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-N-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridine-7-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24995,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),562,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
830,2037051,25023722,BindingDB,"4-[7-(3-aminopropoxy)-1-ethyl-4-(1H-pyrrol-3-yl)-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",25000,"4-[7-(3-aminopropoxy)-1-ethyl-4-(1H-pyrrol-3-yl)-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25000,2734,Rho-associated protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2734,Q13464,Rho-associated protein kinase 1,6093.0,ROCK1,9606.0,Homo sapiens (human),,IC50 (nM),126,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
831,2037052,25023723,BindingDB,"4-[7-(3-aminopropoxy)-1-ethyl-4-(1H-pyrazol-4-yl)-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",25001,"4-[7-(3-aminopropoxy)-1-ethyl-4-(1H-pyrazol-4-yl)-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25001,2734,Rho-associated protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2734,Q13464,Rho-associated protein kinase 1,6093.0,ROCK1,9606.0,Homo sapiens (human),,IC50 (nM),224,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
832,2037053,25023723,BindingDB,"4-[7-(3-aminopropoxy)-1-ethyl-4-(1H-pyrazol-4-yl)-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",25001,"4-[7-(3-aminopropoxy)-1-ethyl-4-(1H-pyrazol-4-yl)-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25001,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),3160,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
833,2037054,25023724,BindingDB,"4-[7-(3-aminopropoxy)-4-(2-cyclopropylethynyl)-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",25002,"4-[7-(3-aminopropoxy)-4-(2-cyclopropylethynyl)-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25002,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),79,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
834,2037080,25023728,BindingDB,"4-(4-(3-Aminoprop-1-yn-1-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine",25006,"4-[4-(3-aminoprop-1-yn-1-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25006,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),794,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
835,2037081,25023728,BindingDB,"4-(4-(3-Aminoprop-1-yn-1-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine",25006,"4-[4-(3-aminoprop-1-yn-1-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25006,2737,Ribosomal protein S6 kinase alpha-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2737,Q15418,Ribosomal protein S6 kinase alpha-1,6195.0,RPS6KA1,9606.0,Homo sapiens (human),,IC50 (nM),251,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
836,2037088,25023728,BindingDB,"4-(4-(3-Aminoprop-1-yn-1-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine",25006,"4-[4-(3-aminoprop-1-yn-1-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25006,2734,Rho-associated protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2734,Q13464,Rho-associated protein kinase 1,6093.0,ROCK1,9606.0,Homo sapiens (human),,IC50 (nM),200,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
837,2037089,25023729,BindingDB,"4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-7-(4-aminobutoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol",25007,"4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-7-(4-aminobutoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25007,1612,RAC-gamma serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1612,Q9Y243,RAC-gamma serine/threonine-protein kinase,10000.0,AKT3,9606.0,Homo sapiens (human),,IC50 (nM),69,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
838,2037090,25023729,BindingDB,"4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-7-(4-aminobutoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol",25007,"4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-7-(4-aminobutoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25007,527,RAC-beta serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=527,P31751,RAC-beta serine/threonine-protein kinase,208.0,AKT2,9606.0,Homo sapiens (human),,IC50 (nM),9,PMID:18800763|DOI:10.1021/jm8004527,https://www.ncbi.nlm.nih.gov/pubmed/18800763|https://doi.org/10.1021/jm8004527,18800763,10.1021/jm8004527,
839,2037214,25023758,BindingDB,"Imidazo[1,2-a]pyridine derivative, 8",25053,"3-{6-chloroimidazo[1,2-a]pyridin-3-yl}-1-[(2-methyl-5-nitrobenzene)sulfonyl]-1H-pyrrole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25053,1622,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1622,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",5290.0,PIK3CA,9606.0,Homo sapiens (human),,IC50 (nM),100,PMID:17049248|DOI:10.1016/j.bmc.2006.09.047,https://www.ncbi.nlm.nih.gov/pubmed/17049248|https://doi.org/10.1016/j.bmc.2006.09.047,17049248,10.1016/j.bmc.2006.09.047,
840,2037215,25023759,BindingDB,"4-{6-Chloroimidazo[1,2-a]pyridin-3-yl}-2-[(2-methyl-5-nitrophenyl)sulfanyl]-1,3-thiazole",25054,"4-{6-chloroimidazo[1,2-a]pyridin-3-yl}-2-[(2-methyl-5-nitrophenyl)sulfanyl]-1,3-thiazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25054,1622,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1622,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",5290.0,PIK3CA,9606.0,Homo sapiens (human),,IC50 (nM),82,PMID:17049248|DOI:10.1016/j.bmc.2006.09.047,https://www.ncbi.nlm.nih.gov/pubmed/17049248|https://doi.org/10.1016/j.bmc.2006.09.047,17049248,10.1016/j.bmc.2006.09.047,
841,2036580,25023778,BindingDB,(2E)-3-{4-[3-(adamantan-1-yl)-4-aminophenyl]-3-chlorophenyl}prop-2-enoic acid,25124,(2E)-3-{4-[3-(adamantan-1-yl)-4-aminophenyl]-3-chlorophenyl}prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25124,2620,Tyrosine-protein phosphatase non-receptor type 11 [205-593],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2620,Q06124,Tyrosine-protein phosphatase non-receptor type 11,5781.0,PTPN11,9606.0,Homo sapiens (human),,IC50 (nM),1830,PMID:18759424|DOI:10.1021/jm800456k,https://www.ncbi.nlm.nih.gov/pubmed/18759424|https://doi.org/10.1021/jm800456k,18759424,10.1021/jm800456k,
842,2036581,25023779,BindingDB,(2E)-3-{4-[3-(adamantan-1-yl)-4-fluorophenyl]-3-chlorophenyl}prop-2-enoic acid,25125,(2E)-3-{4-[3-(adamantan-1-yl)-4-fluorophenyl]-3-chlorophenyl}prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25125,2620,Tyrosine-protein phosphatase non-receptor type 11 [205-593],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2620,Q06124,Tyrosine-protein phosphatase non-receptor type 11,5781.0,PTPN11,9606.0,Homo sapiens (human),,IC50 (nM),2110,PMID:18759424|DOI:10.1021/jm800456k,https://www.ncbi.nlm.nih.gov/pubmed/18759424|https://doi.org/10.1021/jm800456k,18759424,10.1021/jm800456k,
843,2036582,25023780,BindingDB,(2E)-3-[3-chloro-4-(4-fluorophenyl)phenyl]prop-2-enoic acid,25126,(2E)-3-[3-chloro-4-(4-fluorophenyl)phenyl]prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25126,2620,Tyrosine-protein phosphatase non-receptor type 11 [205-593],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2620,Q06124,Tyrosine-protein phosphatase non-receptor type 11,5781.0,PTPN11,9606.0,Homo sapiens (human),,IC50 (nM),500000,PMID:18759424|DOI:10.1021/jm800456k,https://www.ncbi.nlm.nih.gov/pubmed/18759424|https://doi.org/10.1021/jm800456k,18759424,10.1021/jm800456k,
844,2036583,25023781,BindingDB,"(2E)-3-[3-chloro-4-(4-hydroxy-3-{tricyclo[3.3.1.0^{3,7}]nonan-3-yl}phenyl)phenyl]prop-2-enoic acid",25129,"(2E)-3-[3-chloro-4-(4-hydroxy-3-{tricyclo[3.3.1.0^{3,7}]nonan-3-yl}phenyl)phenyl]prop-2-enoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25129,2620,Tyrosine-protein phosphatase non-receptor type 11 [205-593],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2620,Q06124,Tyrosine-protein phosphatase non-receptor type 11,5781.0,PTPN11,9606.0,Homo sapiens (human),,IC50 (nM),3910,PMID:18759424|DOI:10.1021/jm800456k,https://www.ncbi.nlm.nih.gov/pubmed/18759424|https://doi.org/10.1021/jm800456k,18759424,10.1021/jm800456k,
845,2036584,25023782,BindingDB,(2E)-3-{3-chloro-4-[4-hydroxy-3-(1-methylcyclohexyl)phenyl]phenyl}prop-2-enoic acid,25130,(2E)-3-{3-chloro-4-[4-hydroxy-3-(1-methylcyclohexyl)phenyl]phenyl}prop-2-enoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25130,2620,Tyrosine-protein phosphatase non-receptor type 11 [205-593],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2620,Q06124,Tyrosine-protein phosphatase non-receptor type 11,5781.0,PTPN11,9606.0,Homo sapiens (human),,IC50 (nM),6400,PMID:18759424|DOI:10.1021/jm800456k,https://www.ncbi.nlm.nih.gov/pubmed/18759424|https://doi.org/10.1021/jm800456k,18759424,10.1021/jm800456k,
846,2036585,25023783,BindingDB,"(2E)-3-{3-chloro-4-[4-hydroxy-3-(2-methyl-1,3-dithian-2-yl)phenyl]phenyl}prop-2-enoic acid",25132,"(2E)-3-{3-chloro-4-[4-hydroxy-3-(2-methyl-1,3-dithian-2-yl)phenyl]phenyl}prop-2-enoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25132,2620,Tyrosine-protein phosphatase non-receptor type 11 [205-593],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2620,Q06124,Tyrosine-protein phosphatase non-receptor type 11,5781.0,PTPN11,9606.0,Homo sapiens (human),,IC50 (nM),10200,PMID:18759424|DOI:10.1021/jm800456k,https://www.ncbi.nlm.nih.gov/pubmed/18759424|https://doi.org/10.1021/jm800456k,18759424,10.1021/jm800456k,
847,2036586,25023784,BindingDB,"7-(2-cyclohexylethyl)-6-[4-(4-acetylpiperazin-1-yl)phenoxymethyl]-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile",25134,"2-cyano-pyrropyrimidine, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25134,9613,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9613,O70370,Cathepsin S,13040.0,Ctss,10090.0,Mus musculus (house mouse),,IC50 (nM),10,PMID:18754655|DOI:10.1021/jm800839j,https://www.ncbi.nlm.nih.gov/pubmed/18754655|https://doi.org/10.1021/jm800839j,18754655,10.1021/jm800839j,
848,2036587,25023784,BindingDB,"7-(2-cyclohexylethyl)-6-[4-(4-acetylpiperazin-1-yl)phenoxymethyl]-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile",25134,"2-cyano-pyrropyrimidine, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25134,50000685,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50000685,O35186,Cathepsin K,29175.0,Ctsk,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),>10000,PMID:18754655|DOI:10.1021/jm800839j,https://www.ncbi.nlm.nih.gov/pubmed/18754655|https://doi.org/10.1021/jm800839j,18754655,10.1021/jm800839j,
849,2036588,25023784,BindingDB,"7-(2-cyclohexylethyl)-6-[4-(4-acetylpiperazin-1-yl)phenoxymethyl]-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile",25134,"2-cyano-pyrropyrimidine, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25134,2049,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2049,P43235,Cathepsin K,1513.0,CTSK,9606.0,Homo sapiens (human),,IC50 (nM),1650,PMID:18754655|DOI:10.1021/jm800839j,https://www.ncbi.nlm.nih.gov/pubmed/18754655|https://doi.org/10.1021/jm800839j,18754655,10.1021/jm800839j,
850,2036589,25023784,BindingDB,"7-(2-cyclohexylethyl)-6-[4-(4-acetylpiperazin-1-yl)phenoxymethyl]-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile",25134,"2-cyano-pyrropyrimidine, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25134,50002012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50002012,P07154,Procathepsin L,25697.0,Ctsl,10116.0,Rattus norvegicus (Norway rat),,IC50 (nM),>10000,PMID:18754655|DOI:10.1021/jm800839j,https://www.ncbi.nlm.nih.gov/pubmed/18754655|https://doi.org/10.1021/jm800839j,18754655,10.1021/jm800839j,
851,2036590,25023784,BindingDB,"7-(2-cyclohexylethyl)-6-[4-(4-acetylpiperazin-1-yl)phenoxymethyl]-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile",25134,"2-cyano-pyrropyrimidine, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25134,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606.0,Homo sapiens (human),,IC50 (nM),5200,PMID:18754655|DOI:10.1021/jm800839j,https://www.ncbi.nlm.nih.gov/pubmed/18754655|https://doi.org/10.1021/jm800839j,18754655,10.1021/jm800839j,
852,2036621,25023793,BindingDB,"Trifluoromethyl ketone, 11",25151,"9,9,9-trifluoro-8-oxo-N-(3-phenylphenyl)nonanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25151,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),33,PMID:18308563|DOI:10.1016/j.bmcl.2008.02.025,https://www.ncbi.nlm.nih.gov/pubmed/18308563|https://doi.org/10.1016/j.bmcl.2008.02.025,18308563,10.1016/j.bmcl.2008.02.025,
853,2036622,25023793,BindingDB,"Trifluoromethyl ketone, 11",25151,"9,9,9-trifluoro-8-oxo-N-(3-phenylphenyl)nonanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25151,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),1400,PMID:18308563|DOI:10.1016/j.bmcl.2008.02.025,https://www.ncbi.nlm.nih.gov/pubmed/18308563|https://doi.org/10.1016/j.bmcl.2008.02.025,18308563,10.1016/j.bmcl.2008.02.025,
854,2036623,25023793,BindingDB,"Trifluoromethyl ketone, 11",25151,"9,9,9-trifluoro-8-oxo-N-(3-phenylphenyl)nonanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25151,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,IC50 (nM),120,PMID:18308563|DOI:10.1016/j.bmcl.2008.02.025,https://www.ncbi.nlm.nih.gov/pubmed/18308563|https://doi.org/10.1016/j.bmcl.2008.02.025,18308563,10.1016/j.bmcl.2008.02.025,
855,2036624,25023793,BindingDB,"Trifluoromethyl ketone, 11",25151,"9,9,9-trifluoro-8-oxo-N-(3-phenylphenyl)nonanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25151,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),200,PMID:18308563|DOI:10.1016/j.bmcl.2008.02.025,https://www.ncbi.nlm.nih.gov/pubmed/18308563|https://doi.org/10.1016/j.bmcl.2008.02.025,18308563,10.1016/j.bmcl.2008.02.025,
856,2036625,25023794,BindingDB,"Ketoamide, 12",25152,CHEMBL112446,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25152,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,,,PMID:18308563|DOI:10.1016/j.bmcl.2008.02.025,https://www.ncbi.nlm.nih.gov/pubmed/18308563|https://doi.org/10.1016/j.bmcl.2008.02.025,18308563,10.1016/j.bmcl.2008.02.025,
857,2036626,25023794,BindingDB,"Ketoamide, 12",25152,CHEMBL112446,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25152,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,IC50 (nM),10,PMID:18308563|DOI:10.1016/j.bmcl.2008.02.025,https://www.ncbi.nlm.nih.gov/pubmed/18308563|https://doi.org/10.1016/j.bmcl.2008.02.025,18308563,10.1016/j.bmcl.2008.02.025,
858,2036627,25023794,BindingDB,"Ketoamide, 12",25152,CHEMBL112446,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25152,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),12,PMID:18308563|DOI:10.1016/j.bmcl.2008.02.025,https://www.ncbi.nlm.nih.gov/pubmed/18308563|https://doi.org/10.1016/j.bmcl.2008.02.025,18308563,10.1016/j.bmcl.2008.02.025,
859,2036628,25023794,BindingDB,"Ketoamide, 12",25152,CHEMBL112446,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25152,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,,,PMID:18308563|DOI:10.1016/j.bmcl.2008.02.025,https://www.ncbi.nlm.nih.gov/pubmed/18308563|https://doi.org/10.1016/j.bmcl.2008.02.025,18308563,10.1016/j.bmcl.2008.02.025,
860,2036629,25023795,BindingDB,"N-ethyl-5-(2,2,2-trifluoroacetyl)thiophene-2-carboxamide",25155,CHEMBL462146,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25155,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),7100,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
861,2036630,25023795,BindingDB,"N-ethyl-5-(2,2,2-trifluoroacetyl)thiophene-2-carboxamide",25155,CHEMBL462146,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25155,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),1000,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
862,2036631,25023795,BindingDB,"N-ethyl-5-(2,2,2-trifluoroacetyl)thiophene-2-carboxamide",25155,CHEMBL462146,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25155,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
863,2036660,25023801,BindingDB,"1-[5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2,2-trifluoroethan-1-one",25162,"1-[5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2,2-trifluoroethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25162,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),300,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
864,2036661,25023801,BindingDB,"1-[5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2,2-trifluoroethan-1-one",25162,"1-[5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2,2-trifluoroethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25162,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,IC50 (nM),1700,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
865,2036662,25023801,BindingDB,"1-[5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2,2-trifluoroethan-1-one",25162,"1-[5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2,2-trifluoroethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25162,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),130,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
866,2036663,25023801,BindingDB,"1-[5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2,2-trifluoroethan-1-one",25162,"1-[5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2,2-trifluoroethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25162,2556,Histone deacetylase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2556,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),,IC50 (nM),200,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
867,2036664,25023802,BindingDB,"2,2,2-trifluoro-1-[5-({3-phenyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazin-7-yl}carbonyl)thiophen-2-yl]ethan-1-one",25164,"2,2,2-trifluoro-1-[5-({3-phenyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazin-7-yl}carbonyl)thiophen-2-yl]ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25164,2556,Histone deacetylase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2556,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),,IC50 (nM),310,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
868,2036665,25023802,BindingDB,"2,2,2-trifluoro-1-[5-({3-phenyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazin-7-yl}carbonyl)thiophen-2-yl]ethan-1-one",25164,"2,2,2-trifluoro-1-[5-({3-phenyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazin-7-yl}carbonyl)thiophen-2-yl]ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25164,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),320,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
869,2036666,25023802,BindingDB,"2,2,2-trifluoro-1-[5-({3-phenyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazin-7-yl}carbonyl)thiophen-2-yl]ethan-1-one",25164,"2,2,2-trifluoro-1-[5-({3-phenyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazin-7-yl}carbonyl)thiophen-2-yl]ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25164,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),370,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
870,2036667,25023802,BindingDB,"2,2,2-trifluoro-1-[5-({3-phenyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazin-7-yl}carbonyl)thiophen-2-yl]ethan-1-one",25164,"2,2,2-trifluoro-1-[5-({3-phenyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazin-7-yl}carbonyl)thiophen-2-yl]ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25164,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
871,2036668,25023802,BindingDB,"2,2,2-trifluoro-1-[5-({3-phenyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazin-7-yl}carbonyl)thiophen-2-yl]ethan-1-one",25164,"2,2,2-trifluoro-1-[5-({3-phenyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazin-7-yl}carbonyl)thiophen-2-yl]ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25164,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),5500,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
872,2036669,25023803,BindingDB,"N-benzyl-N-methyl-5-(2,2,2-trifluoro-1-hydroxyethyl)thiophene-2-carboxamide",25165,"N-benzyl-N-methyl-5-(2,2,2-trifluoro-1-hydroxyethyl)thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25165,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
873,2036670,25023803,BindingDB,"N-benzyl-N-methyl-5-(2,2,2-trifluoro-1-hydroxyethyl)thiophene-2-carboxamide",25165,"N-benzyl-N-methyl-5-(2,2,2-trifluoro-1-hydroxyethyl)thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25165,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
874,2036682,25023805,BindingDB,5-[Methyl(quinoxalin-6-ylmethyl)carbamoyl]thiophene-2-carboxylic acid,25167,5-[methyl(quinoxalin-6-ylmethyl)carbamoyl]thiophene-2-carboxylic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25167,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
875,2036683,25023805,BindingDB,5-[Methyl(quinoxalin-6-ylmethyl)carbamoyl]thiophene-2-carboxylic acid,25167,5-[methyl(quinoxalin-6-ylmethyl)carbamoyl]thiophene-2-carboxylic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25167,2556,Histone deacetylase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2556,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
876,2036684,25023806,BindingDB,"N-[(4-methoxyphenyl)methyl]-5-(2,2,3,3,3-pentafluoropropanoyl)thiophene-2-carboxamide",25170,"N-[(4-methoxyphenyl)methyl]-5-(2,2,3,3,3-pentafluoropropanoyl)thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25170,2556,Histone deacetylase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2556,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
877,2036685,25023806,BindingDB,"N-[(4-methoxyphenyl)methyl]-5-(2,2,3,3,3-pentafluoropropanoyl)thiophene-2-carboxamide",25170,"N-[(4-methoxyphenyl)methyl]-5-(2,2,3,3,3-pentafluoropropanoyl)thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25170,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
878,2036686,25023806,BindingDB,"N-[(4-methoxyphenyl)methyl]-5-(2,2,3,3,3-pentafluoropropanoyl)thiophene-2-carboxamide",25170,"N-[(4-methoxyphenyl)methyl]-5-(2,2,3,3,3-pentafluoropropanoyl)thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25170,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
879,2036687,25023806,BindingDB,"N-[(4-methoxyphenyl)methyl]-5-(2,2,3,3,3-pentafluoropropanoyl)thiophene-2-carboxamide",25170,"N-[(4-methoxyphenyl)methyl]-5-(2,2,3,3,3-pentafluoropropanoyl)thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25170,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,IC50 (nM),2900,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
880,2036688,25023806,BindingDB,"N-[(4-methoxyphenyl)methyl]-5-(2,2,3,3,3-pentafluoropropanoyl)thiophene-2-carboxamide",25170,"N-[(4-methoxyphenyl)methyl]-5-(2,2,3,3,3-pentafluoropropanoyl)thiophene-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25170,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),4200,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
881,2036689,25023807,BindingDB,"5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophene-2-phosphonic acid",25171,"5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophene-2-phosphonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25171,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
882,2036690,25023807,BindingDB,"5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophene-2-phosphonic acid",25171,"5-(2,3-dihydro-1H-indol-1-ylcarbonyl)thiophene-2-phosphonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25171,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
883,2036741,25023813,BindingDB,"2,2,2-Trifluoro-1-(5-{[(4-methoxyphenyl)methoxy]methyl}thiophen-2-yl)ethan-1-one",25177,"2,2,2-trifluoro-1-(5-{[(4-methoxyphenyl)methoxy]methyl}thiophen-2-yl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25177,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
884,2036742,25023813,BindingDB,"2,2,2-Trifluoro-1-(5-{[(4-methoxyphenyl)methoxy]methyl}thiophen-2-yl)ethan-1-one",25177,"2,2,2-trifluoro-1-(5-{[(4-methoxyphenyl)methoxy]methyl}thiophen-2-yl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25177,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),2700,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
885,2036743,25023813,BindingDB,"2,2,2-Trifluoro-1-(5-{[(4-methoxyphenyl)methoxy]methyl}thiophen-2-yl)ethan-1-one",25177,"2,2,2-trifluoro-1-(5-{[(4-methoxyphenyl)methoxy]methyl}thiophen-2-yl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25177,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),5500,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
886,2036744,25023813,BindingDB,"2,2,2-Trifluoro-1-(5-{[(4-methoxyphenyl)methoxy]methyl}thiophen-2-yl)ethan-1-one",25177,"2,2,2-trifluoro-1-(5-{[(4-methoxyphenyl)methoxy]methyl}thiophen-2-yl)ethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25177,2556,Histone deacetylase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2556,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),,IC50 (nM),410,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
887,2036745,25023814,BindingDB,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-3-sulfonamide",25178,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-3-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25178,2556,Histone deacetylase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2556,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),,IC50 (nM),2500,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
888,2036746,25023814,BindingDB,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-3-sulfonamide",25178,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-3-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25178,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),9400,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
889,2036747,25023814,BindingDB,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-3-sulfonamide",25178,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-3-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25178,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
890,2036748,25023814,BindingDB,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-3-sulfonamide",25178,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-3-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25178,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
891,2036749,25023814,BindingDB,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-3-sulfonamide",25178,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-3-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25178,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
892,2036750,25023815,BindingDB,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-2-sulfonamide",25179,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-2-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25179,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
893,2036751,25023815,BindingDB,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-2-sulfonamide",25179,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-2-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25179,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
894,2036752,25023815,BindingDB,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-2-sulfonamide",25179,"N-benzyl-N-methyl-5-(2,2,2-trifluoroacetyl)thiophene-2-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25179,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),1200,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
895,2036778,25023818,BindingDB,"Thiazole derivative, 29c",25182,"N-benzyl-N-methyl-2-(2,2,2-trifluoroacetyl)-1,3-thiazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25182,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
896,2036779,25023819,BindingDB,"Thiazole derivative, 29g",25183,"N-(cyclohexylmethyl)-2-(2,2,2-trifluoroacetyl)-1,3-thiazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25183,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
897,2036780,25023819,BindingDB,"Thiazole derivative, 29g",25183,"N-(cyclohexylmethyl)-2-(2,2,2-trifluoroacetyl)-1,3-thiazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25183,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,IC50 (nM),7600,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
898,2036781,25023819,BindingDB,"Thiazole derivative, 29g",25183,"N-(cyclohexylmethyl)-2-(2,2,2-trifluoroacetyl)-1,3-thiazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25183,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),2900,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
899,2036782,25023819,BindingDB,"Thiazole derivative, 29g",25183,"N-(cyclohexylmethyl)-2-(2,2,2-trifluoroacetyl)-1,3-thiazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25183,2556,Histone deacetylase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2556,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),,IC50 (nM),1500,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
900,2036783,25023819,BindingDB,"Thiazole derivative, 29g",25183,"N-(cyclohexylmethyl)-2-(2,2,2-trifluoroacetyl)-1,3-thiazole-5-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25183,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,IC50 (nM),850,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
901,2036784,25023820,BindingDB,"1-[5-(2,3-dihydro-1H-indol-1-ylcarbonyl)-1H-pyrrol-2-yl]-2,2,2-trifluoroethan-1-one",25184,"1-[5-(2,3-dihydro-1H-indol-1-ylcarbonyl)-1H-pyrrol-2-yl]-2,2,2-trifluoroethan-1-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25184,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
902,2036796,25023822,BindingDB,"N-(cyclohexylmethyl)-4-(2,2,2-trifluoroacetyl)benzamide",25186,CHEMBL248486,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25186,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
903,2036797,25023822,BindingDB,"N-(cyclohexylmethyl)-4-(2,2,2-trifluoroacetyl)benzamide",25186,CHEMBL248486,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25186,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
904,2036798,25023822,BindingDB,"N-(cyclohexylmethyl)-4-(2,2,2-trifluoroacetyl)benzamide",25186,CHEMBL248486,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25186,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
905,2036799,25023823,BindingDB,"5-(2,2,2-Trifluoroacetyl)pyridine-2-carboxamide",25187,"5-(2,2,2-trifluoroacetyl)pyridine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25187,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
906,2036800,25023823,BindingDB,"5-(2,2,2-Trifluoroacetyl)pyridine-2-carboxamide",25187,"5-(2,2,2-trifluoroacetyl)pyridine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25187,1995,Histone deacetylase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1995,O15379,Histone deacetylase 3,8841.0,HDAC3,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
907,2036801,25023823,BindingDB,"5-(2,2,2-Trifluoroacetyl)pyridine-2-carboxamide",25187,"5-(2,2,2-trifluoroacetyl)pyridine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25187,2556,Histone deacetylase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2556,Q9UBN7,Histone deacetylase 6,10013.0,HDAC6,9606.0,Homo sapiens (human),,IC50 (nM),4200,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
908,2036802,25023823,BindingDB,"5-(2,2,2-Trifluoroacetyl)pyridine-2-carboxamide",25187,"5-(2,2,2-trifluoroacetyl)pyridine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25187,6107,Histone deacetylase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6107,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
909,2036803,25023823,BindingDB,"5-(2,2,2-Trifluoroacetyl)pyridine-2-carboxamide",25187,"5-(2,2,2-trifluoroacetyl)pyridine-2-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25187,2791,"Histone deacetylase 4 [653-1084,H976Y]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2791,P56524,Histone deacetylase 4,9759.0,HDAC4,9606.0,Homo sapiens (human),,,,PMID:18440229|DOI:10.1016/j.bmcl.2008.02.026,https://www.ncbi.nlm.nih.gov/pubmed/18440229|https://doi.org/10.1016/j.bmcl.2008.02.026,18440229,10.1016/j.bmcl.2008.02.026,
910,2036804,25023824,BindingDB,"3-{[3-Chloro-7-(1,3-thiazol-5-yl)quinolin-4-yl]amino}phenol",25188,"3-{[3-chloro-7-(1,3-thiazol-5-yl)quinolin-4-yl]amino}phenol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25188,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),100,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
911,2036805,25023825,BindingDB,4-Methyl-3-{[6-(pyridin-4-yl)-2-(trifluoromethyl)quinolin-4-yl]amino}phenol,25189,4-methyl-3-{[6-(pyridin-4-yl)-2-(trifluoromethyl)quinolin-4-yl]amino}phenol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25189,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),>1000,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
912,2036806,25023826,BindingDB,2-Chloro-4-fluoro-5-({7-[3-({[2-(morpholin-4-yl)ethyl]amino}methyl)phenyl]quinolin-4-yl}amino)phenol,25190,2-chloro-4-fluoro-5-({7-[3-({[2-(morpholin-4-yl)ethyl]amino}methyl)phenyl]quinolin-4-yl}amino)phenol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25190,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),75,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
913,2036807,25023827,BindingDB,"4-Chloro-2-fluoro-5-({7-[2-(hydroxymethyl)-1,3-thiazol-4-yl]quinolin-4-yl}amino)phenol",25192,"4-chloro-2-fluoro-5-({7-[2-(hydroxymethyl)-1,3-thiazol-4-yl]quinolin-4-yl}amino)phenol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25192,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),25,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
914,2036808,25023828,BindingDB,4-Methyl-3-{[7-(pyridin-2-yl)quinolin-4-yl]amino}phenol,25193,4-methyl-3-{[7-(pyridin-2-yl)quinolin-4-yl]amino}phenol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25193,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),75,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
915,2036809,25023829,BindingDB,3-{[7-(Pyridin-2-yl)quinolin-4-yl]amino}phenol,25194,3-{[7-(pyridin-2-yl)quinolin-4-yl]amino}phenol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25194,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),6,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
916,2036810,25023830,BindingDB,4-Methyl-3-{[6-(pyridin-3-yl)quinolin-4-yl]amino}phenol,25195,4-methyl-3-{[6-(pyridin-3-yl)quinolin-4-yl]amino}phenol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25195,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),80,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
917,2036811,25023831,BindingDB,4-[(5-hydroxy-2-methylphenyl)amino]-N-(propan-2-yl)quinoline-6-carboxamide,25196,4-[(5-hydroxy-2-methylphenyl)amino]-N-(propan-2-yl)quinoline-6-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25196,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),95,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
918,2036812,25023832,BindingDB,N-(cyclopropylmethyl)-4-[(5-hydroxy-2-methylphenyl)amino]quinoline-6-sulfonamide,25197,"6-substituted 4-anilinoquinoline, 37",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25197,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),90,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
919,2036813,25023833,BindingDB,5-{[7-(1-Benzofuran-2-yl)quinolin-4-yl]amino}-2-bromophenol,25199,5-{[7-(1-benzofuran-2-yl)quinolin-4-yl]amino}-2-bromophenol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25199,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),85,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
920,2036814,25023834,BindingDB,4-Methyl-3-((6-(methylsulfonyl)-7-(2-(morpholinomethyl)thiazol-4-yl)quinolin-4-yl)amino)phenol,25200,"3-({6-methanesulfonyl-7-[2-(morpholin-4-ylmethyl)-1,3-thiazol-4-yl]quinolin-4-yl}amino)-4-methylphenol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25200,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),34,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
921,2036815,25023835,BindingDB,4-Chloro-5-({6-chloro-7-[5-(morpholin-4-ylmethyl)furan-2-yl]quinolin-4-yl}amino)-2-fluorophenol,25201,"4-Anilino-6,7-disubstituted quinoline, 41",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25201,5974,Proto-oncogene tyrosine-protein kinase receptor Ret,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5974,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),,IC50 (nM),>1000,PMID:17884497|DOI:10.1016/j.bmcl.2007.07.104,https://www.ncbi.nlm.nih.gov/pubmed/17884497|https://doi.org/10.1016/j.bmcl.2007.07.104,17884497,10.1016/j.bmcl.2007.07.104,
922,2036816,25023836,BindingDB,"2-N-(5-chloro-2H-1,3-benzodioxol-4-yl)-4-N-(3,4,5-trimethoxyphenyl)-1,3,5-triazine-2,4-diamine",25203,"2-N-(5-chloro-2H-1,3-benzodioxol-4-yl)-4-N-(3,4,5-trimethoxyphenyl)-1,3,5-triazine-2,4-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25203,5496,Ephrin type-B receptor 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5496,P54760,Ephrin type-B receptor 4,2050.0,EPHB4,9606.0,Homo sapiens (human),,IC50 (nM),2960,PMID:18434142|DOI:10.1016/j.bmcl.2008.04.015,https://www.ncbi.nlm.nih.gov/pubmed/18434142|https://doi.org/10.1016/j.bmcl.2008.04.015,18434142,10.1016/j.bmcl.2008.04.015,
923,2036817,25023837,BindingDB,"4-N-(5-chloro-2H-1,3-benzodioxol-4-yl)-6-N-(3,4,5-trimethoxyphenyl)pyrimidine-4,6-diamine",25204,"4,6-Pyrimidine derivative, 6",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25204,5496,Ephrin type-B receptor 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5496,P54760,Ephrin type-B receptor 4,2050.0,EPHB4,9606.0,Homo sapiens (human),,IC50 (nM),2540,PMID:18434142|DOI:10.1016/j.bmcl.2008.04.015,https://www.ncbi.nlm.nih.gov/pubmed/18434142|https://doi.org/10.1016/j.bmcl.2008.04.015,18434142,10.1016/j.bmcl.2008.04.015,
924,2036858,25023888,BindingDB,"Bisphosphonate, 36",25286,3-(dodecyloxy)-1-(2-hydrogen phosphonato-2-phosphonoethyl)pyridin-1-ium,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25286,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),3020,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
925,2036859,25023890,BindingDB,"{2-[5-(Decyloxy)pyridin-3-Yl]ethane-1,1-Diyl}bis(Phosphonic Acid)",25291,"bisphosphonate, 40",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25291,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),4570,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
926,2036860,25023891,BindingDB,{2-[5-(Dodecyloxy)pyridin-3-yl]-1-phosphonoethyl}phosphonic acid,25292,"bisphosphonate, 41",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25292,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),5010,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
927,2036861,25023892,BindingDB,"Bisphosphonate, 42",25293,3-hexyl-1-(2-hydrogen phosphonato-2-phosphonoethyl)pyridin-1-ium,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25293,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),6310,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
928,2036862,25023893,BindingDB,"Bisphosphonate, 44",25295,"3-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-1-(2-hydrogen phosphonato-2-phosphonoethyl)pyridin-1-ium",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25295,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),8910,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
929,2036863,25023895,BindingDB,"[1,3-Bis(2,4-dichlorophenyl)-2-phosphonopropan-2-yl]phosphonic acid",25300,"[1,3-bis(2,4-dichlorophenyl)-2-phosphonopropan-2-yl]phosphonic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25300,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),27540,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
930,2036864,25023896,BindingDB,(2-Carbamimidamido-1-hydroxy-1-phosphonoethyl)phosphonic acid,25304,(2-carbamimidamido-1-hydroxy-1-phosphonoethyl)phosphonic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25304,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),74130,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
931,2036865,25023897,BindingDB,"Bisphosphonate, 52",25305,"bisphosphonate, 52",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25305,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),79430,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
932,2036866,25023899,BindingDB,"Bisphosphonate, 54",25306,3-[3-(2-ethoxyethoxy)propyl]-1-(2-hydrogen phosphonato-2-phosphonoethyl)pyridin-1-ium,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25306,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),93330,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
933,2036867,25023901,BindingDB,"Bisphosphonate, 58",25309,"bisphosphonate, 58",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25309,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),117490,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
934,2036868,25023903,BindingDB,"Bisphosphonate, 59",25310,1-(2-hydrogen phosphonato-2-hydroxy-2-phosphonoethyl)pyridin-1-ium,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25310,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),141250,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
935,2036869,25023904,BindingDB,"Bisphosphonate, 63",25312,1-(2-hydrogen phosphonato-2-phosphonoethyl)-3-(1H-imidazol-5-yl)pyridin-1-ium,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25312,2814,Geranylgeranyl pyrophosphate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2814,O95749,Geranylgeranyl pyrophosphate synthase,9453.0,GGPS1,9606.0,Homo sapiens (human),,IC50 (nM),316230,PMID:18800762|DOI:10.1021/jm800325y,https://www.ncbi.nlm.nih.gov/pubmed/18800762|https://doi.org/10.1021/jm800325y,18800762,10.1021/jm800325y,
936,2036870,25023923,BindingDB,,25354,"8-benzyl-4-(cyclohexylamino)-1,3,8-triazaspiro[4.5]dec-3-en-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25354,5093,Beta-secretase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5093,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:18811140|DOI:10.1021/jm800914n,https://www.ncbi.nlm.nih.gov/pubmed/18811140|https://doi.org/10.1021/jm800914n,18811140,10.1021/jm800914n,
937,2036871,25023924,BindingDB,,25355,"8-benzyl-4-(cyclohexylamino)-1-(3-methylbutyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25355,5093,Beta-secretase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5093,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:18811140|DOI:10.1021/jm800914n,https://www.ncbi.nlm.nih.gov/pubmed/18811140|https://doi.org/10.1021/jm800914n,18811140,10.1021/jm800914n,
938,2036872,25023925,BindingDB,,25356,"1,8-dibenzyl-4-(cyclohexylamino)-1,3,8-triazaspiro[4.5]dec-3-en-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25356,5093,Beta-secretase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5093,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:18811140|DOI:10.1021/jm800914n,https://www.ncbi.nlm.nih.gov/pubmed/18811140|https://doi.org/10.1021/jm800914n,18811140,10.1021/jm800914n,
939,2036873,25023926,BindingDB,,25357,"8-benzyl-4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25357,5093,Beta-secretase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5093,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,IC50 (nM),11000,PMID:18811140|DOI:10.1021/jm800914n,https://www.ncbi.nlm.nih.gov/pubmed/18811140|https://doi.org/10.1021/jm800914n,18811140,10.1021/jm800914n,
940,2036874,25023927,BindingDB,,25358,"N-{4-[8-benzyl-4-(cyclohexylamino)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-1-yl]phenyl}acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25358,5093,Beta-secretase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5093,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,IC50 (nM),8000,PMID:18811140|DOI:10.1021/jm800914n,https://www.ncbi.nlm.nih.gov/pubmed/18811140|https://doi.org/10.1021/jm800914n,18811140,10.1021/jm800914n,
941,2036875,25023928,BindingDB,,25359,"4-(cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25359,5093,Beta-secretase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5093,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:18811140|DOI:10.1021/jm800914n,https://www.ncbi.nlm.nih.gov/pubmed/18811140|https://doi.org/10.1021/jm800914n,18811140,10.1021/jm800914n,
942,2036876,25023929,BindingDB,,25360,"4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(4-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25360,5093,Beta-secretase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5093,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:18811140|DOI:10.1021/jm800914n,https://www.ncbi.nlm.nih.gov/pubmed/18811140|https://doi.org/10.1021/jm800914n,18811140,10.1021/jm800914n,
943,2036877,25023930,BindingDB,,25361,"N-(4-{[4-(cyclohexylamino)-1-(3-fluorophenyl)-2-oxo-1,3,8-triazaspiro[4.5]dec-3-en-8-yl]methyl}phenyl)acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25361,5093,Beta-secretase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5093,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,IC50 (nM),2800,PMID:18811140|DOI:10.1021/jm800914n,https://www.ncbi.nlm.nih.gov/pubmed/18811140|https://doi.org/10.1021/jm800914n,18811140,10.1021/jm800914n,
944,2036878,25023931,BindingDB,,25362,"4-(cyclohexylamino)-1-(3-fluorophenyl)-8-[(3-phenylphenyl)methyl]-1,3,8-triazaspiro[4.5]dec-3-en-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25362,5093,Beta-secretase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5093,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,IC50 (nM),4600,PMID:18811140|DOI:10.1021/jm800914n,https://www.ncbi.nlm.nih.gov/pubmed/18811140|https://doi.org/10.1021/jm800914n,18811140,10.1021/jm800914n,
945,2036879,25023932,BindingDB,,25363,"4-(cyclohexylamino)-1-(3-fluorophenyl)-8-{[3-(2-methylphenyl)phenyl]methyl}-1,3,8-triazaspiro[4.5]dec-3-en-2-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25363,5093,Beta-secretase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5093,P56817,Beta-secretase 1,23621.0,BACE1,9606.0,Homo sapiens (human),,IC50 (nM),110,PMID:18811140|DOI:10.1021/jm800914n,https://www.ncbi.nlm.nih.gov/pubmed/18811140|https://doi.org/10.1021/jm800914n,18811140,10.1021/jm800914n,
946,2036891,25023944,BindingDB,"(4-methyl-1,7,4-dioxazecan-9-yl) N-[(1S,2R)-1-benzyl-2-hydroxy-3-[isobutyl-(4-methoxyphenyl)sulfonyl-amino]propyl]carbamate",25376,"(R)-(hydroxyethylamino)sulfonamide isostere, 3m",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25376,125,"Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=125,P03367,Gag-Pol polyprotein,,,11686.0,Human immunodeficiency virus type 1 (BRU ISOLATE),,Ki (nM),19,PMID:18783203|DOI:10.1021/jm8004543,https://www.ncbi.nlm.nih.gov/pubmed/18783203|https://doi.org/10.1021/jm8004543,18783203,10.1021/jm8004543,
947,2036892,25023945,BindingDB,"7-benzyl-8-(3,5-dimethyl-1H-pyrazol-1-yl)-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",25384,"7-benzyl-8-(3,5-dimethyl-1H-pyrazol-1-yl)-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25384,2857,Serine/threonine-protein kinase B-raf,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2857,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),,IC50 (nM),57710,PMID:18783202|DOI:10.1021/jm800539g,https://www.ncbi.nlm.nih.gov/pubmed/18783202|https://doi.org/10.1021/jm800539g,18783202,10.1021/jm800539g,
948,2036893,25023946,BindingDB,"8-{[(2E)-3-chlorobut-2-en-1-yl]sulfanyl}-7-(2-hydroxy-4-phenylbutyl)-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",25385,"8-{[(2E)-3-chlorobut-2-en-1-yl]sulfanyl}-7-(2-hydroxy-4-phenylbutyl)-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25385,2857,Serine/threonine-protein kinase B-raf,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2857,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),,IC50 (nM),3750,PMID:18783202|DOI:10.1021/jm800539g,https://www.ncbi.nlm.nih.gov/pubmed/18783202|https://doi.org/10.1021/jm800539g,18783202,10.1021/jm800539g,
949,2036894,25023948,BindingDB,"N-[5-(2-{[2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}amino)ethyl]amino}-1-hydroxyethyl)-2-hydroxyphenyl]formamide",25394,"Bivalent derivative, 12a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25394,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),1979,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
950,2036895,25023948,BindingDB,"N-[5-(2-{[2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}amino)ethyl]amino}-1-hydroxyethyl)-2-hydroxyphenyl]formamide",25394,"Bivalent derivative, 12a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25394,5059,Beta-2 adrenergic receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5059,P07550,Beta-2 adrenergic receptor,154.0,ADRB2,9606.0,Homo sapiens (human),,Ki (nM),>10000,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
951,2036896,25023949,BindingDB,"(2R,3R,4S,5R)-2-{6-[(2-{[2-(3-amino-4-hydroxyphenyl)-2-hydroxyethyl]amino}ethyl)amino]-9H-purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol",25395,"(2R,3R,4S,5R)-2-{6-[(2-{[2-(3-amino-4-hydroxyphenyl)-2-hydroxyethyl]amino}ethyl)amino]-9H-purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25395,5059,Beta-2 adrenergic receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5059,P07550,Beta-2 adrenergic receptor,154.0,ADRB2,9606.0,Homo sapiens (human),,Ki (nM),>10000,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
952,2036897,25023949,BindingDB,"(2R,3R,4S,5R)-2-{6-[(2-{[2-(3-amino-4-hydroxyphenyl)-2-hydroxyethyl]amino}ethyl)amino]-9H-purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol",25395,"(2R,3R,4S,5R)-2-{6-[(2-{[2-(3-amino-4-hydroxyphenyl)-2-hydroxyethyl]amino}ethyl)amino]-9H-purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25395,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),2749,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
953,2036898,25023950,BindingDB,"N-[5-(2-{[4-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}amino)butyl]amino}-1-hydroxyethyl)-2-hydroxyphenyl]formamide",25396,"Bivalent derivative, 12c",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25396,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),1914,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
954,2036899,25023950,BindingDB,"N-[5-(2-{[4-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}amino)butyl]amino}-1-hydroxyethyl)-2-hydroxyphenyl]formamide",25396,"Bivalent derivative, 12c",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25396,5059,Beta-2 adrenergic receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5059,P07550,Beta-2 adrenergic receptor,154.0,ADRB2,9606.0,Homo sapiens (human),,Ki (nM),863,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
955,2036900,25023951,BindingDB,"(2R,3R,4S,5R)-2-{6-[(4-{[2-(3-amino-4-hydroxyphenyl)-2-hydroxyethyl]amino}butyl)amino]-9H-purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol",25397,"(2R,3R,4S,5R)-2-{6-[(4-{[2-(3-amino-4-hydroxyphenyl)-2-hydroxyethyl]amino}butyl)amino]-9H-purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25397,5059,Beta-2 adrenergic receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5059,P07550,Beta-2 adrenergic receptor,154.0,ADRB2,9606.0,Homo sapiens (human),,Ki (nM),4314,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
956,2036901,25023951,BindingDB,"(2R,3R,4S,5R)-2-{6-[(4-{[2-(3-amino-4-hydroxyphenyl)-2-hydroxyethyl]amino}butyl)amino]-9H-purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol",25397,"(2R,3R,4S,5R)-2-{6-[(4-{[2-(3-amino-4-hydroxyphenyl)-2-hydroxyethyl]amino}butyl)amino]-9H-purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25397,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),1014,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
957,2036902,25023952,BindingDB,"N-[5-(2-{[6-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}amino)hexyl]amino}-1-hydroxyethyl)-2-hydroxyphenyl]formamide",25398,"Bivalent derivative, 12e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25398,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),436,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
958,2036903,25023952,BindingDB,"N-[5-(2-{[6-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}amino)hexyl]amino}-1-hydroxyethyl)-2-hydroxyphenyl]formamide",25398,"Bivalent derivative, 12e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25398,5059,Beta-2 adrenergic receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5059,P07550,Beta-2 adrenergic receptor,154.0,ADRB2,9606.0,Homo sapiens (human),,Ki (nM),311,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
959,2036904,25023953,BindingDB,"Bivalent derivative, 18",25399,"Bivalent derivative, 18",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25399,5059,Beta-2 adrenergic receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5059,P07550,Beta-2 adrenergic receptor,154.0,ADRB2,9606.0,Homo sapiens (human),,Ki (nM),2296,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
960,2036905,25023953,BindingDB,"Bivalent derivative, 18",25399,"Bivalent derivative, 18",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25399,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),1907,PMID:18783211|DOI:10.1021/jm800613s,https://www.ncbi.nlm.nih.gov/pubmed/18783211|https://doi.org/10.1021/jm800613s,18783211,10.1021/jm800613s,
961,2036906,25023954,BindingDB,"2-(2,4-Dichlorophenoxy)-5-phenylphenol",25402,"2-(2,4-dichlorophenoxy)-5-phenylphenol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25402,2820,Enoyl-ACP reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2820,,,,,,,,IC50 (nM),140,PMID:17567585|DOI:10.1074/jbc.M701813200,https://www.ncbi.nlm.nih.gov/pubmed/17567585|https://doi.org/10.1074/jbc.M701813200,17567585,10.1074/jbc.M701813200,
962,2036907,25023955,BindingDB,"4-(2,4-Dichlorophenoxy)-3-hydroxybenzonitrile",25403,"4&#8208;(2,4&#8208;dichlorophenoxy)&#8208;3&#8208;hydroxybenzonitrile (19)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25403,2820,Enoyl-ACP reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2820,,,,,,,,IC50 (nM),49,PMID:17567585|DOI:10.1074/jbc.M701813200,https://www.ncbi.nlm.nih.gov/pubmed/17567585|https://doi.org/10.1074/jbc.M701813200,17567585,10.1074/jbc.M701813200,
963,2036908,25023956,BindingDB,"2-(2,4-dichlorophenoxy)-5-(2H-1,2,3,4-tetrazol-5-yl)phenol",25404,"2-(2,4-dichlorophenoxy)-5-(2H-1,2,3,4-tetrazol-5-yl)phenol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25404,2820,Enoyl-ACP reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2820,,,,,,,,IC50 (nM),>100000,PMID:17567585|DOI:10.1074/jbc.M701813200,https://www.ncbi.nlm.nih.gov/pubmed/17567585|https://doi.org/10.1074/jbc.M701813200,17567585,10.1074/jbc.M701813200,
964,2036909,25023957,BindingDB,"4-(2,4-Dichlorophenoxy)-3-hydroxybenzamide",25405,"4-(2,4-dichlorophenoxy)-3-hydroxybenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25405,2820,Enoyl-ACP reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2820,,,,,,,,IC50 (nM),21000,PMID:17567585|DOI:10.1074/jbc.M701813200,https://www.ncbi.nlm.nih.gov/pubmed/17567585|https://doi.org/10.1074/jbc.M701813200,17567585,10.1074/jbc.M701813200,
965,2036910,25023958,BindingDB,"2-(2,4-Dichlorophenoxy)-5-ethylphenol",25407,"2&#8208;(2,4&#8208;dichlorophenoxy)&#8208;5&#8208;ethylphenol (11)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25407,2820,Enoyl-ACP reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2820,,,,,,,,IC50 (nM),110,PMID:17567585|DOI:10.1074/jbc.M701813200,https://www.ncbi.nlm.nih.gov/pubmed/17567585|https://doi.org/10.1074/jbc.M701813200,17567585,10.1074/jbc.M701813200,
966,2036911,25023959,BindingDB,"2-(2,4-Dichlorophenoxy)-5-propylphenol",25408,"2-(2,4-dichlorophenoxy)-5-propylphenol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25408,2820,Enoyl-ACP reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2820,,,,,,,,IC50 (nM),210,PMID:17567585|DOI:10.1074/jbc.M701813200,https://www.ncbi.nlm.nih.gov/pubmed/17567585|https://doi.org/10.1074/jbc.M701813200,17567585,10.1074/jbc.M701813200,
967,2036912,25023960,BindingDB,"5-Butyl-2-(2,4-dichlorophenoxy)phenol",25409,"5-butyl-2-(2,4-dichlorophenoxy)phenol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25409,2820,Enoyl-ACP reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2820,,,,,,,,IC50 (nM),480,PMID:17567585|DOI:10.1074/jbc.M701813200,https://www.ncbi.nlm.nih.gov/pubmed/17567585|https://doi.org/10.1074/jbc.M701813200,17567585,10.1074/jbc.M701813200,
968,2030169,25033539,Comparative Toxicogenomics Database (CTD),PF-04691502,C570662,"2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one",https://ctdbase.org/detail.go?type=chem&acc=C570662,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),"2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one results in decreased susceptibility to VEGFA protein|2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one results in decreased expression of VEGFA protein|2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one results in decreased secretion of VEGFA protein",,,PMID:23639247,https://www.ncbi.nlm.nih.gov/pubmed/23639247,23639247,,
969,2030170,25051295,Therapeutic Target Database (TTD),Pyrazole derivative 24,D0S5NS,Pyrazole derivative 24,https://idrblab.net/ttd/data/drug/details/D0S5NS,T76685,Cannabinoid receptor 1 (CB1),https://idrblab.net/ttd/data/target/details/T76685,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
970,2030171,25051779,Therapeutic Target Database (TTD),Pyrazole derivative 25,D0J5NB,Pyrazole derivative 25,https://idrblab.net/ttd/data/drug/details/D0J5NB,T76685,Cannabinoid receptor 1 (CB1),https://idrblab.net/ttd/data/target/details/T76685,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
971,2030172,25062281,Therapeutic Target Database (TTD),Furopyridine derivative 1,D02XYT,Furopyridine derivative 1,https://idrblab.net/ttd/data/drug/details/D02XYT,T76685,Cannabinoid receptor 1 (CB1),https://idrblab.net/ttd/data/target/details/T76685,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
972,2030173,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0004145,Tyrosine-protein kinase JAK1,https://www.drugbank.ca/bio_entities/BE0004145,P23458,Tyrosine-protein kinase JAK1,3716.0,JAK1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:31450973,https://www.ncbi.nlm.nih.gov/pubmed/31450973,31450973,,
973,2030174,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0002408,Tyrosine-protein kinase JAK2,https://www.drugbank.ca/bio_entities/BE0002408,O60674,Tyrosine-protein kinase JAK2,3717.0,JAK2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:31450973,https://www.ncbi.nlm.nih.gov/pubmed/31450973,31450973,,
974,2030175,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0003493,Tyrosine-protein kinase JAK3,https://www.drugbank.ca/bio_entities/BE0003493,P52333,Tyrosine-protein kinase JAK3,3718.0,JAK3,9606.0,Homo sapiens (human),Inhibitor,,,PMID:31450973,https://www.ncbi.nlm.nih.gov/pubmed/31450973,31450973,,
975,2030176,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0004146,Non-receptor tyrosine-protein kinase TYK2,https://www.drugbank.ca/bio_entities/BE0004146,P29597,Non-receptor tyrosine-protein kinase TYK2,7297.0,TYK2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:31450973,https://www.ncbi.nlm.nih.gov/pubmed/31450973,31450973,,
976,2030177,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0000264,Activin receptor type-1,https://www.drugbank.ca/bio_entities/BE0000264,Q04771,Activin receptor type-1,90.0,ACVR1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:31450973,https://www.ncbi.nlm.nih.gov/pubmed/31450973,31450973,,
977,2030178,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0000147,Receptor-type tyrosine-protein kinase FLT3,https://www.drugbank.ca/bio_entities/BE0000147,P36888,Receptor-type tyrosine-protein kinase FLT3,2322.0,FLT3,9606.0,Homo sapiens (human),Inhibitor,,,PMID:34768286,https://www.ncbi.nlm.nih.gov/pubmed/34768286,34768286,,
978,2030229,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate,,,,,,,
979,2030230,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606.0,Homo sapiens (human),Substrate,,,,,,,
980,2030231,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),Substrate,,,,,,,
981,2030232,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0003536,Cytochrome P450 2C19,https://www.drugbank.ca/bio_entities/BE0003536,P33261,Cytochrome P450 2C19,1557.0,CYP2C19,9606.0,Homo sapiens (human),Substrate,,,,,,,
982,2030233,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0002433,Cytochrome P450 1A2,https://www.drugbank.ca/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606.0,Homo sapiens (human),Substrate,,,,,,,
983,2030234,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0003549,Cytochrome P450 2B6,https://www.drugbank.ca/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
984,2030235,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0003541,UDP-glucuronosyltransferase 1-1,https://www.drugbank.ca/bio_entities/BE0003541,P22309,UDP-glucuronosyltransferase 1A1 ,54658.0,UGT1A1,9606.0,Homo sapiens (human),Inhibitor|Inducer,,,,,,,
985,2030236,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0003538,UDP-glucuronosyltransferase 1-9,https://www.drugbank.ca/bio_entities/BE0003538,O60656,UDP-glucuronosyltransferase 1A9,54600.0,UGT1A9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
986,2030237,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606.0,Homo sapiens (human),Substrate,,,,,,,
987,2030238,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,,,,,
988,2030239,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0001004,Solute carrier organic anion transporter family member 1B1,https://www.drugbank.ca/bio_entities/BE0001004,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Substrate,,,,,,,
989,2030240,25062766,DrugBank,Momelotinib,DB11763,Momelotinib,https://www.drugbank.ca/drugs/DB11763,BE0003659,Solute carrier organic anion transporter family member 1B3,https://www.drugbank.ca/bio_entities/BE0003659,Q9NPD5,Solute carrier organic anion transporter family member 1B3,28234.0,SLCO1B3,9606.0,Homo sapiens (human),Substrate,,,,,,,
990,2030241,25066467,Therapeutic Target Database (TTD),Rebastinib,D0E0NM,DCC-2036,https://idrblab.net/ttd/data/drug/details/D0E0NM,T92144,Angiopoietin 1 receptor (TEK),https://idrblab.net/ttd/data/target/details/T92144,Q02763,Angiopoietin-1 receptor,7010.0,TEK,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
991,2029527,25068753,BindingDB,"5H-Benzo(6,7)cyclohepta(1,2-d)pyrimidin-2-amine, 4-((3R)-3-amino-1-pyrrolidinyl)-6,7-dihydro-",26396,"2,4-diamino-5,6-disubstituted pyrimidine, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26396,2292,Histamine H4 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2292,Q91ZY1,Histamine H4 receptor,170704.0,Hrh4,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),3.8,PMID:18817367|DOI:10.1021/jm800670r,https://www.ncbi.nlm.nih.gov/pubmed/18817367|https://doi.org/10.1021/jm800670r,18817367,10.1021/jm800670r,
992,2029528,25068753,BindingDB,"5H-Benzo(6,7)cyclohepta(1,2-d)pyrimidin-2-amine, 4-((3R)-3-amino-1-pyrrolidinyl)-6,7-dihydro-",26396,"2,4-diamino-5,6-disubstituted pyrimidine, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26396,2289,Histamine H4 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2289,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606.0,Homo sapiens (human),,Ki (nM),4.7,PMID:18817367|DOI:10.1021/jm800670r,https://www.ncbi.nlm.nih.gov/pubmed/18817367|https://doi.org/10.1021/jm800670r,18817367,10.1021/jm800670r,
993,2029531,25068753,Therapeutic Target Database (TTD),"5H-Benzo(6,7)cyclohepta(1,2-d)pyrimidin-2-amine, 4-((3R)-3-amino-1-pyrrolidinyl)-6,7-dihydro-",D0P8DW,A-943931,https://idrblab.net/ttd/data/drug/details/D0P8DW,T26500,Histamine H4 receptor (H4R),https://idrblab.net/ttd/data/target/details/T26500,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
994,2029526,25069914,BindingDB,"N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-[6-(morpholin-4-yl)pyridin-2-yl]pyrimidin-4-yl]acetamide",26247,"N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-[6-(morpholin-4-yl)pyridin-2-yl]pyrimidin-4-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26247,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),130,PMID:18947224|DOI:10.1021/jm800851u,https://www.ncbi.nlm.nih.gov/pubmed/18947224|https://doi.org/10.1021/jm800851u,18947224,10.1021/jm800851u,
995,2029532,25071004,BindingDB,"6-[(3R)-3-(methylamino)pyrrolidin-1-yl]-3,5-diazatricyclo[9.4.0.0^{2,7}]pentadeca-1(15),2(7),3,5,11,13-hexaen-4-amine",26397,"2,4-diamino-5,6-disubstituted pyrimidine, 11",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26397,2292,Histamine H4 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2292,Q91ZY1,Histamine H4 receptor,170704.0,Hrh4,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),5.1,PMID:18817367|DOI:10.1021/jm800670r,https://www.ncbi.nlm.nih.gov/pubmed/18817367|https://doi.org/10.1021/jm800670r,18817367,10.1021/jm800670r,
996,2029646,25071004,BindingDB,"6-[(3R)-3-(methylamino)pyrrolidin-1-yl]-3,5-diazatricyclo[9.4.0.0^{2,7}]pentadeca-1(15),2(7),3,5,11,13-hexaen-4-amine",26397,"2,4-diamino-5,6-disubstituted pyrimidine, 11",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26397,2289,Histamine H4 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2289,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606.0,Homo sapiens (human),,Ki (nM),3.5,PMID:18817367|DOI:10.1021/jm800670r,https://www.ncbi.nlm.nih.gov/pubmed/18817367|https://doi.org/10.1021/jm800670r,18817367,10.1021/jm800670r,
997,2029529,25071319,BindingDB,"(4-(Piperazin-1-yl)-6,7-dihydro-5H-benzo(6,7)cyclohepta(1,2-d)pyrimidin-2-yl)amine",26395,"2,4-diamino-5,6-disubstituted pyrimidine, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26395,2289,Histamine H4 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2289,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606.0,Homo sapiens (human),,Ki (nM),71,PMID:18817367|DOI:10.1021/jm800670r,https://www.ncbi.nlm.nih.gov/pubmed/18817367|https://doi.org/10.1021/jm800670r,18817367,10.1021/jm800670r,
998,2029530,25071319,BindingDB,"(4-(Piperazin-1-yl)-6,7-dihydro-5H-benzo(6,7)cyclohepta(1,2-d)pyrimidin-2-yl)amine",26395,"2,4-diamino-5,6-disubstituted pyrimidine, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26395,2292,Histamine H4 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2292,Q91ZY1,Histamine H4 receptor,170704.0,Hrh4,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),7.6,PMID:18817367|DOI:10.1021/jm800670r,https://www.ncbi.nlm.nih.gov/pubmed/18817367|https://doi.org/10.1021/jm800670r,18817367,10.1021/jm800670r,
999,2029687,25071940,BindingDB,"6-(Piperazin-1-yl)-3,5-diazatricyclo[8.4.0.0^{2,7}]tetradeca-1(14),2,4,6,10,12-hexaen-4-amine",26393,"2,4-diamino-5,6-disubstituted pyrimidine, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26393,2289,Histamine H4 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2289,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606.0,Homo sapiens (human),,Ki (nM),51.9,PMID:18817367|DOI:10.1021/jm800670r,https://www.ncbi.nlm.nih.gov/pubmed/18817367|https://doi.org/10.1021/jm800670r,18817367,10.1021/jm800670r,
1000,2029688,25071940,BindingDB,"6-(Piperazin-1-yl)-3,5-diazatricyclo[8.4.0.0^{2,7}]tetradeca-1(14),2,4,6,10,12-hexaen-4-amine",26393,"2,4-diamino-5,6-disubstituted pyrimidine, 7",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26393,2292,Histamine H4 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2292,Q91ZY1,Histamine H4 receptor,170704.0,Hrh4,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),9.2,PMID:18817367|DOI:10.1021/jm800670r,https://www.ncbi.nlm.nih.gov/pubmed/18817367|https://doi.org/10.1021/jm800670r,18817367,10.1021/jm800670r,
1001,2029533,25073775,IUPHAR/BPS Guide to PHARMACOLOGY,"Benzamide, 2-[[2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyridinyl]amino]-N-methyl-",8742,VS-4718,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8742,2180,protein tyrosine kinase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2180,Q05397,Focal adhesion kinase 1,5747.0,PTK2,9606.0,Homo sapiens (human),Inhibition,pIC50,8.82,PMID:20234191,https://www.ncbi.nlm.nih.gov/pubmed/20234191,20234191,,
1002,2029543,25074004,BindingDB,"N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-{6-[(2-methoxyethyl)(methyl)amino]pyridin-2-yl}pyrimidin-4-yl]acetamide",26254,"N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-{6-[(2-methoxyethyl)(methyl)amino]pyridin-2-yl}pyrimidin-4-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26254,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),55,PMID:18947224|DOI:10.1021/jm800851u,https://www.ncbi.nlm.nih.gov/pubmed/18947224|https://doi.org/10.1021/jm800851u,18947224,10.1021/jm800851u,
1003,2029544,25074311,Therapeutic Target Database (TTD),4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine,D0AH8Q,4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine,https://idrblab.net/ttd/data/drug/details/D0AH8Q,T75243,Serine/threonine-protein kinase mTOR (mTOR),https://idrblab.net/ttd/data/target/details/T75243,P42345,Serine/threonine-protein kinase mTOR,2475.0,MTOR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1004,2029545,25074312,Therapeutic Target Database (TTD),4-(2-(thiophen-3-yl)-9H-purin-6-yl)morpholine,D0F1SI,4-(2-(thiophen-3-yl)-9H-purin-6-yl)morpholine,https://idrblab.net/ttd/data/drug/details/D0F1SI,T75243,Serine/threonine-protein kinase mTOR (mTOR),https://idrblab.net/ttd/data/target/details/T75243,P42345,Serine/threonine-protein kinase mTOR,2475.0,MTOR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1005,2029546,25074313,BindingDB,"N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-[5-(morpholin-4-yl)pyridin-3-yl]pyrimidin-4-yl]acetamide",26245,"N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-[5-(morpholin-4-yl)pyridin-3-yl]pyrimidin-4-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26245,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),220,PMID:18947224|DOI:10.1021/jm800851u,https://www.ncbi.nlm.nih.gov/pubmed/18947224|https://doi.org/10.1021/jm800851u,18947224,10.1021/jm800851u,
1006,2029547,25074316,BindingDB,"Acetamide, N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-[6-(4-methoxy-1-piperidinyl)-2-pyridinyl]-4-pyrimidinyl]-",26256,"N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-[6-(4-methoxypiperidin-1-yl)pyridin-2-yl]pyrimidin-4-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26256,2129,Adenosine receptor A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2129,P30542,Adenosine receptor A1,134.0,ADORA1,9606.0,Homo sapiens (human),,Ki (nM),85,PMID:18947224|DOI:10.1021/jm800851u,https://www.ncbi.nlm.nih.gov/pubmed/18947224|https://doi.org/10.1021/jm800851u,18947224,10.1021/jm800851u,
1007,2029548,25074458,IUPHAR/BPS Guide to PHARMACOLOGY,H-Leu-Glu-Ser-Ile-Phe-Arg-Ser-Leu-Leu-Phe-Arg-Val-Met-OH,6240,MMK-1,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6240,223,FPR2/ALX,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=223,P25090,N-formyl peptide receptor 2,2358.0,FPR2,9606.0,Homo sapiens (human),Full agonist,pEC50,8.7,PMID:9853614|PMID:11435499,https://www.ncbi.nlm.nih.gov/pubmed/9853614|https://www.ncbi.nlm.nih.gov/pubmed/11435499,9853614|11435499,,
1008,2029549,25074888,Comparative Toxicogenomics Database (CTD),Aptaa-lhrh,C042691,"LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-",https://ctdbase.org/detail.go?type=chem&acc=C042691,2796,GNRH1,https://ctdbase.org/detail.go?type=gene&acc=2796,,,2796.0,GNRH1,9539.0,Macaca (macaques),"LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)- inhibits the reaction [GNRH1 protein results in increased expression of LHB protein]|lhrh, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)- inhibits the reaction [GNRH1 protein results in increased abundance of testosterone]",,,PMID:3882872,https://www.ncbi.nlm.nih.gov/pubmed/3882872,3882872,,
1009,2029550,25074888,Comparative Toxicogenomics Database (CTD),Aptaa-lhrh,C042691,"LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-",https://ctdbase.org/detail.go?type=chem&acc=C042691,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972.0,LHB,9539.0,Macaca (macaques),"LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)- inhibits the reaction [GNRH1 protein results in increased expression of LHB protein]|lhrh, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)- results in decreased expression of LHB protein",,,PMID:3882872,https://www.ncbi.nlm.nih.gov/pubmed/3882872,3882872,,
1010,2029561,25074888,Comparative Toxicogenomics Database (CTD),Aptaa-lhrh,C042691,"LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-",https://ctdbase.org/detail.go?type=chem&acc=C042691,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972.0,LHB,70699.0,unidentified monkey,"LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)- results in decreased secretion of LHB protein",,,PMID:2656304,https://www.ncbi.nlm.nih.gov/pubmed/2656304,2656304,,
1011,2029562,25074888,Comparative Toxicogenomics Database (CTD),Aptaa-lhrh,C042691,"LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-",https://ctdbase.org/detail.go?type=chem&acc=C042691,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617.0,PRL,10116.0,Rattus norvegicus (Norway rat),"LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)- inhibits the reaction [haloperidol results in increased expression of PRL protein]",,,PMID:3906589,https://www.ncbi.nlm.nih.gov/pubmed/3906589,3906589,,
1012,2029563,25074888,Comparative Toxicogenomics Database (CTD),Aptaa-lhrh,C042691,"LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-",https://ctdbase.org/detail.go?type=chem&acc=C042691,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617.0,PRL,70699.0,unidentified monkey,"LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)- results in decreased secretion of PRL protein",,,PMID:2656304,https://www.ncbi.nlm.nih.gov/pubmed/2656304,2656304,,
1013,2029564,25077649,Toxin and Toxin Target Database (T3DB),N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(2-azanyl-2-oxidanylidene-ethyl)carbamoyl]pyrrolidin-1-yl]-5-[bis(azanyl)methylideneamino]-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-naphthalen-2-yl-1-oxidanylidene-propan-2-yl]amino],T3D2855,Nafarelin,http://www.t3db.ca/toxins/T3D2855,BE0000203,Gonadotropin-releasing hormone receptor,http://www.t3db.ca/biodb/bio_entities/BE0000203,P30968,Gonadotropin-releasing hormone receptor,2798.0,GNRHR,9606.0,Homo sapiens (human),"Like gnrh, initial or intermittent administration of nafarelin stimulates release of the gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland, which in turn transiently increases production of estradiol in females and testosterone in both sexes. however, with continuous daily administration, nafarelin continuously occupies the gnrh receptor. A reversible down-regulation of the gnrh receptors in the pituitary gland and desensitization of the pituitary gonadotropes occur. this causes a significant and sustained decline in the production of LH and FSH. A decline in gonadotropin production and release causes a dramatic reversible decrease in synthesis of estradiol, progesterone, and testosterone by the ovaries or testes. like normal endometrium, endometriotic implants contain estrogen receptors. estrogen stimulates the growth of endometrium. use of nafarelin induces anovulation and amenorrhea and decreases serum concentrations of estradiol to the postmenopausal range, which induces atrophy of endometriotic implants. nafarelin does not abolish the underlying pathophysiology of endometriosis, however.",,,PMID:18048412,https://www.ncbi.nlm.nih.gov/pubmed/18048412,18048412,,
1014,2029565,25077649,Toxin and Toxin Target Database (T3DB),N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(2-azanyl-2-oxidanylidene-ethyl)carbamoyl]pyrrolidin-1-yl]-5-[bis(azanyl)methylideneamino]-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-naphthalen-2-yl-1-oxidanylidene-propan-2-yl]amino],T3D2855,Nafarelin,http://www.t3db.ca/toxins/T3D2855,BE0000472,Putative gonadotropin-releasing hormone II receptor,http://www.t3db.ca/biodb/bio_entities/BE0000472,Q96P88,Putative gonadotropin-releasing hormone II receptor,,,9606.0,Homo sapiens (human),"Like gnrh, initial or intermittent administration of nafarelin stimulates release of the gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland, which in turn transiently increases production of estradiol in females and testosterone in both sexes. however, with continuous daily administration, nafarelin continuously occupies the gnrh receptor. A reversible down-regulation of the gnrh receptors in the pituitary gland and desensitization of the pituitary gonadotropes occur. this causes a significant and sustained decline in the production of LH and FSH. A decline in gonadotropin production and release causes a dramatic reversible decrease in synthesis of estradiol, progesterone, and testosterone by the ovaries or testes. like normal endometrium, endometriotic implants contain estrogen receptors. estrogen stimulates the growth of endometrium. use of nafarelin induces anovulation and amenorrhea and decreases serum concentrations of estradiol to the postmenopausal range, which induces atrophy of endometriotic implants. nafarelin does not abolish the underlying pathophysiology of endometriosis, however.",,,PMID:18048412,https://www.ncbi.nlm.nih.gov/pubmed/18048412,18048412,,
1015,2029566,25079271,BindingDB,cyclo[Arg-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Bip-Pro-Asp-Gly],21747,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(4-aminobutyl)-4,19-bis[(2S)-butan-2-yl]-34-(3-carbamimidamidopropyl)-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-49-[(4-phenylphenyl)methyl]-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21747,8073,Prothrombin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8073,P00735,Prothrombin ,280685.0,F2,9913.0,Bos taurus (cattle),,Ki (nM),25600,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
1016,2029567,25079271,BindingDB,cyclo[Arg-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Bip-Pro-Asp-Gly],21747,"2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(4-aminobutyl)-4,19-bis[(2S)-butan-2-yl]-34-(3-carbamimidamidopropyl)-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-49-[(4-phenylphenyl)methyl]-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecaazapentacyclo[29.20.4.0^{7,11}.0^{13,17}.0^{43,47}]pentapentacontan-40-yl]acetic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21747,2203,Suppressor of tumorigenicity 14 protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2203,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,6768.0,ST14,9606.0,Homo sapiens (human),,Ki (nM),1000,PMID:17985858|DOI:10.1021/jm0704898,https://www.ncbi.nlm.nih.gov/pubmed/17985858|https://doi.org/10.1021/jm0704898,17985858,10.1021/jm0704898,
1017,2029568,25084484,Therapeutic Target Database (TTD),Conotoxin GI,D0I4PC,alpha-conotoxin GI,https://idrblab.net/ttd/data/drug/details/D0I4PC,T79961,Muscarinic acetylcholine receptor M5 (CHRM5),https://idrblab.net/ttd/data/target/details/T79961,P08912,Muscarinic acetylcholine receptor M5,1133.0,CHRM5,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1018,2029694,25091011,Therapeutic Target Database (TTD),"[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P",D0C3OY,RPKPfQwFwLL-NH2,https://idrblab.net/ttd/data/drug/details/D0C3OY,T59604,Growth hormone secretagogue receptor 1 (GHSR),https://idrblab.net/ttd/data/target/details/T59604,Q92847,Growth hormone secretagogue receptor type 1,2693.0,GHSR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1019,2029647,25093227,Therapeutic Target Database (TTD),4-(2-Hydroxyphenyl)-2-methoxybenzonitrile,D02ZEE,2'-Hydroxy-3-methoxy-biphenyl-4-carbonitrile,https://idrblab.net/ttd/data/drug/details/D02ZEE,T46521,Androgen receptor messenger RNA (AR mRNA),https://idrblab.net/ttd/data/target/details/T46521,P10275,Androgen receptor,367.0,AR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1020,2029648,25093231,Therapeutic Target Database (TTD),"4-((1R,2R)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile",D07TVI,PF-0998425,https://idrblab.net/ttd/data/drug/details/D07TVI,T46521,Androgen receptor messenger RNA (AR mRNA),https://idrblab.net/ttd/data/target/details/T46521,P10275,Androgen receptor,367.0,AR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1021,2029649,25093373,Therapeutic Target Database (TTD),"4-[2-(3-Hydroxyphenyl)-1,3-thiazol-5-yl]phenol",D00SLE,"3-[5-(4-hydroxyphenyl)-1,3-thiazol-2-yl]phenol",https://idrblab.net/ttd/data/drug/details/D00SLE,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1022,2029650,25093374,Therapeutic Target Database (TTD),"3-[2-(3-Hydroxyphenyl)-1,3-thiazol-5-yl]phenol",D00YNA,"3,3-(1,3-Thiazole-2,5-diyl)diphenol",https://idrblab.net/ttd/data/drug/details/D00YNA,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1023,2029651,25093374,Therapeutic Target Database (TTD),"3-[2-(3-Hydroxyphenyl)-1,3-thiazol-5-yl]phenol",D00YNA,"3,3-(1,3-Thiazole-2,5-diyl)diphenol",https://idrblab.net/ttd/data/drug/details/D00YNA,T37848,Albendazole monooxygenase (CYP3A4),https://idrblab.net/ttd/data/target/details/T37848,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1024,2029652,25093377,Therapeutic Target Database (TTD),"3-[2-(3-Hydroxyphenyl)-1,3-thiazol-4-yl]phenol",D0T6WL,"3,3'-(1,3-Thiazol-2,4-diyl)diphenol",https://idrblab.net/ttd/data/drug/details/D0T6WL,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1025,2029653,25093379,Therapeutic Target Database (TTD),"3-[5-(3-Hydroxyphenyl)-1,2,4-thiadiazol-3-yl]phenol",D0A4XA,"3,3'-(1,2,4-thiadiazole-3,5-diyl)diphenol",https://idrblab.net/ttd/data/drug/details/D0A4XA,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1026,2029654,25093384,Therapeutic Target Database (TTD),3-(5-Phenylthiophen-2-yl)phenol,D0G1DN,3-(5-phenyl-2-thienyl)phenol,https://idrblab.net/ttd/data/drug/details/D0G1DN,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1027,2029655,25093386,Therapeutic Target Database (TTD),3-[5-(4-Hydroxyphenyl)-2-thienyl]phenol,D01ZCG,3-[5-(4-hydroxyphenyl)-2-thienyl]phenol,https://idrblab.net/ttd/data/drug/details/D01ZCG,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1028,2029675,25093387,Therapeutic Target Database (TTD),"3,3'-Thiene-2,5-diyldiphenol",D0TA0J,"3,3'-thiene-2,5-diyldiphenol",https://idrblab.net/ttd/data/drug/details/D0TA0J,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1029,2029676,25093389,Therapeutic Target Database (TTD),4-[4-(3-Hydroxyphenyl)thiophen-2-yl]phenol,D0NM0P,3-[5-(4-Hydroxyphenyl)-3-thienyl]phenol,https://idrblab.net/ttd/data/drug/details/D0NM0P,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1030,2029677,25093389,Therapeutic Target Database (TTD),4-[4-(3-Hydroxyphenyl)thiophen-2-yl]phenol,D0NM0P,3-[5-(4-Hydroxyphenyl)-3-thienyl]phenol,https://idrblab.net/ttd/data/drug/details/D0NM0P,T37848,Albendazole monooxygenase (CYP3A4),https://idrblab.net/ttd/data/target/details/T37848,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1031,2029678,25093391,Therapeutic Target Database (TTD),3-[4-(4-Hydroxyphenyl)-2-thienyl]phenol,D0I5YT,"3,4'-(thiophene-2,4-diyl)diphenol",https://idrblab.net/ttd/data/drug/details/D0I5YT,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1032,2029679,25093392,Therapeutic Target Database (TTD),"3,3'-Thiene-2,4-diyldiphenol",D08OQX,"3,3'-Thiene-2,4-diyldiphenol",https://idrblab.net/ttd/data/drug/details/D08OQX,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1033,2029680,25093397,Therapeutic Target Database (TTD),3-[4-(4-Hydroxyphenyl)phenyl]phenol,D0C9KZ,"1,1':4',1''-terphenyl-3,4''-diol",https://idrblab.net/ttd/data/drug/details/D0C9KZ,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1034,2029681,25093398,Therapeutic Target Database (TTD),3-[5-(3-Hydroxyphenyl)pyridin-2-yl]phenol,D07VXQ,"3,3'-Pyridine-2,5-diyldiphenol",https://idrblab.net/ttd/data/drug/details/D07VXQ,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1035,2029682,25093399,Therapeutic Target Database (TTD),3-[5-(3-Hydroxyphenyl)pyrazin-2-yl]phenol,D0DC3E,"3,3'-pyrazine-2,5-diyldiphenol",https://idrblab.net/ttd/data/drug/details/D0DC3E,T44011,Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1),https://idrblab.net/ttd/data/target/details/T44011,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1036,2029569,25099184,Therapeutic Target Database (TTD),AZ-960,D0OP3D,AZ960,https://idrblab.net/ttd/data/drug/details/D0OP3D,T08391,Janus kinase 2 (JAK-2),https://idrblab.net/ttd/data/target/details/T08391,O60674,Tyrosine-protein kinase JAK2,3717.0,JAK2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1037,2029683,25099191,IUPHAR/BPS Guide to PHARMACOLOGY,Aprocitentan,10070,aprocitentan,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10070,220,ETB receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=220,P24530,Endothelin receptor type B,1910.0,EDNRB,9606.0,Homo sapiens (human),Antagonist,pA2,5.5,PMID:18780830,https://www.ncbi.nlm.nih.gov/pubmed/18780830,18780830,,
1038,2029684,25099191,IUPHAR/BPS Guide to PHARMACOLOGY,Aprocitentan,10070,aprocitentan,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10070,220,ETB receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=220,P24530,Endothelin receptor type B,1910.0,EDNRB,9606.0,Homo sapiens (human),Antagonist,pIC50,6.01,PMID:18780830,https://www.ncbi.nlm.nih.gov/pubmed/18780830,18780830,,
1039,2029685,25099191,IUPHAR/BPS Guide to PHARMACOLOGY,Aprocitentan,10070,aprocitentan,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10070,219,ETA receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=219,P25101,Endothelin-1 receptor,1909.0,EDNRA,9606.0,Homo sapiens (human),Antagonist,pA2,6.7,PMID:18780830,https://www.ncbi.nlm.nih.gov/pubmed/18780830,18780830,,
1040,2029686,25099191,IUPHAR/BPS Guide to PHARMACOLOGY,Aprocitentan,10070,aprocitentan,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10070,219,ETA receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=219,P25101,Endothelin-1 receptor,1909.0,EDNRA,9606.0,Homo sapiens (human),Antagonist,pIC50,8.47,PMID:18780830,https://www.ncbi.nlm.nih.gov/pubmed/18780830,18780830,,
1041,2029570,25101223,Therapeutic Target Database (TTD),"(R)-3-(4-isopropylphenyl)-7-methyl-N-(1-phenoxypropan-2-yl)pyrazolo[1,5-a]pyrimidine-6-carboxamide",D07NDW,PMID18752940C9n,https://idrblab.net/ttd/data/drug/details/D07NDW,T88185,Nicotinic acid receptor (HCAR2),https://idrblab.net/ttd/data/target/details/T88185,Q8TDS4,Hydroxycarboxylic acid receptor 2,338442.0,HCAR2,9606.0,Homo sapiens (human),Modulator (allosteric modulator),,,,,,,
1042,2029695,25101945,BindingDB,"6-[3-(Methylamino)azetidin-1-yl]-3,5-diazatricyclo[9.4.0.0^{2,7}]pentadeca-1(15),2(7),3,5,11,13-hexaen-4-amine",26398,"2,4-diamino-5,6-disubstituted pyrimidine, 12",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26398,2289,Histamine H4 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2289,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606.0,Homo sapiens (human),,Ki (nM),11,PMID:18817367|DOI:10.1021/jm800670r,https://www.ncbi.nlm.nih.gov/pubmed/18817367|https://doi.org/10.1021/jm800670r,18817367,10.1021/jm800670r,
1043,2029979,25101945,BindingDB,"6-[3-(Methylamino)azetidin-1-yl]-3,5-diazatricyclo[9.4.0.0^{2,7}]pentadeca-1(15),2(7),3,5,11,13-hexaen-4-amine",26398,"2,4-diamino-5,6-disubstituted pyrimidine, 12",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26398,2292,Histamine H4 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2292,Q91ZY1,Histamine H4 receptor,170704.0,Hrh4,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),3.6,PMID:18817367|DOI:10.1021/jm800670r,https://www.ncbi.nlm.nih.gov/pubmed/18817367|https://doi.org/10.1021/jm800670r,18817367,10.1021/jm800670r,
1044,2029689,25102846,Drug Gene Interaction database (DGIdb),Cabozantinib s-malate,,CABOZANTINIB S-MALATE,https://www.dgidb.org/drugs/rxcui:1363267,,KDR,https://www.dgidb.org/genes/hgnc:6307,,,3791.0,KDR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1045,2029690,25102846,Drug Gene Interaction database (DGIdb),Cabozantinib s-malate,,CABOZANTINIB S-MALATE,https://www.dgidb.org/drugs/rxcui:1363267,,NRAS,https://www.dgidb.org/genes/hgnc:7989,,,4893.0,NRAS,9606.0,Homo sapiens (human),,,,,,,,
1046,2029691,25102846,Drug Gene Interaction database (DGIdb),Cabozantinib s-malate,,CABOZANTINIB S-MALATE,https://www.dgidb.org/drugs/rxcui:1363267,,FLT3,https://www.dgidb.org/genes/hgnc:3765,,,2322.0,FLT3,9606.0,Homo sapiens (human),,,,,,,,
1047,2029692,25102846,Drug Gene Interaction database (DGIdb),Cabozantinib s-malate,,CABOZANTINIB S-MALATE,https://www.dgidb.org/drugs/rxcui:1363267,,KIT,https://www.dgidb.org/genes/hgnc:6342,,,3815.0,KIT,9606.0,Homo sapiens (human),,,,,,,,
1048,2029693,25102847,IUPHAR/BPS Guide to PHARMACOLOGY,Cabozantinib,5887,cabozantinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5887,2185,ret proto-oncogene,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2185,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,5979.0,RET,9606.0,Homo sapiens (human),Inhibition,pIC50,7.96,PMID:29657135,https://www.ncbi.nlm.nih.gov/pubmed/29657135,29657135,,
1049,2029980,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,90204,ZSWIM1,https://ctdbase.org/detail.go?type=gene&acc=90204,,,90204.0,ZSWIM1,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZSWIM1 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1050,2029981,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,348793,WDR53,https://ctdbase.org/detail.go?type=gene&acc=348793,,,348793.0,WDR53,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of WDR53 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1051,2029982,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,54554,WDR5B,https://ctdbase.org/detail.go?type=gene&acc=54554,,,54554.0,WDR5B,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of WDR5B mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1052,2029983,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,112840,WDR89,https://ctdbase.org/detail.go?type=gene&acc=112840,,,112840.0,WDR89,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of WDR89 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1053,2029984,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,29062,WDR91,https://ctdbase.org/detail.go?type=gene&acc=29062,,,29062.0,WDR91,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of WDR91 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1054,2029985,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7465,WEE1,https://ctdbase.org/detail.go?type=gene&acc=7465,,,7465.0,WEE1,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of WEE1 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1055,2029986,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,9589,WTAP,https://ctdbase.org/detail.go?type=gene&acc=9589,,,9589.0,WTAP,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of WTAP mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1056,2029995,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,57002,YAE1,https://ctdbase.org/detail.go?type=gene&acc=57002,,,57002.0,YAE1,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of YAE1 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1057,2029996,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7525,YES1,https://ctdbase.org/detail.go?type=gene&acc=7525,,,7525.0,YES1,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of YES1 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1058,2029997,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,55432,YOD1,https://ctdbase.org/detail.go?type=gene&acc=55432,,,55432.0,YOD1,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of YOD1 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1059,2029998,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,253943,YTHDF3,https://ctdbase.org/detail.go?type=gene&acc=253943,,,253943.0,YTHDF3,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of YTHDF3 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1060,2029999,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,58486,ZBED5,https://ctdbase.org/detail.go?type=gene&acc=58486,,,58486.0,ZBED5,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBED5 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1061,2030000,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,22890,ZBTB1,https://ctdbase.org/detail.go?type=gene&acc=22890,,,22890.0,ZBTB1,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB1 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1062,2030001,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,27107,ZBTB11,https://ctdbase.org/detail.go?type=gene&acc=27107,,,27107.0,ZBTB11,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB11 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1063,2030002,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7541,ZBTB14,https://ctdbase.org/detail.go?type=gene&acc=7541,,,7541.0,ZBTB14,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB14 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1064,2030084,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,49854,ZBTB21,https://ctdbase.org/detail.go?type=gene&acc=49854,,,49854.0,ZBTB21,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB21 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1065,2030085,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,9841,ZBTB24,https://ctdbase.org/detail.go?type=gene&acc=9841,,,9841.0,ZBTB24,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB24 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1066,2030086,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,57684,ZBTB26,https://ctdbase.org/detail.go?type=gene&acc=57684,,,57684.0,ZBTB26,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB26 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1067,2030087,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,79842,ZBTB3,https://ctdbase.org/detail.go?type=gene&acc=79842,,,79842.0,ZBTB3,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB3 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1068,2030088,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,403341,ZBTB34,https://ctdbase.org/detail.go?type=gene&acc=403341,,,403341.0,ZBTB34,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB34 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1069,2030089,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,9880,ZBTB39,https://ctdbase.org/detail.go?type=gene&acc=9880,,,9880.0,ZBTB39,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB39 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1070,2030090,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,360023,ZBTB41,https://ctdbase.org/detail.go?type=gene&acc=360023,,,360023.0,ZBTB41,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB41 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1071,2030091,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,23099,ZBTB43,https://ctdbase.org/detail.go?type=gene&acc=23099,,,23099.0,ZBTB43,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB43 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1072,2030102,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,84878,ZBTB45,https://ctdbase.org/detail.go?type=gene&acc=84878,,,84878.0,ZBTB45,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB45 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1073,2030103,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,166793,ZBTB49,https://ctdbase.org/detail.go?type=gene&acc=166793,,,166793.0,ZBTB49,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB49 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1074,2030104,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,9925,ZBTB5,https://ctdbase.org/detail.go?type=gene&acc=9925,,,9925.0,ZBTB5,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB5 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1075,2030105,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,10773,ZBTB6,https://ctdbase.org/detail.go?type=gene&acc=10773,,,10773.0,ZBTB6,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB6 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1076,2030106,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,221504,ZBTB9,https://ctdbase.org/detail.go?type=gene&acc=221504,,,221504.0,ZBTB9,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZBTB9 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1077,2030107,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,84872,ZC3H10,https://ctdbase.org/detail.go?type=gene&acc=84872,,,84872.0,ZC3H10,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZC3H10 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1078,2030108,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,85416,ZIC5,https://ctdbase.org/detail.go?type=gene&acc=85416,,,85416.0,ZIC5,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZIC5 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1079,2030109,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,342357,ZKSCAN2,https://ctdbase.org/detail.go?type=gene&acc=342357,,,342357.0,ZKSCAN2,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZKSCAN2 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1080,2030148,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,387032,ZKSCAN4,https://ctdbase.org/detail.go?type=gene&acc=387032,,,387032.0,ZKSCAN4,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZKSCAN4 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1081,2030149,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,23660,ZKSCAN5,https://ctdbase.org/detail.go?type=gene&acc=23660,,,23660.0,ZKSCAN5,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZKSCAN5 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1082,2030150,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,140831,ZSWIM3,https://ctdbase.org/detail.go?type=gene&acc=140831,,,140831.0,ZSWIM3,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZSWIM3 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1083,2030151,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,221302,ZUP1,https://ctdbase.org/detail.go?type=gene&acc=221302,,,221302.0,ZUP1,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZUP1 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1084,2030152,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7746,ZSCAN9,https://ctdbase.org/detail.go?type=gene&acc=7746,,,7746.0,ZSCAN9,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZSCAN9 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1085,2030153,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7745,ZKSCAN8,https://ctdbase.org/detail.go?type=gene&acc=7745,,,7745.0,ZKSCAN8,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZKSCAN8 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1086,2030154,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,9205,ZMYM5,https://ctdbase.org/detail.go?type=gene&acc=9205,,,9205.0,ZMYM5,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZMYM5 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1087,2030155,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7556,ZNF10,https://ctdbase.org/detail.go?type=gene&acc=7556,,,7556.0,ZNF10,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF10 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1088,2030208,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,163227,ZNF100,https://ctdbase.org/detail.go?type=gene&acc=163227,,,163227.0,ZNF100,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF100 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1089,2030209,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,94039,ZNF101,https://ctdbase.org/detail.go?type=gene&acc=94039,,,94039.0,ZNF101,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF101 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1090,2030210,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,163071,ZNF114,https://ctdbase.org/detail.go?type=gene&acc=163071,,,163071.0,ZNF114,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF114 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1091,2030211,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7559,ZNF12,https://ctdbase.org/detail.go?type=gene&acc=7559,,,7559.0,ZNF12,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF12 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1092,2030212,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7693,ZNF134,https://ctdbase.org/detail.go?type=gene&acc=7693,,,7693.0,ZNF134,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF134 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1093,2030213,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7695,ZNF136,https://ctdbase.org/detail.go?type=gene&acc=7695,,,7695.0,ZNF136,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF136 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1094,2030214,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7561,ZNF14,https://ctdbase.org/detail.go?type=gene&acc=7561,,,7561.0,ZNF14,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF14 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1095,2030215,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,85463,ZC3H12C,https://ctdbase.org/detail.go?type=gene&acc=85463,,,85463.0,ZC3H12C,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZC3H12C mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1096,2030303,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,54877,ZCCHC2,https://ctdbase.org/detail.go?type=gene&acc=54877,,,54877.0,ZCCHC2,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZCCHC2 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1097,2030304,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,85364,ZCCHC3,https://ctdbase.org/detail.go?type=gene&acc=85364,,,85364.0,ZCCHC3,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZCCHC3 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1098,2030305,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,9839,ZEB2,https://ctdbase.org/detail.go?type=gene&acc=9839,,,9839.0,ZEB2,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZEB2 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1099,2030306,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7763,ZFAND5,https://ctdbase.org/detail.go?type=gene&acc=7763,,,7763.0,ZFAND5,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZFAND5 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1100,2030307,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,124961,ZFP3,https://ctdbase.org/detail.go?type=gene&acc=124961,,,124961.0,ZFP3,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZFP3 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1101,2030308,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7538,ZFP36,https://ctdbase.org/detail.go?type=gene&acc=7538,,,7538.0,ZFP36,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZFP36 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1102,2030309,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,678,ZFP36L2,https://ctdbase.org/detail.go?type=gene&acc=678,,,678.0,ZFP36L2,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZFP36L2 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1103,2030310,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,643836,ZFP62,https://ctdbase.org/detail.go?type=gene&acc=643836,,,643836.0,ZFP62,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZFP62 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1104,2030311,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,339559,ZFP69,https://ctdbase.org/detail.go?type=gene&acc=339559,,,339559.0,ZFP69,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZFP69 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1105,2030312,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,284406,ZFP82,https://ctdbase.org/detail.go?type=gene&acc=284406,,,284406.0,ZFP82,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZFP82 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1106,2030313,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7543,ZFX,https://ctdbase.org/detail.go?type=gene&acc=7543,,,7543.0,ZFX,9606.0,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZFX mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
1107,2029571,25107716,IUPHAR/BPS Guide to PHARMACOLOGY,N-[(4-cyanophenyl)methyl]-6-[4-(2-phenylphenyl)piperazin-1-yl]hexanamide,8436,LP-211,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8436,1,5-HT1A receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1,P08908,5-hydroxytryptamine receptor 1A,3350.0,HTR1A,9606.0,Homo sapiens (human),Agonist,pKi,6.73,PMID:18800769,https://www.ncbi.nlm.nih.gov/pubmed/18800769,18800769,,
1108,2029572,25108103,Therapeutic Target Database (TTD),2-[4-(2-Thienyl)phenyl]-4-methylmorpholin-2-ol,D0K1QV,2-[4-(2-Thienyl)phenyl]-4-methylmorpholin-2-ol,https://idrblab.net/ttd/data/drug/details/D0K1QV,T81850,Squalene synthetase (FDFT1),https://idrblab.net/ttd/data/target/details/T81850,P37268,Squalene synthase,2222.0,FDFT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1109,2029573,25108105,Therapeutic Target Database (TTD),"3-[4-(Thiophen-2-yl)phenyl]-octahydropyrido[2,1-c]morpholin-3-ol",D0D7IQ,PMID18754614C4,https://idrblab.net/ttd/data/drug/details/D0D7IQ,T81850,Squalene synthetase (FDFT1),https://idrblab.net/ttd/data/target/details/T81850,P37268,Squalene synthase,2222.0,FDFT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1110,2029601,25108235,Therapeutic Target Database (TTD),"2-[4-(4-Bromophenyl)phenyl]-4-methyl-octahydro-1,4-benzoxazine-2-ol",D06PMR,PMID18754614C18,https://idrblab.net/ttd/data/drug/details/D06PMR,T81850,Squalene synthetase (FDFT1),https://idrblab.net/ttd/data/target/details/T81850,P37268,Squalene synthase,2222.0,FDFT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1111,2029602,25108301,Therapeutic Target Database (TTD),2-[4-(4-Bromophenyl)phenyl]-4-methylmorpholin-2-ol,D0U9GN,PMID18754614C17,https://idrblab.net/ttd/data/drug/details/D0U9GN,T81850,Squalene synthetase (FDFT1),https://idrblab.net/ttd/data/target/details/T81850,P37268,Squalene synthase,2222.0,FDFT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1112,2029603,25108303,Therapeutic Target Database (TTD),"3-[4-(4-Bromophenyl)phenyl]-octahydropyrido[2,1-c]morpholin-3-ol",D0A7FI,PMID18754614C19,https://idrblab.net/ttd/data/drug/details/D0A7FI,T81850,Squalene synthetase (FDFT1),https://idrblab.net/ttd/data/target/details/T81850,P37268,Squalene synthase,2222.0,FDFT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1113,2029604,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,10090.0,Mus musculus (house mouse),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [cisplatin affects the localization of AIFM1 protein],,,PMID:15983031,https://www.ncbi.nlm.nih.gov/pubmed/15983031,15983031,,
1114,2029605,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel affects the folding of and results in increased activity of BAK1 protein],,,PMID:17308071,https://www.ncbi.nlm.nih.gov/pubmed/17308071,17308071,,
1115,2029606,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [doxorubicin results in increased activity of BAK1 protein],,,PMID:15917298,https://www.ncbi.nlm.nih.gov/pubmed/15917298,15917298,,
1116,2029607,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel affects the folding of and results in increased activity of BAX protein]|benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel affects the localization of BAX protein],,,PMID:17308071,https://www.ncbi.nlm.nih.gov/pubmed/17308071,17308071,,
1117,2029608,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637.0,BID,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of BID protein],,,PMID:16777994,https://www.ncbi.nlm.nih.gov/pubmed/16777994,16777994,,
1118,2029609,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637.0,BID,10090.0,Mus musculus (house mouse),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [GW 7845 results in increased cleavage of BID protein],,,PMID:17400580,https://www.ncbi.nlm.nih.gov/pubmed/17400580,17400580,,
1119,2029610,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [bortezomib results in increased cleavage of and results in increased activity of CASP2 protein],,,PMID:18723477,https://www.ncbi.nlm.nih.gov/pubmed/18723477,18723477,,
1120,2029611,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [doxorubicin results in increased activity of CASP2 protein]|benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [doxorubicin promotes the reaction [CASP2 protein results in increased cleavage of PRKCD protein]],,,PMID:15917298,https://www.ncbi.nlm.nih.gov/pubmed/15917298,15917298,,
1121,2029612,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP2 protein],,,PMID:16777994,https://www.ncbi.nlm.nih.gov/pubmed/16777994,16777994,,
1122,2029613,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone results in decreased activity of CASP2 protein,,,PMID:30713602,https://www.ncbi.nlm.nih.gov/pubmed/30713602,30713602,,
1123,2029614,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,9606.0,Homo sapiens (human),[benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone results in decreased activity of CASP2 protein] which results in decreased susceptibility to methyl antcinate A,,,PMID:20557081,https://www.ncbi.nlm.nih.gov/pubmed/20557081,20557081,,
1124,2029615,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone results in decreased activity of CASP2 protein,,,PMID:14732211|PMID:15158148|PMID:15983031|PMID:17308071|PMID:18723477|PMID:20557081|PMID:20661774,https://www.ncbi.nlm.nih.gov/pubmed/14732211|https://www.ncbi.nlm.nih.gov/pubmed/15158148|https://www.ncbi.nlm.nih.gov/pubmed/15983031|https://www.ncbi.nlm.nih.gov/pubmed/17308071|https://www.ncbi.nlm.nih.gov/pubmed/18723477|https://www.ncbi.nlm.nih.gov/pubmed/20557081|https://www.ncbi.nlm.nih.gov/pubmed/20661774,14732211|15158148|15983031|17308071|18723477|20557081|20661774,,
1125,2029616,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased activity of CASP3 protein]|benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased activity of CASP3 protein],,,PMID:22002103,https://www.ncbi.nlm.nih.gov/pubmed/22002103,22002103,,
1126,2029617,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel results in increased cleavage of and results in increased activity of CASP3 protein],,,PMID:17308071,https://www.ncbi.nlm.nih.gov/pubmed/17308071,17308071,,
1127,2029696,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [flubendazole results in increased cleavage of CASP3 protein],,,PMID:32652169,https://www.ncbi.nlm.nih.gov/pubmed/32652169,32652169,,
1128,2029697,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP3 protein],,,PMID:16777994,https://www.ncbi.nlm.nih.gov/pubmed/16777994,16777994,,
1129,2029698,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP8 protein],,,PMID:16777994,https://www.ncbi.nlm.nih.gov/pubmed/16777994,16777994,,
1130,2029699,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [bortezomib results in increased cleavage of and results in increased activity of CASP9 protein],,,PMID:18723477,https://www.ncbi.nlm.nih.gov/pubmed/18723477,18723477,,
1131,2029700,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel results in increased cleavage of and results in increased activity of CASP9 protein],,,PMID:17308071,https://www.ncbi.nlm.nih.gov/pubmed/17308071,17308071,,
1132,2029701,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP9 protein],,,PMID:16777994,https://www.ncbi.nlm.nih.gov/pubmed/16777994,16777994,,
1133,2029702,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of CDKN1A protein],,,PMID:16777994,https://www.ncbi.nlm.nih.gov/pubmed/16777994,16777994,,
1134,2029703,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [doxorubicin results in increased phosphorylation of MAPK8 protein],,,PMID:15917298,https://www.ncbi.nlm.nih.gov/pubmed/15917298,15917298,,
1135,2029743,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel results in increased cleavage of PARP1 protein],,,PMID:17308071,https://www.ncbi.nlm.nih.gov/pubmed/17308071,17308071,,
1136,2029744,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [flavanones results in increased cleavage of PARP1 protein],,,PMID:21616090,https://www.ncbi.nlm.nih.gov/pubmed/21616090,21616090,,
1137,2029745,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [doxorubicin promotes the reaction [CASP2 protein results in increased cleavage of PRKCD protein]],,,PMID:15917298,https://www.ncbi.nlm.nih.gov/pubmed/15917298,15917298,,
1138,2029746,25108684,Comparative Toxicogenomics Database (CTD),Z-Vdvad-fmk,C427308,benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone,https://ctdbase.org/detail.go?type=chem&acc=C427308,9475,ROCK2,https://ctdbase.org/detail.go?type=gene&acc=9475,,,9475.0,ROCK2,9606.0,Homo sapiens (human),Benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [ouabain results in increased cleavage of ROCK2 protein],,,PMID:20661774,https://www.ncbi.nlm.nih.gov/pubmed/20661774,20661774,,
1139,2029747,25110406,Therapeutic Target Database (TTD),"2-({4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]-2,3-dihydro-1H-inden-1-yl}amino)ethan-1-ol",D00ZXX,CYM5442,https://idrblab.net/ttd/data/drug/details/D00ZXX,T13852,Sphingosine-1-phosphate receptor 1 (S1PR1),https://idrblab.net/ttd/data/target/details/T13852,P21453,Sphingosine 1-phosphate receptor 1,1901.0,S1PR1,9606.0,Homo sapiens (human),Agonist,,,,,,,
1140,2029748,25110701,BindingDB,(5-chloropyridin-3-yl) 1H-indole-4-carboxylate,429304,acs.jmedchem.1c00409_ST.426,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=429304,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),56,,,,,
1141,2029749,25113671,BindingDB,Descladinose Clarithromycin-N-benzyltriazolylheptahydroxamic Acid,27188,"triazole-linked clarithromycin-based compound, 24d",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27188,1996,Histone deacetylase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1996,Q9BY41,Histone deacetylase 8,55869.0,HDAC8,9606.0,Homo sapiens (human),,IC50 (nM),1390,PMID:19093884|DOI:10.1021/jm801128g,https://www.ncbi.nlm.nih.gov/pubmed/19093884|https://doi.org/10.1021/jm801128g,19093884,10.1021/jm801128g,
1142,2029750,25113671,BindingDB,Descladinose Clarithromycin-N-benzyltriazolylheptahydroxamic Acid,27188,"triazole-linked clarithromycin-based compound, 24d",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27188,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),1.9,PMID:19093884|DOI:10.1021/jm801128g,https://www.ncbi.nlm.nih.gov/pubmed/19093884|https://doi.org/10.1021/jm801128g,19093884,10.1021/jm801128g,
1143,2029751,25122902,Therapeutic Target Database (TTD),Pmid22153340C20,D09MLQ,PMID22153340C20,https://idrblab.net/ttd/data/drug/details/D09MLQ,T03500,Matrix metalloproteinase-12 (MMP-12),https://idrblab.net/ttd/data/target/details/T03500,P39900,Macrophage metalloelastase,4321.0,MMP12,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1144,2029785,25126798,Drug Gene Interaction database (DGIdb),Ruxolitinib,,RUXOLITINIB,https://www.dgidb.org/drugs/rxcui:1193326,,VHL,https://www.dgidb.org/genes/hgnc:12687,,,7428.0,VHL,9606.0,Homo sapiens (human),,,,,,,,
1145,2029786,25126798,Drug Gene Interaction database (DGIdb),Ruxolitinib,,RUXOLITINIB,https://www.dgidb.org/drugs/rxcui:1193326,,FLT3,https://www.dgidb.org/genes/hgnc:3765,,,2322.0,FLT3,9606.0,Homo sapiens (human),,,,,,,,
1146,2029787,25127713,DrugBank,Poziotinib,DB12114,Poziotinib,https://www.drugbank.ca/drugs/DB12114,BE0000767,Epidermal growth factor receptor,https://www.drugbank.ca/bio_entities/BE0000767,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),Inhibitor|Binder,,,PMID:27188206,https://www.ncbi.nlm.nih.gov/pubmed/27188206,27188206,,
1147,2029788,25127713,Drug Gene Interaction database (DGIdb),Poziotinib,,POZIOTINIB,https://www.dgidb.org/drugs/ncit:C98838,,EGFR,https://www.dgidb.org/genes/hgnc:3236,,,1956.0,EGFR,9606.0,Homo sapiens (human),,,,,,,,
1148,2029903,25131287,BindingDB,(E)-3-(4-(benzyloxy)-3-methoxyphenyl)-N-hydroxyacrylamide (4b),232979,(E)-3-(4-(benzyloxy)-3-methoxyphenyl)-N-hydroxyacrylamide (4b),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=232979,50000490,Histone deacetylase (HDAC1 and HDAC2),https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50000490,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),1.34e+4,PMID:19558346|DOI:10.3109/14756360903049034,https://www.ncbi.nlm.nih.gov/pubmed/19558346|https://doi.org/10.3109/14756360903049034,19558346,10.3109/14756360903049034,
1149,2029907,25131288,BindingDB,(E)-N-hydroxy-3-(3-methoxy-4-(thiophen-2-ylmethoxy)phenyl)acrylamide (4d),232981,(E)-N-hydroxy-3-(3-methoxy-4-(thiophen-2-ylmethoxy)phenyl)acrylamide (4d),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=232981,50000490,Histone deacetylase (HDAC1 and HDAC2),https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50000490,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),1.11e+4,PMID:19558346|DOI:10.3109/14756360903049034,https://www.ncbi.nlm.nih.gov/pubmed/19558346|https://doi.org/10.3109/14756360903049034,19558346,10.3109/14756360903049034,
1150,2029789,25134326,Drug Gene Interaction database (DGIdb),"N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine",,ALK INHIBITOR ASP3026,https://www.dgidb.org/drugs/ncit:C116727,,ALK,https://www.dgidb.org/genes/hgnc:427,,,238.0,ALK,9606.0,Homo sapiens (human),,,,,,,,
1151,2037027,25138109,BindingDB,"1-(3-Methylphenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26322,"1-(3-methylphenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26322,1526,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1526,P97477,Aurora kinase A,20878.0,Aurka,10090.0,Mus musculus (house mouse),,IC50 (nM),9,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1152,2037028,25138109,BindingDB,"1-(3-Methylphenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26322,"1-(3-methylphenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26322,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),54,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1153,2037029,25138110,BindingDB,"1-(3-Methoxyphenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26323,"1-(3-methoxyphenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26323,1526,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1526,P97477,Aurora kinase A,20878.0,Aurka,10090.0,Mus musculus (house mouse),,IC50 (nM),50,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1154,2037030,25138111,BindingDB,"1-(3-Ethynylphenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26324,"1-(3-ethynylphenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26324,1526,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1526,P97477,Aurora kinase A,20878.0,Aurka,10090.0,Mus musculus (house mouse),,IC50 (nM),41,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1155,2037031,25138112,BindingDB,"1-(3-Fluorophenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26325,"1-(3-fluorophenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26325,1526,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1526,P97477,Aurora kinase A,20878.0,Aurka,10090.0,Mus musculus (house mouse),,IC50 (nM),23,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1156,2037032,25138112,BindingDB,"1-(3-Fluorophenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26325,"1-(3-fluorophenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26325,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),18,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1157,2037033,25138113,BindingDB,"1-(4-Chlorophenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26327,"1-(4-chlorophenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26327,1526,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1526,P97477,Aurora kinase A,20878.0,Aurka,10090.0,Mus musculus (house mouse),,IC50 (nM),39,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1158,2037055,25138118,BindingDB,"1-Cyclohexyl-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26332,"1-cyclohexyl-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26332,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),61,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1159,2037056,25138118,BindingDB,"1-Cyclohexyl-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26332,"1-cyclohexyl-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26332,1526,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1526,P97477,Aurora kinase A,20878.0,Aurka,10090.0,Mus musculus (house mouse),,IC50 (nM),270,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1160,2037057,25138119,BindingDB,"1-[3-(Pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26333,"1-[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26333,1526,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1526,P97477,Aurora kinase A,20878.0,Aurka,10090.0,Mus musculus (house mouse),,IC50 (nM),4,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1161,2037058,25138119,BindingDB,"1-[3-(Pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26333,"1-[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26333,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),22,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1162,2037059,25138120,BindingDB,"1-{3-[2-(Azetidin-1-yl)ethyl]phenyl}-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26334,"1-{3-[2-(azetidin-1-yl)ethyl]phenyl}-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26334,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),120,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1163,2037060,25138120,BindingDB,"1-{3-[2-(Azetidin-1-yl)ethyl]phenyl}-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",26334,"1-{3-[2-(azetidin-1-yl)ethyl]phenyl}-3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1,3-thiazol-2-yl]urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26334,1526,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1526,P97477,Aurora kinase A,20878.0,Aurka,10090.0,Mus musculus (house mouse),,IC50 (nM),53,PMID:18678489|DOI:10.1016/j.bmcl.2008.07.073,https://www.ncbi.nlm.nih.gov/pubmed/18678489|https://doi.org/10.1016/j.bmcl.2008.07.073,18678489,10.1016/j.bmcl.2008.07.073,
1164,2037061,25138121,BindingDB,"6-[(2-Aminoethyl)amino]-3-[(4-ethylphenyl)methyl]-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione",26336,"6-[(2-aminoethyl)amino]-3-[(4-ethylphenyl)methyl]-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26336,761,Prokineticin receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=761,Q8TCW9,Prokineticin receptor 1,10887.0,PROKR1,9606.0,Homo sapiens (human),,Ki (nM),440,PMID:19006379|DOI:10.1021/jm800854e,https://www.ncbi.nlm.nih.gov/pubmed/19006379|https://doi.org/10.1021/jm800854e,19006379,10.1021/jm800854e,
1165,2037082,25138126,BindingDB,"(2E,4R)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pent-2-enamide",26342,"(2E,4R)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pent-2-enamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26342,3035,KiSS-1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3035,Q969F8,KiSS-1 receptor,84634.0,KISS1R,9606.0,Homo sapiens (human),,IC50 (nM),32,PMID:19007202|DOI:10.1021/jm800930w,https://www.ncbi.nlm.nih.gov/pubmed/19007202|https://doi.org/10.1021/jm800930w,19007202,10.1021/jm800930w,
1166,2037083,25138127,BindingDB,"(2E,4S)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pent-2-enamide",26343,"(2E,4S)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pent-2-enamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26343,3035,KiSS-1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3035,Q969F8,KiSS-1 receptor,84634.0,KISS1R,9606.0,Homo sapiens (human),,IC50 (nM),460,PMID:19007202|DOI:10.1021/jm800930w,https://www.ncbi.nlm.nih.gov/pubmed/19007202|https://doi.org/10.1021/jm800930w,19007202,10.1021/jm800930w,
1167,2037084,25138128,BindingDB,"(2S,4R)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pentanamide",26344,"(2S,4R)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26344,3035,KiSS-1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3035,Q969F8,KiSS-1 receptor,84634.0,KISS1R,9606.0,Homo sapiens (human),,IC50 (nM),380,PMID:19007202|DOI:10.1021/jm800930w,https://www.ncbi.nlm.nih.gov/pubmed/19007202|https://doi.org/10.1021/jm800930w,19007202,10.1021/jm800930w,
1168,2037085,25138129,BindingDB,"(2R,4R)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pentanamide",26345,"(2R,4R)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26345,3035,KiSS-1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3035,Q969F8,KiSS-1 receptor,84634.0,KISS1R,9606.0,Homo sapiens (human),,IC50 (nM),5.7,PMID:19007202|DOI:10.1021/jm800930w,https://www.ncbi.nlm.nih.gov/pubmed/19007202|https://doi.org/10.1021/jm800930w,19007202,10.1021/jm800930w,
1169,2037086,25138130,BindingDB,"(2S,4S)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pentanamide",26346,"(2S,4S)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26346,3035,KiSS-1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3035,Q969F8,KiSS-1 receptor,84634.0,KISS1R,9606.0,Homo sapiens (human),,IC50 (nM),32,PMID:19007202|DOI:10.1021/jm800930w,https://www.ncbi.nlm.nih.gov/pubmed/19007202|https://doi.org/10.1021/jm800930w,19007202,10.1021/jm800930w,
1170,2037087,25138131,BindingDB,"(2R,4S)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pentanamide",26347,"(2R,4S)-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl]carbamoyl}butyl]-5-[(2S)-2-[(4-fluorophenyl)formamido]-3-phenylpropanamido]-4-hydroxy-2-(2-methylpropyl)pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26347,3035,KiSS-1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3035,Q969F8,KiSS-1 receptor,84634.0,KISS1R,9606.0,Homo sapiens (human),,IC50 (nM),0.24,PMID:19007202|DOI:10.1021/jm800930w,https://www.ncbi.nlm.nih.gov/pubmed/19007202|https://doi.org/10.1021/jm800930w,19007202,10.1021/jm800930w,
1171,2037203,25138164,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 10p",26417,"7-[(3,5-dimethoxyphenyl)amino]-5-[(furan-2-ylmethyl)amino]imidazo[1,2-a]pyrimidine-8-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26417,763,Tyrosine-protein kinase SYK,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=763,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606.0,Homo sapiens (human),,IC50 (nM),2500,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686,10.1016/j.bmc.2008.10.070,
1172,2037216,25138167,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 10s",26420,"7-[(3,5-dimethoxyphenyl)amino]-5-{[(4-methanesulfonylphenyl)methyl]amino}imidazo[1,2-a]pyrimidine-8-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26420,763,Tyrosine-protein kinase SYK,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=763,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606.0,Homo sapiens (human),,IC50 (nM),11300,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686,10.1016/j.bmc.2008.10.070,
1173,2037217,25138168,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 10t",26421,"imidazo[1,2-c]pyrimidine-8-carboxamide, 10t",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26421,763,Tyrosine-protein kinase SYK,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=763,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606.0,Homo sapiens (human),,IC50 (nM),4800,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686,10.1016/j.bmc.2008.10.070,
1174,2037218,25138168,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 10t",26421,"imidazo[1,2-c]pyrimidine-8-carboxamide, 10t",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26421,759,Tyrosine-protein kinase ZAP-70,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=759,P43403,Tyrosine-protein kinase ZAP-70,7535.0,ZAP70,9606.0,Homo sapiens (human),,IC50 (nM),420,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686,10.1016/j.bmc.2008.10.070,
1175,2037219,25138169,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 11",26422,"4-[({8-carbamoyl-7-[(3,5-dimethoxyphenyl)amino]imidazo[1,2-a]pyrimidin-5-yl}amino)methyl]benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26422,759,Tyrosine-protein kinase ZAP-70,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=759,P43403,Tyrosine-protein kinase ZAP-70,7535.0,ZAP70,9606.0,Homo sapiens (human),,IC50 (nM),180,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686,10.1016/j.bmc.2008.10.070,
1176,2037220,25138169,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 11",26422,"4-[({8-carbamoyl-7-[(3,5-dimethoxyphenyl)amino]imidazo[1,2-a]pyrimidin-5-yl}amino)methyl]benzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26422,763,Tyrosine-protein kinase SYK,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=763,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606.0,Homo sapiens (human),,IC50 (nM),8100,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686,10.1016/j.bmc.2008.10.070,
1177,2037221,25138170,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 12",26423,"5-{[(4-carbamoylphenyl)methyl]amino}-7-[(3,5-dimethoxyphenyl)amino]imidazo[1,2-a]pyrimidine-8-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26423,763,Tyrosine-protein kinase SYK,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=763,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606.0,Homo sapiens (human),,IC50 (nM),8700,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686,10.1016/j.bmc.2008.10.070,
1178,2037222,25138170,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 12",26423,"5-{[(4-carbamoylphenyl)methyl]amino}-7-[(3,5-dimethoxyphenyl)amino]imidazo[1,2-a]pyrimidine-8-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26423,759,Tyrosine-protein kinase ZAP-70,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=759,P43403,Tyrosine-protein kinase ZAP-70,7535.0,ZAP70,9606.0,Homo sapiens (human),,IC50 (nM),660,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686,10.1016/j.bmc.2008.10.070,
1179,2029790,25138277,BindingDB,,27081,"3-{3-[5-(morpholin-4-ylmethyl)-1H-1,3-benzodiazol-2-yl]-1H-pyrazol-4-yl}-1-phenylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27081,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),1800,PMID:19143567|DOI:10.1021/jm800984v,https://www.ncbi.nlm.nih.gov/pubmed/19143567|https://doi.org/10.1021/jm800984v,19143567,10.1021/jm800984v,
1180,2029791,25138277,BindingDB,,27081,"3-{3-[5-(morpholin-4-ylmethyl)-1H-1,3-benzodiazol-2-yl]-1H-pyrazol-4-yl}-1-phenylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27081,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),5500,PMID:19143567|DOI:10.1021/jm800984v,https://www.ncbi.nlm.nih.gov/pubmed/19143567|https://doi.org/10.1021/jm800984v,19143567,10.1021/jm800984v,
1181,2029792,25138277,BindingDB,,27081,"3-{3-[5-(morpholin-4-ylmethyl)-1H-1,3-benzodiazol-2-yl]-1H-pyrazol-4-yl}-1-phenylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27081,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),12,PMID:19143567|DOI:10.1021/jm800984v,https://www.ncbi.nlm.nih.gov/pubmed/19143567|https://doi.org/10.1021/jm800984v,19143567,10.1021/jm800984v,
1182,2029793,25138277,BindingDB,,27081,"3-{3-[5-(morpholin-4-ylmethyl)-1H-1,3-benzodiazol-2-yl]-1H-pyrazol-4-yl}-1-phenylurea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27081,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),54,PMID:19143567|DOI:10.1021/jm800984v,https://www.ncbi.nlm.nih.gov/pubmed/19143567|https://doi.org/10.1021/jm800984v,19143567,10.1021/jm800984v,
1183,2029794,25138278,BindingDB,,27078,"N-[3-(1H-1,3-benzodiazol-2-yl)-1H-pyrazol-4-yl]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27078,4981,Aurora kinase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4981,Q96GD4,Aurora kinase B,9212.0,AURKB,9606.0,Homo sapiens (human),,IC50 (nM),180,PMID:19143567|DOI:10.1021/jm800984v,https://www.ncbi.nlm.nih.gov/pubmed/19143567|https://doi.org/10.1021/jm800984v,19143567,10.1021/jm800984v,
1184,2029795,25138278,BindingDB,,27078,"N-[3-(1H-1,3-benzodiazol-2-yl)-1H-pyrazol-4-yl]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27078,1325,Aurora kinase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1325,O14965,Aurora kinase A,6790.0,AURKA,9606.0,Homo sapiens (human),,IC50 (nM),5.9,PMID:19143567|DOI:10.1021/jm800984v,https://www.ncbi.nlm.nih.gov/pubmed/19143567|https://doi.org/10.1021/jm800984v,19143567,10.1021/jm800984v,
1185,2029796,25138278,BindingDB,,27078,"N-[3-(1H-1,3-benzodiazol-2-yl)-1H-pyrazol-4-yl]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27078,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),230,PMID:19143567|DOI:10.1021/jm800984v,https://www.ncbi.nlm.nih.gov/pubmed/19143567|https://doi.org/10.1021/jm800984v,19143567,10.1021/jm800984v,
1186,2029797,25138278,BindingDB,,27078,"N-[3-(1H-1,3-benzodiazol-2-yl)-1H-pyrazol-4-yl]benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27078,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),52,PMID:19143567|DOI:10.1021/jm800984v,https://www.ncbi.nlm.nih.gov/pubmed/19143567|https://doi.org/10.1021/jm800984v,19143567,10.1021/jm800984v,
1187,2029798,25141061,BindingDB,"(2s,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-N-(6-{[(1r)-4-Carbamimidamido-1-{[(1r)-4-Carbamimidamido-1-Carbamoylbutyl]carbamoyl}butyl]amino}-6-Oxohexyl)-3,4-Dihydroxytetrahydrofuran-2-Carboxamide",27222,"6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]hexanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27222,1494,cAMP-dependent protein kinase catalytic subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1494,P05132,cAMP-dependent protein kinase catalytic subunit alpha ,18747.0,Prkaca,10090.0,Mus musculus (house mouse),,IC50 (nM),2600,PMID:19143565|DOI:10.1021/jm800797n,https://www.ncbi.nlm.nih.gov/pubmed/19143565|https://doi.org/10.1021/jm800797n,19143565,10.1021/jm800797n,
1188,2029799,25141061,BindingDB,"(2s,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-N-(6-{[(1r)-4-Carbamimidamido-1-{[(1r)-4-Carbamimidamido-1-Carbamoylbutyl]carbamoyl}butyl]amino}-6-Oxohexyl)-3,4-Dihydroxytetrahydrofuran-2-Carboxamide",27222,"6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]hexanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27222,1494,cAMP-dependent protein kinase catalytic subunit alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1494,P05132,cAMP-dependent protein kinase catalytic subunit alpha ,18747.0,Prkaca,10090.0,Mus musculus (house mouse),,,,PMID:19143565|DOI:10.1021/jm800797n,https://www.ncbi.nlm.nih.gov/pubmed/19143565|https://doi.org/10.1021/jm800797n,19143565,10.1021/jm800797n,
1189,2029800,25141067,BindingDB,,35181,"indazole-benzimidazole, 17",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35181,304,Cyclin-A2 [177-432]/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=304,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),10000,PMID:19097791|DOI:10.1016/j.bmcl.2008.11.105,https://www.ncbi.nlm.nih.gov/pubmed/19097791|https://doi.org/10.1016/j.bmcl.2008.11.105,19097791,10.1016/j.bmcl.2008.11.105,
1190,2029801,25141067,BindingDB,,35181,"indazole-benzimidazole, 17",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35181,606,Protein kinase C zeta type,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=606,Q05513,Protein kinase C zeta type,5590.0,PRKCZ,9606.0,Homo sapiens (human),,IC50 (nM),23.3,PMID:19097791|DOI:10.1016/j.bmcl.2008.11.105,https://www.ncbi.nlm.nih.gov/pubmed/19097791|https://doi.org/10.1016/j.bmcl.2008.11.105,19097791,10.1016/j.bmcl.2008.11.105,
1191,2029802,25141068,BindingDB,,35173,"indazole-benzimidazole, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35173,304,Cyclin-A2 [177-432]/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=304,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),1040,PMID:19097791|DOI:10.1016/j.bmcl.2008.11.105,https://www.ncbi.nlm.nih.gov/pubmed/19097791|https://doi.org/10.1016/j.bmcl.2008.11.105,19097791,10.1016/j.bmcl.2008.11.105,
1192,2029837,25141068,BindingDB,,35173,"indazole-benzimidazole, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35173,606,Protein kinase C zeta type,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=606,Q05513,Protein kinase C zeta type,5590.0,PRKCZ,9606.0,Homo sapiens (human),,IC50 (nM),5.18,PMID:19097791|DOI:10.1016/j.bmcl.2008.11.105,https://www.ncbi.nlm.nih.gov/pubmed/19097791|https://doi.org/10.1016/j.bmcl.2008.11.105,19097791,10.1016/j.bmcl.2008.11.105,
1193,2029838,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,NTRK3,https://www.dgidb.org/genes/hgnc:8033,,,4916.0,NTRK3,9606.0,Homo sapiens (human),,,,,,,,
1194,2029839,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,NTRK1,https://www.dgidb.org/genes/hgnc:8031,,,4914.0,NTRK1,9606.0,Homo sapiens (human),,,,,,,,
1195,2029840,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,NTRK3,https://www.dgidb.org/genes/hgnc:8033,,,4916.0,NTRK3,9606.0,Homo sapiens (human),,,,,,,,
1196,2029841,25141092,Drug Gene Interaction database (DGIdb),Entrectinib,,ENTRECTINIB,https://www.dgidb.org/drugs/rxcui:2197862,,NTRK1,https://www.dgidb.org/genes/hgnc:8031,,,4914.0,NTRK1,9606.0,Homo sapiens (human),,,,,,,,
1197,2029842,25145656,Drug Gene Interaction database (DGIdb),Capmatinib,,CAPMATINIB,https://www.dgidb.org/drugs/rxcui:2362165,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),,,,,,,,
1198,2029843,25147499,BindingDB,"[4-(3-{[2-chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino}propoxy)-1H-indol-1-yl]acetic acid",27174,"1H-indol-1-yl tertiary amine, 18",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27174,878,Oxysterols receptor LXR-beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=878,P55055,Oxysterols receptor LXR-beta,7376.0,NR1H2,9606.0,Homo sapiens (human),,,,PMID:19167885|DOI:10.1016/j.bmcl.2009.01.004,https://www.ncbi.nlm.nih.gov/pubmed/19167885|https://doi.org/10.1016/j.bmcl.2009.01.004,19167885,10.1016/j.bmcl.2009.01.004,
1199,2029844,25147499,BindingDB,"[4-(3-{[2-chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino}propoxy)-1H-indol-1-yl]acetic acid",27174,"1H-indol-1-yl tertiary amine, 18",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27174,877,Oxysterols receptor LXR-alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=877,Q13133,Oxysterols receptor LXR-alpha,10062.0,NR1H3,9606.0,Homo sapiens (human),,,,PMID:19167885|DOI:10.1016/j.bmcl.2009.01.004,https://www.ncbi.nlm.nih.gov/pubmed/19167885|https://doi.org/10.1016/j.bmcl.2009.01.004,19167885,10.1016/j.bmcl.2009.01.004,
1200,2029845,25147760,Therapeutic Target Database (TTD),"2-[4-(2-Bromo-5-thienyl)phenyl]-4-methyl-octahydro-1,4-benzoxazin-2-ol",D0Q1XK,PMID18754614C9,https://idrblab.net/ttd/data/drug/details/D0Q1XK,T81850,Squalene synthetase (FDFT1),https://idrblab.net/ttd/data/target/details/T81850,P37268,Squalene synthase,2222.0,FDFT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1201,2029846,25150907,BindingDB,Descladinose Clarithromycin-N-benzyltriazolylhexahydroxamic Acid,27186,"triazole-linked clarithromycin-based compound, 24b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27186,1967,Histone deacetylase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1967,Q13547,Histone deacetylase 1,3065.0,HDAC1,9606.0,Homo sapiens (human),,IC50 (nM),44.3,PMID:19093884|DOI:10.1021/jm801128g,https://www.ncbi.nlm.nih.gov/pubmed/19093884|https://doi.org/10.1021/jm801128g,19093884,10.1021/jm801128g,
1202,2029847,25150907,BindingDB,Descladinose Clarithromycin-N-benzyltriazolylhexahydroxamic Acid,27186,"triazole-linked clarithromycin-based compound, 24b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27186,1996,Histone deacetylase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1996,Q9BY41,Histone deacetylase 8,55869.0,HDAC8,9606.0,Homo sapiens (human),,IC50 (nM),4750,PMID:19093884|DOI:10.1021/jm801128g,https://www.ncbi.nlm.nih.gov/pubmed/19093884|https://doi.org/10.1021/jm801128g,19093884,10.1021/jm801128g,
1203,2030003,25154868,BindingDB,N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide,26740,N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26740,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),595,PMID:17949010|DOI:10.1021/bi701378g,https://www.ncbi.nlm.nih.gov/pubmed/17949010|https://doi.org/10.1021/bi701378g,17949010,10.1021/bi701378g,
1204,2030004,25154868,BindingDB,N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide,26740,N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26740,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),51.9,PMID:17949010|DOI:10.1021/bi701378g,https://www.ncbi.nlm.nih.gov/pubmed/17949010|https://doi.org/10.1021/bi701378g,17949010,10.1021/bi701378g,
1205,2030005,25154868,BindingDB,N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide,26740,N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26740,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),248,PMID:17949010|DOI:10.1021/bi701378g,https://www.ncbi.nlm.nih.gov/pubmed/17949010|https://doi.org/10.1021/bi701378g,17949010,10.1021/bi701378g,
1206,2029908,25156556,BindingDB,"N-carbamimidoylglycyl deriv., 29a",31455,"N-carbamimidoylglycyl deriv., 29a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31455,513,RAC-alpha serine/threonine-protein kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=513,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),,IC50 (nM),17000,PMID:19179081|DOI:10.1016/j.bmc.2008.09.058,https://www.ncbi.nlm.nih.gov/pubmed/19179081|https://doi.org/10.1016/j.bmc.2008.09.058,19179081,10.1016/j.bmc.2008.09.058,
1207,2030006,25163987,DrugBank,"2-[(2-Chloro-4-Iodophenyl)amino]-N-{[(2r)-2,3-Dihydroxypropyl]oxy}-3,4-Difluorobenzamide",DB07046,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",https://www.drugbank.ca/drugs/DB07046,BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,https://www.drugbank.ca/bio_entities/BE0000870,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,5604.0,MAP2K1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1208,2029574,25164165,Therapeutic Target Database (TTD),Bicyclic heteroaryl amide derivative 1,D0PI1X,Bicyclic heteroaryl amide derivative 1,https://idrblab.net/ttd/data/drug/details/D0PI1X,T63414,P2X purinoceptor 7 (P2RX7),https://idrblab.net/ttd/data/target/details/T63414,Q99572,P2X purinoceptor 7,5027.0,P2RX7,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1209,2029575,25164462,BindingDB,"KSP Inhibitor, 4d",92865,"KSP Inhibitor, 4d",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92865,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,,,PMID:20718440|DOI:10.1021/bi1005283,https://www.ncbi.nlm.nih.gov/pubmed/20718440|https://doi.org/10.1021/bi1005283,20718440,10.1021/bi1005283,
1210,2029576,25164463,BindingDB,2-(4-methoxyphenylamino)-1-(2-(trifluoromethyl)benzyl)-1H-benzo[d]imidazole-5-carboxylic acid,50293759,2-(4-methoxyphenylamino)-1-(2-(trifluoromethyl)benzyl)-1H-benzo[d]imidazole-5-carboxylic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50293759,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,,,PMID:20718440|DOI:10.1021/bi1005283,https://www.ncbi.nlm.nih.gov/pubmed/20718440|https://doi.org/10.1021/bi1005283,20718440,10.1021/bi1005283,
1211,2029577,25164661,BindingDB,2-(4-sulfamoylphenylamino)-1-(2-(trifluoromethyl)benzyl)-1H-benzo[d]imidazole-5-carboxamide,50293744,2-(4-sulfamoylphenylamino)-1-(2-(trifluoromethyl)benzyl)-1H-benzo[d]imidazole-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50293744,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,,,PMID:20718440|DOI:10.1021/bi1005283,https://www.ncbi.nlm.nih.gov/pubmed/20718440|https://doi.org/10.1021/bi1005283,20718440,10.1021/bi1005283,
1212,2029578,25164869,BindingDB,"KSP Inhibitor, 4g",92866,"KSP Inhibitor, 4g",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92866,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,,,PMID:20718440|DOI:10.1021/bi1005283,https://www.ncbi.nlm.nih.gov/pubmed/20718440|https://doi.org/10.1021/bi1005283,20718440,10.1021/bi1005283,
1213,2029579,25165270,BindingDB,"KSP Inhibitor, 4c",92864,"KSP Inhibitor, 4c",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92864,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,,,PMID:20718440|DOI:10.1021/bi1005283,https://www.ncbi.nlm.nih.gov/pubmed/20718440|https://doi.org/10.1021/bi1005283,20718440,10.1021/bi1005283,
1214,2029580,25165474,BindingDB,2-(4-(methylsulfonyl)phenylamino)-1-(2-(trifluoromethyl)benzyl)-1H-benzo[d]imidazole-5-carboxamide,50293753,2-(4-(methylsulfonyl)phenylamino)-1-(2-(trifluoromethyl)benzyl)-1H-benzo[d]imidazole-5-carboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50293753,50003206,Kinesin-like protein KIF11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003206,P52732,Kinesin-like protein KIF11,3832.0,KIF11,9606.0,Homo sapiens (human),,,,PMID:20718440|DOI:10.1021/bi1005283,https://www.ncbi.nlm.nih.gov/pubmed/20718440|https://doi.org/10.1021/bi1005283,20718440,10.1021/bi1005283,
1215,2029581,25166913,Therapeutic Target Database (TTD),Glasdegib,D0S5LO,PF-04449913,https://idrblab.net/ttd/data/drug/details/D0S5LO,T75243,Serine/threonine-protein kinase mTOR (mTOR),https://idrblab.net/ttd/data/target/details/T75243,P42345,Serine/threonine-protein kinase mTOR,2475.0,MTOR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1216,2029330,25167777,ChEMBL,Omipalisib,CHEMBL1236962,OMIPALISIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1236962/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",5290.0,PIK3CA,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:24900173|PMID:15705718,https://www.ncbi.nlm.nih.gov/pubmed/24900173|https://www.ncbi.nlm.nih.gov/pubmed/15705718,24900173|15705718,,
1217,2029331,25167777,ChEMBL,Omipalisib,CHEMBL1236962,OMIPALISIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1236962/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",5291.0,PIK3CB,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:24900173|PMID:15705718,https://www.ncbi.nlm.nih.gov/pubmed/24900173|https://www.ncbi.nlm.nih.gov/pubmed/15705718,24900173|15705718,,
1218,2029332,25167777,ChEMBL,Omipalisib,CHEMBL1236962,OMIPALISIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1236962/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:24900173|PMID:15705718,https://www.ncbi.nlm.nih.gov/pubmed/24900173|https://www.ncbi.nlm.nih.gov/pubmed/15705718,24900173|15705718,,
1219,2029333,25167777,ChEMBL,Omipalisib,CHEMBL1236962,OMIPALISIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1236962/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,Q8WYR1,Phosphoinositide 3-kinase regulatory subunit 5,23533.0,PIK3R5,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:24900173|PMID:15705718,https://www.ncbi.nlm.nih.gov/pubmed/24900173|https://www.ncbi.nlm.nih.gov/pubmed/15705718,24900173|15705718,,
1220,2029334,25167777,ChEMBL,Omipalisib,CHEMBL1236962,OMIPALISIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1236962/,CHEMBL3559703,PI3-kinase class I,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3559703/,Q92569,Phosphatidylinositol 3-kinase regulatory subunit gamma,8503.0,PIK3R3,9606.0,Homo sapiens (human),PI3-kinase class I inhibitor,,,PMID:24900173|PMID:15705718,https://www.ncbi.nlm.nih.gov/pubmed/24900173|https://www.ncbi.nlm.nih.gov/pubmed/15705718,24900173|15705718,,
1221,2029419,25167777,ChEMBL,Omipalisib,CHEMBL1236962,OMIPALISIB,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1236962/,CHEMBL2842,Serine/threonine-protein kinase mTOR,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2842/,P42345,Serine/threonine-protein kinase mTOR,2475.0,MTOR,9606.0,Homo sapiens (human),Serine/threonine-protein kinase mtor inhibitor,,,PMID:24900173|PMID:15705718,https://www.ncbi.nlm.nih.gov/pubmed/24900173|https://www.ncbi.nlm.nih.gov/pubmed/15705718,24900173|15705718,,
1222,2029420,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,PTEN,https://www.dgidb.org/genes/hgnc:9588,,,5728.0,PTEN,9606.0,Homo sapiens (human),,,,,,,,
1223,2029618,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,AKT2,https://www.dgidb.org/genes/hgnc:392,,,208.0,AKT2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1224,2029619,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,PIK3R3,https://www.dgidb.org/genes/hgnc:8981,,,8503.0,PIK3R3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1225,2030007,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,PIK3R3,https://www.dgidb.org/genes/hgnc:8981,,,8503.0,PIK3R3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1226,2030008,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,PIK3R1,https://www.dgidb.org/genes/hgnc:8979,,,5295.0,PIK3R1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1227,2030009,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,MTOR,https://www.dgidb.org/genes/hgnc:3942,,,2475.0,MTOR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1228,2030010,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,PIK3R1,https://www.dgidb.org/genes/hgnc:8979,,,5295.0,PIK3R1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1229,2030011,25167777,Drug Gene Interaction database (DGIdb),Omipalisib,,OMIPALISIB,https://www.dgidb.org/drugs/ncit:C88270,,PIK3R6,https://www.dgidb.org/genes/hgnc:27101,,,146850.0,PIK3R6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1230,2030012,25169252,BindingDB,"2-Aminobenzimidazole with trans-stilbene, 8v",26879,"2-aminobenzimidazole with trans-stilbene, 8v",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26879,858,Insulin receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=858,P06213,Insulin receptor,3643.0,INSR,9606.0,Homo sapiens (human),,IC50 (nM),330,PMID:18930400|DOI:10.1016/j.bmcl.2008.09.098,https://www.ncbi.nlm.nih.gov/pubmed/18930400|https://doi.org/10.1016/j.bmcl.2008.09.098,18930400,10.1016/j.bmcl.2008.09.098,
1231,2030013,25169252,BindingDB,"2-Aminobenzimidazole with trans-stilbene, 8v",26879,"2-aminobenzimidazole with trans-stilbene, 8v",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26879,5623,Tyrosine-protein kinase ITK/TSK,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5623,Q08881,Tyrosine-protein kinase ITK/TSK,3702.0,ITK,9606.0,Homo sapiens (human),,IC50 (nM),9,PMID:18930400|DOI:10.1016/j.bmcl.2008.09.098,https://www.ncbi.nlm.nih.gov/pubmed/18930400|https://doi.org/10.1016/j.bmcl.2008.09.098,18930400,10.1016/j.bmcl.2008.09.098,
1232,2030072,25169253,BindingDB,"2-Aminobenzimidazole with trans-stilbene, 8x",26881,"2-aminobenzimidazole with trans-stilbene, 8x",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26881,5623,Tyrosine-protein kinase ITK/TSK,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5623,Q08881,Tyrosine-protein kinase ITK/TSK,3702.0,ITK,9606.0,Homo sapiens (human),,IC50 (nM),5,PMID:18930400|DOI:10.1016/j.bmcl.2008.09.098,https://www.ncbi.nlm.nih.gov/pubmed/18930400|https://doi.org/10.1016/j.bmcl.2008.09.098,18930400,10.1016/j.bmcl.2008.09.098,
1233,2030073,25169253,BindingDB,"2-Aminobenzimidazole with trans-stilbene, 8x",26881,"2-aminobenzimidazole with trans-stilbene, 8x",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26881,858,Insulin receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=858,P06213,Insulin receptor,3643.0,INSR,9606.0,Homo sapiens (human),,IC50 (nM),1500,PMID:18930400|DOI:10.1016/j.bmcl.2008.09.098,https://www.ncbi.nlm.nih.gov/pubmed/18930400|https://doi.org/10.1016/j.bmcl.2008.09.098,18930400,10.1016/j.bmcl.2008.09.098,
1234,2030074,25169383,Therapeutic Target Database (TTD),IRAK4 inhibitor rac-45,D0J8VR,IRAK4 inhibitor rac-45,https://idrblab.net/ttd/data/drug/details/D0J8VR,T55398,Renal carcinoma antigen NY-REN-64 (IRAK-4),https://idrblab.net/ttd/data/target/details/T55398,Q9NWZ3,Interleukin-1 receptor-associated kinase 4,51135.0,IRAK4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1235,2029421,25170420,Drug Gene Interaction database (DGIdb),Naproxen etemesil,,NAPROXEN ETEMESIL,https://www.dgidb.org/drugs/ncit:C166529,,PTGS2,https://www.dgidb.org/genes/hgnc:9605,,,5743.0,PTGS2,9606.0,Homo sapiens (human),,,,,,,,
1236,2029422,25171648,Drug Gene Interaction database (DGIdb),Tepotinib,,TEPOTINIB,https://www.dgidb.org/drugs/rxcui:2477103,,ALK,https://www.dgidb.org/genes/hgnc:427,,,238.0,ALK,9606.0,Homo sapiens (human),,,,,,,,
1237,2029423,25171648,Drug Gene Interaction database (DGIdb),Tepotinib,,TEPOTINIB,https://www.dgidb.org/drugs/rxcui:2477103,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),,,,,,,,
1238,2029424,25171648,Drug Gene Interaction database (DGIdb),Tepotinib,,TEPOTINIB,https://www.dgidb.org/drugs/rxcui:2477103,,EGFR,https://www.dgidb.org/genes/hgnc:3236,,,1956.0,EGFR,9606.0,Homo sapiens (human),,,,,,,,
1239,2029620,25171648,Drug Gene Interaction database (DGIdb),Tepotinib,,TEPOTINIB,https://www.dgidb.org/drugs/rxcui:2477103,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1240,2029621,25174099,DrugBank,"(5s)-5-(2-Amino-2-Oxoethyl)-4-Oxo-N-[(3-Oxo-3,4-Dihydro-2h-1,4-Benzoxazin-6-Yl)methyl]-3,4,5,6,7,8-Hexahydro[1]benzothieno[2,3-D]pyrimidine-2-Carboxamide",DB07397,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",https://www.drugbank.ca/drugs/DB07397,BE0001182,Neutrophil collagenase,https://www.drugbank.ca/bio_entities/BE0001182,P22894,Neutrophil collagenase,4317.0,MMP8,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1241,2030075,25174101,DrugBank,1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Naphthalen-1-Ylurea,DB06882,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,https://www.drugbank.ca/drugs/DB06882,BE0000838,Proto-oncogene tyrosine-protein kinase Src,https://www.drugbank.ca/bio_entities/BE0000838,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1242,2030076,25174101,DrugBank,1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Naphthalen-1-Ylurea,DB06882,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,https://www.drugbank.ca/drugs/DB06882,BE0001019,Mitogen-activated protein kinase 14,https://www.drugbank.ca/bio_entities/BE0001019,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1243,2030077,25181321,DrugBank,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",DB07058,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",https://www.drugbank.ca/drugs/DB07058,BE0001065,Glycogen synthase kinase-3 beta,https://www.drugbank.ca/bio_entities/BE0001065,P49841,Glycogen synthase kinase-3 beta,2932.0,GSK3B,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1244,2029622,25181472,Drug Gene Interaction database (DGIdb),Glesatinib,,GLESATINIB,https://www.dgidb.org/drugs/ncit:C77876,,TEK,https://www.dgidb.org/genes/hgnc:11724,,,7010.0,TEK,9606.0,Homo sapiens (human),,,,,,,,
1245,2029623,25181472,Drug Gene Interaction database (DGIdb),Glesatinib,,GLESATINIB,https://www.dgidb.org/drugs/ncit:C77876,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1246,2030078,25181472,Drug Gene Interaction database (DGIdb),Glesatinib,,GLESATINIB,https://www.dgidb.org/drugs/ncit:C77876,,FLT4,https://www.dgidb.org/genes/hgnc:3767,,,2324.0,FLT4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1247,2030079,25181472,Drug Gene Interaction database (DGIdb),Glesatinib,,GLESATINIB,https://www.dgidb.org/drugs/ncit:C77876,,KDR,https://www.dgidb.org/genes/hgnc:6307,,,3791.0,KDR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1248,2030080,25181472,Drug Gene Interaction database (DGIdb),Glesatinib,,GLESATINIB,https://www.dgidb.org/drugs/ncit:C77876,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1249,2030081,25181472,Drug Gene Interaction database (DGIdb),Glesatinib,,GLESATINIB,https://www.dgidb.org/drugs/ncit:C77876,,TEK,https://www.dgidb.org/genes/hgnc:11724,,,7010.0,TEK,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1250,2030082,25181472,Drug Gene Interaction database (DGIdb),Glesatinib,,GLESATINIB,https://www.dgidb.org/drugs/ncit:C77876,,KDR,https://www.dgidb.org/genes/hgnc:6307,,,3791.0,KDR,9606.0,Homo sapiens (human),,,,,,,,
1251,2030083,25181472,Drug Gene Interaction database (DGIdb),Glesatinib,,GLESATINIB,https://www.dgidb.org/drugs/ncit:C77876,,FLT4,https://www.dgidb.org/genes/hgnc:3767,,,2324.0,FLT4,9606.0,Homo sapiens (human),,,,,,,,
1252,2029425,25181492,Therapeutic Target Database (TTD),"US8569313, Inhibitor 15",D0U4EO,"US8569313, Inhibitor 15",https://idrblab.net/ttd/data/drug/details/D0U4EO,T31543,Suppressor of tumorigenicity 14 protein (ST14),https://idrblab.net/ttd/data/target/details/T31543,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,6768.0,ST14,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1253,2029426,25181577,Drug Gene Interaction database (DGIdb),Telotristat Ethyl,,TELOTRISTAT ETHYL,https://www.dgidb.org/drugs/rxcui:1872441,,TPH1,https://www.dgidb.org/genes/hgnc:12008,,,7166.0,TPH1,9606.0,Homo sapiens (human),,,,,,,,
1254,2029427,25182746,Therapeutic Target Database (TTD),N-(2-chloro-4-hydroxyphenyl)-6-(cyclohexylamino)pyrimidine-4-carboxamide,D09LDU,JCXGHZCWAHCYGY-UHFFFAOYSA-N,https://idrblab.net/ttd/data/drug/details/D09LDU,T11241,Sphingosine-1-phosphate receptor 3 (S1PR3),https://idrblab.net/ttd/data/target/details/T11241,Q99500,Sphingosine 1-phosphate receptor 3,1903.0,S1PR3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1255,2029428,25182763,Therapeutic Target Database (TTD),6-(cyclohexyl(ethyl)amino)-N-(4-hydroxy-2-methylphenyl)pyrimidine-4-carboxamide,D0LT2N,ZNFTXQFGUIKQQE-UHFFFAOYSA-N,https://idrblab.net/ttd/data/drug/details/D0LT2N,T11241,Sphingosine-1-phosphate receptor 3 (S1PR3),https://idrblab.net/ttd/data/target/details/T11241,Q99500,Sphingosine 1-phosphate receptor 3,1903.0,S1PR3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1256,2029429,25182901,Therapeutic Target Database (TTD),6-(cyclohexyl(cyclopropylmethyl)amino)-N-(6-methyl-1H-indazol-5-yl)pyrimidine-4-carboxamide,D04UXN,YYDJCLCSBYCSCO-UHFFFAOYSA-N,https://idrblab.net/ttd/data/drug/details/D04UXN,T11241,Sphingosine-1-phosphate receptor 3 (S1PR3),https://idrblab.net/ttd/data/target/details/T11241,Q99500,Sphingosine 1-phosphate receptor 3,1903.0,S1PR3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1257,2029430,25182905,Therapeutic Target Database (TTD),6-(dipropylamino)-N-(2-methyl-4-sulfamoylphenyl)pyrimidine-4-carboxamide,D0I5TH,MHHFJYABEVJNEG-UHFFFAOYSA-N,https://idrblab.net/ttd/data/drug/details/D0I5TH,T11241,Sphingosine-1-phosphate receptor 3 (S1PR3),https://idrblab.net/ttd/data/target/details/T11241,Q99500,Sphingosine 1-phosphate receptor 3,1903.0,S1PR3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1258,2029624,25187967,BindingDB,"N-[4-(4-methoxy-1,3-benzothiazol-2-yl)phenyl]-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide",26732,"Benzothiazole-based analogue, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26732,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),2.0,PMID:21728345|DOI:10.1021/bi200552p,https://www.ncbi.nlm.nih.gov/pubmed/21728345|https://doi.org/10.1021/bi200552p,21728345,10.1021/bi200552p,
1259,2029625,25187967,BindingDB,"N-[4-(4-methoxy-1,3-benzothiazol-2-yl)phenyl]-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide",26732,"Benzothiazole-based analogue, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26732,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),2.1,PMID:21728345|DOI:10.1021/bi200552p,https://www.ncbi.nlm.nih.gov/pubmed/21728345|https://doi.org/10.1021/bi200552p,21728345,10.1021/bi200552p,
1260,2029626,25187967,BindingDB,"N-[4-(4-methoxy-1,3-benzothiazol-2-yl)phenyl]-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide",26732,"Benzothiazole-based analogue, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26732,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),2.0,PMID:21728345|DOI:10.1021/bi200552p,https://www.ncbi.nlm.nih.gov/pubmed/21728345|https://doi.org/10.1021/bi200552p,21728345,10.1021/bi200552p,
1261,2029627,25187967,BindingDB,"N-[4-(4-methoxy-1,3-benzothiazol-2-yl)phenyl]-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide",26732,"Benzothiazole-based analogue, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26732,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),2.3,PMID:21728345|DOI:10.1021/bi200552p,https://www.ncbi.nlm.nih.gov/pubmed/21728345|https://doi.org/10.1021/bi200552p,21728345,10.1021/bi200552p,
1262,2029628,25187967,BindingDB,"N-[4-(4-methoxy-1,3-benzothiazol-2-yl)phenyl]-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide",26732,"Benzothiazole-based analogue, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26732,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),2.5,PMID:21728345|DOI:10.1021/bi200552p,https://www.ncbi.nlm.nih.gov/pubmed/21728345|https://doi.org/10.1021/bi200552p,21728345,10.1021/bi200552p,
1263,2029666,25187967,BindingDB,"N-[4-(4-methoxy-1,3-benzothiazol-2-yl)phenyl]-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide",26732,"Benzothiazole-based analogue, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26732,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),5.1,PMID:21728345|DOI:10.1021/bi200552p,https://www.ncbi.nlm.nih.gov/pubmed/21728345|https://doi.org/10.1021/bi200552p,21728345,10.1021/bi200552p,
1264,2029667,25187967,BindingDB,"N-[4-(4-methoxy-1,3-benzothiazol-2-yl)phenyl]-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide",26732,"Benzothiazole-based analogue, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26732,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),5.1,PMID:21728345|DOI:10.1021/bi200552p,https://www.ncbi.nlm.nih.gov/pubmed/21728345|https://doi.org/10.1021/bi200552p,21728345,10.1021/bi200552p,
1265,2029668,25187967,BindingDB,"N-[4-(4-methoxy-1,3-benzothiazol-2-yl)phenyl]-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide",26732,"Benzothiazole-based analogue, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26732,354,Fatty-acid amide hydrolase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=354,O00519,Fatty-acid amide hydrolase 1,2166.0,FAAH,9606.0,Homo sapiens (human),,IC50 (nM),3.8,PMID:21728345|DOI:10.1021/bi200552p,https://www.ncbi.nlm.nih.gov/pubmed/21728345|https://doi.org/10.1021/bi200552p,21728345,10.1021/bi200552p,
1266,2029431,25193001,Therapeutic Target Database (TTD),"2,3-Bis(diethoxyphosphoryloxy)propyl 2-acetyloxybenzoate",D01PYM,PMID27977313-Compound-48,https://idrblab.net/ttd/data/drug/details/D01PYM,T84581,Cytoplasmic thioredoxin reductase (TXNRD1),https://idrblab.net/ttd/data/target/details/T84581,Q16881,"Thioredoxin reductase 1, cytoplasmic",7296.0,TXNRD1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1267,2029902,25195495,Therapeutic Target Database (TTD),(S)-N-((1-(5-(4-Fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide,D06CKX,SB-649868,https://idrblab.net/ttd/data/drug/details/D06CKX,T73482,Orexin receptor type 1 (HCRTR1),https://idrblab.net/ttd/data/target/details/T73482,O43613,Orexin receptor type 1,3061.0,HCRTR1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1268,2029987,25195495,Drug Gene Interaction database (DGIdb),(S)-N-((1-(5-(4-Fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide,,SB-649868,https://www.dgidb.org/drugs/drugbank:DB14822,,HCRTR1,https://www.dgidb.org/genes/hgnc:4848,,,3061.0,HCRTR1,9606.0,Homo sapiens (human),,,,,,,,
1269,2029988,25195496,IUPHAR/BPS Guide to PHARMACOLOGY,Fluorobexarotene,8904,fluorobexarotene,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8904,610,Retinoid X receptor-α,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=610,P19793,Retinoic acid receptor RXR-alpha,6256.0,RXRA,9606.0,Homo sapiens (human),Agonist,pEC50,7.37,PMID:19791803,https://www.ncbi.nlm.nih.gov/pubmed/19791803,19791803,,
1270,2029989,25195496,IUPHAR/BPS Guide to PHARMACOLOGY,Fluorobexarotene,8904,fluorobexarotene,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8904,610,Retinoid X receptor-α,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=610,P19793,Retinoic acid receptor RXR-alpha,6256.0,RXRA,9606.0,Homo sapiens (human),Agonist,pKi,7.92,PMID:19791803,https://www.ncbi.nlm.nih.gov/pubmed/19791803,19791803,,
1271,2029669,25195503,Therapeutic Target Database (TTD),"4-[4-[2-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]-2-oxoethyl]phenoxy]-N-hydroxybutanamide",D0M5DX,Oxazolyl methylthiothiazole derivative 1,https://idrblab.net/ttd/data/drug/details/D0M5DX,T22956,Cyclin-dependent kinase 3 (CDK3),https://idrblab.net/ttd/data/target/details/T22956,Q00526,Cyclin-dependent kinase 3,1018.0,CDK3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1272,2029670,25195503,Therapeutic Target Database (TTD),"4-[4-[2-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]-2-oxoethyl]phenoxy]-N-hydroxybutanamide",D0M5DX,Oxazolyl methylthiothiazole derivative 1,https://idrblab.net/ttd/data/drug/details/D0M5DX,T44458,Cyclin-dependent kinase 9 (CDK9),https://idrblab.net/ttd/data/target/details/T44458,P50750,Cyclin-dependent kinase 9,1025.0,CDK9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1273,2029671,25195503,Therapeutic Target Database (TTD),"4-[4-[2-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]-2-oxoethyl]phenoxy]-N-hydroxybutanamide",D0M5DX,Oxazolyl methylthiothiazole derivative 1,https://idrblab.net/ttd/data/drug/details/D0M5DX,T49898,Cyclin-dependent kinase 1 (CDK1),https://idrblab.net/ttd/data/target/details/T49898,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1274,2029672,25195503,Therapeutic Target Database (TTD),"4-[4-[2-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]-2-oxoethyl]phenoxy]-N-hydroxybutanamide",D0M5DX,Oxazolyl methylthiothiazole derivative 1,https://idrblab.net/ttd/data/drug/details/D0M5DX,T70176,Cyclin-dependent kinase 2 (CDK2),https://idrblab.net/ttd/data/target/details/T70176,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1275,2029673,25195503,Therapeutic Target Database (TTD),"4-[4-[2-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]-2-oxoethyl]phenoxy]-N-hydroxybutanamide",D0M5DX,Oxazolyl methylthiothiazole derivative 1,https://idrblab.net/ttd/data/drug/details/D0M5DX,T85799,Cyclin-dependent kinase 4 (CDK4),https://idrblab.net/ttd/data/target/details/T85799,P11802,Cyclin-dependent kinase 4,1019.0,CDK4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1276,2029674,25195503,Therapeutic Target Database (TTD),"4-[4-[2-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]-2-oxoethyl]phenoxy]-N-hydroxybutanamide",D0M5DX,Oxazolyl methylthiothiazole derivative 1,https://idrblab.net/ttd/data/drug/details/D0M5DX,T58449,Cyclin-dependent kinase 7 (CDK7),https://idrblab.net/ttd/data/target/details/T58449,P50613,Cyclin-dependent kinase 7,1022.0,CDK7,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1277,2029725,25195503,Therapeutic Target Database (TTD),"4-[4-[2-[[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]amino]-2-oxoethyl]phenoxy]-N-hydroxybutanamide",D0M5DX,Oxazolyl methylthiothiazole derivative 1,https://idrblab.net/ttd/data/drug/details/D0M5DX,T89361,Cyclin-dependent kinase 6 (CDK6),https://idrblab.net/ttd/data/target/details/T89361,Q00534,Cyclin-dependent kinase 6,1021.0,CDK6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1278,2029909,25195533,Therapeutic Target Database (TTD),Darotropium,D0H0UB,Darotropium + 642444,https://idrblab.net/ttd/data/drug/details/D0H0UB,T28893,Muscarinic acetylcholine receptor M1 (CHRM1),https://idrblab.net/ttd/data/target/details/T28893,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606.0,Homo sapiens (human),Agonist,,,,,,,
1279,2029639,25195624,Comparative Toxicogenomics Database (CTD),Bexagliflozin,C000705992,bexagliflozin,https://ctdbase.org/detail.go?type=chem&acc=C000705992,54600,UGT1A9,https://ctdbase.org/detail.go?type=gene&acc=54600,,,54600.0,UGT1A9,9606.0,Homo sapiens (human),UGT1A9 protein results in increased metabolism of bexagliflozin,,,PMID:36867399,https://www.ncbi.nlm.nih.gov/pubmed/36867399,36867399,,
1280,2029726,25197364,Comparative Toxicogenomics Database (CTD),"(E)-2-{4-[(Dimethylamino)methyl]benzylidene}-5,6-dimethoxy-2,3-dihydroinden-1-one",C543150,"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one",https://ctdbase.org/detail.go?type=chem&acc=C543150,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116.0,Rattus norvegicus (Norway rat),"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one results in decreased activity of ACHE protein",,,PMID:19345205,https://www.ncbi.nlm.nih.gov/pubmed/19345205,19345205,,
1281,2029727,25197364,Comparative Toxicogenomics Database (CTD),"(E)-2-{4-[(Dimethylamino)methyl]benzylidene}-5,6-dimethoxy-2,3-dihydroinden-1-one",C543150,"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one",https://ctdbase.org/detail.go?type=chem&acc=C543150,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one inhibits the reaction [hydrogen peroxide results in decreased expression of BCL2 protein]",,,PMID:19345205,https://www.ncbi.nlm.nih.gov/pubmed/19345205,19345205,,
1282,2029728,25197364,Comparative Toxicogenomics Database (CTD),"(E)-2-{4-[(Dimethylamino)methyl]benzylidene}-5,6-dimethoxy-2,3-dihydroinden-1-one",C543150,"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one",https://ctdbase.org/detail.go?type=chem&acc=C543150,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one inhibits the reaction [hydrogen peroxide results in increased activity of CASP3 protein]|2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one inhibits the reaction [hydrogen peroxide results in decreased expression of CASP3 protein]",,,PMID:19345205,https://www.ncbi.nlm.nih.gov/pubmed/19345205,19345205,,
1283,2029729,25197364,Comparative Toxicogenomics Database (CTD),"(E)-2-{4-[(Dimethylamino)methyl]benzylidene}-5,6-dimethoxy-2,3-dihydroinden-1-one",C543150,"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one",https://ctdbase.org/detail.go?type=chem&acc=C543150,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10116.0,Rattus norvegicus (Norway rat),"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of MAPK8 protein]",,,PMID:19345205,https://www.ncbi.nlm.nih.gov/pubmed/19345205,19345205,,
1284,2029730,25197364,Comparative Toxicogenomics Database (CTD),"(E)-2-{4-[(Dimethylamino)methyl]benzylidene}-5,6-dimethoxy-2,3-dihydroinden-1-one",C543150,"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one",https://ctdbase.org/detail.go?type=chem&acc=C543150,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10116.0,Rattus norvegicus (Norway rat),"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of MAPK9 protein]",,,PMID:19345205,https://www.ncbi.nlm.nih.gov/pubmed/19345205,19345205,,
1285,2029731,25197364,Comparative Toxicogenomics Database (CTD),"(E)-2-{4-[(Dimethylamino)methyl]benzylidene}-5,6-dimethoxy-2,3-dihydroinden-1-one",C543150,"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one",https://ctdbase.org/detail.go?type=chem&acc=C543150,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one inhibits the reaction [hydrogen peroxide results in increased expression of TP53 protein]",,,PMID:19345205,https://www.ncbi.nlm.nih.gov/pubmed/19345205,19345205,,
1286,2029732,25197364,Comparative Toxicogenomics Database (CTD),"(E)-2-{4-[(Dimethylamino)methyl]benzylidene}-5,6-dimethoxy-2,3-dihydroinden-1-one",C543150,"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one",https://ctdbase.org/detail.go?type=chem&acc=C543150,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,10116.0,Rattus norvegicus (Norway rat),"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one inhibits the reaction [hydrogen peroxide results in decreased expression of XIAP protein]",,,PMID:19345205,https://www.ncbi.nlm.nih.gov/pubmed/19345205,19345205,,
1287,2029640,25198729,BindingDB,"2-(2,6-dimethoxypyridin-3-yl)-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-N-(2-phenoxyethyl)pyridine-3-carboxamide",28018,"2-(2,6-dimethoxypyridin-3-yl)-6-{[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino}-N-(2-phenoxyethyl)pyridine-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28018,8614,Extracellular calcium-sensing receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8614,P41180,Extracellular calcium-sensing receptor,846.0,CASR,9606.0,Homo sapiens (human),,IC50 (nM),140,PMID:19143533|DOI:10.1021/jm801178c,https://www.ncbi.nlm.nih.gov/pubmed/19143533|https://doi.org/10.1021/jm801178c,19143533,10.1021/jm801178c,
1288,2029990,25199563,Comparative Toxicogenomics Database (CTD),"2-(Aziridin-1-yl)-3-[2-[1-[3-(aziridin-1-yl)-1,4-dioxonaphthalen-2-yl]sulfanylethoxy]ethylsulfanyl]naphthalene-1,4-dione",C507359,"2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone",https://ctdbase.org/detail.go?type=chem&acc=C507359,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),"2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone results in increased activity of CASP3 protein",,,PMID:15642166,https://www.ncbi.nlm.nih.gov/pubmed/15642166,15642166,,
1289,2029991,25199563,Comparative Toxicogenomics Database (CTD),"2-(Aziridin-1-yl)-3-[2-[1-[3-(aziridin-1-yl)-1,4-dioxonaphthalen-2-yl]sulfanylethoxy]ethylsulfanyl]naphthalene-1,4-dione",C507359,"2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone",https://ctdbase.org/detail.go?type=chem&acc=C507359,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10090.0,Mus musculus (house mouse),"2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone results in decreased expression of CDK2 protein",,,PMID:15642166,https://www.ncbi.nlm.nih.gov/pubmed/15642166,15642166,,
1290,2029992,25199563,Comparative Toxicogenomics Database (CTD),"2-(Aziridin-1-yl)-3-[2-[1-[3-(aziridin-1-yl)-1,4-dioxonaphthalen-2-yl]sulfanylethoxy]ethylsulfanyl]naphthalene-1,4-dione",C507359,"2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone",https://ctdbase.org/detail.go?type=chem&acc=C507359,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10090.0,Mus musculus (house mouse),"2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone results in increased expression of CDKN1A protein",,,PMID:15642166,https://www.ncbi.nlm.nih.gov/pubmed/15642166,15642166,,
1291,2029993,25199563,Comparative Toxicogenomics Database (CTD),"2-(Aziridin-1-yl)-3-[2-[1-[3-(aziridin-1-yl)-1,4-dioxonaphthalen-2-yl]sulfanylethoxy]ethylsulfanyl]naphthalene-1,4-dione",C507359,"2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone",https://ctdbase.org/detail.go?type=chem&acc=C507359,7073,TIAL1,https://ctdbase.org/detail.go?type=gene&acc=7073,,,7073.0,TIAL1,10090.0,Mus musculus (house mouse),"2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone results in decreased expression of TIAL1 protein",,,PMID:15642166,https://www.ncbi.nlm.nih.gov/pubmed/15642166,15642166,,
1292,2029994,25199563,Comparative Toxicogenomics Database (CTD),"2-(Aziridin-1-yl)-3-[2-[1-[3-(aziridin-1-yl)-1,4-dioxonaphthalen-2-yl]sulfanylethoxy]ethylsulfanyl]naphthalene-1,4-dione",C507359,"2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone",https://ctdbase.org/detail.go?type=chem&acc=C507359,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090.0,Mus musculus (house mouse),"2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone affects the expression of TRP53 protein",,,PMID:15642166,https://www.ncbi.nlm.nih.gov/pubmed/15642166,15642166,,
1293,2029752,25201460,BindingDB,"5-Methyl-L-tryptophan, 2",92682,"5-Methyl-L-tryptophan, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92682,5265,Trp operon repressor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5265,P0A881,Trp operon repressor,948917.0,trpR,83333.0,Escherichia coli K-12,,,,PMID:3549712,https://www.ncbi.nlm.nih.gov/pubmed/3549712,3549712,,
1294,2029753,25204767,Therapeutic Target Database (TTD),"1H-Indole-3-carboxylic acid, 6-[4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl]methoxy]-1-piperidinyl]-1-methyl-",D0TH6M,PMID30259754-Compound-LY2562175,https://idrblab.net/ttd/data/drug/details/D0TH6M,T51426,Farnesoid X-activated receptor (FXR),https://idrblab.net/ttd/data/target/details/T51426,Q96RI1,Bile acid receptor,9971.0,NR1H4,9606.0,Homo sapiens (human),Agonist,,,,,,,
1295,2029904,25207521,IUPHAR/BPS Guide to PHARMACOLOGY,"2-[[3,4-Dioxo-2-(pyridin-4-ylamino)cyclobuten-1-yl]amino]-2-(3-hydroxyphenyl)acetamide",8163,compound 33 [PMID: 19364658],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8163,1999,casein kinase 1 gamma 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1999,Q9HCP0,Casein kinase I isoform gamma-1,53944.0,CSNK1G1,9606.0,Homo sapiens (human),Inhibition,pIC50,6.8,PMID:19364658,https://www.ncbi.nlm.nih.gov/pubmed/19364658,19364658,,
1296,2029905,25207521,IUPHAR/BPS Guide to PHARMACOLOGY,"2-[[3,4-Dioxo-2-(pyridin-4-ylamino)cyclobuten-1-yl]amino]-2-(3-hydroxyphenyl)acetamide",8163,compound 33 [PMID: 19364658],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8163,1987,checkpoint kinase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1987,O14757,Serine/threonine-protein kinase Chk1,1111.0,CHEK1,9606.0,Homo sapiens (human),Inhibition,pIC50,7.05,PMID:19364658,https://www.ncbi.nlm.nih.gov/pubmed/19364658,19364658,,
1297,2037193,25207521,Therapeutic Target Database (TTD),"2-[[3,4-Dioxo-2-(pyridin-4-ylamino)cyclobuten-1-yl]amino]-2-(3-hydroxyphenyl)acetamide",D01YWE,PMID19364658C33,https://idrblab.net/ttd/data/drug/details/D01YWE,T21307,MAPK-activated protein kinase 2 (MAPKAPK2),https://idrblab.net/ttd/data/target/details/T21307,P49137,MAP kinase-activated protein kinase 2,9261.0,MAPKAPK2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1298,2029906,25209437,Therapeutic Target Database (TTD),CID 25209437,D0HJ5H,BGC-20-1531,https://idrblab.net/ttd/data/drug/details/D0HJ5H,T18876,Prostaglandin E2 receptor EP4 (PTGER4),https://idrblab.net/ttd/data/target/details/T18876,P35408,Prostaglandin E2 receptor EP4 subtype,5734.0,PTGER4,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1299,2037194,25210130,Therapeutic Target Database (TTD),2-(Indolin-1yl)-melatonin,D0S3NS,2-(indolin-1yl)-melatonin,https://idrblab.net/ttd/data/drug/details/D0S3NS,T97613,Melatonin receptor type 1A (MTNR1A),https://idrblab.net/ttd/data/target/details/T97613,P48039,Melatonin receptor type 1A,4543.0,MTNR1A,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1300,2029641,25210476,Therapeutic Target Database (TTD),3-[5-(3-Nitrophenyl)thiophen-2-yl]propanoic acid,D0T2TW,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,https://idrblab.net/ttd/data/drug/details/D0T2TW,T26623,Aldose reductase (AKR1B1),https://idrblab.net/ttd/data/target/details/T26623,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1301,2029754,25210476,DrugBank,3-[5-(3-Nitrophenyl)thiophen-2-yl]propanoic acid,DB07139,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,https://www.drugbank.ca/drugs/DB07139,BE0000747,Aldose reductase,https://www.drugbank.ca/bio_entities/BE0000747,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1302,2029755,25210478,DrugBank,"N-(3,5-Dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide",DB07693,"N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide",https://www.drugbank.ca/drugs/DB07693,BE0000337,Transthyretin,https://www.drugbank.ca/bio_entities/BE0000337,P02766,Transthyretin,7276.0,TTR,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1303,2029756,25210479,DrugBank,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",DB07695,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",https://www.drugbank.ca/drugs/DB07695,BE0000337,Transthyretin,https://www.drugbank.ca/bio_entities/BE0000337,P02766,Transthyretin,7276.0,TTR,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1304,2029757,25210493,DrugBank,"1-[(2,6-Difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",DB07692,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",https://www.drugbank.ca/drugs/DB07692,BE0000088,Pyruvate kinase PKM,https://www.drugbank.ca/bio_entities/BE0000088,P14618,Pyruvate kinase PKM,5315.0,PKM,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1305,2029758,25210531,DrugBank,"3-[(1e,7e)-8-(2,6-Dioxo-1,2,3,6-Tetrahydropyrimidin-4-Yl)-3,6-Dioxa-2,7-Diazaocta-1,7-Dien-1-Yl]benzoic Acid",DB07760,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",https://www.drugbank.ca/drugs/DB07760,BE0003770,Uracil-DNA glycosylase,https://www.drugbank.ca/bio_entities/BE0003770,P13051,Uracil-DNA glycosylase,7374.0,UNG,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1306,2029759,25210792,Therapeutic Target Database (TTD),1-{1-[(5-methoxy-1H-indol-2-yl)carbonyl]piperidin-4-yl}-2-methylpropan-2-ol,D0Q8RC,N-(indolylcarbonyl)-piperidine derivative 1,https://idrblab.net/ttd/data/drug/details/D0Q8RC,T60857,Dihydrodiol dehydrogenase type I (AKR1C3),https://idrblab.net/ttd/data/target/details/T60857,P42330,Aldo-keto reductase family 1 member C3,8644.0,AKR1C3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1307,2029925,25211051,IUPHAR/BPS Guide to PHARMACOLOGY,(2S)-2-[[9-propan-2-yl-6-[[4-(2-pyridinyl)phenyl]methylamino]-2-purinyl]amino]-1-butanol,11064,(S)-CR8,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11064,2009,dual specificity tyrosine phosphorylation regulated kinase 1A,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2009,Q13627,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,1859.0,DYRK1A,9606.0,Homo sapiens (human),Inhibition,pIC50,6.05,PMID:29985601,https://www.ncbi.nlm.nih.gov/pubmed/29985601,29985601,,
1308,2029926,25211051,IUPHAR/BPS Guide to PHARMACOLOGY,(2S)-2-[[9-propan-2-yl-6-[[4-(2-pyridinyl)phenyl]methylamino]-2-purinyl]amino]-1-butanol,11064,(S)-CR8,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11064,1961,cyclin dependent kinase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1961,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),Inhibition,pIC50,7.22,PMID:18574471,https://www.ncbi.nlm.nih.gov/pubmed/18574471,18574471,,
1309,2029930,25211051,IUPHAR/BPS Guide to PHARMACOLOGY,(2S)-2-[[9-propan-2-yl-6-[[4-(2-pyridinyl)phenyl]methylamino]-2-purinyl]amino]-1-butanol,11064,(S)-CR8,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11064,1977,cyclin dependent kinase 5,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1977,Q00535,Cyclin-dependent-like kinase 5 ,1020.0,CDK5,9606.0,Homo sapiens (human),Inhibition,pIC50,6.92,PMID:18574471,https://www.ncbi.nlm.nih.gov/pubmed/18574471,18574471,,
1310,2029642,25211574,BindingDB,"2-((2-((5-(2-(Dimethylamino)acetamido)-2-methoxy-4-methylphenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluorobenzamide",27793,"2-{[2-({5-[2-(dimethylamino)acetamido]-2-methoxy-4-methylphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27793,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),1995,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1311,2029643,25211575,BindingDB,"2-[(2-{[1-(N,N-dimethylglycyl)-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-6-fluorobenzamide",27799,"2-{[2-({1-[2-(dimethylamino)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27799,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),1585,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1312,2029644,25211575,BindingDB,"2-[(2-{[1-(N,N-dimethylglycyl)-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-6-fluorobenzamide",27799,"2-{[2-({1-[2-(dimethylamino)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27799,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),1,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1313,2029645,25211676,BindingDB,"2-{[2-({5-[2-(dimethylamino)acetamido]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27792,"2-{[2-({5-[2-(dimethylamino)acetamido]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27792,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),3162,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1314,2029760,25212148,Drug Gene Interaction database (DGIdb),Sitravatinib,,SITRAVATINIB,https://www.dgidb.org/drugs/ncit:C117734,,FLT3,https://www.dgidb.org/genes/hgnc:3765,,,2322.0,FLT3,9606.0,Homo sapiens (human),,,,,,,,
1315,2029910,25212148,IUPHAR/BPS Guide to PHARMACOLOGY,Sitravatinib,9920,sitravatinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9920,1837,"MER proto-oncogene, tyrosine kinase",https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1837,Q12866,Tyrosine-protein kinase Mer,10461.0,MERTK,9606.0,Homo sapiens (human),Inhibition,pIC50,8.7,PMID:26675259,https://www.ncbi.nlm.nih.gov/pubmed/26675259,26675259,,
1316,2029923,25212148,IUPHAR/BPS Guide to PHARMACOLOGY,Sitravatinib,9920,sitravatinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9920,1835,AXL receptor tyrosine kinase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1835,P30530,Tyrosine-protein kinase receptor UFO,558.0,AXL,9606.0,Homo sapiens (human),Inhibition,pIC50,8.82,PMID:26675259,https://www.ncbi.nlm.nih.gov/pubmed/26675259,26675259,,
1317,2029924,25212148,IUPHAR/BPS Guide to PHARMACOLOGY,Sitravatinib,9920,sitravatinib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9920,1844,discoidin domain receptor tyrosine kinase 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1844,Q16832,Discoidin domain-containing receptor 2,4921.0,DDR2,9606.0,Homo sapiens (human),Inhibition,pIC50,9.3,PMID:26675259,https://www.ncbi.nlm.nih.gov/pubmed/26675259,26675259,,
1318,2037195,25212148,Drug Gene Interaction database (DGIdb),Sitravatinib,,SITRAVATINIB,https://www.dgidb.org/drugs/ncit:C117734,,RET,https://www.dgidb.org/genes/hgnc:9967,,,5979.0,RET,9606.0,Homo sapiens (human),,,,,,,,
1319,2029762,25218564,BindingDB,"2-fluoro-6-{[2-({2-methoxy-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27784,"2-fluoro-6-{[2-({2-methoxy-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27784,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),3162,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1320,2029763,25218564,BindingDB,"2-fluoro-6-{[2-({2-methoxy-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27784,"2-fluoro-6-{[2-({2-methoxy-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27784,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),4,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
1321,2029764,25218564,BindingDB,"2-fluoro-6-{[2-({2-methoxy-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27784,"2-fluoro-6-{[2-({2-methoxy-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27784,1653,Mitogen-activated protein kinase 10,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1653,P53779,Mitogen-activated protein kinase 10,5602.0,MAPK10,9606.0,Homo sapiens (human),,IC50 (nM),5011,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1322,2029765,25218565,BindingDB,"2-fluoro-6-{[2-({2-methoxy-4-methyl-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27785,"2-fluoro-6-{[2-({2-methoxy-4-methyl-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27785,1653,Mitogen-activated protein kinase 10,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1653,P53779,Mitogen-activated protein kinase 10,5602.0,MAPK10,9606.0,Homo sapiens (human),,IC50 (nM),6310,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1323,2029766,25218565,BindingDB,"2-fluoro-6-{[2-({2-methoxy-4-methyl-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27785,"2-fluoro-6-{[2-({2-methoxy-4-methyl-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27785,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),20,PMID:19056263|DOI:10.1016/j.bmcl.2008.11.046,https://www.ncbi.nlm.nih.gov/pubmed/19056263|https://doi.org/10.1016/j.bmcl.2008.11.046,19056263,10.1016/j.bmcl.2008.11.046,
1324,2029767,25218565,BindingDB,"2-fluoro-6-{[2-({2-methoxy-4-methyl-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27785,"2-fluoro-6-{[2-({2-methoxy-4-methyl-5-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27785,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),3891,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1325,2029803,25218566,BindingDB,"2-{[2-({5-[3-(dimethylamino)propoxy]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27786,"2-{[2-({5-[3-(dimethylamino)propoxy]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27786,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),631,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1326,2029804,25218567,BindingDB,"2-{[2-({4-chloro-5-[3-(dimethylamino)propoxy]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27787,"2-{[2-({4-chloro-5-[3-(dimethylamino)propoxy]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27787,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),1258,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1327,2029805,25218568,BindingDB,"2-{[2-({5-[3-(dimethylamino)propyl]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27788,"2-{[2-({5-[3-(dimethylamino)propyl]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27788,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),5011,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1328,2029806,25218569,BindingDB,"2-{[2-({5-[3-(dimethylamino)propyl]-2-methoxy-4-methylphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27789,"2-{[2-({5-[3-(dimethylamino)propyl]-2-methoxy-4-methylphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27789,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),501,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1329,2029807,25218570,BindingDB,"2-fluoro-6-{[2-({2-methoxy-5-[(1-propylpiperidin-4-yl)oxy]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27790,"2-fluoro-6-{[2-({2-methoxy-5-[(1-propylpiperidin-4-yl)oxy]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27790,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),1258,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1330,2029808,25218571,BindingDB,"2-{[2-({4-chloro-2-methoxy-5-[(1-propylpiperidin-4-yl)oxy]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27791,"2-{[2-({4-chloro-2-methoxy-5-[(1-propylpiperidin-4-yl)oxy]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27791,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),3981,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1331,2029848,25218572,BindingDB,"2-{[2-({5-[2-(dimethylamino)-N-methylacetamido]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27794,"2-{[2-({5-[2-(dimethylamino)-N-methylacetamido]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27794,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),10000,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1332,2029849,25218572,BindingDB,"2-{[2-({5-[2-(dimethylamino)-N-methylacetamido]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27794,"2-{[2-({5-[2-(dimethylamino)-N-methylacetamido]-2-methoxyphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27794,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),50,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1333,2029850,25218573,BindingDB,"2-{[2-({5-[2-(dimethylamino)-N-methylacetamido]-2-methoxy-4-methylphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27795,"2-{[2-({5-[2-(dimethylamino)-N-methylacetamido]-2-methoxy-4-methylphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27795,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),63,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1334,2029851,25218573,BindingDB,"2-{[2-({5-[2-(dimethylamino)-N-methylacetamido]-2-methoxy-4-methylphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27795,"2-{[2-({5-[2-(dimethylamino)-N-methylacetamido]-2-methoxy-4-methylphenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27795,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),10000,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1335,2029852,25218574,BindingDB,"2-({2-[(1-acetyl-5-methoxy-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",27796,"2-({2-[(1-acetyl-5-methoxy-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27796,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),6,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1336,2029853,25218574,BindingDB,"2-({2-[(1-acetyl-5-methoxy-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",27796,"2-({2-[(1-acetyl-5-methoxy-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27796,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),126,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1337,2029911,25218575,BindingDB,"2-fluoro-6-[(2-{[1-glycyl-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27797,"2-[(2-{[1-(2-aminoacetyl)-5-methoxy-2,3-dihydro-1H-indol-6-yl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27797,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),1000,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1338,2029912,25218575,BindingDB,"2-fluoro-6-[(2-{[1-glycyl-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27797,"2-[(2-{[1-(2-aminoacetyl)-5-methoxy-2,3-dihydro-1H-indol-6-yl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27797,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),4,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1339,2029913,25218576,BindingDB,"2-fluoro-6-[(2-{[1-(N-methylglycyl)-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27798,"2-fluoro-6-{[2-({5-methoxy-1-[2-(methylamino)acetyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27798,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),2,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1340,2029914,25218576,BindingDB,"2-fluoro-6-[(2-{[1-(N-methylglycyl)-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27798,"2-fluoro-6-{[2-({5-methoxy-1-[2-(methylamino)acetyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27798,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),1995,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1341,2029915,25218577,BindingDB,"2-({2-[(1-{2-[ethyl(methyl)amino]acetyl}-5-methoxy-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",27800,"2-({2-[(1-{2-[ethyl(methyl)amino]acetyl}-5-methoxy-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27800,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),3162,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1342,2029916,25218577,BindingDB,"2-({2-[(1-{2-[ethyl(methyl)amino]acetyl}-5-methoxy-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",27800,"2-({2-[(1-{2-[ethyl(methyl)amino]acetyl}-5-methoxy-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27800,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),3,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1343,2029973,25218578,BindingDB,"2-fluoro-6-({2-[(5-methoxy-1-{2-[methoxy(methyl)amino]acetyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",27801,"2-fluoro-6-({2-[(5-methoxy-1-{2-[methoxy(methyl)amino]acetyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27801,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),50,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1344,2029974,25218578,BindingDB,"2-fluoro-6-({2-[(5-methoxy-1-{2-[methoxy(methyl)amino]acetyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",27801,"2-fluoro-6-({2-[(5-methoxy-1-{2-[methoxy(methyl)amino]acetyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27801,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),794,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1345,2029975,25218579,BindingDB,"2-{[2-({1-[2-(diethylamino)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27802,"2-{[2-({1-[2-(diethylamino)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27802,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),1000,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1346,2029976,25218579,BindingDB,"2-{[2-({1-[2-(diethylamino)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27802,"2-{[2-({1-[2-(diethylamino)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27802,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),2,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1347,2029977,25218580,BindingDB,"2-fluoro-6-{[2-({5-methoxy-1-[2-(pyrrolidin-1-yl)acetyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27803,"2-fluoro-6-{[2-({5-methoxy-1-[2-(pyrrolidin-1-yl)acetyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27803,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),1,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1348,2029978,25218580,BindingDB,"2-fluoro-6-{[2-({5-methoxy-1-[2-(pyrrolidin-1-yl)acetyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27803,"2-fluoro-6-{[2-({5-methoxy-1-[2-(pyrrolidin-1-yl)acetyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27803,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),1259,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1349,2030059,25218581,BindingDB,"2-{[2-({1-[2-(azetidin-1-yl)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27804,"2-{[2-({1-[2-(azetidin-1-yl)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27804,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),1995,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1350,2030060,25218581,BindingDB,"2-{[2-({1-[2-(azetidin-1-yl)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27804,"2-{[2-({1-[2-(azetidin-1-yl)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27804,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),1,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1351,2030061,25218582,BindingDB,"2-fluoro-6-[(2-{[1-(1H-imidazol-1-ylacetyl)-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27805,"2-fluoro-6-{[2-({1-[2-(1H-imidazol-1-yl)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27805,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),32,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1352,2030062,25218582,BindingDB,"2-fluoro-6-[(2-{[1-(1H-imidazol-1-ylacetyl)-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",27805,"2-fluoro-6-{[2-({1-[2-(1H-imidazol-1-yl)acetyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27805,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),631,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1353,2030063,25218583,BindingDB,"2-fluoro-6-{[2-({5-methoxy-1-[2-(morpholin-4-yl)acetyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27806,"2-fluoro-6-{[2-({5-methoxy-1-[2-(morpholin-4-yl)acetyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27806,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),126,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1354,2030064,25218583,BindingDB,"2-fluoro-6-{[2-({5-methoxy-1-[2-(morpholin-4-yl)acetyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27806,"2-fluoro-6-{[2-({5-methoxy-1-[2-(morpholin-4-yl)acetyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27806,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),13,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1355,2030126,25218584,BindingDB,"2-fluoro-6-({2-[(5-methoxy-1-{2-[4-(propan-2-yl)piperazin-1-yl]acetyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",27808,"2-fluoro-6-({2-[(5-methoxy-1-{2-[4-(propan-2-yl)piperazin-1-yl]acetyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27808,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),32,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1356,2030127,25218584,BindingDB,"2-fluoro-6-({2-[(5-methoxy-1-{2-[4-(propan-2-yl)piperazin-1-yl]acetyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",27808,"2-fluoro-6-({2-[(5-methoxy-1-{2-[4-(propan-2-yl)piperazin-1-yl]acetyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27808,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),1585,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1357,2030128,25218585,BindingDB,"2-{[2-({1-[3-(dimethylamino)propanoyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27809,"2-{[2-({1-[3-(dimethylamino)propanoyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27809,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),794,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1358,2030129,25218585,BindingDB,"2-{[2-({1-[3-(dimethylamino)propanoyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27809,"2-{[2-({1-[3-(dimethylamino)propanoyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27809,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),8,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1359,2030130,25218586,BindingDB,"2-fluoro-6-{[2-({5-methoxy-1-[3-(morpholin-4-yl)propanoyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27810,"2-fluoro-6-{[2-({5-methoxy-1-[3-(morpholin-4-yl)propanoyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27810,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),6,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1360,2030131,25218586,BindingDB,"2-fluoro-6-{[2-({5-methoxy-1-[3-(morpholin-4-yl)propanoyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27810,"2-fluoro-6-{[2-({5-methoxy-1-[3-(morpholin-4-yl)propanoyl]-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27810,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),251,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1361,2030163,25218587,BindingDB,"2-fluoro-6-({2-[(5-methoxy-1-{3-[4-(propan-2-yl)piperazin-1-yl]propanoyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",27811,"2-fluoro-6-({2-[(5-methoxy-1-{3-[4-(propan-2-yl)piperazin-1-yl]propanoyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27811,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),1585,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1362,2030164,25218587,BindingDB,"2-fluoro-6-({2-[(5-methoxy-1-{3-[4-(propan-2-yl)piperazin-1-yl]propanoyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",27811,"2-fluoro-6-({2-[(5-methoxy-1-{3-[4-(propan-2-yl)piperazin-1-yl]propanoyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27811,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),4,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1363,2030165,25218588,BindingDB,"2-{[2-({1-[2-(dimethylamino)ethyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27812,"2-{[2-({1-[2-(dimethylamino)ethyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27812,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),40,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1364,2030166,25218588,BindingDB,"2-{[2-({1-[2-(dimethylamino)ethyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27812,"2-{[2-({1-[2-(dimethylamino)ethyl]-5-methoxy-2,3-dihydro-1H-indol-6-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27812,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),100,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1365,2030167,25218589,BindingDB,"2-({2-[(1-acetyl-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",27813,"2-({2-[(1-acetyl-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27813,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),7943,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1366,2030168,25218589,BindingDB,"2-({2-[(1-acetyl-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",27813,"2-({2-[(1-acetyl-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27813,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),25,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1367,2030272,25218590,BindingDB,"2-{[2-({1-[2-(dimethylamino)acetyl]-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27814,"2-{[2-({1-[2-(dimethylamino)acetyl]-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27814,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),1,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1368,2030273,25218590,BindingDB,"2-{[2-({1-[2-(dimethylamino)acetyl]-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27814,"2-{[2-({1-[2-(dimethylamino)acetyl]-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27814,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),6310,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1369,2030274,25218591,BindingDB,"2-fluoro-6-{[2-({6-methoxy-1-[2-(piperidin-1-yl)acetyl]-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27815,"2-fluoro-6-{[2-({6-methoxy-1-[2-(piperidin-1-yl)acetyl]-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27815,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),2512,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1370,2030275,25218591,BindingDB,"2-fluoro-6-{[2-({6-methoxy-1-[2-(piperidin-1-yl)acetyl]-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",27815,"2-fluoro-6-{[2-({6-methoxy-1-[2-(piperidin-1-yl)acetyl]-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27815,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),1,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1371,2030276,25218592,BindingDB,"2-{[2-({1-[3-(dimethylamino)propanoyl]-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27816,"2-{[2-({1-[3-(dimethylamino)propanoyl]-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27816,4953,Insulin-like growth factor 1 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4953,P08069,Insulin-like growth factor 1 receptor,3480.0,IGF1R,9606.0,Homo sapiens (human),,IC50 (nM),10,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1372,2030277,25218592,BindingDB,"2-{[2-({1-[3-(dimethylamino)propanoyl]-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",27816,"2-{[2-({1-[3-(dimethylamino)propanoyl]-6-methoxy-1,2,3,4-tetrahydroquinolin-7-yl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27816,1662,Mitogen-activated protein kinase 8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1662,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),,IC50 (nM),7943,PMID:19071018|DOI:10.1016/j.bmcl.2008.11.077,https://www.ncbi.nlm.nih.gov/pubmed/19071018|https://doi.org/10.1016/j.bmcl.2008.11.077,19071018,10.1016/j.bmcl.2008.11.077,
1373,2030052,25227372,BindingDB,,30448,"benzothiazine-containing analog, 3a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30448,5408,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5408,P26663,Genome polyprotein,,,11105.0,Hepatitis C virus (isolate BK),,IC50 (nM),<10,PMID:18662878|DOI:10.1016/j.bmcl.2008.07.014,https://www.ncbi.nlm.nih.gov/pubmed/18662878|https://doi.org/10.1016/j.bmcl.2008.07.014,18662878,10.1016/j.bmcl.2008.07.014,
1374,2030125,25227372,BindingDB,,30448,"benzothiazine-containing analog, 3a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30448,5408,Genome polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5408,P26663,Genome polyprotein,,,11105.0,Hepatitis C virus (isolate BK),,IC50 (nM),<10,PMID:18722768|DOI:10.1016/j.bmcl.2008.08.017,https://www.ncbi.nlm.nih.gov/pubmed/18722768|https://doi.org/10.1016/j.bmcl.2008.08.017,18722768,10.1016/j.bmcl.2008.08.017,
1375,2029761,25227433,Therapeutic Target Database (TTD),Aryl pyrimidine derivative 1,D03YMA,Aryl pyrimidine derivative 1,https://idrblab.net/ttd/data/drug/details/D03YMA,T44458,Cyclin-dependent kinase 9 (CDK9),https://idrblab.net/ttd/data/target/details/T44458,P50750,Cyclin-dependent kinase 9,1025.0,CDK9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1376,2029927,25227436,Therapeutic Target Database (TTD),Capivasertib,D01ZAQ,Capivasertib,https://idrblab.net/ttd/data/drug/details/D01ZAQ,T71266,RAC-gamma serine/threonine-protein kinase (AKT3),https://idrblab.net/ttd/data/target/details/T71266,Q9Y243,RAC-gamma serine/threonine-protein kinase,10000.0,AKT3,9606.0,Homo sapiens (human),Modulator,,,,,,,
1377,2029928,25227436,Therapeutic Target Database (TTD),Capivasertib,D01ZAQ,Capivasertib,https://idrblab.net/ttd/data/drug/details/D01ZAQ,T67619,RAC-alpha serine/threonine-protein kinase (AKT1),https://idrblab.net/ttd/data/target/details/T67619,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1378,2030196,25227436,Drug Gene Interaction database (DGIdb),Capivasertib,,CAPIVASERTIB,https://www.dgidb.org/drugs/ncit:C102564,,AKT2,https://www.dgidb.org/genes/hgnc:392,,,208.0,AKT2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1379,2030197,25227436,Drug Gene Interaction database (DGIdb),Capivasertib,,CAPIVASERTIB,https://www.dgidb.org/drugs/ncit:C102564,,AKT3,https://www.dgidb.org/genes/hgnc:393,,,10000.0,AKT3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1380,2030198,25227436,Drug Gene Interaction database (DGIdb),Capivasertib,,CAPIVASERTIB,https://www.dgidb.org/drugs/ncit:C102564,,AKT1,https://www.dgidb.org/genes/hgnc:391,,,207.0,AKT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1381,2030199,25227436,Drug Gene Interaction database (DGIdb),Capivasertib,,CAPIVASERTIB,https://www.dgidb.org/drugs/ncit:C102564,,AKT3,https://www.dgidb.org/genes/hgnc:393,,,10000.0,AKT3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1382,2030200,25227436,Drug Gene Interaction database (DGIdb),Capivasertib,,CAPIVASERTIB,https://www.dgidb.org/drugs/ncit:C102564,,AKT1,https://www.dgidb.org/genes/hgnc:391,,,207.0,AKT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1383,2037196,25227436,Drug Gene Interaction database (DGIdb),Capivasertib,,CAPIVASERTIB,https://www.dgidb.org/drugs/ncit:C102564,,PIK3CA,https://www.dgidb.org/genes/hgnc:8975,,,5290.0,PIK3CA,9606.0,Homo sapiens (human),,,,,,,,
1384,2037197,25227436,DrugBank,Capivasertib,DB12218,Capivasertib,https://www.drugbank.ca/drugs/DB12218,BE0000428,RAC-alpha serine/threonine-protein kinase,https://www.drugbank.ca/bio_entities/BE0000428,P31749,RAC-alpha serine/threonine-protein kinase,207.0,AKT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1385,2037198,25227436,DrugBank,Capivasertib,DB12218,Capivasertib,https://www.drugbank.ca/drugs/DB12218,BE0001172,RAC-beta serine/threonine-protein kinase,https://www.drugbank.ca/bio_entities/BE0001172,P31751,RAC-beta serine/threonine-protein kinase,208.0,AKT2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1386,2037199,25227436,DrugBank,Capivasertib,DB12218,Capivasertib,https://www.drugbank.ca/drugs/DB12218,BE0010514,RAC-gamma serine/threonine-protein kinase,https://www.drugbank.ca/bio_entities/BE0010514,Q9Y243,RAC-gamma serine/threonine-protein kinase,10000.0,AKT3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1387,2037200,25227436,DrugBank,Capivasertib,DB12218,Capivasertib,https://www.drugbank.ca/drugs/DB12218,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate,,,,,,,
1388,2037201,25227436,DrugBank,Capivasertib,DB12218,Capivasertib,https://www.drugbank.ca/drugs/DB12218,BE0003679,UDP-glucuronosyltransferase 2B7,https://www.drugbank.ca/bio_entities/BE0003679,P16662,UDP-glucuronosyltransferase 2B7,7364.0,UGT2B7,9606.0,Homo sapiens (human),Substrate,,,,,,,
1389,2037202,25227436,DrugBank,Capivasertib,DB12218,Capivasertib,https://www.drugbank.ca/drugs/DB12218,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1390,2029929,25229528,IUPHAR/BPS Guide to PHARMACOLOGY,"(1S,2S,3R,4R)-3-[5-Chloro-2-(1-ethyl-6-methoxy-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-7-ylamino)-pyrimidin-4-ylamino]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide",8220,compound 15 [PMID: 24900237],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8220,1839,ALK receptor tyrosine kinase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1839,Q9UM73,ALK tyrosine kinase receptor,238.0,ALK,9606.0,Homo sapiens (human),Inhibition,pIC50,7.85,PMID:24900237,https://www.ncbi.nlm.nih.gov/pubmed/24900237,24900237,,
1391,2030051,25230266,Therapeutic Target Database (TTD),"5-(4-(2-(3-Methoxyphenyl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione",D00AUX,MSDC-0602,https://idrblab.net/ttd/data/drug/details/D00AUX,T85435,Insulin receptor (INSR),https://idrblab.net/ttd/data/target/details/T85435,P06213,Insulin receptor,3643.0,INSR,9606.0,Homo sapiens (human),Modulator,,,,,,,
1392,2029917,25231488,BindingDB,"(2R,3R,4S,5R)-2-[6-amino-8-(methylamino)-9H-purin-9-yl]-5-({[4-(aminooxy)butyl](methyl)amino}methyl)oxolane-3,4-diol",28425,"(2R,3R,4S,5R)-2-[6-amino-8-(methylamino)-9H-purin-9-yl]-5-({[4-(aminooxy)butyl](methyl)amino}methyl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28425,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),49,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
1393,2029918,25231489,BindingDB,"(2R,3R,4S,5R)-2-(6-amino-8-phenyl-9H-purin-9-yl)-5-({[4-(aminooxy)butyl](methyl)amino}methyl)oxolane-3,4-diol",28426,"(2R,3R,4S,5R)-2-(6-amino-8-phenyl-9H-purin-9-yl)-5-({[4-(aminooxy)butyl](methyl)amino}methyl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28426,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,,,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
1394,2029919,25231490,BindingDB,"(2R,3R,4S,5R)-2-(6-amino-8-hydroxy-9H-purin-9-yl)-5-({[4-(aminooxy)butyl](methyl)amino}methyl)oxolane-3,4-diol",28427,"(2R,3R,4S,5R)-2-(6-amino-8-hydroxy-9H-purin-9-yl)-5-({[4-(aminooxy)butyl](methyl)amino}methyl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28427,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),11,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
1395,2029920,25231650,BindingDB,"3-({[(2R,3S,4R,5R)-5-(6-amino-8-ethyl-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)propanamide",28433,"3-({[(2R,3S,4R,5R)-5-(6-amino-8-ethyl-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28433,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),4000,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
1396,2029921,25231651,BindingDB,"3-({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)propanamide",28435,"3-({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)propanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28435,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),7000,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
1397,2029922,25231818,BindingDB,"3-({[(2R,3S,4R,5R)-5-(6-amino-8-methyl-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)propanehydrazide",28436,"3-({[(2R,3S,4R,5R)-5-(6-amino-8-methyl-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)propanehydrazide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28436,3423,S-adenosylmethionine decarboxylase proenzyme,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3423,P17707,S-adenosylmethionine decarboxylase proenzyme,262.0,AMD1,9606.0,Homo sapiens (human),,IC50 (nM),170,PMID:19209891|DOI:10.1021/jm801126a,https://www.ncbi.nlm.nih.gov/pubmed/19209891|https://doi.org/10.1021/jm801126a,19209891,10.1021/jm801126a,
1398,2029931,25234918,IUPHAR/BPS Guide to PHARMACOLOGY,"N-[3-[6-[4-[(2R)-1,4-dimethyl-3-oxopiperazin-2-yl]anilino]-4-methyl-5-oxopyrazin-2-yl]-2-methylphenyl]-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide",9263,GDC-0834,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9263,1948,Bruton tyrosine kinase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1948,Q06187,Tyrosine-protein kinase BTK,695.0,BTK,9606.0,Homo sapiens (human),Inhibition,pIC50,8.22,PMID:25701252,https://www.ncbi.nlm.nih.gov/pubmed/25701252,25701252,,
1399,2030216,25234918,Chemical Probes Portal,"N-[3-[6-[4-[(2R)-1,4-dimethyl-3-oxopiperazin-2-yl]anilino]-4-methyl-5-oxopyrazin-2-yl]-2-methylphenyl]-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide",GDC-0834,GDC-0834,https://www.chemicalprobes.org/gdc-0834,,BTK,,Q06187,Tyrosine-protein kinase BTK,695.0,BTK,9606.0,Homo sapiens (human),"Inhibitor, ATP competitive",,6 nM,,,,,"www.doi.org/10.1016/j.bmcl.2015.01.032, www.doi.org/10.1124/jpet.111.181545, www.doi.org/10.1124/dmd.114.061804, https://www.ncbi.nlm.nih.gov/pubmed/?term=25701252, https://pubmed.ncbi.nlm.nih.gov/21521773/, https://pubmed.ncbi.nlm.nih.gov/25845827/"
1400,2030201,25241867,Therapeutic Target Database (TTD),Piperazine derivative 6,D0QC5O,Piperazine derivative 6,https://idrblab.net/ttd/data/drug/details/D0QC5O,T63414,P2X purinoceptor 7 (P2RX7),https://idrblab.net/ttd/data/target/details/T63414,Q99572,P2X purinoceptor 7,5027.0,P2RX7,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1401,2030202,25242512,Comparative Toxicogenomics Database (CTD),Solithromycin,C547755,solithromycin,https://ctdbase.org/detail.go?type=chem&acc=C547755,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Solithromycin inhibits the reaction [lipopolysaccharides results in increased secretion of CXCL8 protein],,,PMID:23359665,https://www.ncbi.nlm.nih.gov/pubmed/23359665,23359665,,
1402,2030203,25242512,Comparative Toxicogenomics Database (CTD),Solithromycin,C547755,solithromycin,https://ctdbase.org/detail.go?type=chem&acc=C547755,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Solithromycin inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of MMP9 protein]|solithromycin inhibits the reaction [tobacco smoke pollution results in increased expression of MMP9 protein],,,PMID:23359665,https://www.ncbi.nlm.nih.gov/pubmed/23359665,23359665,,
1403,2030204,25242512,Comparative Toxicogenomics Database (CTD),Solithromycin,C547755,solithromycin,https://ctdbase.org/detail.go?type=chem&acc=C547755,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Solithromycin inhibits the reaction [lipopolysaccharides results in increased secretion of TNF protein],,,PMID:23359665,https://www.ncbi.nlm.nih.gov/pubmed/23359665,23359665,,
1404,2030205,25243853,DrugBank,"Methyl 1-(4-{[(2,4-diaminopteridin-6-yl)methyl]amino}benzoyl)piperidine-4-carboxylate",DB07689,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",https://www.drugbank.ca/drugs/DB07689,BE0003983,Putative dehydrogenase/reductase SDR family member 4-like 1,https://www.drugbank.ca/bio_entities/BE0003983,P0CG22,Putative dehydrogenase/reductase SDR family member 4-like 1,,,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1405,2030206,25243949,BindingDB,2-ammonio-3-(5-hydroxy-1H-indol-3-yl)propanoate,92700,"5-Hydroxy-L-tryptophan, 22",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92700,5265,Trp operon repressor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5265,P0A881,Trp operon repressor,948917.0,trpR,83333.0,Escherichia coli K-12,,,,PMID:3549712,https://www.ncbi.nlm.nih.gov/pubmed/3549712,3549712,,
1406,2030217,25244225,Therapeutic Target Database (TTD),"(4S,6R)-6-[(2R,4R)-4,6-dihydroxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-5-sulfonatooxyoxane-2-carboxylate",D08PSU,Lmw heparin,https://idrblab.net/ttd/data/drug/details/D08PSU,T84631,Coagulation factor Xa (F10),https://idrblab.net/ttd/data/target/details/T84631,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),Modulator,,,,,,,
1407,2030207,25244553,BindingDB,5-Amino-2-azaniumyl-5-oxopentanoate,93009,"Glutamine Analogue, 1",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=93009,5353,Carbamoyl-phosphate synthase small chain,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5353,P0A6F1,Carbamoyl-phosphate synthase small chain,949025.0,carA,83333.0,Escherichia coli K-12,,Ki (nM),5.4e+4,PMID:1868065|DOI:10.1021/bi00246a005,https://www.ncbi.nlm.nih.gov/pubmed/1868065|https://doi.org/10.1021/bi00246a005,1868065,10.1021/bi00246a005,
1408,2030049,25254071,Therapeutic Target Database (TTD),Apitolisib,D0O6VZ,GDC-0980/RG7422,https://idrblab.net/ttd/data/drug/details/D0O6VZ,T75243,Serine/threonine-protein kinase mTOR (mTOR),https://idrblab.net/ttd/data/target/details/T75243,P42345,Serine/threonine-protein kinase mTOR,2475.0,MTOR,9606.0,Homo sapiens (human),Modulator,,,,,,,
1409,2030050,25254071,Therapeutic Target Database (TTD),Apitolisib,D0O6VZ,GDC-0980/RG7422,https://idrblab.net/ttd/data/drug/details/D0O6VZ,T95913,PI3-kinase gamma (PIK3CG),https://idrblab.net/ttd/data/target/details/T95913,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),Modulator,,,,,,,
1410,2030218,25254071,Drug Gene Interaction database (DGIdb),Apitolisib,,APITOLISIB,https://www.dgidb.org/drugs/ncit:C91731,,BAP1,https://www.dgidb.org/genes/hgnc:950,,,8314.0,BAP1,9606.0,Homo sapiens (human),,,,,,,,
1411,2030219,25254071,Chemical Probes Portal,Apitolisib,APITOLISIB,APITOLISIB,https://www.chemicalprobes.org/gdc-0980,,PIK3CA,,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",5290.0,PIK3CA,9606.0,Homo sapiens (human),Inhibitor,,"4.8 nM, 27 nM, 14 nM, 6.7 nM, 17 nM",,,,,
1412,2030220,25254071,Chemical Probes Portal,Apitolisib,APITOLISIB,APITOLISIB,https://www.chemicalprobes.org/gdc-0980,,PIK3CB,,P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",5291.0,PIK3CB,9606.0,Homo sapiens (human),Inhibitor,,"4.8 nM, 27 nM, 14 nM, 6.7 nM, 17 nM",,,,,
1413,2030221,25254071,Chemical Probes Portal,Apitolisib,APITOLISIB,APITOLISIB,https://www.chemicalprobes.org/gdc-0980,,PIK3CG,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),Inhibitor,,"4.8 nM, 27 nM, 14 nM, 6.7 nM, 17 nM",,,,,
1414,2030222,25254071,Chemical Probes Portal,Apitolisib,APITOLISIB,APITOLISIB,https://www.chemicalprobes.org/gdc-0980,,PIK3CD,,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",5293.0,PIK3CD,9606.0,Homo sapiens (human),Inhibitor,,"4.8 nM, 27 nM, 14 nM, 6.7 nM, 17 nM",,,,,
1415,2030223,25254071,Chemical Probes Portal,Apitolisib,APITOLISIB,APITOLISIB,https://www.chemicalprobes.org/gdc-0980,,MTOR,,P42345,Serine/threonine-protein kinase mTOR,2475.0,MTOR,9606.0,Homo sapiens (human),Inhibitor,,"4.8 nM, 27 nM, 14 nM, 6.7 nM, 17 nM",,,,,
1416,2030053,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,1111,CHEK1,https://ctdbase.org/detail.go?type=gene&acc=1111,,,1111.0,CHEK1,9606.0,Homo sapiens (human),CX 5461 results in increased phosphorylation of CHEK1 protein,,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1417,2030054,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,11200,CHEK2,https://ctdbase.org/detail.go?type=gene&acc=11200,,,11200.0,CHEK2,9606.0,Homo sapiens (human),CX 5461 results in increased phosphorylation of CHEK2 protein,,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1418,2030055,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),CX 5461 results in increased expression of H2AX protein,,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1419,2030056,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,175210,HELQ-1,https://ctdbase.org/detail.go?type=gene&acc=175210,,,175210.0,helq-1,6239.0,Caenorhabditis elegans,HELQ-1 protein affects the susceptibility to CX 5461,,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1420,2030057,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,172027,MUS-81,https://ctdbase.org/detail.go?type=gene&acc=172027,,,172027.0,mus-81,6239.0,Caenorhabditis elegans,MUS-81 protein affects the susceptibility to CX 5461,,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1421,2030058,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),CX 5461 results in increased cleavage of PARP1 protein,,,PMID:32799625,https://www.ncbi.nlm.nih.gov/pubmed/32799625,32799625,,
1422,2030117,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,175810,POLQ-1,https://ctdbase.org/detail.go?type=gene&acc=175810,,,175810.0,polq-1,6239.0,Caenorhabditis elegans,POLQ-1 protein affects the susceptibility to CX 5461,,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1423,2030118,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,5888,RAD51,https://ctdbase.org/detail.go?type=gene&acc=5888,,,5888.0,RAD51,9606.0,Homo sapiens (human),CX 5461 results in increased expression of RAD51 protein,,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1424,2030119,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,6118,RPA2,https://ctdbase.org/detail.go?type=gene&acc=6118,,,6118.0,RPA2,9606.0,Homo sapiens (human),CX 5461 results in increased phosphorylation of RPA2 protein|brca2 protein affects the reaction [CX 5461 results in increased phosphorylation of RPA2 protein],,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1425,2030120,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,172946,RTEL-1,https://ctdbase.org/detail.go?type=gene&acc=172946,,,172946.0,rtel-1,6239.0,Caenorhabditis elegans,RTEL-1 protein affects the susceptibility to CX 5461,,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1426,2030121,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,7158,TP53BP1,https://ctdbase.org/detail.go?type=gene&acc=7158,,,7158.0,TP53BP1,9606.0,Homo sapiens (human),CX 5461 results in increased expression of TP53BP1 protein|brca2 protein affects the reaction [CX 5461 results in increased expression of TP53BP1 protein],,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1427,2030122,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,24104262,RFS-1,https://ctdbase.org/detail.go?type=gene&acc=24104262,,,24104262.0,rfs-1,6239.0,Caenorhabditis elegans,RFS-1 protein affects the susceptibility to CX 5461,,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1428,2030123,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,675,BRCA2,https://ctdbase.org/detail.go?type=gene&acc=675,,,675.0,BRCA2,9606.0,Homo sapiens (human),BRCA2 protein affects the reaction [CX 5461 results in increased phosphorylation of RPA2 protein]|brca2 protein affects the susceptibility to CX 5461|BRCA2 protein affects the reaction [CX 5461 results in increased expression of TP53BP1 protein],,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1429,2030124,25257557,Comparative Toxicogenomics Database (CTD),"2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",C557717,CX 5461,https://ctdbase.org/detail.go?type=chem&acc=C557717,175962,BRC-2,https://ctdbase.org/detail.go?type=gene&acc=175962,,,175962.0,brc-2,6239.0,Caenorhabditis elegans,BRC-2 protein affects the susceptibility to CX 5461,,,PMID:28211448,https://www.ncbi.nlm.nih.gov/pubmed/28211448,28211448,,
1430,2030224,25262965,Chemical Probes Portal,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol",AZD8055,AZD8055,https://www.chemicalprobes.org/azd8055,,MTOR,,P42345,Serine/threonine-protein kinase mTOR,2475.0,MTOR,9606.0,Homo sapiens (human),Inhibitor,,"0.13 ± 0.05 nM, 0.8 ± 0.2 nM, 1.3nM",,,,,
1431,2030262,25459838,Drug Gene Interaction database (DGIdb),N-[4-(1H-indol-2-yl)phenyl]-1-[(5-methylfuran-2-yl)methyl]piperidine-4-carboxamide,,CHEMBL:CHEMBL587923,https://www.dgidb.org/drugs/chembl:CHEMBL587923,,KCNH2,https://www.dgidb.org/genes/hgnc:6251,,,3757.0,KCNH2,9606.0,Homo sapiens (human),,,,,,,,
1432,2030225,26873419,Chemical Probes Portal,(2S)-2-phenyl-N-[2-(pyrrolidin-1-yl)phenyl]butanamide,ML252,ML252,https://www.chemicalprobes.org/ml252,,KCNQ2,,O43526,Potassium voltage-gated channel subfamily KQT member 2,3785.0,KCNQ2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1433,2030261,35397514,Therapeutic Target Database (TTD),"4-Bromanyl-~{n}-(6-Methoxy-1,3-Dimethyl-2-Oxidanylidene-Benzimidazol-5-Yl)-2-Methyl-Benzenesulfonamide",D08RDI,OF-1,https://idrblab.net/ttd/data/drug/details/D08RDI,T35809,Bromodomain-containing protein 1 (BRD1),https://idrblab.net/ttd/data/target/details/T35809,O95696,Bromodomain-containing protein 1,23774.0,BRD1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1434,2030226,40846579,Comparative Toxicogenomics Database (CTD),N-Arachidonoyl-L-Alanine,C483476,N-arachidonoylalanine,https://ctdbase.org/detail.go?type=chem&acc=C483476,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),N-arachidonoylalanine results in decreased phosphorylation of AKT1 protein|acetylcysteine inhibits the reaction [N-arachidonoylalanine results in decreased phosphorylation of AKT1 protein],,,PMID:27411387,https://www.ncbi.nlm.nih.gov/pubmed/27411387,27411387,,
1435,2030263,41023370,IUPHAR/BPS Guide to PHARMACOLOGY,(5-(4-Fluorophenyl)furan-2-carbonyl)-L-aspartic acid,10294,compound 130 [PMID: 29157600],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10294,166,succinate receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=166,Q9BXA5,Succinate receptor 1,56670.0,SUCNR1,9606.0,Homo sapiens (human),Partial agonist,pEC50,5.65,PMID:29157600,https://www.ncbi.nlm.nih.gov/pubmed/29157600,29157600,,
1436,2030264,42519285,IUPHAR/BPS Guide to PHARMACOLOGY,"5-[(3-acetylphenoxy)methyl]-N-methyl-N-[(1S)-1-pyridin-2-ylethyl]-1,2-oxazole-3-carboxamide",8591,ML381,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8591,14,M2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=14,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606.0,Homo sapiens (human),Antagonist,pKi,4.52,PMID:24692176,https://www.ncbi.nlm.nih.gov/pubmed/24692176,24692176,,
1437,2030265,42519285,Therapeutic Target Database (TTD),"5-[(3-acetylphenoxy)methyl]-N-methyl-N-[(1S)-1-pyridin-2-ylethyl]-1,2-oxazole-3-carboxamide",D00WNA,ML381,https://idrblab.net/ttd/data/drug/details/D00WNA,T67684,Muscarinic acetylcholine receptor M3 (CHRM3),https://idrblab.net/ttd/data/target/details/T67684,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1438,2030266,42596951,Therapeutic Target Database (TTD),"(5S)-1'-[(3,5-dimethylphenyl)methyl]-2-ethyl-6,8-dimethoxy-5-methylspiro[5,10-dihydroimidazo[1,5-b][2]benzazepine-3,4'-piperidine]-1-one",D0N1TQ,ER819762,https://idrblab.net/ttd/data/drug/details/D0N1TQ,T18876,Prostaglandin E2 receptor EP4 (PTGER4),https://idrblab.net/ttd/data/target/details/T18876,P35408,Prostaglandin E2 receptor EP4 subtype,5734.0,PTGER4,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1439,2030267,42601552,Drug Gene Interaction database (DGIdb),Faldaprevir,,FALDAPREVIR,https://www.dgidb.org/drugs/ncit:C171746,,IFNL4,https://www.dgidb.org/genes/hgnc:44480,,,101180976.0,IFNL4,9606.0,Homo sapiens (human),,,,,,,,
1440,2030268,42607474,Therapeutic Target Database (TTD),Lysophosphatidylserine,D0M8IT,lysophosphatidylserine,https://idrblab.net/ttd/data/drug/details/D0M8IT,T73859,G-protein coupled receptor 34 (GPR34),https://idrblab.net/ttd/data/target/details/T73859,Q9UPC5,Probable G-protein coupled receptor 34,2857.0,GPR34,9606.0,Homo sapiens (human),Agonist,,,,,,,
1441,2030269,42607474,Therapeutic Target Database (TTD),Lysophosphatidylserine,D0M8IT,lysophosphatidylserine,https://idrblab.net/ttd/data/drug/details/D0M8IT,T87661,G-protein coupled receptor 174 (GPR174),https://idrblab.net/ttd/data/target/details/T87661,Q9BXC1,Probable G-protein coupled receptor 174,84636.0,GPR174,9606.0,Homo sapiens (human),Agonist,,,,,,,
1442,2030270,42607474,IUPHAR/BPS Guide to PHARMACOLOGY,Lysophosphatidylserine,4064,lysophosphatidylserine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4064,145,GPR174,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=145,Q9BXC1,Probable G-protein coupled receptor 174,84636.0,GPR174,9606.0,Homo sapiens (human),Full agonist,pEC50,7.1,PMID:22983457,https://www.ncbi.nlm.nih.gov/pubmed/22983457,22983457,,
1443,2030227,42611190,Chemical Probes Portal,4-((Piperindin-4-yl)-phenyl)-(7-(4-(trifluoromethyl)-phenyl)-2-naphthoic acid,PPTN,PPTN,https://www.chemicalprobes.org/pptn,,P2RY14,,Q15391,P2Y purinoceptor 14,9934.0,P2RY14,9606.0,Homo sapiens (human),Antagonist,,"0.5 nM, 2.3 nM, 35 nM",,,,,
1444,2030271,42611190,Therapeutic Target Database (TTD),4-((Piperindin-4-yl)-phenyl)-(7-(4-(trifluoromethyl)-phenyl)-2-naphthoic acid,D05MXI,PPTN,https://idrblab.net/ttd/data/drug/details/D05MXI,T16555,P2Y purinoceptor 14 (P2RY14),https://idrblab.net/ttd/data/target/details/T16555,Q15391,P2Y purinoceptor 14,9934.0,P2RY14,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1445,2030228,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0000634,Serine/threonine-protein kinase B-raf,https://www.drugbank.ca/bio_entities/BE0000634,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),Inhibitor,,,PMID:23094782,https://www.ncbi.nlm.nih.gov/pubmed/23094782,23094782,,
1446,2030242,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0002433,Cytochrome P450 1A2,https://www.drugbank.ca/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:23094782,https://www.ncbi.nlm.nih.gov/pubmed/23094782,23094782,,
1447,2030243,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565.0,CYP2D6,9606.0,Homo sapiens (human),Inhibitor,,,PMID:23094782,https://www.ncbi.nlm.nih.gov/pubmed/23094782,23094782,,
1448,2030244,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate|Inducer,,,PMID:23094782,https://www.ncbi.nlm.nih.gov/pubmed/23094782,23094782,,
1449,2030245,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1450,2030246,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1451,2030247,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0003549,Cytochrome P450 2B6,https://www.drugbank.ca/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),Inducer,,,,,,,
1452,2030248,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0000785,Multidrug resistance-associated protein 1,https://www.drugbank.ca/bio_entities/BE0000785,P33527,Multidrug resistance-associated protein 1 ,4363.0,ABCC1,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:22454535,https://www.ncbi.nlm.nih.gov/pubmed/22454535,22454535,,
1453,2030249,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:22454535|PMID:25899783,https://www.ncbi.nlm.nih.gov/pubmed/22454535|https://www.ncbi.nlm.nih.gov/pubmed/25899783,22454535|25899783,,
1454,2030250,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,,,,,
1455,2030251,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),Substrate,,,,,,,
1456,2030252,42611257,DrugBank,Vemurafenib,DB08881,Vemurafenib,https://www.drugbank.ca/drugs/DB08881,BE0000925,Alpha-1-acid glycoprotein 1,https://www.drugbank.ca/bio_entities/BE0000925,P02763,Alpha-1-acid glycoprotein 1,5004.0,ORM1,9606.0,Homo sapiens (human),Substrate,,,,,,,
1457,2030253,42611257,Therapeutic Target Database (TTD),Vemurafenib,D0Y9EW,Vemurafenib,https://idrblab.net/ttd/data/drug/details/D0Y9EW,T99089,Serine/threonine-protein kinase B-raf (BRAF),https://idrblab.net/ttd/data/target/details/T99089,P15056,Serine/threonine-protein kinase B-raf,673.0,BRAF,9606.0,Homo sapiens (human),Modulator,,,,,,,
1458,2030294,42628632,BindingDB,3-Benzyl-4-({[6-(Cyclohexylmethyl)pyridin-2-Yl]carbonyl}amino)benzoic Acid,36460,"3-Benzyl-4-(6-(cyclohexylmethyl)picolinamido)benzoic acid, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36460,50000643,Capsid scaffolding protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50000643,P16753,Capsid scaffolding protein,,,10360.0,Human herpesvirus 5 strain AD169,,IC50 (nM),7.4e+3,PMID:24977643|DOI:10.1021/bi5003234,https://www.ncbi.nlm.nih.gov/pubmed/24977643|https://doi.org/10.1021/bi5003234,24977643,10.1021/bi5003234,
1459,2030295,42628632,BindingDB,3-Benzyl-4-({[6-(Cyclohexylmethyl)pyridin-2-Yl]carbonyl}amino)benzoic Acid,36460,"3-Benzyl-4-(6-(cyclohexylmethyl)picolinamido)benzoic acid, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36460,4769,Epstein-Barr nuclear antigen 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4769,P03211,Epstein-Barr nuclear antigen 1,3783774.0,EBNA-1,10377.0,Human herpesvirus 4 strain B95-8 (Epstein-Barr virus (strain B95-8)),,IC50 (nM),7.7e+3,PMID:24977643|DOI:10.1021/bi5003234,https://www.ncbi.nlm.nih.gov/pubmed/24977643|https://doi.org/10.1021/bi5003234,24977643,10.1021/bi5003234,
1460,2030296,42628632,BindingDB,3-Benzyl-4-({[6-(Cyclohexylmethyl)pyridin-2-Yl]carbonyl}amino)benzoic Acid,36460,"3-Benzyl-4-(6-(cyclohexylmethyl)picolinamido)benzoic acid, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36460,6447,Protein UL24 homolog,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6447,Q2HRB2,Protein UL24 homolog,4961477.0,ORF20,868565.0,Human herpesvirus 8 strain GK18,,IC50 (nM),1.5e+3,PMID:24977643|DOI:10.1021/bi5003234,https://www.ncbi.nlm.nih.gov/pubmed/24977643|https://doi.org/10.1021/bi5003234,24977643,10.1021/bi5003234,
1461,2030297,42639643,Chemical Probes Portal,ITI-214 free base,ITI-214,ITI-214,https://www.chemicalprobes.org/iti-214,,PDE1A,,P54750,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",5136.0,PDE1A,9606.0,Homo sapiens (human),Inhibitor,,"0.058 nM, 0.38 nM, 0.035 nM",,,,,
1462,2030298,42639643,Chemical Probes Portal,ITI-214 free base,ITI-214,ITI-214,https://www.chemicalprobes.org/iti-214,,PDE1B,,Q01064,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",5153.0,PDE1B,9606.0,Homo sapiens (human),Inhibitor,,"0.058 nM, 0.38 nM, 0.035 nM",,,,,
1463,2030299,42639643,Chemical Probes Portal,ITI-214 free base,ITI-214,ITI-214,https://www.chemicalprobes.org/iti-214,,PDE1C,,Q14123,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",5137.0,PDE1C,9606.0,Homo sapiens (human),Inhibitor,,"0.058 nM, 0.38 nM, 0.035 nM",,,,,
1464,2030300,42641861,Chemical Probes Portal,"1-Penten-3-one, 1-(4-fluorophenyl)-2-methyl-, oxime, (1E,3E)-",A-079,A-079,https://www.chemicalprobes.org/a-079,,TRPA1,,O75762,Transient receptor potential cation channel subfamily A member 1,8989.0,TRPA1,9606.0,Homo sapiens (human),Antagonist,,67 nM,,,,,
1465,2030301,42642645,BindingDB,Foretinib,50399540,FORETINIB,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50399540,4906,Hepatocyte growth factor receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4906,P08581,Hepatocyte growth factor receptor,4233.0,MET,9606.0,Homo sapiens (human),,IC50 (nM),1.89,PMID:25173590|DOI:10.1016/j.bioorg.2014.07.011,https://www.ncbi.nlm.nih.gov/pubmed/25173590|https://doi.org/10.1016/j.bioorg.2014.07.011,25173590,10.1016/j.bioorg.2014.07.011,
1466,2030302,42642645,BindingDB,Foretinib,50399540,FORETINIB,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50399540,6173,Mast/stem cell growth factor receptor Kit [1-973],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6173,P10721,Mast/stem cell growth factor receptor Kit,3815.0,KIT,9606.0,Homo sapiens (human),,IC50 (nM),6.72,PMID:25173590|DOI:10.1016/j.bioorg.2014.07.011,https://www.ncbi.nlm.nih.gov/pubmed/25173590|https://doi.org/10.1016/j.bioorg.2014.07.011,25173590,10.1016/j.bioorg.2014.07.011,
1467,2036691,42945070,BindingDB,"CB2 Inhibitor, 13",93037,"CB2 Inhibitor, 13",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=93037,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),71430,PMID:23217060|DOI:10.1111/cbdd.12095,https://www.ncbi.nlm.nih.gov/pubmed/23217060|https://doi.org/10.1111/cbdd.12095,23217060,10.1111/cbdd.12095,
1468,2036692,44129620,DrugBank,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,DB07260,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,https://www.drugbank.ca/drugs/DB07260,BE0001680,Leukotriene A-4 hydrolase,https://www.drugbank.ca/bio_entities/BE0001680,P09960,Leukotriene A-4 hydrolase,4048.0,LTA4H,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1469,2036731,44144380,DrugBank,"5-[(3r)-3-(5-Methoxy-2',6'-Dimethylbiphenyl-3-Yl)but-1-Yn-1-Yl]-6-Methylpyrimidine-2,4-Diamine",DB07144,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",https://www.drugbank.ca/drugs/DB07144,BE0000330,Dihydrofolate reductase,https://www.drugbank.ca/bio_entities/BE0000330,P00374,Dihydrofolate reductase,1719.0,DHFR,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1470,2036732,44176354,DrugBank,"(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid",DB07484,"(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid",https://www.drugbank.ca/drugs/DB07484,BE0003753,Carboxypeptidase A1,https://www.drugbank.ca/bio_entities/BE0003753,P15085,Carboxypeptidase A1,1357.0,CPA1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1471,2036733,44176356,DrugBank,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",DB07300,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",https://www.drugbank.ca/drugs/DB07300,BE0001193,3-phosphoinositide-dependent protein kinase 1,https://www.drugbank.ca/bio_entities/BE0001193,O15530,3-phosphoinositide-dependent protein kinase 1,5170.0,PDPK1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1472,2036933,44180784,Therapeutic Target Database (TTD),Aminoazetidine derivative 9,D0U3VU,Aminoazetidine derivative 9,https://idrblab.net/ttd/data/drug/details/D0U3VU,T76685,Cannabinoid receptor 1 (CB1),https://idrblab.net/ttd/data/target/details/T76685,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1473,2036934,44182694,Therapeutic Target Database (TTD),6-(2-(4-(3-(2-Methoxyethoxy)-4-bromobenzyl)piperidino)ethyl)-2H-1-benzopyran-4(3H)-one,D0Y2GJ,DSP-1053,https://idrblab.net/ttd/data/drug/details/D0Y2GJ,T78709,5-HT 1A receptor (HTR1A),https://idrblab.net/ttd/data/target/details/T78709,P08908,5-hydroxytryptamine receptor 1A,3350.0,HTR1A,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1474,2036734,44184093,BindingDB,"1-(1H-benzimidazol-2-yl)ethyl N-(3,4-dichlorophenyl)carbamate",92907,CHK1 compound 2,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92907,4500,Serine/threonine-protein kinase Chk1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4500,O14757,Serine/threonine-protein kinase Chk1,1111.0,CHEK1,9606.0,Homo sapiens (human),,Ki (nM),1.89e+3,PMID:19743875|DOI:10.1021/bi900258v,https://www.ncbi.nlm.nih.gov/pubmed/19743875|https://doi.org/10.1021/bi900258v,19743875,10.1021/bi900258v,
1475,2036735,44187362,Drug Gene Interaction database (DGIdb),Pimasertib,,PIMASERTIB,https://www.dgidb.org/drugs/ncit:C84864,,KRAS,https://www.dgidb.org/genes/hgnc:6407,,,3845.0,KRAS,9606.0,Homo sapiens (human),,,,,,,,
1476,2036736,44187362,Drug Gene Interaction database (DGIdb),Pimasertib,,PIMASERTIB,https://www.dgidb.org/drugs/ncit:C84864,,NRAS,https://www.dgidb.org/genes/hgnc:7989,,,4893.0,NRAS,9606.0,Homo sapiens (human),,,,,,,,
1477,2036935,44187367,Therapeutic Target Database (TTD),Tak-441,D0Q4JM,TAK-441,https://idrblab.net/ttd/data/drug/details/D0Q4JM,T66505,Smoothened homolog (SMO),https://idrblab.net/ttd/data/target/details/T66505,Q99835,Smoothened homolog,6608.0,SMO,9606.0,Homo sapiens (human),Modulator,,,,,,,
1478,2036737,44187953,Drug Gene Interaction database (DGIdb),"1-(4-(3-ethyl-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea",,CHEMBL:CHEMBL589258,https://www.dgidb.org/drugs/chembl:CHEMBL589258,,PTEN,https://www.dgidb.org/genes/hgnc:9588,,,5728.0,PTEN,9606.0,Homo sapiens (human),,,,,,,,
1479,2036936,44194212,Therapeutic Target Database (TTD),Aminoazetidine derivative 1,D01HJQ,Aminoazetidine derivative 1,https://idrblab.net/ttd/data/drug/details/D01HJQ,T76685,Cannabinoid receptor 1 (CB1),https://idrblab.net/ttd/data/target/details/T76685,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1480,2036937,44195571,Therapeutic Target Database (TTD),Snx-5422,D07MPL,SNX-5422,https://idrblab.net/ttd/data/drug/details/D07MPL,T96623,Heat shock protein 90 beta (HSP90B),https://idrblab.net/ttd/data/target/details/T96623,P08238,Heat shock protein HSP 90-beta,3326.0,HSP90AB1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1481,2036938,44195571,Therapeutic Target Database (TTD),Snx-5422,D07MPL,SNX-5422,https://idrblab.net/ttd/data/drug/details/D07MPL,T18477,Heat shock protein 90 alpha (HSP90A),https://idrblab.net/ttd/data/target/details/T18477,P07900,Heat shock protein HSP 90-alpha,3320.0,HSP90AA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1482,2036738,44197007,Therapeutic Target Database (TTD),"N,N-diethyl-2-[2-(4-methoxyphenyl)-6,8-dimethylimidazo[1,2-b]pyridazin-3-yl]acetamide",D0P1TH,"Imidazo[1,2-b]pyridazine acetamide derivative 2",https://idrblab.net/ttd/data/drug/details/D0P1TH,T75440,Translocator protein (TSPO),https://idrblab.net/ttd/data/target/details/T75440,P30536,Translocator protein,706.0,TSPO,9606.0,Homo sapiens (human),Ligand,,,,,,,
1483,2036739,44197008,Therapeutic Target Database (TTD),"2-[6,8-dimethyl-2-(4-methylphenyl)imidazo[1,2-b]pyridazin-3-yl]-N,N-diethylacetamide",D08RTY,"Imidazo[1,2-b]pyridazine acetamide derivative 3",https://idrblab.net/ttd/data/drug/details/D08RTY,T75440,Translocator protein (TSPO),https://idrblab.net/ttd/data/target/details/T75440,P30536,Translocator protein,706.0,TSPO,9606.0,Homo sapiens (human),Ligand,,,,,,,
1484,2036740,44197009,Therapeutic Target Database (TTD),"2-[2-(4-chlorophenyl)-6,8-dimethylimidazo[1,2-b]pyridazin-3-yl]-N,N-diethylacetamide",D04ESE,"Imidazo[1,2-b]pyridazine acetamide derivative 4",https://idrblab.net/ttd/data/drug/details/D04ESE,T75440,Translocator protein (TSPO),https://idrblab.net/ttd/data/target/details/T75440,P30536,Translocator protein,706.0,TSPO,9606.0,Homo sapiens (human),Ligand,,,,,,,
1485,2036777,44197028,Therapeutic Target Database (TTD),"N,N-diethyl-2-[2-(4-hydroxyphenyl)-6,8-dimethylimidazo[1,2-b]pyridazin-3-yl]acetamide",D0K3MV,"Imidazo[1,2-b]pyridazine acetamide derivative 7",https://idrblab.net/ttd/data/drug/details/D0K3MV,T75440,Translocator protein (TSPO),https://idrblab.net/ttd/data/target/details/T75440,P30536,Translocator protein,706.0,TSPO,9606.0,Homo sapiens (human),Ligand,,,,,,,
1486,2036939,44200882,Therapeutic Target Database (TTD),Testolone,D09ZLZ,RAD-140,https://idrblab.net/ttd/data/drug/details/D09ZLZ,T11211,Androgen receptor (AR),https://idrblab.net/ttd/data/target/details/T11211,P10275,Androgen receptor,367.0,AR,9606.0,Homo sapiens (human),Modulator,,,,,,,
1487,2036940,44201334,Therapeutic Target Database (TTD),SV2Nzo0lau,D04CJE,ATF-936,https://idrblab.net/ttd/data/drug/details/D04CJE,T92076,Extracellular calcium-sensing receptor (CASR),https://idrblab.net/ttd/data/target/details/T92076,P41180,Extracellular calcium-sensing receptor,846.0,CASR,9606.0,Homo sapiens (human),Antagonist,,,,,,,
1488,2036941,44205240,DrugBank,Baricitinib,DB11817,Baricitinib,https://www.drugbank.ca/drugs/DB11817,BE0004145,Tyrosine-protein kinase JAK1,https://www.drugbank.ca/bio_entities/BE0004145,P23458,Tyrosine-protein kinase JAK1,3716.0,JAK1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:28255337|PMID:27028914|PMID:30871014,https://www.ncbi.nlm.nih.gov/pubmed/28255337|https://www.ncbi.nlm.nih.gov/pubmed/27028914|https://www.ncbi.nlm.nih.gov/pubmed/30871014,28255337|27028914|30871014,,
1489,2036942,44205240,DrugBank,Baricitinib,DB11817,Baricitinib,https://www.drugbank.ca/drugs/DB11817,BE0002408,Tyrosine-protein kinase JAK2,https://www.drugbank.ca/bio_entities/BE0002408,O60674,Tyrosine-protein kinase JAK2,3717.0,JAK2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:27028914|PMID:28255337|PMID:30871014,https://www.ncbi.nlm.nih.gov/pubmed/27028914|https://www.ncbi.nlm.nih.gov/pubmed/28255337|https://www.ncbi.nlm.nih.gov/pubmed/30871014,27028914|28255337|30871014,,
1490,2036943,44205240,DrugBank,Baricitinib,DB11817,Baricitinib,https://www.drugbank.ca/drugs/DB11817,BE0003493,Tyrosine-protein kinase JAK3,https://www.drugbank.ca/bio_entities/BE0003493,P52333,Tyrosine-protein kinase JAK3,3718.0,JAK3,9606.0,Homo sapiens (human),Inhibitor,,,PMID:30871014,https://www.ncbi.nlm.nih.gov/pubmed/30871014,30871014,,
1491,2036774,44232532,IUPHAR/BPS Guide to PHARMACOLOGY,(2E)-2-[7-fluoro-1-(2-methylpropyl)-2-oxoindol-3-ylidene]acetic acid,10274,ASP7663,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10274,485,TRPA1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=485,Q8BLA8,Transient receptor potential cation channel subfamily A member 1,277328.0,Trpa1,10090.0,Mus musculus (house mouse),Activation,pEC50,6.3,PMID:24291101,https://www.ncbi.nlm.nih.gov/pubmed/24291101,24291101,,
1492,2036775,44240744,IUPHAR/BPS Guide to PHARMACOLOGY,(2-((4-Fluoro-3-(trifluoromethyl)phenyl)amino)-4-(pyridin-4-yl)thiazol-5-yl)methanol,3966,JNJ1930942,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3966,468,nicotinic acetylcholine receptor α7 subunit,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=468,P36544,Neuronal acetylcholine receptor subunit alpha-7,,,9606.0,Homo sapiens (human),Positive,,5.1,PMID:21084390,https://www.ncbi.nlm.nih.gov/pubmed/21084390,21084390,,
1493,2036776,44240744,IUPHAR/BPS Guide to PHARMACOLOGY,(2-((4-Fluoro-3-(trifluoromethyl)phenyl)amino)-4-(pyridin-4-yl)thiazol-5-yl)methanol,3966,JNJ1930942,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3966,468,nicotinic acetylcholine receptor α7 subunit,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=468,,,1139.0,CHRNA7,9606.0,Homo sapiens (human),Positive,,5.1,PMID:21084390,https://www.ncbi.nlm.nih.gov/pubmed/21084390,21084390,,
1494,2029714,44246261,Therapeutic Target Database (TTD),4-((4-(Methylamino)phenyl)diazenyl)benzenesulfonamide,D00RDE,4-(4'-N-Methylphenyl)diazenylbenzenesulfonamide,https://idrblab.net/ttd/data/drug/details/D00RDE,T64567,Carbonic anhydrase IX (CA-IX),https://idrblab.net/ttd/data/target/details/T64567,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1495,2029715,44246267,Therapeutic Target Database (TTD),3-(4'-Aminophenyl)diazenylbenzenesulfonamide,D0H4CF,3-((4-aminophenyl)diazenyl)benzenesulfonamide,https://idrblab.net/ttd/data/drug/details/D0H4CF,T64567,Carbonic anhydrase IX (CA-IX),https://idrblab.net/ttd/data/target/details/T64567,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1496,2029716,44246267,Therapeutic Target Database (TTD),3-(4'-Aminophenyl)diazenylbenzenesulfonamide,D0H4CF,3-((4-aminophenyl)diazenyl)benzenesulfonamide,https://idrblab.net/ttd/data/drug/details/D0H4CF,T16987,Carbonic anhydrase XII (CA-XII),https://idrblab.net/ttd/data/target/details/T16987,O43570,Carbonic anhydrase 12,771.0,CA12,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1497,2029717,44246267,Therapeutic Target Database (TTD),3-(4'-Aminophenyl)diazenylbenzenesulfonamide,D0H4CF,3-((4-aminophenyl)diazenyl)benzenesulfonamide,https://idrblab.net/ttd/data/drug/details/D0H4CF,T20401,Carbonic anhydrase II (CA-II),https://idrblab.net/ttd/data/target/details/T20401,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1498,2029718,44250208,Therapeutic Target Database (TTD),(R)-{3-[(4-Chlorophenyl)-(2-chloropyridin-3-yl)methoxy]azetidin-1-yl}piperidin-1-ylmethanone,D0ZM1T,VER-156085,https://idrblab.net/ttd/data/drug/details/D0ZM1T,T37693,Cannabinoid receptor 2 (CB2),https://idrblab.net/ttd/data/target/details/T37693,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1499,2029719,44250208,Therapeutic Target Database (TTD),(R)-{3-[(4-Chlorophenyl)-(2-chloropyridin-3-yl)methoxy]azetidin-1-yl}piperidin-1-ylmethanone,D0ZM1T,VER-156085,https://idrblab.net/ttd/data/drug/details/D0ZM1T,T76685,Cannabinoid receptor 1 (CB1),https://idrblab.net/ttd/data/target/details/T76685,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1500,2029720,44250365,Therapeutic Target Database (TTD),N-(6-phenoxypyridin-3-yl)-1H-indole-3-carboxamide,D07DQO,N-(6-phenoxypyridin-3-yl)-1H-indole-3-carboxamide,https://idrblab.net/ttd/data/drug/details/D07DQO,T83813,5-HT 2C receptor (HTR2C),https://idrblab.net/ttd/data/target/details/T83813,P28335,5-hydroxytryptamine receptor 2C,3358.0,HTR2C,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1501,2029721,44255320,Therapeutic Target Database (TTD),Grassystatin A,D0Y5IQ,Grassystatin a,https://idrblab.net/ttd/data/drug/details/D0Y5IQ,T30727,Caspase-11 (CASP11),https://idrblab.net/ttd/data/target/details/T30727,P49662,Caspase-4,837.0,CASP4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1502,2029722,44255320,Therapeutic Target Database (TTD),Grassystatin A,D0Y5IQ,Grassystatin a,https://idrblab.net/ttd/data/drug/details/D0Y5IQ,T27602,Cationic trypsinogen (PRSS1),https://idrblab.net/ttd/data/target/details/T27602,P07477,Trypsin-1,5644.0,PRSS1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1503,2029723,44255320,Therapeutic Target Database (TTD),Grassystatin A,D0Y5IQ,Grassystatin a,https://idrblab.net/ttd/data/drug/details/D0Y5IQ,T67102,Cathepsin D (CTSD),https://idrblab.net/ttd/data/target/details/T67102,P07339,Cathepsin D,1509.0,CTSD,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1504,2029724,44255320,Therapeutic Target Database (TTD),Grassystatin A,D0Y5IQ,Grassystatin a,https://idrblab.net/ttd/data/drug/details/D0Y5IQ,T22839,Pancreatic elastase 1 (CELA1),https://idrblab.net/ttd/data/target/details/T22839,Q9UNI1,Chymotrypsin-like elastase family member 1,1990.0,CELA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1505,2036963,44814409,Chemical Probes Portal,"N-{4-[(1r,3s,5s)-3-Amino-5-Methylcyclohexyl]pyridin-3-Yl}-6-(2,6-Difluorophenyl)-5-Fluoropyridine-2-Carboxamide",PIM-447,PIM-447,https://www.chemicalprobes.org/pim-447,,PIM2,,Q9P1W9,Serine/threonine-protein kinase pim-2,11040.0,PIM2,9606.0,Homo sapiens (human),Inhibitor,,"0.006 nM, 0.018 nM, 0.009 nM",,,,,"www.doi.org/10.1021/acs.jmedchem.5b01275, https://pubmed.ncbi.nlm.nih.gov/26505898/"
1506,2036964,44814409,Chemical Probes Portal,"N-{4-[(1r,3s,5s)-3-Amino-5-Methylcyclohexyl]pyridin-3-Yl}-6-(2,6-Difluorophenyl)-5-Fluoropyridine-2-Carboxamide",PIM-447,PIM-447,https://www.chemicalprobes.org/pim-447,,PIM3,,Q86V86,Serine/threonine-protein kinase pim-3,415116.0,PIM3,9606.0,Homo sapiens (human),Inhibitor,,"0.006 nM, 0.018 nM, 0.009 nM",,,,,"www.doi.org/10.1021/acs.jmedchem.5b01275, https://pubmed.ncbi.nlm.nih.gov/26505898/"
